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There are many benefits associated with participation in cardiac rehabilitation exercise 
programmes  following  MI,  CABG  and  PTCA.  Sustaining  these  benefits  requires 
maintenance  of  physical  activity  in  the  long-term.  Evidence  suggests  that 
improvements  in  physical  activity  decline  following  completion  of  formal  exercise 
programmes.  The  research  is  limited  on  interventions  to  improve  maintenance  of 
physical  activity  after  completion  of exercise-based  cardiac  rehabilitation.  Exercise 
consultation is based on established behaviour change theories and uses strategies to 
promote and  maintain  physical  activity.  A pilot study found that exercise consultation 
improved short-term maintenance of physical activity following  completion of a phase 
III exercise programme. However, the long-term effect of the exercise consultation has 
not been studied. 
Aims: The primary aim of this randomised-controlled trial was to evaluate the effect of 
an  exercise  consultation  (experimental  condition)  compared  with  standard  exercise 
information (contr91  condition)  on  maintenance of physical activity six  and  12  months 
following  completion  of a  phase  III  hospital-based  exercise  programme.  Secondary 
aims included assessing the effect of an exercise consultation compared with exercise 
information  on  physiological  and  psychological  variables  at  six  and  12  months. 
Methods:  Seventy  cardiac  patients  were  recruited  on  completion  of  a  phase  I  II 
exerc,ise  programme.  The experimental  group received  an  exercise consultation  and 
exercise information at baseline and six months, and a support phone call at three and 
nine  months.  The  control  group  received  exercise  information  at  baseline  and  six 
months,  and  a support phone call  at 3 and  9 months to  maintain equal  contact time 
between the  groups.  Measurements  recorded  at  baseline,  six  and  12  months  were; 
physical activity (Stanford Seven-Day Physical Activity Recall, CSA accelerometer and 
Stage of Exercise Behaviour Change); cardiorespiratory fitness,  processes of exercise 
behaviour change, lipid profile, anxiety and depression (HADS),  quality of life (SF-36), 
mortality and morbidity. 
Results:  At  baseline,  total  activity  measured  by  the  7  -Day  Recall  was  300 
minutes/week in  the experimental  group and  275  minutes/week in  the  control  group, 
thus  both  groups were  meeting  guidelines for regular  physical  activity.  Total  activity 
assessed by the 7  -Day Recall was  maintaine~ in the experimental group compared to 
the control group from baseline to  12 months (98%CI -295, -20). Total activity did not 
significantly change from baseline to six (98%CI -43,  191) and  12 months (98%CI -63, 
1 154) in  the  experimental group.  Similarly,  total  activity counts/week measured  by  the 
CSA  accelerometer  remained  unchanged  from  baseline  to  six  (98%CI  -705643, 
860599) and  12  months (98
% CI  -381927,  504719)  in  the  experimental group.  In  the 
control  group,  total  activity measured  by  the 7  -Day  Recall  significantly decreased  by 
115  minutes/week  from  baseline  to  12  months  (98%CI  -228,  -28)  and  63 
minutes/week  from  six  to  12  months  (98%CI  -126,  -5).  Additionally,  CSA 
accelerometer  counts/week  decreased  from  baseline  by  5.2%  (98%CI  -680366, 
349212) at six months and 8%  (98%CI -906564,  268168) at  12 months, although this 
decline was not significant. A comparable, significant decrease in peak oxygen uptake 
(V02)  was recorded from baseline to 12 months by 6.7% (1.8 ml/kg/min; 98%CI -3.2, -
0.3) in the experimental group and 9.4% (2.3 ml/kg/min; -3.8, -0.8) in the control group. 
Conversely,  exercise duration (seconds) did  not significantly change from  baseline to 
six and 12 months in the either group. There was a significant improvement in the V02 
at the lactate threshold  (V02  L  T)  in  the  experimental  group compared to  the  control 
group from  baseline  to  6  months  (98%CI  -185.4,  -12.6)  and  12  months  (98%CI  -
216.7, -34.6).  In  t~e control group, there was a trend for a decrease in V02  LT by 52 
ml/min (98%CI -116,  12) from baseline to six months. In the experimental group, there 
was a trend for an increase in V02 L  T by 47ml/min from baseline to six months (98%CI 
-14,  109) and a significant increase by  81  mllmin from  baseline to  12 months (98%CI 
22,  140).  The  frequency  of using  nine  out  of  10  processes  of exercise  behaviour 
change did not Significantly change from baseline to six and 12 months in either group. 
From  baseline to  12  months, there was a significant decrease in  the  use of dramatic 
relief  in  the  control  group  (98%CI  -2.5,  -0.5)  and  environmental  re-evaluation  in  the 
experimental group (98%CI -3,  -0.5). Weight and BMI did not significantly change over 
the study period in either group. Median lipid values at baseline were within the normal 
range in  both groups.  No significant changes in total cholesterol, triglycerides and low 
density  lipoproteins  (LDL)  cholesterol  were  observed  from  baseline  to  follow-up  in 
either  group.  There  was  a  significant  increase  in  high  density  lipoproteins  (HDL) 
cholesterol  by  0.11  mmol/I  from  baseline  to  12  months  in  the  experimental  group 
(98
% CI  0.04,  0.18), with no significant change in the control group.  Median values for 
anxiety  and  depression  were  within  the  normal  range  at  baseline  and  did  not 
significantly change at six and 12 months in either group. Baseline scores for all quality 
of  life  subscales  were  high  in  both  groups  and  did  not  significantly  change  from 
baseline to follow-up in  either group.  However, there was a trend for an  improvement 
in social function, pain, role limitations due to physical problems, role limitations due to 
11 emotional  problems and  energy/vitality from  baseline to  follow-up  in  the  experimental 
group.  In  the  control  group,  there was  a trend  for a decline  in  role  limitations due to 
emotional  problems,  energy/vitality,  and  physical  function  from  baseline to  follow-up. 
Mortality was 5.7%  (2/35)  in the control group and 0%  in the experimental group over 
12 months. The revascularisation  rate (i.e.  CABG and  PTCA)  in the experimental and 
control group was 11.40/0 (4/35) and 00 /0,  respectively. 
Conclusions:  This  study  demonstrated  that  the  exercise  consultation  was  more 
effective than  exercise information  in  maintaining self-reported  physical  activity for  12 
months after completion  of a phase  III  exercise programme.  However,  the  change  in 
CSA  accelerometer  readings  over  the  12-month  study  period  did  not  parallel  the 
significant  decrease  in  self-reported  physical  activity  observed  in  the  control  group. 
The  exercise  consultation  was  not  effective  in  maintaining  exercise  capacity  for  12 
months after completion of phase III. Significant decreases in peak V02 from  baseline 
to 12 months were observed in both groups. In contrast, an improvement in the V02 at 
the  lactate  threshold,  which  is  an  index  of  submaximal  endurance  capacity,  was 
recorded  in  the  experimental  group  compared  to  the  control  group from  baseline  to 
follow-up.  Finally,  the exercise consultation  had  no  significant effect on  processes of 
exercise  behaviour change,  lipid  profile  and  psychological  function.  These  variables 
were  normal  at  baseline  and  were  maintained  over the study period  in  both  groups. 
The  results  of  this  study  demonstrate  that  the  exercise  consultation  may  be  an 
effective  intervention  for  maintaining  physical  activity  after  completion  of  phase  III 
hospital-based  exercise  programmes.  The  exercise  consultation  is  a  minimal 
intervention that could be delivered by physiotherapists to patients at the end of phase 
III  or  by  British  Association  of  Cardiac  Rehabilitation  (BACR)  trained  exercise 
instructors to patients in phase IV. 
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XlV CHAPTER ONE 
INTRODUCTION 
This  chapter  reviews  the  literature  that  is  relevant  to  this  thesis.  Section  one 
describes  the  definitions  and  phases  of  cardiac  rehabilitation,  the  benefits  of 
exercise-based  cardiac  rehabilitation  and  participation  in  exercise-based  cardiac 
rehabilitation.  Section  two  discusses  theoretical  models  that  have  been  used  to 
understand  physical  activity  behaviour change.  In  addition,  interventions  based  on 
theoretical  models  to  improve  maintenance  of  physical  activity  are  discussed. 
Sections three and four critically review methods for measuring physical activity and 
psychological  function,  respectively.  The  literature  review  was  conducted  using  1) 
internet databases (Le.  Medline, Web of Science and  Embase) using keywords and 
phrases  appropriate  to  the  topic  being  reviewed,  2)  Evidence  from  systematic 
reviews  and  meta-analyses  and  3)  A  search  of  the  scientific  literature  using 
references cited in relevant literature reviews and published papers. 
SECTION ONE 
EXERCISE-BASED CARDIAC REHABILITATION 
Definitions of Cardiac Rehabilitation 
Cardiac  rehabilitation  has  been  defined  as  comprehensive,  long-term  programmes 
encompassing  medical  evaluation,  cardiac  risk  factor  modification,  prescribed 
exercise,  education  and  counselling.  These  programmes  are  designed  to  limit  the 
physiologic  and  psychological  effects  of cardiac  illness,  reduce  the  risk  for  sudden 
death or reinfarction, control cardiac symptoms, stabilise or reverse the atherosclerotic 
process,  and  enhance  the  psychosocial  and  vocational  status  of selected  patients.
1 
Recent  national  guidelines  on  cardiac  rehabilitation  published  by  the  Scottish 
Intercollegiate  Guidelines  Network  (SIGN)2  described  cardiac  rehabilitation  as  "the 
process by which  patients with cardiac disease,  in  partnership with  a multidisciplinary 
team  of health professionals are  encouraged and  supported to  achieve  and  maintain 
optimal physical and psychosocial health." 
1 Four Phases of Cardiac Rehabilitation 
In  the  UK,  cardiac  rehabilitation  is  divided  into  four  phases.  UK  guidelines  have 
provided  recommendations  on  the  structure  and  content  of  cardiac  rehabilitation 
programmes.
3 
However,  few  cardiac  rehabilitation  programmes  actually  adhere  to 
these  guidelines.
4 
Thus,  cardiac  rehabilitation  programmes  vary  considerably  In 
content,  client  groups  offered  the  service,  length  of intervention,  the  type  of health 
professionals involved in the delivery and the setting for that delivery.5 
Phase I (in-patient) 
Phase I occurs during the inpatient stage or after a step change in the patient's cardiac 
condition. A step change is defined as  myocardial infarction (MI), the onset of angina, 
any emergency hospital admission for coronary heart disease (CHD),  cardiac surgery 
or angioplasty,  or the first diagnosis of heart failure.  The key  elements of this  phase 
are  medical  evaluation,  reassurance,  information/education,  correction  of  cardiac 
misconceptions,  risk factor assessment,  mobilisation  and  discharge planning.  Family 
and partners are usually involved from this stage. 
Phase II (early out-patient) 
Phase  II  is  the immediate post discharge period  and  can  vary  in  length from 4 to  6 
weeks,  depending  on  the  cardiac  condition  (e.g.  after  CABG  this  phase  can  be 
approximately six weeks,  whereas  post  MI  this  period  may  last four weeks).  In  this 
phase,  patients and family receive support from  hospital or community-based  health 
professionals  through  home  visits  or  telephone  contact.  Additional  education  and 
information  is  provided to  reinforce  risk  factor modification  and  behavioural  change. 
Further medical evaluation risk stratifies the individual for future management. 
Phase III (intermediate out-patient) 
Exercise training, education, psychological support and risk factor modification are the 
key  components  of phase  III  programmes.  A  recent  survey  of cardiac  rehabilitation 
services  in  Scotland  found  that  the  majority  of  phase  III  programmes  involved 
supervised  exercise training  once or twice per week in  a hospital setting.
s 
However, 
some  programmes  offered  exercise  training  in  community  or  home-based  settings. 
The duration of phase III  exercise programmes varied  from  five to  13 weeks,  with  a 
median  duration  of  11.5  weeks.  Most  of  the  programmes  had  an  educational 
2 component, which provided patients with information on the CHD process, risk factors, 
benefits of exercise,  drug therapy,  relaxation training  and  stress  management.  Some 
programmes also offered psychological and vocational counselling. 
Phase IV (long-term maintenance) 
Phase  IV involves the  long-term  maintenance  of physical  activity  and  other  lifestyle 
changes  in  the  community.  Cardiac  support  groups,  which  offer  group  exercise 
classes or phase IV maintenance exercise programmes delivered by exercise leaders 
trained  by  the  British  Association  of Cardiac  Rehabilitation  (BACR)  are  available  in 
some  areas.  Generally,  patients  do  not  receive  follow-up  from  cardiac  rehabilitation 
staff in  phase IV.  Instead, the majority of patients  receive  most or all  of their care  in 
primary  care.
2  The  patient's  clinical  status,  medication  and  risk  factors  should  be 
regularly  reviewed  by  his  or  her general  practitioner  and  other  primary  care  health 
professionals during phase IV. 
The  structure  of  cardiac  rehabilitation  in  North  America  is  different  from  UK 
programmes.  Phase  I is  the  in-patient stage,  which  is  similar to  the  UK.  In  America, 
patients  in  phase  II  attend  supervised  hospital-based  exercise  programmes  lasting 
approximately 12 weeks.  Phase  III  involves  hospital  or community-based  supervised 
exercise  programmes  lasting  three  to  six  months.  Phase  IV  is  the  long-term 
maintenance stage, similar to UK programmes. 
Exercise Prescription for Health and Fitness 
Exercise Prescription for Healthy Adults 
In 1990, the American College of Sports Medicine (ACSM) published guidelines on the 
quantity  and  quality  of exercise  needed  to  develop  and  maintain  cardiorespiratory 
fitness in the healthy adult.
6 These guidelines, summarised in Table 1, recommend 20 
minutes or more of continuous,  moderate to vigorous intensity aerobic exercise (60% 
to  90%  of maximum  heart rate  or 50%  to  85%  of maximum  aerobic capacity)  on  3 
days  a  week  to  improve  cardiorespiratory  fitness.  To  maintain  the  training  effect, 
exercise  must  be  continued  on  a  regular  basis,  as  a  significant  reduction  in 
cardiorespiratory  fitness  occurs  after  2  weeks  of  stopping  training.  Although  the 
minimal  level  of  exercise  necessary  to  maintain  fitness  is  not  known,  evidence 
3 suggests that missing  an  exercise session periodically or reducing the frequency and 
duration of training will not adversely effect cardiorespiratory fitness as long as training 
intensity is maintained. 
7 
More  recent  evidence  demonstrates  that  lower  levels  of  physical  activity,  than  the 
amount  required  to  improve  fitness,  can  produce  substantial  health  benefits. 
Therefore,  the quantity and  quality of activity needed to  attain  health-related benefits 
differ from what is  recommended for fitness benefits.
6  In  1995, the American College 
of Sports  Medicine  (ACSM)  and  Centers for Disease  Control  and  Prevention  (CDC) 
published guidelines on the quality and quantity of physical activity required to improve 
health  and  prevent disease.
8  These guidelines,  summarised  in  Table  1,  recommend 
accumulating at least 30 minutes of moderate intensity physical activity on  most days 
of the week.  Thirty minutes of moderate activity each day can  be  achieved by adding 
some moderate physical  activity into the  daily routine.  For example,  taking the stairs 
instead  of the  lift,  and  brisk walking  instead  of driving  short distances.  Furthermore, 
many daily activities such  as  gardening,  household  chores  and  washing  the car can 
contribute to the 3D-minute per day total if performed at a moderate intensity (i.e. effort 
equal to a brisk walk). 
The  1995  recommendation  is  intended  to  complement  the  1990  exercise  guideline. 
For  example,  sedentary  individuals  or  those  who  are  not  regularly  active  will  gain 
substantial health benefits by increasing their physical activity to achieve 30 minutes of 
moderate activity on  most days.  In  addition,  it is  much  easier for these individuals to 
incorporate  small  amounts  of  moderate  activity  into  their  daily  routine  rather  than 
engaging  in  structured,  planned  programmes  of exercise.  However,  individuals who 
are moderately active will  gain additional  health  and fitness benefits by  achieving the 
1990 exercise recommendations.
6 Table 1 Physical Activity Recommendations for Healthy Adults 
1990  ACSM  exercise  recommendation  to  improve  and  maintain 
cardiorespiratory fitness: 
•  A  minimum  of  3  x  20  minutes  of  continuous,  moderate  to  vigorous 
intensity aerobic exercise per week. 
1995 ACSM  and  CDC  physical  activity  recommendation  to  promote  health 
and prevent disease: 
•  Accumulate at least 30  minutes of moderate intensity physical activity on 
five or more days per week. 
The  1995  recommendation  is  distinct  from  the  1990  guideline  as  it  emphasises 
moderate intensity activity, the 30 minute a day total can  be achieved by accumulating 
short bouts  of activity,  and  this amount of physical  activity  produces  health  benefits, 
but may not nece~sarily improve fitness.
8 
Exercise Prescription for Cardiac Rehabilitation Participants 
The  primary goals  of exercise training  in  cardiac  rehabilitation  are  to  counteract the 
deleterious  effects  of bed rest,  avoid  the  deconditioning  effects  of physical  inactivity 
imposed  by  CHD,  increase  aerobic  capacity  and  modify  risk  factors.
3 
In  1995,  the 
British  Association  of  Cardiac  Rehabilitation  (BACR)  produced  guidelines  on  the 
amount of exercise required to achieve these benefits.
3 Patients in phase I (in-patient) 
are  advised  to  engage  in  self-care  activities,  general  range  of motion  exercise  and 
walk short  distances  to  counteract the  deleterious  effects  of prolonged  bed  rest.  In 
phase  II,  patients undertake daily living  activities and gradually increase the duration, 
frequency  and  intensity of walking to  increase functional  and  endurance  capacity.  In 
phase III, 20 to 30 minutes of moderate to vigorous intensity (70% to 85% of maximum 
heart  rate)  exercise  on  three  days  a  week  is  recommended  to  improve  aerobic 
capacity  and  modify  risk  factors.  Results  from  a  systematic  review  found  that 
exercising  at this level for three months increased exercise tolerance by  30% to 50% 
and peak V0
2 by 10 to 20%.1  However, recent SIGN guidelines
2 
state that participation 
in  low to  moderate  intensity exercise  (50%  to  75%  of  maximal  HR)  is  sufficient for 
most cardiac patients.  Most phase  III  programmes offer supervised exercise once or 
twice a week, thus SIGN guidelines recommend that patients should be encouraged to 
5 participate in  moderate activity on days that formal exercise training is not taking place 
to achieve the exercise prescription.
2
;3 
The  exercise  prescription  for phase  IV  participants  is  not  as  clearly  defined  as  the 
recommendations for patients in  phases I to  III.  BACR  guidelines recommended that 
patients in  phase IV should engage in 20 minutes or more of continuous,  moderate to 
vigorous intensity aerobic exercise on  three days  per week to  improve  and  maintain 
fitness.
3
;6  This  exercise  prescription  is  similar  to  the  1990  ACSM  exercise 
recommendations to increase fitness in  healthy adults.
3 Recent SIGN guidelines
2 state 
that phase IV participants should  continue regular moderate intensity exercise in  the 
long-term to sustain benefits, however the frequency and duration of this exercise was 
not  described.  American  cardiac  rehabilitation  guidelines
9  have  endorsed  the  1995 
ACSM/CDC physical  activity recommendation of accumulating  at  least 30  minutes of 
moderate  intensity  physical  activity  on  five  days  per  week  to  promote  health.
8  This 
level of physical activity may be easier for cardiac patients to incorporate into their daily 
routine  and  sustain  in  the  long-term.  Table  2  summarises  the  physical  activity 
recommendations for cardiac patients in phases III and IV. 
6 Table  2  Physical  Activity  Recommendations  in  Phase  III  and  IV  Cardiac 
Rehabilitation 
Phase III Cardiac Rehabilitation 
•  ~o to  30  minutes  (excluding  warm-up  and  cool  down)  of low  to  moderate 
Intensity aerobic exercise (e.g. walking, cycling,  circuit training) on three days 
a week. 
And 
•  Moderate  intensity  physical  activity  (e.g.  walking)  on  days  when  not 
participating in formal exercise training. 
Phase IV Cardiac Rehabilitation 
•  A  minimum  of 20  minutes (excluding warm-up and  cool  down)  of moderate 
intensity exercise on three days per week. 
And/Or 
•  Accumulate 30  minutes or more of moderate intensity physical  activity on  at 
least five days per week. 
The Need for Cardiac Rehabilitation 
Compared with  the  rest  of the  UK,  Scotland  has  a disproportionately high  incidence 
and  prevalence  of  coronary  heart  disease  (CHO). S  Every  year  in  Scotland, 
approximately  8,000  people  survive  a  myocardial  infarction,  6,000  people  undergo 
coronary artery bypass surgery or angioplasty, and  13,000 people require emergency 
admission to hospital with chest pain (excluding MI). All of these patients would benefit 
from  participation  in  cardiac  rehabilitation  services.  In  addition,  cardiac  rehabilitation 
would  also  be  beneficial for an  estimated 33,000 angina  patients,  6,000 heart failure 
patients  and  500  additional  patients  having  other  forms  of  cardiac  surgery  (e.g. 
transplantation).  In  total,  approximately  66,500  patients  annually  may  be  eligible for 
cardiac rehabilitation in Scotland.s 
Provision of Cardiac Rehabilitation 
Despite the  need for cardiac rehabilitation services, the provision of programmes in 
the UK is inadequate.
10
-
12 A recent survey estimated that only 17% to 25% of eligible 
patients attend cardiac rehabilitation annually in  Scotland.
11  Another Scottish survey 
found  that the  proportion  of patients  discharged  from  hospital with  a diagnosis  of 
7 CHD  who  attended  cardiac  rehabilitation  varied  between  2%  to  46%  in  different 
health  board  areas.
10 
A  assessment  of cardiac  rehabilitation  services  in  the  UK  , 
reported that approximately 14% to  23% of infarct patients,  33%)  to  56% of CABG 
patients and 6 to  10% of PTCA patients  are enrolled  in  programmes. 12  Generally, 
cardiac  rehabilitation  is  offered  to  patients  following  MI  or  CABG,  whereas  the 
provision  is  limited  for  women,  elderly  patients,  and  those  with  angina  or  heart 
failure.
10
-
14 
Studies on  the provision of cardiac rehabilitation  in  North America  have 
found similar results. 15;16  Thus,  it seems that many patients that would  benefit from 
cardiac rehabilitation are not being offered these services. 
Uptake to Cardiac Rehabilitation 
Even when patients are offered cardiac rehabilitation,  uptake rates to  programmes 
are  variable  and  can  be  low.  The  percentage  of  patients  attending  cardiac 
rehabilitation  programmes,  following  invitation,  ranges  from  13%  to  74%14;17-20.  In 
1996, Pell18 found that 59% of MI  patients, who were invited, participated in phase III 
rehabilitation programmes based in four Glasgow hospitals. 
Factors associated with uptake to cardiac rehabilitation 
Numerous studies have identified factors influencing uptake to supervised phase II 
and "' cardiac rehabilitation exercise programmes, whereas the research is  limited 
on variables associated with maintenance of physical activity in phase IV. 
Research  has found  that  participation  in  formal  cardiac rehabilitation  programmes 
following  a  MI  was significantly higher for men  (49%)  compared to  women  (34%), 
and  younger patients  of both  sexes were more likely to  attend  compared to  older 
patients.21  Other  studies  have  shown  comparable  results  for  age  14;22;23  and 
gender,17;23 whereas Pell24  found that these factors did not influence participation in 
cardiac  rehabilitation.  The  strength  of the  physician's  recommendation  to  attend 
rehabilitation  is  an  important  determinant  of  participation,23;25  and  this 
recommendation  was  stronger  for  men  compared  to  women.23  Other  reasons 
associated  with  non-participation  in  cardiac  rehabilitation  include;  conflicting  work 
and  family  commitments,26  medical  problems,25  inconvenient  timing  of 
programmes,25;27 transport problems,10;25 social deprivation,14;24 being under the care 
of a GP compared to a cardiologist,18 inactive leisure habits,17 and being moderately 
functionally  impaired.17  Utilisation  of rehabilitation  is  lower  for  single  or widowed 
8 patients  compared  to  those  who  are  married  and  uptake  rates  are  higher  for 
employed patients or those who  are  better educated.
17  Patients with  a strong  belief 
that  their  cardiac  disease  is  controllable  and  those  who  attributed  their  heart 
condition to their lifestyle are  more likely to  attend rehabilitation. 22  Finally,  uptake is 
not predicted by a patient's intention to attend cardiac rehabilitation.22 
Menu-Based Cardiac Rehabilitation 
Generally,  cardiac rehabilitation programmes provide a fixed  package of rehabilitation 
due to resource limitations, which may not to  meet the needs of many patients.
5 This 
may  explain  the  low  referral,  uptake  and  adherence  rates  to  cardiac  rehabilitation 
programmes  among  certain  patient  groups.  National  guidelines  recommend  that 
rehabilitation  should  be  menu-based,  which  means  tailoring  rehabilitation  services to 
suit  the  patient's  needs  and  their  readiness  to  make  lifestyle  changes.2 A  flexible 
menu-based approach may improve participation in  cardiac rehabilitation  and  prevent 
certain  patient  groups  such  as  the  elderly  and  heart  failure  patients  from  being 
excluded.  However,  few  cardiac  rehabilitation  programmes  in  the  UK  are  currently 
providing menu-based services.2 
Benefits of Exercise-Based Cardiac Rehabilitation 
This  section  reviews  the  benefits  of  exercise-based  cardiac  rehabilitation  on 
mortality,  morbidity,  exercise  capacity,  physical  activity,  psychological  functioning 
and coronary risk factors. 
Terminology 
In  this  literature  review,  cardiac  rehabilitation  programmes  that  include  exercise 
training,  education  and  risk factor modification are  termed  "comprehensive cardiac 
rehabilitation  programmes."  Early  clinical  trials  of  cardiac  rehabilitation  included 
exercise training as the sole intervention, thus these programmes are referred to  as 
"exercise  only  rehabilitation."  The  term  "exercise-based  cardiac  rehabilitation" 
includes  both  comprehensive  and  exercise  only  rehabilitation  programmes.  In 
addition,  most  the  trials  investigating  the  efficacy  of  exercise-based  cardiac 
rehabilitation  have  included  phase  II  and  III  cardiac  rehabilitation  programmes, 
whereas  few  studies  have  evaluated  the  effect  of  interventions  in  phase  IV. 
9 Therefore,  evidence  for  the  benefits  of exercise-based  cardiac  rehabilitation  are 
primarily based on phase II  and III programmes. 
Mortality and Morbidity 
A number of randomised-controlled trials have reported a reduction  in  mortality with 
exercise-based cardiac rehabilitation  compared  to  usual  care following  myocardial 
infarction, although only a few trials have reported a statistically significant reduction. 
In the majority of these studies, the sample size was too small to detect a significant 
difference between the  intervention  and  control  group.28  Combining  the data from 
these  trials  in  a  meta-analysis  increases  the  power  of  the  statistical  analysis,29 
thereby  providing  a  more  accurate  estimate  in  the  size  of the  effect of exercise-
based cardiac rehabilitation on mortality and morbidity. 
Oldridge
30 
conducted  a  meta-analysis  investigating  the  effect  of  comprehensive 
cardiac  rehabilitation  following  myocardial  infarction  on  total  and  cardiovascular 
mortality  and  re.currence  of  non-fatal  MI.  Ten  randomized-controlled  trials  of 
comprehensive rehabilitation,  which  included  risk  factor management and exercise 
training  after myocardial  infarction  with  at  least a two  year follow-up  period  were 
included in the analysis. In the majority of trials, the intervention was initiated 6 to 12 
weeks  after myocardial  infarction.  Results  revealed  a  significant  reduction  in  total 
mortality  by  24%  and  cardiovascular  mortality  by  25%  with  cardiac  rehabilitation 
compared to usual care. The duration of the rehabilitation programmes varied from 6 
weeks to  48 months;  subgroup  analysis  revealed  that  longer interventions  had  a 
greater benefit on  total  mortality than  short-term  programmes.  In  contrast,  cardiac 
rehabilitation  had  no  significant  effect  on  the  recurrence  of non-fatal  myocardial 
infarction.  Similarly,  another meta-analysis
31  of 22  randomised  controlled  trials  of 
exercise-based cardiac rehabilitation after MI  reported a significant decrease in total 
mortality  by  20%  and  cardiovascular  mortality  by  22%  after an  average  of  three 
years follow-up. Furthermore, cardiac rehabilitation had a significant beneficial effect 
on the recurrence of fatal MI  throughout the three-year follow-up period.  In  contrast, 
the rates of non-fatal MI  were comparable between the two groups throughout the 3 
years.  The  time  from  myocardial  infarction  to  randomisation  ranged  from  1  to  3 
months  in  the  majority  of studies.  A  recent  meta-analysis  conducted  by  Jolliffe
28 
included more studies (41)  and  a  greater number of patients  (n  = 7683) who  had 
suffered an  MI, angina, or undergone CABG or PTCA compared to the earlier meta-
10 analyses.
30
;31  In addition, Jolliffe excluded a number of trials that were included in the 
previous  reviews  because  they  lacked  a true  control  group  or  a clear  method  of 
randomisation. This study found that exercise only rehabilitation significantly reduced 
total  mortality by 27%,  cardiac mortality by  31 % and  fatal  MI  by  35%  compared  to 
usual  care.
28 
Comprehensive  cardiac  rehabilitation  produced  a  non-significant 
reduction in total mortality by 13% and Significantly lowered cardiac mortality by 26% 
and  fatal  MI  by  28%.  Conversely,  both  exercise  only  and  comprehensive 
rehabilitation  had  no  significant effect on  rates  of non-fatal  MI,  or revascularisation 
(Le.  CABG or PTCA) compared with  usual care,  although few trials reported CABG 
or PTCA as an outcome. 
Although the three meta-analyses varied considerably in the trials they included and 
excluded,  they  consistently  found  that  exercise-based  cardiac  rehabilitation 
improved survivaI.
28
;30;31  In addition, all three meta-analyses determined the separate 
effect of exercise only and comprehensive cardiac rehabilitation on survival. Jolliffe
28 
reported  greater. mortality  benefits  for  exercise  only  rehabilitation  compared  to 
comprehensive rehabilitation.  However,  the  difference in  mortality between exercise 
only  rehabilitation  and  comprehensive  rehabilitation  exercise  were  not  significant. 
Oldridge
30  found  that  both  types  of  intervention  were  comparable,  whereas 
O'Conner
31  stated  that  comprehensive  rehabilitation  was  more  effective  than 
exercise  only  rehabilitation.  These  inconsistent  findings,  the  small  number  of 
exercise  only  trials  and  the  possibility  that  advice  on  risk  factors  was  included  in 
exercise only interventions does not allow definite conclusions to  be  reached  about 
the  independent  effect  of  the  exercise  component  of  cardiac  rehabilitation  on 
mortality.  There  are  several  mechanisms  by  which  exercise-based  cardiac 
rehabilitation  may  improve  survival  of  cardiac  patients.  They  include  improved 
coronary blood flow, decreased ventricular arrhythmias, improved cardiovascular risk 
factor profile,  reduced  psychological  distress
32  improved  cardiovascular fitness,  or 
increased patient surveillance.
3o 
There  are  concerns  regarding  the  results  of  these  meta-analyses.  Firstly,  most 
studies  involved  predominantly  middle-aged  males  following  myocardial  infarction, 
thereby  limiting  the  generalisability  of the  results  to  women,  elderly  patients  and 
other cardiac  groups.  Secondly,  thrombolysis  and  medication  was  not reported  in 
many  trials,  which  would  have  affected  clinical  outcomes  if  more  intervention 
11 patients  received  these  treatments  compared  to  control  patients.  Finally,  it  is 
impossible  to  identify  the  optimal  duration  and  content  of  cardiac  rehabilitation 
programmes  to  improve  survival  due  to  the  different  interventions  used  in  the 
studies.  The  exercise  component  of  the  programmes  varied  from  supervised 
exercise  training  to  home-based  walking  programmes,  which  differed  in  the 
frequency,  duration  and  intensity  of  exercise.  In  addition,  many  programmes 
included  stress  management,  diet,  smoking  cessation  and  psychological 
interventions. The duration  of rehabilitation  ranged  from  6 weeks to  greater than  1 
year. The time from the cardiac event to initiation of the intervention, length of follow-
up and type of participant were not consistent across trials,  which creates problems 
in  the interpretation of the results.  A review of exercise-based cardiac rehabilitation 
stated  that  evaluating  the  cardiac  rehabilitation  literature  is  difficult  due  to  the 
variability of the interventions and populations studied.
33 
Exercise Capacity 
Exercise capacity may  be  reduced  following  a myocardial  infarction  due  to  infarct-
related  damage  to  the  myocardium  and  the  deconditioning  effects  of  physical 
inactivity  during  hospitalisation.
34  Conversely,  a  spontaneous  improvement  in 
exercise  capacity  occurs  in  the  first  3  months  after  myocardial  infarction  without 
exercise  training.35-
41  In  addition,  increases  in  exercise  capacity  after treatment  of 
CHD  with  CABG  and  PTCA  have  been  observed  in  the  absence  of  exercise 
training.34 However, further improvements in exercise capacity with training following 
MI, CABG and PTCA have been documented, as discussed in the next section. 
The  effect  of exercise-based  cardiac  rehabilitation  on  exercise  capacity  has  been 
widely  studied.  A  systematic  review
1  published  in  1995  found  that  the  majority  of 
randomised  and  non-randomised  controlled  trials  reported  statistically  significant 
improvements  in  exercise  capacity  with  exercise-only  or  comprehensive  cardiac 
rehabilitation  compared  to  usual  care  in  patients with  CHD.  The review reported  that 
exercise tolerance on  the treadmill increased by  30  to  50%  and  peak oxygen  uptake 
increased by  10 to  20%  after three months of moderate to vigorous intensity exercise 
three times a week for 20 to 40 minutes. The current exercise prescription for phase III 
participants is  based  on  these findings.  However,  most of the  studies included  in  the 
systematic  review  involved  predominantly  middle-aged  male  patients  of  low  to 
moderate risk following a MI. Thus, the benefit of exercise-based cardiac rehabilitation 
12 to increase exercise capacity  is  well  established  in  this  patient  population.  Although, 
several trials have reported significant, comparable improvements in exercise capacity 
after exercise-based  cardiac  rehabilitation  in  men  and  women,3S;42-44  and  in  patients 
older and younger than 70 years of age.4S;46  This systematic review was published  in 
1995,  thus  more  recent  randomised-controlled  trials  evaluating  the  effect of cardiac 
rehabilitation  exercise  training  on  exercise  capacity  are  described  in  Table  3.  In 
addition,  the  review  did  not  report  the  long-term  effect  of cardiac  rehabilitation  on 
exercise capacity, thus Table 3 also includes randomised-controlled trials reporting the 
long-term effect of cardiac rehabilitation on exercise capacity. 
As illustrated in Table 3,  eighteen of these controlled trials reported an  improvement 
in  exercise  capacity  with  exercise-based  cardiac  rehabilitation  compared  to  usual 
care. 3S-37;47-S0;S4-63;67  In  contrast,  three  randomised-controlled trialss1 ;s2;79  reported  no 
significant  difference  in  exercise  capacity  between  the  intervention  and  control 
groups. Although the evidence suggests that participation in exercise-based cardiac 
rehabilitation  imp~oves exercise  capacity,  it  is  important to  determine whether this 
increase in exercise capacity is maintained following programme completion. 
Nine studies have investigated the effect of exercise-based cardiac rehabilitation on 
exercise  capacity  in  the  long-term  after  programme  completion  (see  Table 
3).37;SO;S1;S3;SS;S6;63;67;79  Liddell randomised 116 patients 5 weeks after MI to a phase "" 
comprehensive  rehabilitation  programme  or  usual  care. S6  In  phase  I  (in-patient) 
patients received education and support, in phase" (out-patient) they participated in 
5  months  of supervised  and  home-based  exercise  training,  group  education  on 
lifestyle  modification,  and  received  support  phone  calls.  Patients  in  usual  care 
received  information  on  risk factors  and  leisure  activities,  and  attended  outpatient 
clinics  one,  three and  12  months after MI.  Results  revealed  that exercise capacity 
was significantly higher in the intervention group compared to the control group at 6 
months  (end  of programme)  and  at  five  years  follow-up.  However,  the  change  in 
exercise  capacity  from  baseline  to  follow-up  was  not  documented  in  this  study. 
Similarly,  Lisspers  and  Hofman-Bang  reported  that  the  improvement  in  exercise 
capacity with 12  months of comprehensive cardiac rehabilitation compared to  usual 
care was maintained for a further 12 months following programme completion.
63 
13 In  contrast,  seven  studies  have found  that  improvements in  exercise capacity with 
cardiac  rehabilitation  exercise  training  are  not  sustained  in  the  long-term  after 
I  t·  37'50'51'53'55'67'79  55  programme  comp e Ion.  '  ,  ,  ,  "  Carson  compared  the  effect  of  a  12  week 
exercise programme with usual care on  exercise capacity in  303 male patients who 
had  suffered a  MI  in  the  previous 6 weeks.  The improvement in  exercise  capacity 
was significantly greater in the intervention group compared to the control group at 5 
months (end of the programme), and  at 1 and 2 years follow-up.  However, exercise 
capacity  was  similar  in  the  intervention  and  control  groups  at  3-years,  due  to  a 
gradual  decline in  exercise  capacity  in  the  intervention  group  during  the  follow-up 
period.  Similarly, Oldridge found that the increase in exercise capacity after 8 weeks 
of comprehensive rehabilitation had declined at  12  months,  reaching  a similar level 
to the control group.37 Stahle compared three months of supervised exercise training 
with standard care on exercise performance and self-reported physical activity in  101 
elderly patients (>65 years) discharged after a MI  or unstable angina. Three months 
of exercise training significantly improved self-reported physical activity and exercise 
tolerance  compa~ed with  standard  care.67  However,  there  were  no  differences  in 
physical  activity  and  exercise  tolerance  between  the  groups  at  12  months.67  The 
authors suggested that continued exercise training is required to prevent a decline in 
initial improvements in physical activity and exercise capacity. 
Overall, the literature suggests that improvements in exercise capacity with exercise-
based cardiac rehabilitation  may not persist in  the  long-term,  suggesting that many 
patients  do  not  continue  to  exercise  after  they  have  completed  a  cardiac 
rehabilitation  programme.  However,  only  one  of  these  trials  assessed  patients' 
physical activity levels during the follow-up period.67  Cardiac rehabilitation guidelines 
recommend  continuation  of  exercise  following  completion  of  formal  exercise 
programmes to sustain the initial improvements in exercise capacity.1 
Mechanisms for Increased Exercise Capacity after Exercise Training 
The significance of an increase in exercise capacity is that CHD patients will be able 
to  accomplish  all  submaximal  activity  at  reduced  physiological  stress.  Ades  found 
that  increases  in  self-reported  physical  functioning  after  3  months  of  cardiac 
rehabilitation  exercise  training  was  significantly  associated  with  improvements  in 
exercise capacity.69  The mechanism for the improvement in  exercise capacity after 
training  in  individuals with  CHD  is  primarily due to  peripheral  (skeletal  muscle and 
14 vascular)  adaptations  rather  than  central  (cardiac)  adaptations.70- 73.  Peripheral 
adaptations  include  increases  in  arteriovenous  oxygen  difference,74  blood  flow74;75 
and  aerobic  metabolism76  in  active  skeletal  muscle  at  maximal  exercise. 
Furthermore, increases in  fibre area,  capillary density and  oxidative enzyme activity 
have been observed in  skeletal  muscles after training.74  These peripheral  changes 
reflect  an  improvement  in  the  supply  of  oxygen  to  active  skeletal  muscles,  and 
enhanced  oxygen  extraction  and  utilisation  by  the  exercising  muscles.  Some 
researchers  have  reported  enhanced  cardiac  performance  with  exercise  training, 
including increases in ejection fraction,61  cardiac output,?? stroke volume and oxygen 
pulse61  at  maximal  exercise,  which  indicates  an  increased  capacity  of  the 
cardiovascular system to transport oxygen to skeletal and cardiac muscle. Whereas, 
other studies found no  changes in  cardiac function with exercise training.74;75  These 
inconsistent findings could reflect differences in the methods used to assess cardiac 
function  and  to  variations  in  the  duration  and  intensity  of exercise  training.  It  has 
been suggested that intense exercise training for one year or more may be  required 
to  increase  cardiac  function  of  individuals  with  CHD. 70;78 
15 Table 3: Effect of Exercise-Based Cardiac Rehabilitation on Exercise Capacity (EC) after MI, CABG and PTCA 
Study 
BetheU
36 
RCT 
Oldridge
37 
RCT 
DeBusk
35 
RCT 
DeBusk
47 
RCT 
Subjects 
N=200, 6 wks post MI. 
1000/0 males, <65 years 
N=201, 6 wks post MI. 
90%  males, 52 years. 
Patients had moderate 
anxiety or depression. 
N=70, 3 wks post MI 
21Gs& 1CG 
100
%  males, 52yrs. 
N=585, 3-6 wks post MI 
78%  males, 57 years (all 
<70 years). 
Design  Results 
Intervention: Community-based sup circuit training 3 times/week for  Sig greater improvement in estimated V02max 
12 weeks.  in IG vs CG. 
Usual care: Advice on unsupervised exercise. 
FU: 3 m from baseline (4-5 m post MI). 
Intervention: 8 wk hospital-based CPo  Sup exercise (65% maxHR),  Sig i  in EC in both groups from baseline to 8 
2 times/week for 50 mins. Weekly gp counselling.  wks & 12 m. Sig difference favouring IG at 8 
Usual care: not described.  wks but not 12 m. (EC  J..  in IG at 12 m). 
FU: End of programme & 12m. 
Intervention: 8 wks of Sup exercise 3 times/wk, 60 mins or home  Sig i  in estimated METs in all three gps, but i 
exercise 5 times/wk, 30 mins at 70-85% maxHR.  was sig greater in the 2 IGs vs CG.  EC i  by 
Usual care: not described.  34% in CG, 41 % in home gp & 53% in sup gpo 
FU:  11  weeks. 
Intervention: Home-based CPo  Exercise, 60-85% maxHR,  5  EC sig i  by 2.1  METs in the IG group. At 6 m, 
days/wk, 30 mins. Behavioural intervention for smoking, exercise &  EC was sig greater in IG vs CG (9.3 METs vs 
lipids. Mail & phone contact for 1 yr.  8.4 METs). Baseline EC was not reported. 
Usual care:  Education on smoking, diet and exercise. 
FU: 6m. 
16 Dugmore
48 
Non-
randomised 
Dressend
49 
RCT 
Liddell
56 
RCT 
N=124, 3 wks post MI 
98%  males. 
Subjects split into good & 
bad prognosis gps. 
N=50 4 wks post MI 
31G & 1 CG 
100% males, 54 years 
N=116, 5 wks post MI 
870/0 males, 56 yrs (all 
<66 yrs) 
Intervention: 12m hospital sup exercise 3 times/wk. Good 
prognosis:65 to 800/0 pkV02.  Bad prognosis: 50 to 65% pkV02. 
Usual care: not reported 
FU: 4,  8 and 12 months. 
Intervention: 5 wk phase II  hospital-based sup exercise training 
(70%  V02max), 35 mins/session either 1, 2 or 3 times/wk. 
Usual care: restricted to light activities «50% V02 max) at home. 
FU:  End of 5 wk programme. 
Peak V02,  RPP and exercise duration were 
sig higher in good and bad prognosis IG vs 
matcheq CG at 4,  8 and 12 m.  Did not report 
change from baseline. 
Treadmill duration sig t in IGs (20-25%) & CG 
(100/0).  Sig t in V02 max in IGs by 16%  (1/wk), 
19% (2/wk), 20% (3/wk) & NS t by 8%  in V02 
max in CG. t in treadmill duration & V02 max 
was sig greater in the IGs training 2 & 3 
times/wk vs CG. 
Intervention: CP involving Phase 1 (inpatient) education & support.  EC was sig higher in the IG vs CG at 6 m & 5 
Phase II  (outpatient) sup exercise for 1 hour/wk & education for  yrs. t in EC from baseline to FU not reported. 
6m. Patients encouraged to exercise unsupervised. Frequent 
phone contact. 
Usual care: Information on risk factors, & attended outpatient 
clinics 1, 3 and 12m post MI & GP annually. 
FU: 6m (end of phase 2) & 5 yrs. 
17 Heldal
50 
RCT 
Holmback51 
RCT 
N=37, 4 wks post MI 
1000/0 males, 53 years 
(all <66 years). 
N=69, 6 wks post MI 
97%) males, 55 years 
Kalli052  &  N=375, 2 wks post MI 
Hamalainen  80%  males, <65 years. 
53 RCT 
Roman54  N=193 2m post MI 
RCT  100%  males, 54 years, 
(all <71  years). 
Intervention: Hospital, outpatient intensive exercise programme for 
4 wks. Sup exercise 5 days/wk, 2 hrs/session, 85% HR max. 
Usual Care: encouraged to walk at a moderate speed. 
FU: 4 wks (end of intervention) & 6m post MI. 
Intervention: 12-wk hospital prog involving sup exercise, 2 
times/wk, 45 mins/session. Intensity 70-85% HRmax initially, then 
100% max HR. Patients told to exercise after programme. 
Usual Care: regular medical care, no emphasis on exercise. 
FU: 1 yr post MI. 
Intervention: CP including smoking & diet advice, psychological 
counselling & sup exercise. No detail on content & length of 
training. Programme was intense for 3m, but patients had contact 
with staff for 3 yrs. Frequent medical review. 
Usual care: follow-up by own GP. 
FU: 1, 2,  3, 6,  10 yrs post MI. 
Intervention: Hospital outpatient sup exercise, 50% V02 max, 3 
times/wk for a mean of 42 m. 
Usual Care: not detailed. 
FU: 6 & 12m post MI. 
18 
From Om to 4 wks, EC t sig more in IG vs CG. 
From Om to 6m, there was a NS t in EC by 
6% in CG & a sig t by 14% in IG. Between gp 
diff for the change was NS. 
EC t sig by 10% in IG & NS t by 2%)  in CG. 
The between group difference for the change 
was not sig. 
No sig difference in EC between IG vs CG 
throughout the 10-yr FU. But changes from 
baseline were not reported. Similar % of 
patients exercising regularly in IG & CG, but 
actual percentages not reported. 
Peak V02 sig t IG after 6m of training and a 
further NS t at 12m. EC did not sig change in 
CG. Sig diff between gps at 6 & 12m. Carson
55 
RCT 
Froelicher
57 
RCT 
Wosornu
58 
RCT 
Oldenburg
59 
RCT 
N=303, 6 wks post MI 
100% males, 51  years 
(all <70 years). 
N=53, mean time from 
CABG to study entry was 
2 yrs, range 6m - 9 yrs. 
1000/0 males, 54 years. 
Intervention: 12 wk outpatient circuit training twice/wk. Intensity not 
specified. Told to exercise after programme. 
Usual care: not detailed. 
FU: 5 months, 1,2 and 3 years. 
Intervention: 12m hospital sup exercise programme, 8 wks of 
exercise with ECG monitoring, 45 mins, 3 times/wk, 60% V02 max. 
After 8 wks, patients attended a walk/jog programme. 
Usual care: offered a walking programme <50% V02 max 
FU: 12m 
N=81, CABG in past 12m  Intervention: 6m hospital sup aerobic exer or strength training, 12 
(median 12 wks).  to 40 mins, 3 times/wk. Intensity based on ACSM 1990 guidelines. 
2 IGs & 1CG  Usual care: Told to engage in usual activities. 
100% males, ~7  years.  FU: 3 & 6m. 
N=86 4-8 wks post CABG  Intervention: Hospital CP, 6 weekly gp sessions for 3 hrs, booster 
90%  males, 59 years 
(all<70 years). 
sessions at 8 & 12m, sup exercise & education on risk factors. 
Behavioural skills included, goal-setting, skills training, self-
monitoring & support. Exercise goals: 30-40 mins/day. 
Usual Care: not detailed. 
FU: 4 & 12m post CABG. 
19 
From baseline to 5m, exercise duration sig t 
in both groups. EC was sig higher in IG vs CG 
at 5m, 1 & 2 yrs. No diff between gps at 3 yrs. 
Mean attendance at exercise sessions was 
82% (range 65-97%). V02 max t by 7.1 % in 
IG & ~ by 2.90/0 in CG. Between gp difference 
for the change in EC was sig. 
EC sig t by 1.4 METs at 3m & 2 METs at 6m 
in the aerobic gp vs no change (0.2 METs) in 
CG. From baseline to 6m, METs t by 29%) in 
aerobic gp, 15% in strength gp & 2% in CG. 
Baseline to 4m, peak V02 t  by 6.2 ml/kg/min 
(21 %) in CG & 4.5 ml/kg/min (14%) in IG. 
Baseline to 12m, peak V02 t by 6.7 (21 %) 
ml/kg/min in  IG & 5.5 ml/kg/min (19%) in CG. 
t in EC was sig  greater in IG vs CG at 12m 
but not 4m. Willoughbl  N=92 6 wks post CABG 
o Non- 2 IGs & 1 CG 
randomised  830/0  males, 69 years (all 
>63 years). 
Intervention: 12 wk phase II  hospital programme, sup exercise for 
20-45 mins, 3 times/week, 65%  maxHR (low intensity gp) or 85% 
maxHR (high intensity gp). Patients did not exercise outwith phase 
II. 
Usual care: no formal programme. 
FU: 12 wks (end of programme). 
Exercise duration & V02 max sig t  in the 2 
IGs vs CG. V02 max ,J,  by 2%)  in CG & sig t  by 
23% in low intensity gp & 38% in high intensity 
gpo  The t  in EC was sig greater in high vs low 
intensity gp, thus found a dose response 
effect. 
Higgins
79 
RCT 
N=99 post-PTCA  Intervention: 2m home CP, involved 3 home visits & monthly phone  Similar sig tin EC in IG & CG at 10 wks & 
Lisspers
62 & 
Hofman-
Bang
63 
RCT 
Majority males, 48 yrs (all  calls, unsupervised moderate walking & behavioural strategies to  12m, no diff between groups. 
<64 yrs). 
N=87 2 wks post PTCA 
85% males, 53 years 
«65 years). 
modify risk factors; goal-setting, self-monitoring, feedback, skills 
training & support. 
Usual care: in-patient education on CHD. 
FU: During admission, 10 wks & 1 yr post PTCA. 
Intervention: 12-month CPo  Phase 1(4 wks): lectures, discussions, 
skills training, goal setting & relapse prevention to t  motivation for 
changing stress, exercise, diet & smoking. 11 m home programme 
(phase II), regular contact, self-monitoring, feedback of changes, 
problem solving & replanning discussions. 
Usual Care: followed-up by own physician. 
FU:  12 & 24m. 
20 
Baseline to 12m, EC sig t by 11 % in  IG & no 
change in CG, sig between group difference. 
This difference was maintained at 24m. Belardinelli
61 
RCT 
N=  118 25 days post 
PTCA 
80%  males, 57 years. 
Intervention: 6m hospital sup exercise 3 times/week, 30 mins, 60% 
peakV02. 
Usual care: given a list of suitable "mild" activities &  activity diary 
FU: 6m from study entry. 
Peak V02, lactate threshold, & oxygen pulse 
at a given workload sig t  in IG vs CG. Peak 
V02 t by 26%  in IG.  83%  of IG & 7%  of CG t 
their EC by ~ 1 MET. 76% of CG had a lower 
peak V02 at 6m vs baseline. 
Note.  MI = myocardial infarction, CABG = Coronary artery bypass graft, PTCA = Percutaneous transluminal coronary angioplasty, FU = Follow-up, Gp = Group, IG = 
Intervention group, CG =  Control Group, EC =  Exercise capacity, RCT =  Randomised controlled trial, m =  month, wks =  weeks, yrs =  years, CP =  comprehensive programme, 
diff =  difference, prog =  programme, NS =  non-significant, Sup =  Supervised, t =  increase,  ~ =  decrease, Sig  =  Significant, RPP =  rate pressure product. 
21 Submaximal Endurance Capacity 
In  addition  to  increased  exercise  capacity,  exercise  training  also  improves 
submaximal  endurance  capacity  in  patients  with  CHD,  as  demonstrated  by  a 
significant  reduction  in  patients'  rate  of perceived  exertion  (RPE)  at  submaximal 
levels of exercise49;68;8o  and  a delayed onset of the lactate threshold.61 ;75;81;82  These 
effects are beneficial to the daily activities of cardiac patients. The lactate threshold 
is the exercise V02 at which the concentration of lactate in  arterial blood  increases 
above the  resting  value  due to  the supplementation  of aerobic  energy  production 
with  anaerobic  metabolism  during  heavy  exercise.83  Below  the  lactate  threshold, 
exercise at a given work rate can be sustained for a prolonged period of time without 
fatigue and with  relatively  little  stress to the subject.  In  contrast,  work rates  above 
the lactate threshold  lead  to  metabolic acidosis,  an  increased ventilatory response 
and  fatigue,  thus  exercise  above this  threshold  cannot  be  sustained  as  long.  The 
delayed  onset  of  the  lactate  threshold  after  exercise  training  enhances  an 
individual's ability to perform exercise at a given work rate.  Proposed  mechanisms 
for the  higher lactate  threshold  after training  include  improved  oxygen  supply  to 
active  skeletal  muscles,  increased  oxidative  capacity of mitochondria  and  delayed 
activation of type II  muscles fibres that function anaerobically.83 Hambrecht reported 
a  7%  increase in V02 at the lactate threshold after 12  months of unsupervised and 
supervised exercise training compared with an  8%  decrease in  the control group in 
patients with  CHD.84  Although,  this  study found  that patients  had to  expend  1400 
calories  per week,  which  equated  to  3.3  hours  of vigorous  intensity  exercise,  to 
delay  the  onset  of the  lactate  threshold.  In  contrast,  other  studies  have  found 
significant improvements in  the lactate threshold after 3 to 6 months of training at a 
lower intensity and frequency of exercise.61 ;75;81 
Angina and Ischaemia 
A  major benefit of exercise training  for patients with  CHD is  the  delayed  onset of 
angina and ischaemia during exercise. Angina and ischaemia occurs at a fixed rate 
pressure product (RPP), which is  an index of myocardial oxygen demand and  is the 
product of heart rate and systolic blood pressure (HR x SSP).34 Several studies have 
reported  a  lower  myocardial  oxygen  demand  with  exercise-based  cardiac 
rehabilitation,  demonstrated  by  a  significant  decrease  in  RPP  during  submaximal 
exercise.49;57;58;80;82;85  A  decline  in  RPP  is  a  result  of a  decrease  in  heart rate  and 
systoliC  blood  pressure  at  a  given  submaximal  workload.  In  addition,  a  lower 
22 submaximal heart rate increases the period of diastole, thus coronary blood flow will 
be enhanced as 80% of blood flow through the coronary arteries takes place during 
diastole.  The  overall  effect  is  that  at  any  given  submaximal  level  of  exercise, 
myocardial oxygen demand is  reduced  and  coronary  blood  flow is  enhanced,  thus 
patients  can  perform  a  greater  amount  of work  before  the  onset  of  angina  or 
ischaemia.
70 
Debusk reported a significant reduction in  angina and ECG determined 
ischaemia  during  exercise  testing  after  8  weeks  of supervised  exercise  training 
compared to controls in  a group of post MI  patients.35  Other studies found improved 
myocardial  perfusion  during  exercise  testing,  indicating  a  reduction  in  myocardial 
ischaemia with exercise training in CHD patients.61 ;86 
Physical Activity Levels 
This  section  reviews  the  evidence  on  the  effect  of  exercise-based  cardiac 
rehabilitation  on  physical  activity.  The  literature was  searched  from  1979 to  2003 
using Embase and Medline databases. The following key words were used:  cardiac 
rehabilitation,  myocardial  infarction,  coronary  artery  bypass  surgery  (CABG), 
coronary  heart  disease  (CHD),  percutaneous  transluminal  coronary  angioplasty 
(PTCA),  coronary  artery  disease,  exercise,  physical  activity,  compliance  and 
adherence.  In  addition,  relevant  studies  were  identified  from  references  cited  in 
published  papers  and  reviews  of  cardiac  rehabilitation.  Thirteen  randomised 
controlled  trials,39;56;59;62;63;67;79;84;88;90-94  1  non-randomised  controlled  trial,98  1  case-
control  study97  and  5  observational  studies20;87;89;95;96  investigating  the  effect  of 
exercise-based cardiac rehabilitation on physical activity are described in Table 4. 
Short-term Effect 
Ten  randomised-controlled  trials39;56;62;63;67;79;84;88;91;98  and  two  observational 
studies89;96 reported increases in physical activity after participation in exercise-based 
cardiac rehabilitation  (see  Table  4).  In  contrast,  two  randomised  controlled  trials 
reported  comparable  significant increases  in  physical  activity  in  both  rehabilitation 
and  control  groups  at follow-up.  The  major  limitation  of these  trials  involves  the 
method  used  to  measure  physical  activity.  These  studies  relied  on  self-report 
measures  of physical  activity,  and  except  for  one  studl
9 
objective  measures  of 
physical  activity were  not  employed.  In  addition,  only  four  studies
84
;88;89;96  used  a 
valid and reliable questionnaire to measure physical activity. 
23 Physical  activity  guidelines  for  cardiac  patients  and  healthy  adults  recommend 
accumulating 30  minutes of moderate activity on  at  least five days per week,  which 
is  equivalent to  expending  a  minimum  of 1000  calories  per week  during  physical 
activity  to  achieve  health  and  fitness  benefits.8 ;9;34  Thus,  results  from  two  of  the 
observational studies discussed in Table 4 demonstrate that exercise-based cardiac 
rehabilitation  improves  patients'  physical  activity  habits  to  levels  recommended  by 
current  guidelines.89;96  Although,  these  studies  did  not  assess  whether  patients 
continued to achieve these guidelines in the long-term. However, greater amounts of 
physical activity than those recommended by current guidelines may be  required to 
slow the progression of coronary atherosclerosis in  CHD  patients.  Hambrecht found 
that expending a minimum of 1600 calories per week during leisure physical activity 
was  required  to  slow  the  progression  of CHD,  whereas  regression  of CHD  was 
noted  in  highly motivated  patients who expended  an  average  of 2200  calories  per 
week,  amounting  to  between  5  and  6  hours  of  vigorous  physical  exercise. 84 
Although,  it  is  unlikely that the  majority of patients with  CHD  would  engage  in  this 
amount of physical activity. 
Long-Term Effect 
Twelve  studies  investigated  the  long-term  effect  of  exercise-based  cardiac 
rehabilitation  on  physical  activity  (see  Table  4).20;56;59;63;67;79;84;87;91 ;94;96;98  Two 
randomised-controlled  trials59;63  found  that  improvements  in  physical  activity  with 
cardiac rehabilitation were maintained following  programme completion.  In  addition, 
Hambrecht84  found  that  physical  activity  related  energy  expenditure  measured  by 
questionnaire was significantly higher in the intervention group compared to controls 
56"67"79"91"94"98 
at  12 months follow-up.  In  contrast,  six randomised controlled trials  '  ,  ,  ,  ,  and 
three observational studies20;87;96  found  a decline in  patients'  physical  activity levels 
following completion of cardiac rehabilitation exercise programmes.  Bock evaluated 
the  proportion  of  patients  meeting  current  physical  activity  guidelines  (i.e. 
accumulating  30  minutes or more  of moderate  activity on  most days  of the  week) 
and  measured physical activity by self-report in  62 cardiac patients who  attended a 
12-week supervised cardiac rehabilitation exerCise programme.
96 
At the beginning of 
rehabilitation,  43%  of participants were meeting the physical activity guidelines.  On 
programme  completion,  96%  of participants  were  meeting  the  guidelines  and  the 
amount of time spent in  moderate and  hard intensity physical activity had increased 
significantly.  In  contrast, three months after rehabilitation,  the proportion of patients 
24 achieving  the  recommendations  had  decreased  to  80%  and  nearly  50%  of 
participants  had  reduced  their physical  activity  levels  compared  to  the  end  of the 
programme. Similarly, Stahle reported a significant improvement in exercise capacity 
and physical activity with three months of exercise training compared to usual care. 67 
However,  physical  activity  levels  and  exercise  capacity  were  similar  between  the 
groups at 12 months, as physical activity and fitness had declined in the intervention 
group. 
Bethell reported a significant increase in exercise capacity and  physical activity after 
three months of supervised exercise training  compared to  usual  care. 91  In  a fo"ow-
up  study,  the  number  of  patients  who  continued  to  exercise  regularly  after 
completing the rehabilitation programme was assessed annually for 11  years using a 
postal  questionnaire.  The  response  rate  was  greater than  70%  throughout the  11 
year  follow-up.  In  the  intervention  group,  the  proportion  of  patients  exercising 
regularly rapidly fell  from  70%  to  40% during year one  and  then gradually declined 
over  subsequent years,  until  only  25%  of  rehabilitated  patients  were  exercising 
regularly from year seven onwards.  In  addition, 25%  of patients in the control group 
reported exercising regularly throughout the  11-year follow-up period.  These results 
suggest that a short-term exercise programme was more effective than usual care in 
improving  physical  activity habits for up  to  six  years.  However,  these findings  also 
show  that  the  majority  of patients  were  not  exercising  regularly  in  the  long-term 
following  cessation  of  supervised  exercise  training.  Similarly,  other  studies 
(described  in  Table 4)  have reported  that only  12% to  50%  of patients continue to 
exercise regularly  12  months to  9 years after completion  of exercise-based cardiac 
rehabilitation.20;56;87;94;95  The  major limitation  of these  studies  is  definition  of regular 
exercise,  which  varied  greatly  and  was  not  based  on  current  physical  activity 
recommendations.  For example,  in  studies by  Bethell91  and  Prosser,94 patients were 
categorised as  regular exercisers if they engaged  in  vigorous physical  activity (e.g. 
swimming,  jogging  etc),  whereas  moderate  intensity  activities  were  excluded. 
Current cardiac rehabilitation guidelines
2 recommend moderate intensity exercise for 
most cardiac patients, thus these studies may have underestimated the proportion of 
patients who  maintained a sufficient level of physical activity to  benefit their health. 
In  other studies,  patients were considered to  be  regular exercisers if they exercised 
twice a week8 ?  or "had  started to  exercise post MI.,,56  Thus,  the number of patients 
who  remain  regularly  active  after exercise-based  cardiac  rehabilitation  is  variable 
25 and depends on the length of follow-up and the definition of regular physical activity. 
Only  one  study  used  the  current  physical  activity  guidelines  to  determine  the 
proportion  of patients who  remained  regularly  active  after exercise  rehabilitation. 96 
Nine  randomised-controlled  trials  and  three  observational  studies  examined  the 
long-term  impact  of  cardiac  rehabilitation  on  physical  activity.  Six  of  the  nine 
randomised-controlled trials found that improvements in physical activity with cardiac 
rehabilitation  declined  in  the  long-term.  In  addition,  all  three  observational  studies 
reported  that  physical  activity was  not  maintained  in  the  long-term.  However,  the 
results  of  the  observational  studies  must  be  interpretetd  with  caution  as  these 
studies  are  more  prone  to  potential  bias  and  confounding  factors  than  controlled 
trials. 
In  summary,  the  evidence  suggests  that  participation  in  exercise-based  cardiac 
rehabilitation can  improve physical activity levels.  However,  it seems that the impact 
of cardiac rehabilitation exercise programmes on  long-term maintenance of physical 
activity is  limited  .. Several  studies  reported that increased  levels of physical  activity 
are not maintained in the long-term following completion of formal programmes. 
26 Table 4: Effect of Exercise-Based Cardiac Rehabilitation on Physical Activity 
Study 
Heath
88 
RCT 
Bertie
39 
RCT 
Engblom
90 
RCT 
Patients  Design 
N=65 10d  Intervention: 12-wk sup or home exercise programme, 30-40 mins 5 
post CABG  times/wk, 70-90%  peakHR. Exercise counselling & prescription after 
21Gs & 1  CG  programme. Usual Care: Information on risk factors & activity. 
N=81  3 wks 
post MI 
N=228, 
CABG. 
87%  males, 
54 years (all 
FU: 6 - 8m post CABG. 
Outcomes: Leisure PA in kcals/wk assessed by questionnaire. 
Intervention: 4 wk hospital CP involving risk factor advice, sup exercise 
twice/wk & encouraged to do an exercise video daily. 
Usual care: Information on risk factors. 
FU: 4m post hospital discharge. 
Outcomes: Mean km walked/day using a pedometer 
Intervention: Hospital CPo  Phase I:  3d pre-CABG, information on surgery & 
recovery. Phase II: 6 wks post-CABG, risk factor education, & 21  hrs sup 
exercise for 3 wks. Phase III: 8m post CABG, 2d refresher of phase II. 
Usual care: Instructions on gradually t activity. FU: 6 & 12m. 
< 65 years).  Outcomes: Self-report PA.  No definition of regular exercise. 
27 
Results 
PA was sig lower in CG (1089 kcals/wk) vs 
home IG (2058 kcals/week) & sup IG (2,549 
kcals/week) at FU. 
At Om,  distance walked per day was 4.5 km in 
CG & 5.1  km in IG. At 4m, distance 
walked/day was sig higher in IG (8.2 km) vs 
CG (6.6 km). 
From pre CABG to 6 & 12m FU,  %  of patients 
exercising regularly sig t in IG (22% to 42%) & 
CG (t 10% to 38%), no diff between gps. Bethell
91 
RCT 
Stahle
67 
RCT 
Higgins
79 
RCT 
N=200 6  Intervention: 12 wk community sup exercise 3 times/wk. 
wks post MI  Usual care: advice on unsupervised exercise. 
FU: annually for 11  yrs. 
Outcomes: Self-reported PA. Regular exercise defined as participating in 
vigorous exercise. Duration or frequency not assessed. 
N=101  6  Intervention: Hospital sup exercise 3 times/wk for 3m & once/wk for further 
wks post MI  3m. After programme, patients encouraged to attend community classes. 
or unstable  Usual Care: Advised to walk daily & attended monthly meetings. 
angina  FU: 3 & 12m. 
N=99 post 
PTCA 
Outcomes: PA on a 6-point scale: 1  =sedentary & 6= strenuous exercise 
(e.g. jogging, swimming) 23hrs/wk. 
Intervention: 2m home CP, home visits & phone calls, unsupervised 
moderate PA & behavioural strategies to modify risk factors; goal-setting, 
self-monitoring, feedback, skills training & support. 
Usual care: in-patient education on CHD. 
FU: pre-PTCA, 10 wks & 1 yr post PTCA. 
Outcomes: % patients exercising = 1-3 times/wk for 20 mins/session. 
28 
Questionnaire response rate was approx 70%. 
0/0  of IG exercising regularly ~ from 70%  to 
40%  in yr 1, then gradually ~ to 25% at yr 7, 
remained at that level. 25% CG exercised 
regularly over 11  yrs. 
PA sigt in IG (mean 4.5) vs CG (mean 3.9) at 
3m. at 12m, PA was 3.8 in IG & 3.6 in CG, no 
diff between gps. Changes in PA at 3m were 
not maintained at 12m in IG. 
% of IG exercising sig t  from 35% at Om to 
88% at 10 wks & 72% at 12m. % of CG 
exercising did not sig change from 53% at Om, 
to 59%  at 10 wks, to 61 % at 12m. Sig diff 
between gps at 10 wks, not 12 m. Oldenburg
59 
RCT 
Lisspers
62 & 
Hofman-
Bang
63 
RCT 
Liddell
56 
RCT 
N=864-8 
wks post 
CABG 
90%  males, 
59 years 
(all<70 
years). 
N=87 2 wks 
post PTCA 
85% males, 
53 years 
«65 years). 
N=116,5 
wks post MI 
Intervention: 6wk hospital CP, 1 gp session/wk for 3 hrs & booster sessions  PA sig t in both gps from Om to 4m & this 
at 8 & 12m. Sup exercise & education on risk factors. Behavioural skills:  level was maintained at 12m. No sig diff 
goals, skills training, self-monitoring, support. Exercise goals: 30mins/d walk  between gps. Did not report levels of PA 
Usual Care: not detailed.  participation. 
FU: 4 & 12m post CABG. 
Outcomes: Regular exercisers: ~  3/wk, moderate exercisers: 2/wk & non-
exercisers: ::; 1/wk. 
Intervention: 12-month CPo  Phase I: 4 wks, lectures, discussions, skills 
training, goal setting & relapse prevention to change stress, exercise, diet & 
smoking. 11 m home programme (phase II), regular contact, self-monitoring, 
feedback, problem solving & replanning discussions. 
Usual Care: followed-up by own physician. 
FU: 12 & 24m. 
Outcomes: Exercise session = effort equal to brisk walk for 20 mins. 
Intervention: CPo  Phase 1 (inpatient) education & support. Phase II 
(outpatient) sup exercise 1 hr/wk & education for 6m. Patients were 
From Om to 12m, the frequency of exercise 
sessions t sig in IG (2.5 to 5/wk) vs CG (2.5 to 
3/wk)  , which was maintained at 24m. At 12m, 
56% of IG & 41 % of the CG exercised at least 
twice/wk. 
87% males,  encouraged to exercise unsupervised. Frequent phone contact. 
% patients exercising was sig greater in IG 
(67%) vs CG (28%) at 1 yr.  No sig diff 
between IG (41%) & CG (28%) at 5 yrs. 
56 yrs (all  Usual care: Risk factor information & attended clinics 1,3 & 12m post MI. 
<66 yrs)  FU: 1 & 5 yrs. 
Outcomes: PA assessed by statements "started to exercise post Min 
29 Carlsson
92 
RCT 
Hambrecht
84 
RCT 
Haskell
93 
RCT 
N=1684 
wks post MI 
N=62 with 
CHD. 
Intervention: 3m CP, counselling on diet, smoking & PA. 40mins of sup 
exercise ~2/wk. End of programme, received exercise plan & education. 
Usual care: medical evaluation, risk factor education & exercise programme. 
FU: 12m. 
Outcomes: PA: 1  =sedentary, 2=walking/cycling daily for ~30  mins, 3=sport 
activities ~1/week, 4=sport activities ~2/wk, 5=vigorous exercise. 
Intervention: 3 wk inpatient programme; low fat diet & sup exercise 6 
times/d for 10 mins at 75%  maxV02. Out-patient programme; unsupervised 
exercise, 30 mins/d & 2 sup exercise sessions/wk 60 mins. 
Usual care: information on exercise & diet. 
FU: 12 months 
Outcomes: EE (kcals/wk) by Minnesota leisure time PA questionnaire. 
N=300 with  Intervention: Home CP, individualised goals to modify risk factors. PA 
CHD  programme involved daily PA e.g. walking, climbing stairs, & aerobic 
years, 80%  exercise for ~30mins on 5d at 70-85%maxHR. Phone & mail contact. 
males.  Usual Care: medical review by GP. 
FU: annually for 4 yrs. 
Outcomes: PA measured by 7 day PA recall. 
30 
At hospital admission, 69%  IG & 78%  of CG 
were physically active (i.e. categories 2 - 5). At 
12 m,  77% of IG & 70%  of CG were physically 
active. 78% IG & 67%  CG who were sedentary 
at baseline were active at 12m, no sig diff 
between gps. 
At 12m, EE was 1,876 kcals/wk IG & 1,187 
kcals/wk CG (p<0.05). In total gp, EE was sig 
lower in patients with progression of CHD 
(1022 kcals/wk), vs no change in CHD (1533 
kcals/wk) or regression of CHD (2204 
kcals/wk). 
At baseline, 79% of IG & 72% of CG exercised 
regularly (p>0.05). At FU, % of IG exercising 
regularly sig t to 90% vs CG (70%). Prosser
94 
RCT 
N=291 6  Intervention: 3m sup exercise for 45 mins/session, twice/wk. 
wks post MI  Usual care: not mentioned. FU: 6-9 years post MI. 
Outcomes: Questionnaire on %  patients exercising vigorously (> 6 METs). 
> 70%  response rate.  19%  IG were exercising 
at FU vs 2%  of CG. 
Ben-Ari
98  N=175 1 wk  Intervention: 12 wk CP involving education on risk factors & sup exercise 45 
mins, 2-3d/wk at 70-85% maxHR. 
% of patients exercising ~  2 times/wk 89% in 
IG and 72% in CG at 3m (p<0.05). No sig diff 
at 18m (75%  IG vs 70%  CG). 
Non- post PTCA. 
randomised 
controlled trial 
Morrin
89 
Cohort 
Perk
97 
Case-control 
Usual Care: information on risk factors & PA. 
FU: 3 & 18m. 
Outcomes: self-report PA. 
126> 6 wks  Intervention: 6m hospital CP, education, sup exercise twice/wk, 50-75% 
post cardiac  HRR & unsupervised activity for 200-400 mins/wk (1,200-2,000 kcals/wk). 
event.  Individualised goals for risk factors, feedback on risk factors at 0,3 & 6m. 
FU: 3 & 6m. Outcomes: EE in kcal/wk assessed by 7 Day PA Recall. 
81 % adherence rate to the programme. Sig t 
in PA from Om (830kcals/wk) to 3m (1345 
kcals/wk) & 6m (1325 kcal/wk). 
N=1576 
wks post 
CABG 
Intervention: 3m hospital CPo  Education, sup exercise 2/wk, 100% maxHR &  66% of IG were regular exercisers vs 460/0 of 
individualised home exercise programme. After 3m, patients attended a  CG (p=0.05). IG, mean duration of training/wk 
community programme.  was 6.5 hrs vs 5.2 hrs/wk CG (p=0.07). 
Usual care: medical review at 1 year. 
FU: Mean 38 months after CABG. 
Outcomes: PA assessed by a mailed questionnaire (not validated). 
31 Kinsel
7 
Cohort 
Fontana
20 
Cohort 
Vidmar
95 
Cohort 
Bock
96 
Cohort 
N=48 post-
CABG 
N=50 post 
Mlor 
CABG. 
N=138 
patients 
N=62 after 
MI, CABG 
or PTCA. 
Intervention: 12 wk phase II home exercise programme. Patients were 
advised to walk or cycle 3- 4 times/wk after programme. 
FU: 4 yrs. Outcomes: leisure PA, including frequency, intensity &duration. 
Intervention: Hospital sup exercise for 35 mins/session, 3 times/wk, 85% 
maxHR for 12 wks. FU: 12 weeks, 6 and 12 months. 
Outcomes: % patients attending programme, % completing programme, & 
% continuing to exercise after programme. 
Intervention: 12wk phase II  hospital CP, exercise training & education on 
risk factors. 
FU: patients who had completed phase II  in the past 8 yrs 
Outcomes: PA questionnaire (not validated). 
Intervention: 12wk phase II  CP, sup exercise 1 hr,  3 times/wk, 60-80% 
HRR, risk factor education & guidelines for home activity. 
FU:  12 wks (programme completion) & 6m. 
Outcomes: 7  -Day PA Recall (mins/wk) & Stage of Exercise Behaviour 
Change. Regular PA = accumulate ~  30mins moderate PA on 5d /wk. 
80%  compliance to programme. 41 % were 
exercising at least twice/wk at 4 yrs. 
52% attended programme. 39% completed 
programme. % continuing to exercise after 
prog was 60% at 12 wks, 30% at 6m & 37%) at 
12m. 
39% (138/352) response rate. 87%) of patients 
were exercising, either unsupervised or at a 
phase III maintenance programme. 44% 
engaged in moderate PA for 40 mins~  3/wk. 
26% dropped out programme. At  Om,  47% 
patients were regularly PA. At 12 wks, 96% 
were regularly PA & mins/wk of PA sig t. 6 m, 
80% were regularly PA.  12 wks to 6m, 42% 
participants regressed (i.e. mins/wk of PA .J,). 
Note. MI  = myocardial infarction, CABG = Coronary artery bypass graft, PTCA = Percutaneous transluminal coronary angioplasty, CHD = coronary heart disease, FU -
Follow-up, Gp = Group, IG = Intervention group, CG = Control Group, EC = Exercise capacity, PA =  Physical activity, EE = Energy expenditure, RCT =  Randomised 
controlled trial, m = month, wks = weeks, Sup = Supervised, t = increase,  .,l..  = decrease, Sig  = Significant, d = days, diff = difference, CP = comprehensive programme, 
HRR = heart rate reserve. 
32 Psychological Functioning 
Psychological  distress following  myocardial  infarction  is  common  and  can  lead  to 
poor outcomes.
2 
The prevalence of depression in  patients following MI  ranges from 
15%  to  45%.
2 
Patients  diagnosed  with  major depression  according  to  DSM-III-R 
(Diagnostic and Statistical Manual of Mental Disorders revised third edition) criteria 
(16%)  seven days  after a  MI  were at a  significantly greater risk  of dying  over the 
subsequent 6  months than  non-depressed  patients. 10o  Furthermore,  the  increased 
risk  remained  after controlling  for previous  MI,  ejection  fraction  and  other clinical 
indicators of disease severity.  Another study  reported  that moderate symptoms of 
depression measured using the Beck Depression Inventory (score ~ 10) immediately 
after MI  predicted  mortality over the following  18  months.101  Again this  effect was 
independent of other post  MI  risk factors.  Mayou  observed that  patients  suffering 
from  psychological  distress  (15%)  measured  using  the  Hospital  Anxiety  and 
Depression Scale three days after MI  reported  poorer quality of life,  more cardiac 
symptoms, exercising less, continuing to smoke, and greater use of health services 
over the subsequent 12  months  compared  to  nondistressed  patients.102  Evidence 
also suggests that depressed patients are less likely to adhere to medical treatment 
or lifestyle changes including exercise programmes.103-105  In  addition,  psychological 
distress  after an  acute cardiac event  does  not  improve  in  many  patients  without 
treatment.102;106  Therefore, as distressed subjects are at an increased risk of adverse 
outcomes following a MI, an aim of cardiac rehabilitation is to "limit the psychological 
effects of cardiac illness and to enhance psychosocial status".1 
Numerous studies have examined the effect of exercise-based cardiac rehabilitation 
I  f 
..  d·b d·  T  bl  5 32;37;38;51;59;61;63;66;67;79;89;107-109 
on  psychologica  unctlonmg,  as  escn  e  In  a  e  . 
Most  of these  studies  found  that  exercise-based  cardiac  rehabilitation  produced 
psychological  benefits  with  exercise-based  cardiac 
rehabilitation.  32;37;38;51;59;61;63;66;67;79;89;107-109  Similarly, systematic reviews found that the 
majority  of  controlled  trials  reported  statistically  significant  improvements  in 
psychological  functioning  with  comprehensive  rehabilitation  compared  to  usual 
care.  1;246  However,  it  is  impossible  to  determine  which  components  of 
comprehensive cardiac rehabilitation programmes (e.g. exercise training, education, 
individual and group counselling etc) were responsible for the psychological benefits. 
The  reviews  also  found  that  exercise  training  as  the  sole  component  of cardiac 
rehabilitation improved psychological wellbeing  and  quality of Iife.
1
;246  However, the 
33 direct effect of exercise training  on  psychological  outcomes  is  confounded  by  the 
consequence of group interaction,  the  formation  of social  support networks during 
supervised  exercise  programmes,  and  support  and  guidance  from  cardiac 
rehabilitation staff, which are likely to affect anxiety,  depression and quality of life.  It 
is thought that improved psychological function with exercise training was a result of 
increased fitness.  However,  Newton  reported  that  improvements  in  psychological 
functioning after a 10-week rehabilitation exercise programme compared with routine 
care  were  independent  of  changes  in  fitness. 38  Overall,  evidence  suggests  that 
exercise-based cardiac rehabilitation enhances psychological wellbeing.  In  addition, 
Denollet  found  that  reducing  psychological  distress  with  comprehensive 
rehabilitation improved long-term mortality.32 
Long-term Effects 
The long-term effects of exercise-based cardiac rehabilitation  on  quality of life  and 
psychological  functioning  have  been  examined.37;51;59;61;63;66;67;79;107;109;11o  A 
randomised  controlled  trial  of  118  patients  following  PTCA  reported  significant 
improvements in  quality of life assessed using the  Short-Form 36 after 6 months of 
supervised exercise training. 61  Furthermore, the positive change in  quality of life was 
maintained six months after programme completion. In contrast, quality of life did not 
significantly improve in  the control group over the  12-month study period.  Similarly, 
other controlled trials have found that 6 to  12 weeks of comprehensive rehabilitation 
enhanced psychosocial functioning compared to  usual care for 6 to 12 months after 
MI  and CABG.110;111 
Conversely,  several  randomised  controlled  trials  found  no  significant  difference  in 
psychological functioning  between  the  intervention  and  control  groups  in  the  long-
term.37;51;59;63;66;67;79  Stahle randomised 101  elderly patients 6 weeks following MI to a 
3  month  supervised  exercise  programme  or  usual  care. 67  Significantly  greater 
improvements  in  many  quality  of life  dimensions,  assessed  by  a  disease-specific 
questionnaire, were observed after 3 months of exercise training compared to  usual 
care.  However, quality of life gradually improved in the control group and declined in 
the rehabilitated group, thus similar scores were observed between the groups at  12 
months.  Similarly, Oldridge37 found that 8 weeks of supervised exercise training and 
psychological  group counselling  significantly  improved  anxiety,  emotions  and  total 
quality  of  life  measured  using  the  Quality  of  Life  after  MI  (QLMI)  compared  to 
34 standard care.  However,  these differences were no  longer significant at  12 months 
because anxiety levels and quality of life had  significantly improved over time  in the 
control group. 
There  are  several  explanations  for  the  lack  of  long-term  effects  of  exercise 
rehabilitation  on  psychological  outcomes.  Firstly,  improvements  in  psychological 
functioning  and  quality of life following  MI,37;66;67  CABG59  and  PTCA63;79  have  been 
observed  in  both  rehabilitated  patients  and  control  patients  in  the  long-term.  It  is 
expected that many patients will  experience an  enhanced quality of life after CABG 
and  PTCA  due  to  relief  from  angina  and  increased  functional  capacity  without 
rehabilitation.  Similarly,  improvements  in  quality of life  after MI  may  be  due  to  the 
natural course of recovery after an  infarct. Therefore, it is possible that a short-term 
comprehensive rehabilitation programme accelerates the improvements in  quality of 
life,  whereas  without  rehabilitation  the  improvements  occur  at  a  slower  rate. 
Secondly,  in  several  studies usual  care  patients  received  more  contact with  health 
care  professional.s  than  normal,59;67;79  which  may  have  contributed  to  the  gradual 
improvement  in  quality  of  life  observed  in  control  patients.  Finally,  compliance  to 
lifestyle  changes  may  decline  after  completion  of  exercise-based  cardiac 
rehabilitation leading to the deterioration in  quality of life in  the long-term viewed by 
some researchers.66;67 
In  summary,  studies  determining  the  long-term  effects  of cardiac  rehabilitation  on 
psychological outcomes produced inconsistent results.  Several  authors reported  no 
significant  differences  between  intervention  and  control  groups  in  psychological 
functioning and quality of life in the long-term, due to gradual improvements in these 
outcomes  in  control  patients  over time  and  possibly  as  a result  of poor long-term 
compliance  with  lifestyle  changes  in  rehabilitated  patients.  Furthermore,  the 
instruments  used  to  measure  psychological  outcomes  differ widely  (see  Table  5), 
and these variations may account for the inconsistent results observed. 
Psychologically Distressed Patients 
The  greatest  psychological  benefits  of exercise-based  cardiac  rehabilitation  may 
occur in  patients with poor quality of life and  high levels of psychological distress at 
study  entry.108;110;112;113  Lewin110  randomised  176  patients  3  days  after  MI  to  a 6 
week  home-based  comprehensive  rehabilitation  programme  or  usual  care  and 
35 measured psychological  distress  using  the  Hospital Anxiety  and  Depression  Scale 
(HADS) at 6 weeks, 6 months and  1 year.  Fifty two percent of the study group were 
psychologically distressed at  baseline,  determined by  a HADS  score  ~ 8 on  anxiety 
or  depression  subscales.  In  the  distressed  group,  mean  anxiety  and  depression 
scores significantly decreased  in  the  rehabilitation  group and  remained  unchanged 
in  the control group at 6 weeks,  6 months and  1 year.  In  the  non-distressed group, 
mean  anxiety and  depression scores were  low at  baseline  and  did  not significantly 
change  in  either group during  the  12-month  study  period.  Thus,  the  psychological 
benefits of exercise-based cardiac rehabilitation were confined to  patients who were 
psychologically distressed immediately after MI. 
A large observational  study found  that depressed  patients  had  a reduced  exercise 
capacity,  higher  levels  of  anxiety  and  hostility  (measured  using  the  Symptom 
Questionnaire)  and  poorer  quality  of  life  (assessed  with  the  Short-Form  36) 
compared to  nondepressed  patients who  had  recently  experienced aMI, CABG  or 
PTCA.
108  Followi~g  12  weeks  of  comprehensive  rehabilitation,  improvements  in 
anxiety,  depression  and  most  subscales  of  the  Short-Form  36  were  significantly 
greater in  the  depressed  group  compared  to  the  nondepressed  group.  Overall,  it 
seems that patients with  poor quality of life or suffering from  psychological distress 
following an acute cardiac event may be particularly responsive to the psychological 
effects of cardiac rehabilitation. 
36 Table 5: Effect of Exercise-Based Cardiac Rehabilitation on Psychological Function 
Study  Subjects  Design  Outcomes 
Oldridge
37  N=201 6 wks post MI  Intervention: 8 wk hospital-based CPo  Sup  QoL: Time Trade-off, 
RCT  90%  males, 52 years.  exercise (65%  maxHR), twice/week, 50 mins.  Quality of life after MI 
All patients were  Weekly gp counselling.  (QLMI) & Quality of 
moderately anxious or  Usual care: not described.  Wellbeing (QW8). 
depressed.  FU: 8 wks, 4, 8,  & 12m. 
Stern
66  N=91, 6wks-12m MI  Intervention: 12 wk out-patient sup exercise  Scaled Interview to 
RCT  86% males, 54 yrs.  training 3 times/wk at 85%  maxHR. 12 wks of  Assess Maladjustment 
Subjects were high  gp counselling on managing stress & risk  (SSIAM), National 
risk.  factors, relaxation & education.  Institute of Mental 
Usual care: told not to engage in sup exercise  Health (NiMH) Self 
or counselling.  Report Mood Scale. 
FU: 3,  6,  & 12m. 
Newton
38  N=22 6 wks post MI  Intervention:10 wk hospital CP, 3 exercise  Beck Depression 
RCT  sessions/wk (2 sup,  1 home), 60-80% maxHR &  Inventory (BOI) and 
education on risk factors.  Profile of Mood States 
Usual Care: Education on risk factors.  (POMS). 
FU:  10 wks (end of programme). 
37 
Results 
Similar, ig, t in all QoL measures in IG & 
CG at 12m. Sig i  in QLMI & anxiety in IG 
vs CG at 8 wks. QLMI t in 67%  of IG & 
52% CG at 8 wks (p <0.05). At 12m, 70% 
of IG & CG had i  QLMI. 
At 3m, IG had sig lower scores for 
depression & fatigue (NiMH), less 
dependent on spouses & more sociable 
(SSIAM) vs CG. Other QoL changes were 
similar in IG & CG from Om to FU. QoL i 
over time in CG & improvements in IG J. 
from 6 to 12m. 
Anxiety, & depression (POMS) & 
depression (BOI) sig J- in IG vs CG. Sig 
improvement in anger & total mood 
disturbance (POMS) in IG vs CG. Sig i  in 
fatigue (POMS) in  IG & CG. Denollee
2  N=150 3-6 wks post  Intervention: 3m hospital CP, sup exercise 3  Mortality & emotional  Sig improvement in negative affect in IG v: 
Non- MlorCABG  times/wk at 50-75% pkV02. psychosocial gp  distress (positive &  CG. Greater % of IG improved & smaller 
randomised  100% males, 58  sessions & individualised psychological therapy  negative affect) using  % deteriorated in negative affect vs CG. 
years.  if needed.  Global Mood Scale  17% CG & 4% IG died at 9yrs (p<0.05). 
Usual Care: not documented.  (GMS).  Mortality was associated with deterioration 
FU: 3m, mortality assessed at 9yrs.  in negative affect. 
Engblom
107  N=228, CABG.  Intervention: Hospital CPo  Phase I:  pre-CABG,  Beck Depression  Depression was sig lower in IG vs CG at 
RCT  87%  males, 54 years  information on surgery. Phase II: education, 21  Inventory (801),  60m. 30% of IG & 34% CG were 
(all < 65 years).  hrs of sup exercise for 3 wks & psychology  Nottingham Health  depressed (BDI  ~13) pre-CABG. At 60m, 
Patients were  counselling. Phase III: 8m,  2-d refresher of  Profile (NHP).  22% IG & 29% CG were depressed 
randomised pre- phase II. Phase IV: 30m, 1-d refresher.  (p>O.05). Physical mobility (NHP) was sig 
CABG.  Usual care: instructions on t activity.  better in IG vs CG at 60m. 
FU: 2,  8,  30 & 60 months post CA8G. 
Milani
108  N=338 4-6 wks post  Intervention: 12 wk phase II hospital CPo  Depression, anxiety &  At Om,  depressed gp had poorer EC, SF-
Observation  MI, CA8G or PTCA.  Education on risk factors & psychological  somatisation measured  36 & more anxious vs non-depressed gp 
78%  males, 61  years.  adaptation to CHD, sup exercise 3 times/wk,  using Symptom  (p<0.05). FU, sig improvement in all scores 
30-40 mins, 70-85% maxHR & encouraged to  Questionnaire.  in depressed gpo  Sig greater improvement 
exercise unsupervised 1-3 times/wk.  Depression: cutoff> 6.  in scores in depressed vs non-depressed 
FU:  12 wks.  QoL assessed using  group. 67% of depressed gp were not 
Short-Form 36 (SF-36).  depressed at FU. 
38 Stahle
67 
~~-
Several QoL scales t sig in IG and CG at  N=101 6 wks post MI  Intervention: Hospital sup exercise 3  QoL: Disease-specific 
RCT  or unstable angina  times/week for 3m & once/wk for a further 3m.  Karolinska  FU. Sig diff between gps at 3m, for 
75%  males, 71  years  After programme, patients were encouraged to  Questionnaire  symptoms, PA & fitness, no sig diff at 12m 
(>64 years).  attend community classes.  Wellbeing: visual  3m changes in IG were not maintained. 
Usual Care: Advised to walk daily & attended  analogue scale. 
monthly information meetings. 
FU: 3 & 12m. 
Morrin
89  N=  126 > 6 weeks post  Intervention: 6m hospital CP, education, sup  QoL assessed by Short- Sig t in SF-36 scales at 3 & 6m, except 
Observation  cardiac event.  exercise twice/wk, 50-75% HRR &  Form 36.  mental health which sig improved by 6 
74%  males, 61  years.  unsupervised activity for 200-400 mins/wk. Set  months, but not 3 m. At baseline, QoL was 
individual goals for risk factors & given  lower vs USA norms. At 6m, most scales 
psychological counseling if required.  were similar in patients vs USA norms. 
Follow-up: 3 & 6m. 
Holmback
51  N=69, 6 wks post MI  Intervention: 12 wk hospital programme, sup  Questionnaire (not  No diff between IG & CG for changes in 
RCT  97%  males, 55 years  exercise, 2 times/wk, 45 mins/session. 70 to  validated) measured  QoL measures. But the change in QoL 
85% HRmax initially, then 100% max HR.  QoL (anxiety,  from Om to 1 yr was not reported. 
Patients told to exercise after intervention.  depression, self-
Usual Care: regular medical care.  confidence) & perceived 
FU:  1 yr post MI.  physical performance. 
39 Oldenburg
59 
RCT 
Higgins
79 
RCT 
N=86 4-8 wks post 
CABG 
900/0 males, 59 years 
(all<70 years). 
N=99 post-PTCA 
Majority males, 48 yrs 
(all <64 yrs). 
Intervention: Hospital CP, 6 weekly gp sessions 
for 3 hrs & booster sessions at 8 & 12m. Sup 
exercise & education on smoking, diet & 
exercise. Behavioural skills included goal 
setting, skills training, self-monitoring & support. 
Usual Care: not detailed. 
FU: 4 & 12m post CABG. 
Intervention: 2m home CP, involved home visits 
& phone calls, unsupervised walking & 
behavioural strategies to modify risk factors; 
goal-setting, self-monitoring, skills training & 
support. 
Usual care: education on CHD. 
FU: During admission, 10 wks & 1 yr. 
40 
QoL assessed by ST  AI, 
depression, anxiety & 
somatisation scales of 
SCL-90 & General 
Health Questionnaire 
(GHQ). 
EC assessed with 
Seattle Angina 
Questionnaire (SAQ). 
Psychological 
Adjustment to Illness 
Scale (PAIS-SR). 
QoL, subscales of the SCL  -90 & %  of 
patients with a high score on GHQ sig 
improved in IG & CG over time, with no difi 
between gps. 
PAIS-SR & EC sig t in IG & CG over time, 
with no diff between gps. Hofman-
Bang
63 
RCT 
N=87 2 wks post 
PTCA 
85%  males, 53 years 
«65 years). 
Belardinelli
61  N=118 25 days post 
PTCA 
RCT  80%  males, 57 years. 
Sandler
109  N=215 6 wks post MI 
RCT  90%  males, 55 years 
«72 years). 
Intervention: 12-month CPo  Phase I:  lectures, 
discussions, skills training, goal setting & 
relapse prevention for changing risk factors. 
11 m home programme, regular contact, self-
monitoring, problem solving. 
Usual Care: FU by own physician. 
FU: 12 & 24m. 
Intervention: 6m hospital sup exercise 3 
times/week, 30 mins, 60% peakV02. 
Usual care: given a list of suitable "mild" 
activities & activity diary. FU: 6 & 12m. 
Intervention: 6 wk hospital CP, 2 1-hr sup 
Anxiety using STAI &  No sig diff between gps for anxiety, 
depression using SOl.  depression or QoL at 12 or 24m. Many of 
Angina Pectoris QoL:  these outcomes improved in both gps. 
activity, symptoms, 
emotional distress & life 
satisfaction. 
QoL measured using 
Short-Form 36 & Duke 
Activity Status Index 
(DASI). 
Hospital Anxiety and 
DASI and all SF-36 scales, except social 
functioning sig tin IG, with no change in 
CG. Sig between gp diff for the change in 
SF-36 scores at 6 & 12m. 
exercise classes/wk, 1 education & relaxation  Depression Scale 
At Om,  24% IG & 18% CG were clinically 
anxious. % of anxious patients ,J..  to 9% in 
IG & t  to 21 % in CG at FU. Anxiety sig  ,J..  session/wk, 3 1-hr gp sessions on psychological  (HADS), 10 was cut off 
issues.  score for clinical anxiety  in IG, no change in CG. No change in 
Usual Care: not detailed.  or depression.  depression in IG or CG, 3% of patients 
FU: 6,  12, 24 wks  were depressed at Om. 
Note. QoL = Quality of Life, MI = myocardial infarction, CASG = Coronary artery bypass graft, PTCA = Percutaneous transluminal coronary angioplasty, FU = 
Follow-up, Gp = Group, IG = Intervention group, CG =  Control Group, EC =  Exercise capacity, RCT =  Randomised controlled trial, m =  month, wks =  weeks, Sup = 
Supervised, t =  increase, -i =  decrease, Sig  =  Significant, Diff =  difference, CP =  comprehensive programme, QoL =  quality of life. 
-1-1 Lipids 
Elevated  levels  of  total  cholesterol  and  LDL  cholesterol,  and  low  levels  of  HDL 
cholesterol  are  risk  factors  for  recurrent  coronary  events  after  a  myocardial 
.  f  t'  114;115  R  .  In  arc Ion.  andomlsed  controlled  trials  have  demonstrated  that  a  reduction  in 
total cholesterol and LDL cholesterol with lipid lowering therapy significantly decreased 
mortality, the incidence of non fatal MI  and the need for coronary revascularisation in 
patients  with  CHD.116-119  Thus,  national  guidelines  recommend  that  individuals  with 
CHD should have a total cholesterol and LDL cholesterol level less than 5 mmol/l and 
3  mmolll  respectively to  reduce the  risk  of recurrent cardiac events.2 ;115  In  addition, 
American  guidelines  state  that  triglyceride  concentrations  should  be  less  than  5.2 
mmol/l and HDL cholesterol  should  be  greater than  0.91  mmol/1.
120  To achieve  and 
maintain these lipid targets, interventions to modify diet,  increase physical activity and 
reduce  weight  are  recommended,120  and  lipid  lowering  medication  should  be 
prescribed  to  individuals  with  a  total  cholesterol  2  5mmolll  or  LDL  cholesterol  2  3 
mmo1/1.
2;115  Although, recent results from the Heart Protection Study indicate that CHD 
patients  should  be  prescribed  lipid  lowering  medication  irrespective  of  their  initial 
cholesterol  level.119  This  study  found  that  a  reduction  in  total  cholesterol  and  LDL 
cholesterol  with  medication  in  individuals  with  baseline  concentrations  of  total 
cholesterol and LDL cholesterol below the recommended targets significantly reduced 
cardiovascular  mortality,  the  incidence  of non  fatal  MI  and  the  need  for  coronary 
revascularisation.119 
Evidence suggests that exercise only rehabilitation has little impact on blood lipids in 
patients  with  CHD.1 ;28  Recently,  a  meta-analysis
28 
reported  that  exercise  only 
rehabilitation did not improve total cholesterol, LDL cholesterol, HDL cholesterol and 
triglycerides  compared with  usual  care,  although  the  results  were  based  on  only 
three studies.  In  agreement with these findings,  a  systematic review  reported  that 
studies  using  exercise  only  rehabilitation  documented  inconsistent effects  on  lipid 
levels.1 In  contrast,  a  recent  randomised  controlled  trial
61 
reported  a  significant 
decrease in total cholesterol, LDL cholesterol, triglycerides and a significant increase 
in  HDL cholesterol after 6 months of moderate- intensity exercise training compared 
to non exercising controls in  a group of post PTCA patients. An observational study 
reported  that  three  months  of  exercise  training  significantly  increased  HDL 
cholesterol by 8%, with no effect on the other lipid levels.
121 
Patients with abnormal 
lipid levels at baseline demonstrated significant improvements with exercise training. 
42 Conversely,  comprehensive  rehabilitation  programmes,  which  combine  dietary 
modification and  exercise training,  are effective in  managing  lipids  in  patients with 
CHD 1;28;47;79;84;89;93;108;122;123  R  It  f  .  28 
.  esu  s  0  a  meta-analysIs  found  that  comprehensive 
rehabilitation  substantially  decreased  total  cholesterol  and  LDL  cholesterol 
I 
produced  a  small  significant decrease  in  triglyceride  levels  and  had  no  significant 
effect on  HDL cholesterol compared  to  usual  care.  Similarly,  a systematic review1 
reported  that  the  majority  of randomised  and  non-randomised  controlled  trials  of 
comprehensive  rehabilitation,  which  included  exercise  training,  and  dietary 
intervention  documented  significant  improvements  in  total  cholesterol,  LDL 
cholesterol and triglyceride levels. Whereas, few trials recorded significant increases 
in  HDL cholesterol with comprehensive rehabilitation compared to usual care. 
Improvements  in  lipid  levels  with  comprehensive  rehabilitation  viewed  in  several 
studies were  influenced  by  increased  use  of lipid  lowering  medication  during  the 
study  period  in  the  intervention  group.47;89;93;123  Debusk  found  that  12  months  of 
home-based  comprehensive  rehabilitation  was  more  effective  than  usual  care  in 
reducing  total  cholesterol  and  LDL  cholesterol,  and  significantly  more  intervention 
patients had an  LDL cholesterol  value  below the  recommended  level  at  6  and  12 
months.47  In  contrast,  there  was  no  significant  difference  between  groups  for 
triglyceride or HDL cholesterol levels.  However,  a substantial proportion of patients 
in the intervention group (83%) had been prescribed lipid-lowering medication during 
the study period compared to the patients receiving  usual care (20%).  The authors 
attributed  most  of the  reduction  in  total  cholesterol  and  LDL  cholesterol  to  the 
medication  effects.  Other trials  documenting  improved  lipid  profiles  with  exercise-
based  cardiac  rehabilitation  have  not  reported  whether  changes  in  lipid  lowering 
medication  occurred  over  the  study  period,  although  this  factor  may  have 
confounded the results.55;79;108;122 
The  evidence  suggests  that  cardiac  rehabilitation  exercise  training  is  not 
recommended as a sole intervention for lipid modification because of its inconsistent 
effects on  lipid  levels.  Comprehensive cardiac rehabilitation,  which includes dietary 
advice,  lipid-lowering therapy and exercise training is the most effective programme 
to  produce favourable lipid  profiles and  reach  national lipid targets  in  patients with 
CHD.9 Adherence to Exercise-based Cardiac Rehabilitation 
Adherence (or compliance) is  the extent to which  recommendations (e.g.  exercise, 
diet or medication) to patients by health professionals are followed. 1 
Supervised Exercise Programmes 
In  the UK,  the  majority of phase  III  cardiac rehabilitation  programmes involve group 
exercise training for 5 to 13 weeks.s It has been estimated that between 9% to 49% of 
cardiac patients drop out of supervised rehabilitation exercise programmes lasting  12 
weeks  or less.
18
;43;44  In  addition,  approximately  40%  to  50%  of patients  dropout  of 
longer-term supervised exercise programmes lasting 6 months or longer.1 ;124-127 These 
dropout rates  are similar to  attrition  rates  from  exercise  programmes in  the  general 
population.
128 
Additionally,  Dorn  127  reported  that  adherence  to  a  3  year  cardiac 
rehabilitation exercise programme declined  over time and  only  a  small  proportion  of 
patients  were  attending  the  programme  at  3  years.  However,  a  dropout  from  a 
supervised  exercise  programme  does  not  necessarily  mean  that  the  patient  has 
stopped exercising. Oldridge  19 found that 50% of dropouts from a 6-month supervised 
exercise programme continued to exercise regularly.  One third of the dropouts stated 
that they discontinued the  supervised  programme  because they felt  better and  had 
gained what they had wanted from the exercise classes, thus 6 months of supervised 
exercise training was not required for all patients. 
Factors Influencing Adherence to Supervised Exercise Programmes 
A  number of demographic,  medical and  psychosocial variables  have been  shown to 
influence adherence to supervised cardiac exercise programmes.  Factors associated 
with  dropout  from  supervised  exercise  programmes  include  having  a  blue-collar 
occupation,19;129;130 angina,130 a reduced ejection fraction,131  inactive leisure habits,19;129 
.  ..  24  I  k'  19;129;130  D  127  b  d  greater socio-economlc deprivation,  and current y smo  Ing.  orn  0  serve 
lower attendance rates at supervised exercise for men with a less favourable CHD risk 
factor profile;  such  as  a  current  smokers,  lower exercise  capacity,  higher levels  of 
cholesterol  and  triglycerides  and  a  8MI  greater  than  25.  Common  reasons  for 
programme dropout or poor attendance at group exercise cited  by  patients  included 
transport problems,18;43 medical problems,43;130 work or domestic commitments,  18;26;43;44 
lack of motivation  or interest,26;130  inconvenient timing  of programmes
26 
and  beliefs that rehabilitation  would  not be  beneficial.18  Presence  of anxiety or depression  have 
been  shown  to  be  important  predictors  of  non-compliance  to  cardiac  rehabilitation 
.  103'104'131 
exercise  programmes.  "  A  large  observational  study  found  that  depressed 
patients  were  twice  as  likely  to  dropout  of  cardiac  rehabilitation  compared  to 
d  d  f  104  non  epresse  pa lents.  Age and  gender have not shown  any consistent pattern  in 
predicting who will adhere. Higher dropout rates and  lower adherence rates to cardiac 
rehabilitation have been reported for women compared to  men,44;132;133 although these 
findings  have been  inconsistent.  23;43  Several  studies found  that age did  not influence 
dh  t  d'  h  b'I'  .  103'104'125'131  127  a  erence  0  car  lac re  a  I Itatlon  '  ,  ,  whereas, Dorn  reported that older men 
were more compliant than younger men. Old ridge  130  also found that younger patients 
were more likely to dropout of supervised exercise. 
Maintenance of Physical Activity after Programme Completion 
Several trials have shown  a decline in  patients'  physical  activity levels,  fitness  and 
quality  of  life  following  completion  of  cardiac  rehabilitation  exercise 
19'20'56'67'79'91'94-96'98  .  .  .  programmes.  '  ,  ,  ,  "  ,  Furthermore, the majority of patients do not continue 
to exercise regularly after cessation of supervised exercise training.20;56;87;94;95 
Factors Influencing Maintenance of  Physical activity 
As  previously  discussed,  numerous  studies  have  identified  factors  that  predict 
dropout  and  adherence  in  supervised  exercise  programmes.  In  contrast,  the 
research  is  limited  on  the  factors  that  influence  maintenance  of  exercise  and 
physical activity following programme completion.  Understanding these factors is  an 
important  step  in  the  development  of  interventions  to  improve  maintenance  of 
physical activity and exercise in the long-term. 
Patients are expected to  remain  regularly active  in  the long-term  in  phase  IV  after 
completion of phase III  exercise programmes. However, the transition from phase III 
to  phase  IV is  a challenging  time  for cardiac  patients  as  they  do  not  receive  the 
support  and  follow-up  from  cardiac  rehabilitation  staff  that  they  received  during 
phase  111.2  Instead,  they  have  to  maintain  physical  activity  and  other  health 
behaviours on  their own.  Membership of cardiac support groups, which  offer group 
exercise or attending cardiac maintenance programmes delivered by  BACR trained 
exercise leaders  may help patients to remain  active  in  this  phase,  However,  these 
exercise  opportunities  are  not  available  in  all  areas,  Furthermore,  many  patients 
45 would not be  able to attend community programmes due to  barriers associated with 
supervised  exercise training  including transportation  problems,  limited  access,  and 
work  and  domestic  conflicts.  In  addition,  the  effectiveness  of  phase  IV  exercise 
programmes  to  maintain  the  benefits  gained  during  phase  III  exercise  training 
including exercise capacity and  increased physical activity has not been assessed in 
the UK.2 
Improving Maintenance of  Physical Activity in Cardiac Rehabilitation 
In  the  UK,  the  majority  of  phase  III  cardiac  rehabilitation  programmes  involve 
supervised  exercise training  lasting  6 to  12  weeks.  Although  supervised  exercise  is 
important  to  teach  patients  to  self-monitor  their  exercise  intensity  and  increase 
patients'  confidence  for  exercise,  it  is  unlikely  that  participation  in  a  supervised 
exercise programme will facilitate independent exercise after programme completion.
2 
This  is  reflected  by  the  low  proportion of patients who  continue to  engage  in  regular 
physical activity in the long-term after completion of supervised exercise programmes. 
In  addition,  high  ~ropout rates  from  supervised  exercise  programmes  is  associated 
with barriers such as; the programmes may be inconvenient or may interfere with work 
or domestic commitments,  the  location  may  be  difficult to  access  (especially  in  rural 
areas),  and  even  if accessed,  parking  or transport  may  cause  problems.  It  is  now 
recognised  that  this  restricted  approach  to  exercise  prescription  does  not  meet  the 
varied  needs  and  goals  of  the  CHD  population.  Therefore  alternative  models  to 
traditional exercise-based cardiac rehabilitation have been proposed. 
Studies  have  found  that home-based exercise  programmes for low to  moderate  risk 
patients  are  as  effective  as  supervised  exercise  training.
41
;8o;88;179  Other  trials  have 
reported  significant  improvements  in  exercise  habits,  functional  capacity  and  blood 
lipids  with  home  based  comprehensive  cardiac  rehabilitation  compared  with  usual 
care.47;79;86;110  Therefore,  home  exercise  programmes  may  overcome  some  of  the 
barriers  associated  with  supervised  exercise  and  improve  exercise  adherence.  In 
addition,  SIGN  guidelines  on  cardiac  rehabilitation  recommend  that  participants  of 
phase III  supervised exercise programmes should  also incorporate moderate physical 
activity  into  their daily  lifestyle to  produce  better  adherence  to  exercise  in  the  long-
term.
2 
46 In  a  recent  study,  Carlson
99 
compared  the  effect  of  a  traditional  phase  III 
programme, involving three supervised exercise sessions a week for 6 months,  with 
a  modified  phase  III  programme  designed  to  enhance  patients'  self-efficacy  for 
independent exercise.  The study found  that  both  interventions  produced  significant 
and comparable improvements in  body weight, exercise capacity,  and blood lipids at 
6  months.  However,  significantly  fewer  participants  dropped  out  of  the  modified 
programme (80/0)  compared to the traditional programme (24%).  In addition, the total 
number  of exercise  sessions  and  the  mean  number  of sessions  per  week  were 
significantly  higher  for  patients  in  the  modified  programme  compared  to  the 
traditional programme. These results show that encouraging phase III participants to 
exercise  independently  and  enhance  their  self-efficacy  for  independent  exercise 
improves  exercise  adherence.  The  high  dropout rates  from  facility-based  exercise 
highlights the  importance for developing  independent exercise  behaviour in  cardiac 
patients  so  that physical  activity can  be  maintained  in  the  long-term.  Thompson  180 
recommended that low risk cardiac patients should move rapidly from hospital-based 
exercise training .to  unsupervised exercise (when they are  able to  self-monitor their 
exercise  intensity)  with  regular  support  from  rehabilitation  staff  to  ensure  that 
increased exercise levels are carried over from formal rehabilitation programmes. 
The  study  by  Brubaker  is  the  only  trial  to  investigate  the  efficacy  of  phase  IV 
exercise programmes.
181  This study randomized  31  patients,  who  had  completed  a 
12  week  phase  III  supervised  exercise  programme  to  either  a 9 month  phase  IV 
home-based  maintenance programme  or  standard  care.  In  addition,  a comparison 
group (n  = 17) who attended a phase  IV supervised maintenance programme after 
completion  of  phase  III  were  randomly  selected.  The  phase  IV  home-based 
programme lasted  9 months and  included  an  initial  one  to  one  discussion with  the 
patient  on  monitoring  of exercise  intensity,  self-monitoring  of daily  activity  levels, 
problem solving exercise barriers, and regular telephone contact to discuss exercise 
compliance,  feedback  on  exercise  levels  and  to  provide  support  and 
encouragement.  Standard  care  involved  advice  on  continuing  with  exercise  and 
other lifestyle modifications. The comparison group attended a phase IV supervised 
maintenance programme for 9 months,  involving supervised exercise training  three 
times  a week  and  regular counselling  on  exercise  compliance  and  modification  of 
other  risk  factors.  Exercise  capacity,  blood  lipids,  and  body  composition  were 
assessed  before  and  after phase  III  and  at  9 months  follow-up.  Results  revealed comparable,  significant  improvements  in  these  outcomes  in  all  3  groups  on 
completion  phase  III.  In  addition,  these  improvements  in  blood  lipids,  exercise 
capacity and body composition achieved in phase III were maintained in all groups at 
9 months follow-up.  Thus,  although  the  standard  care  patients  received  no  further 
intervention in phase IV, they also maintained these changes. However, a number of 
patients  stated  knowing  that they were  being  reassessed  at  12  months  motivated 
them maintain lifestyle changes. These findings suggest that a home-based exercise 
programme is just as effective for patients who cannot attend a phase IV supervised 
maintenance exercise programme.  The fact that the standard care  patients did just 
as  well  suggests that follow-up testing  alone  may  be  sufficient to  maintain  lifestyle 
changes after phase III. 
SUMMARY OF SECTION ONE 
Overall,  there  are  many  physiological  and  psychological  benefits  to  be  gained  by 
participating in  e~ercise-based cardiac rehabilitation following  MI,  CABG  and  PTCA. 
Achieving  these  benefits  depend  on  good  adherence  to  cardiac  rehabilitation 
programmes.  In  addition,  sustaining  these  benefits  and  preventing  further  cardiac 
events requires maintenance of regular physical activity and  other lifestyle changes 
in  the  long-term.  However,  the  evidence  suggests  that  improvements  in  exercise 
capacity,  physical activity and  quality of life decline over time following  programme 
completion.  Many  studies  have  examined  the  factors  affecting  dropout  and 
adherence to supervised exercise programmes. Whereas, the research is limited on 
the factors that contribute to  maintenance of physical  activity following  programme 
completion.  Understanding these factors  is  an  important step in  the development of 
interventions to  improve  maintenance of physical  activity  and  exercise in  the  long-
term. 
48 SECTION TWO 
PHYSICAL ACTIVITY BEHAVIOUR CHANGE 
Theoretical Models of Behaviour Change 
In  a  recent  review,  Biddle  states  that  predicting,  understanding  and  explaining 
behaviour  should  be  carried  out  within  a  theoretical  framework. 134  A  number  of 
theoretical models of behaviour change  have been  used to  understand adherence to 
exercise  and  physical  activity  in  the  general  population.  These  include;  the  Health 
Belief  Model,  Theory  of  Reasoned  Action,  Theory  of  Planned  Behaviour,  Social 
Cognitive  Theory,  Decisional  Balance,  Relapse  Prevention  Model,  and  the 
Transtheoretical  Model.  Several  of these models have also  been  used to  understand 
participation  in  physical  activity  in  cardiac  rehabilitation  settings.  In  addition,  these 
models  have  provided  a  theoretical  framework  for  the  development  of  effective 
interventions  to  enhance  adherence  to  exercise  and  physical  activity  in  the  general 
population.134  There  is  little  research  on  effective  strategies  to  improve  exercise 
adherence in cardiac rehabilitation settings. 
Health Belief Model 
Oldridge  used  the  Health  Belief  Model  (HBM),  which  predicts  the  likelihood  of  an 
individual  taking  recommended  health  action  to  prevent  or  control  a disease,135  to 
predict  compliance  and  dropout  in  a  6  month  cardiac  rehabilitation  exercise 
programme.129  Results revealed that the components of the HBM; barriers to exercise, 
benefits  of  exercise,  and  susceptibility  of  disease  were  not  significantly  different 
between  compliers  and  dropouts.  In  contrast,  cues  to  exercise  were  significantly 
associated  with  compliance  to  cardiac  rehabilitation.  The  life  threatening  nature  of 
coronary heart disease may serve as  a cue to initiation of exercise behaviour change 
for  many  patients.  Furthermore,  the  severity  of  disease  threat  was  significantly 
associated with compliance to the exercise programme, but in the opposite direction to 
that proposed by the HBM. The threat of disea~e was greater for dropouts compared 
to compliers, thus individuals who perceived their condition  as more severe were less 
likely to comply with the exercise programme. In general, the study found that the HBM 
was  of limited  use  in  predicting  compliance  to  exercise-based  cardiac  rehabilitation. 
Similarly,  Biddle and  Mutrie stated that the HBM has been somewhat unsuccessful  in 
49 predicting  adoption  and  maintenance of physical  activity and  exercise  in  a variety  of 
I  t·  136  Th·  popu a Ions.  IS  may be  because many  people  adopt and  adhere  to  exercise for 
motives other than to prevent or control a disease. 
Theories of Reasoned Action and Planned Behaviour 
The theory of reasoned action (TRA)  137 proposes that behaviour is directly determined 
by  an  individual's  intention  to  perform  a  behaviour.  Intention  is  determined  by  two 
variables:  1)  a person's attitude,  which  is  indicated  by the  person's  beliefs  about the 
behaviour,  as  well  as  the  evaluation  of  the  likely  outcomes  of  the  behaviour;  2) 
subjective (social) norm, which is the beliefs of significant others (e.g. family, friends or 
health professionals) and the extent to which the individual is motivated to comply with 
such  beliefs or people.  This theory has been  used to  predict attendance at exercise-
based cardiac rehabilitation.
22  Cooper found that 72% of cardiac rehabilitation patients 
stated  that  they  intended  to  participate  in  cardiac  rehabilitation,  however  the 
attendance  rate  was  only 40%.22  This finding  suggests that  intention  alone  may  not 
predict future hea.lth  behaviour. This may be because even though many people have 
a strong  intention to exercise, there are barriers that may interfere with  their ability to 
do so. 
The Theory of Planned Behaviour (TPB)  138 extends the TRA by adding the factor of 
perceived  behavioural  control.  Perceived  behavioural  control  is  defined  as  the 
perceived  ease  or  difficulty  of performing  the  behaviour,  and  takes  into  account 
barriers that may prevent individuals from  performing the behaviour.  A recent meta-
analysis has provided support for the utility of the TBP to predict exercise behaviour 
in  the  general  population.
139  Results  revealed  that  attitude  towards  exercise  and 
perceived  behavioural  control  are  important  determinants  of  both  intention  to 
exercise  and  actual  exercise  behaviour.  In  addition,  intention  to  exercise  had  a 
substantial effect on  exercise behaviour, whereas subjective norms had a moderate 
effect on intention, and no effect on behaviour. 
Blanchard140  found  that  the  TPB  was  useful  for  understanding  exercise  adherence 
during  an  8-week  phase  1/  cardiac  rehabilitation  exercise  programme.  This  study 
reported  that attitude towards  exercise,  subjective  norms  and  perceived  behavioural 
control  were  significant  predictors  of  exercise  intention  (i.e.  intention  to  attend 
scheduled exercise sessions).  In  addition,  exercise  intention was  the  sole  significant 
50 predictor of adherence  to  the  phase  II  exercise  programme,  However,  as  exercise 
intention  explained  only  12%  of the variance  in  exercise  adherence  in  this  study,  it 
seems that other factors may explain additional variance in exercise adherence during 
phase II  cardiac rehabilitation. This theoretical model has not been used to understand 
exercise adherence after completion of cardiac rehabilitation exercise programmes. 
Social Cognitive Theory 
The  Social  Cognitive  Theory  (SCT)  proposes  that  personal  (e.g.  cognitions,  body 
composition,  age),  environmental  (e.g.  social  support,  weather,  access  to  facilities, 
stimulus  control)  and  behavioural  (e.g.  intensity,  and  frequency  of physical  activity) 
factors  influence  behaviour.136  An  important  component  of the  SCT,  social  support, 
has  been  found  to  influence  participation  in  cardiac  rehabilitation. 132;141  A significant 
relationship  between  exercise  adherence  and  perceived  benefits  and  barriers  to 
exercise  has  been  demonstrated  in  patients  with  CHD.142-144  Tirrell  reported  that 
individuals who perceived a greater number of benefits and fewer barriers to exercise 
reported greater adherence to  exercise between 6 and  18 months following CABG. 143 
Self-efficacy is  defined as  an  individual's confidence  in  his  or her ability to  perform a 
specific behaviour.145  There is  a significant positive  relationship  between  self-efficacy 
and  compliance  to  exercise  in  cardiac  rehabilitation  settings. 95;142  A  cross-sectional 
study  examined  the  relationship  between  exercise  self-efficacy  and  exercise 
adherence  in  a  group  of cardiac  patients  who  had  completed  a  12-week  phase  II 
supervised  exercise  programme.95  Questionnaires  were  used  to  assess  exercise 
behaviour,  and  two  components  of self-efficacy;  the  individual's  perceived  ability  to 
perform  daily  living  activities  (e.g.  walking,  jogging,  climbing  stairs  etc)  and  the 
individual's perceived ability to  continue to  exercise regularly over the  next 3 months 
despite  certain  barriers  (exercise  barriers  efficacy).  The  study  found  that  both 
components of self-efficacy were significantly higher for individuals who continued  to 
exercise  regularly  following  programme  completion.  Results  suggest that  identifying 
barriers  to  exercise  and  influencing  sources  of  self-efficacy  to  overcome  exercise 
barriers  could  improve  maintenance  of exercise  following  completion  of supervised 
rehabilitation programmes. 
Overall,  it seems that self-efficacy,  social  support and  perceived  barriers to  exercise 
have important influences on  adherence to exercise in cardiac rehabilitation.  Similarly, 
these factors are significant determinants of physical activity behaviour in  the general 
51 population.128 
Interventions Based on Social Cognitive Theory (SCT) 
General Population 
Interventions  based  on  the  SeT have  improved  adherence  to  exercise  in  healthy 
subjects.  Strategies such as  enhancing social  support,146;147  goal  setting,  148  decision 
balance-sheet  techniques  146;149  and  relapse  prevention  training  147;150  improved 
attendance  at  exercise  programmes  and  maintenance  of  exercise  following 
programme  completion.  Decisional  balance-based  interventions,  which  involve 
comparing the perceived costs (cons) and benefits (pros) of engaging in  a behaviour, 
have been shown to increase attendance at supervised exercise programmes  146  and 
was effective in maintaining attendance at a fitness centre. 149 Providing individuals with 
personalised feedback and  praise during exercise and  involving  individuals in  setting 
flexible  exercise  goals  significantly  increased  attendance  at  a  10  week  exercise 
programme and enhanced maintenance of exercise for three months after termination 
of the exercise programme.148 
Cardiac Rehabilitation 
Several  researchers  have  incorporated  strategies  based  on  the  SeT  into  their 
cardiac  rehabilitation  programmes.47;59;62;79;93;99;151;152  However,  some  of  these 
studies47;59;62;79;93  have  used  SeT strategies  to  modify  multiple  health  behaviours, 
thus  it  is  not  always  clear whether these  techniques  were  applied  to  exercise  in 
cardiac  rehabilitation.  Carlson
99  compared  the  effect  of  a  traditional  phase  III 
rehabilitation programme, involving three supervised exercise sessions per week for 
6  months,  with  a  modified  phase  III  programme  that  was  designed  to  enhance 
patients'  self-efficacy  for  independent  exercise.  At  the  start  of  the  modified 
programme,  participants  attended  three  supervised  exercise  sessions  a  week, 
however  the  frequency  of  supervised  sessions  was  gradually  reduced  to  one 
supervised session every two weeks at 6 months to facilitate independent exercise. 
Participants of both  programmes were encouraged to exercise for 30  minutes five 
times per week (either supervised or independently). At 6 months, both interventions 
produced  significant  and  comparable  improvements  in  body  weight,  exercise 
capacity,  and  blood  lipids.  However,  adherence to  the  exercise  recommendations 
(Le.  5 x 30-minute sessions/week) was significantly greater for modified programme 
participants  compared  to  participants  of the  traditional  programme.  These  results 
52 suggest  that  enhancing  a  participant's  self-efficacy  for  independent  exercise 
improves exercise adherence in  phase III.  It would have been interesting to  assess 
exercise  behaviour during  phase  IV to  determine  whether the  modified  phase  III 
programme was  superior to  traditional  rehabilitation  for improving  maintenance  of 
exercise after phase III. 
Debusk47  reported a significant improvement in  exercise capacity after a six-month 
home-based rehabilitation programme, which used SCT techniques to  modify CHD 
risk  factors  (e.g.  smoking,  diet  and  exercise).  The  strategies  used  were  self-
monitoring,  feedback,  goal  setting,  relapse  prevention  training,  problem-solving 
barriers,  behavioural  contracting  and  social  support.  However,  as  physical  activity 
and  exercise  capacity  were  not  assessed  in  the  long-term  after  programme 
completion,  it  is  not possible to tell  if this  programme was  effective  in  maintaining 
changes  in  activity  and  fitness.  Lisspers62  reported  that  a  12-month  rehabilitation 
programme following PTCA, which used health education and behavioural strategies 
derived from SC"'f to modify CHD risk factors was more effective than  usual care in 
improving exercise capacity and exercise habits  at 12  months.  Furthermore,  these 
improvements in fitness and exercise participation were maintained 12 months after 
the end of the intervention period.63  In contrast, other studies have shown that short-
term  comprehensive  programmes  based  on  the  SCT  had  no  lasting  effect  on 
physical activity habits at 12 months.59;79 
Relapse Prevention Model 
Relapse is a breakdown or set back in a person's attempt to change or modify a target 
behaviour. The relapse prevention model was developed to treat addictive behaviours 
such as alcoholism and smoking.153 The model proposes that relapse may result from 
an individual's inability to cope with situations that pose a risk of return to the previous 
behaviour. For example,  a former smoker finds himself or herself in  a social situation 
with  lots  of smokers.  Thus,  helping the  individual to  acquire strategies to  cope with 
high-risk situations will  both reduce the risk of an  initial  lapse,  and  prevent any lapse 
from escalating into a total relapse.  Simkin  154  assessed coping responses to  high risk 
situations  for  exercise  relapse  (e.g.  negative  mood,  boredom,  lack  of time)  in  29 
healthy women who had adopted exercise without formal  intervention.  The womens' 
activity  levels  were  measured  weekly  for  14  weeks.  The  study  found  that  66%  of 
participants  experienced  a  lapse  (defined  as  not  exercising  for  1  week)  and  41 % 
S3 experienced a relapse (defined a not exercising for 3 or more consecutive weeks) over 
the 14 monitored weeks. Participants who experienced a relapse reported significantly 
fewer behavioural and cognitive strategies to  cope  with  high-risk situations compared 
to  participants  who  did  not  relapse.  These  findings  suggest  that  acquiring  effective 
strategies to cope with exercise barriers may prevent relapse. 
The  relapse  prevention  model  has  been  used  to  improve exercise  adherence  in  the 
I  I t·  147;150;155  B  I'  genera  popu a Ion.  e Isle reported that relapse  prevention training increased 
attendance at a ten week exercise programme and improved maintenance of exercise 
for 12 weeks following  programme completion.
150  King 155  evaluated the  effect of self-
monitoring and relapse prevention techniques on maintenance of physical activity for 6 
months in  a group of healthy subjects who had completed a six month programme of 
moderate  intensity  home-based  exercise.  Fifty-one  subjects  were  randomised  to 
receive  strategies for maintaining exercise adherence,  including  daily self-monitoring 
of activity and  relapse prevention or a comparison group who underwent weekly self-
monitoring  of activity.  The  results  revealed  that  the  intervention  group  engaged  in 
significantly  more  exercise  sessions  over  the  6-month  period  compared  to  the 
comparison  group.  Therefore,  daily  self-monitoring  of  activity  levels  and  relapse 
prevention training improved exercise adherence. 
The  research  suggests  that  relapse  prevention  training  is  an  effective  strategy  for 
improving  exercise  adherence  in  the  general  population.  Despite  the  high  dropout 
rates  from  cardiac  rehabilitation  exercise  programmes  and  poor  long-term 
maintenance  of  physical  activity  following  programme  completion,  there  is  limited 
research on the effect of relapse prevention training on exercise adherence in cardiac 
rehabilitation settings.  Relapse prevention training  154  involves teaching individuals that 
a lapse from exercising (e.g.  missing an  exercise session)  need  not lead to  a relapse 
(e.g.  missing a week without exercising) and a lapse can be prevented from escalating 
into  a  complete  relapse  (e.g.  return  to  a  sedentary  lifestyle).  The  individual  is 
encouraged to identify situations that are  likely to  lead to  a lapse.  Potential  high-risk 
situations relevant to exercise include bad weather,  an increase in work commitments, 
change  in  routine,  injury or illness.  Individuals  are  encouraged  to  develop  a plan  to 
cope with these high risk situations; for example the plan for coping with  bad weather 
could be using exercise video tapes, increased work commitments could be overcome 
by  rescheduling  an  activity  session  or engaging  in  a shorter  bout  of activity.  Such 
54 coping is believed to prevent escalation of a lapse into a relapse. 
Transtheoretical Model (TTM) 
The Transtheoretical Model (TIM) proposes that individuals attempting to change their 
physical activity behaviour progress through five stages of change. 156 The stages differ 
according  to  an  individual's  intention  and  behaviour,  and  have  been  labelled; 
Precontemplation  (inactive  and  no  intention to  change),  Contemplation  (inactive,  but 
intending to change in the next 6 months),  Preparation (engaging in some activity, but 
not regularly), Action (regularly physically active, but only began in the past 6 months), 
Maintenance  (regularly  active  for  more  than  six  months).  Thus,  according  to  this 
model, maintenance of physical activity is defined as being regularly active for at least 
6 months.  Movement through these stages  often  occurs  in  a cyclic pattern  because 
many individuals relapse back to an earlier stage when  attempting behaviour change. 
In  fact,  many individuals progress and  regress through the  stages of change several 
times  before  reaching  maintenance.  Action  is  an  unstable  stage  during  which 
individuals are at high risk of relapse. 
Studies  have  reported  an  increase  in  self-reported  physical  activity  and 
cardiorespiratory fitness with advancing stage of change in  healthy adults and  cardiac 
rehabilitation  participants.96;144;157-159  A  recent  meta-analysis  found  an  increase  in 
physical  activity  as  individuals  moved  to  a  higher  stage  of  change.
159 
The  largest 
increase in  physical  activity  occurred  as  subjects  moved  from  preparation  to  action, 
this is the point at which individuals engage in regular physical activity. 
Three  components  of the  TIM are  hypothesised  to  mediate  the  behaviour  change 
process. These are the processes of change, the decisional balance and self-efficacy. 
The processes of change are strategies that people use when changing their exercise 
behaviour.16o There are ten processes, which have been grouped into five experiential 
and  five  behavioural  processes and  a description  of each  is  provided  in  Table  6.  In 
1992,  Marcus  developed  a  questionnaire  to  measure  the  use  of  each  process  of 
change  for  individuals  who  were  in  different  stages  of  change  for  exercise 
behaviour.
16o 
55 Table 6: Processes of Exercise Behaviour Change  160 
Process of Change  Definition 
Experiential 
Consciousness raising  Efforts  by  the  individual  to  seek  information  and  gain 
understanding  and  feedback  about  physical  activity  (e.g. 
reading articles about exercise to learn more on it). 
Dramatic relief  Emotional  experiences  related  to  physical  inactivity  and  its 
consequences  (e.g.  warnings  about the  health  hazards  of 
inactivity emotionally affect the person). 
Environmental 
reevaluation 
Self-reevaluation 
Social liberation 
Behavioural 
Counterconditioning 
Helping relationships 
Reinforcement 
management 
Self-liberation 
Stimulus control 
Evaluation  by  the  individual  of  how  inactivity  affects  the 
physical  and  social  environment  (e.g.  the  person  wonders 
how their inactivity affects others). 
Emotional and cognitive reevaluation by the individual of the 
values  of  physical  activity  (e.g.  what  are  the  benefits  of 
physical activity to me?). 
The  individual's  awareness,  availability  and  acceptance  of 
physical  activity  in  society  (e.g.  awareness  of changes  in 
society that make it easier for the exerciser). 
Substituting  situations  of inactivity for physical  activity  (e.g. 
taking the stairs instead of the lift). 
Trusting and  using the support of others during attempts to 
change physical activity behaviour (e.g.  having a friend who 
encourages the person to exercise). 
Changing  the  contingencies  that  control  or  maintain 
inactivity  (e.g.  the  person  rewards  himself or herself when 
they exercise). 
The  individual's  commitment  to  physical  activity  (e.g.  the 
individual makes commitments to exercise). 
Control  of  situations  that  trigger  inactivity  (e.g.  individual 
removes things that contribute to inactivity). 
56 A recent meta-analysis  159  found that use  of the processes of change vary  across the 
five stages of change, as depicted in Figure 1. The use of experiential and behavioural 
processes  increases with  advancing  stage,  with  the  largest  increase  occurring  from 
precontemplation to contemplation and  preparation to action.  Furthermore, the use of 
behavioural  processes  is  more  important  than  experiential  processes  from  the 
contemplation stage onwards. There is little change  in  process use from the  action to 
maintenance  stages,  implying  that maintenance of physical  activity  does  not  require 
further  changes  in  experiential  and  behavioural  strategies,  or  that  individuals  use 
additional  strategies  to  those  proposed  by  the  processes  of  change.  Similarly,  an 
observational  study  of patients  who  had  previously  attended  a cardiac  rehabilitation 
programme  found  that the  experiential  and  behavioural  processes  were  used  more 
frequently  with  advancing  stage  of  exercise  behaviour  change.
144  In  contrast,  Jue 
reported  no  significant difference  in  process  use  among  the  five  stages  of exercise 
behaviour change in  a group of elderly patients after CABG.
161  However, the process 
of  change  questionnaire  was  developed  for  a  younger,  working  population,  and 
therefore may not be valid for an elderly, retired population. 
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Figure  1  Relationship  between  the  stages  and  processes  of  exercise 
behaviour change  159 
PC  = Precontempl~tion, C = Contemplation,  P = Preparation,  A = Action,  M = 
Maintenance. 
A  longitudinal  study  measured  changes  in  the  stages  and  processes  of change  for 
exercise behaviour from  baseline to 6 months  in  a group of healthy subjects.
162 At 6 
months,  subjects  were  categorised  into  four groups;  stable  sedentary  (remained  in 
either  precontemplation  or  contemplation  at  both  assessments),  stable  active 
(remained  in  preparation,  action  or  maintenance  at  both  assessments),  adopters 
(progression  from  precontemplation,  or  contemplation  to  preparation,  action  or 
maintenance),  and  relapsers  (regression  from  preparation,  action  or maintenance to 
either contemplation or precontemplation).  This study found that process use did  not 
change  for  subjects  in  the  stable  active  or stable  sedentary  categories.  However 
process use was  significantly greater for subjects who  remained  active compared to 
those  who  stayed  inactive  over  the  study  period.  Subjects  in  the  adoption  group 
reported  a significant increase  in  the use  of experiential  and  behavioural  processes, 
whereas  those  in  the  relapse  group  reported  a significant  decline  in  the  use  of  all 
behavioural  processes  and  1 experiential  process  (dramatic  relief). These  findings 
suggest  that  continued  use  of behavioural  strategies  may  be  important  to  prevent 
relapse. Furthermore, a significant decline in dramatic relief among relapsers suggests 
that belief in the health benefits of physical activity may decrease considerably when 
58 individuals  are  no  longer physically  active  or that inactivity  is  no  longer seen  as  an 
emotional issue. 
Decisional balance involves a comparison of the  perceived  costs (cons) and  benefits 
(pros) of engaging in a behaviour. As previously described, studies have demonstrated 
a  significant  relationship  between  exercise  adherence  and  perceived  benefits  and 
barriers to exercise in patients with CHD.142-144 Decisional balance is also related to the 
t  f  .  b h'  h  144'159'163'164  159  sage 0  exercise  e  aVlour c  ange.  '  ,  ,  The meta-analysis  reported that the 
pros  of exercise increase with  advancing  stage  of change,  with the  largest increase 
evident  from  the  precontemplation  to  the  contemplation  stage  (see  Figure  2).  The 
perceived  cons  of change  decreased  across  the  stages,  with  the  most pronounced 
decline  occurring  from  precontemplation  to  contemplation.  Therefore,  it  seems  that 
increasing the pros of exercise and  decreasing the cons to  exercise are important to 
enhance  behaviour  change.  Similarly,  Hellman  reported  a decline  in  the  perceived 
barriers  to  exercise  and  an  increase  in  the  perceived  benefits  of  exercise  with 
advancing  stage  of change  in  a  group  of patients  who  had  previously  attended  in-
patient cardiac rehabilitation.144 
Self-efficacy was integrated into the TIM from  Bandura's Self-Efficacy Theory,145  and 
is  defined  as  an  individual's  confidence  in  his  or  her  ability  to  perform  a  specific 
behaviour.  As  previously  discussed,  self-efficacy  is  an  important  determinant  of 
exercise  compliance  in  cardiac  rehabilitation. 95;142  Findings  from  a  recent  meta-
analysis  demonstrated  a  significant  relationship  between  exercise  self-efficacy  and 
stage of change, as illustrated in Figure 3. The graph shows that exercise self-efficacy 
increases  with  each  forward  movement  in  stage  of  change.  Individuals  in  the 
precontemplation  stage  demonstrate  the  lowest  self-efficacy,  whereas  those  in 
maintenance  have  the  highest  self-efficacy.  Furthermore,  the  relationship  between 
exercise self-efficacy and stage of change is  nonlinear,  and  self-efficacy seems to be 
especially  important when  moving  from  action  to  maintenance.  Similarly,  Hellman  144 
reported  that  exercise  self-efficacy  is  significantly  related  to  stage  of  exercise 
behaviour change in cardiac rehabilitation participants. 
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Figure 2  Relationship between  decisional balance and  the stages of exercise 
behaviour change.
159 
PC  =  Precontemplation,  C  =  Contemplation,  P  =  Preparation,  A  =  Action,  M  = 
Maintenance. 
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Figure 3 Relationship between self-efficacy and the stages of exercise behaviour 
change.
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60 Application of  the Transtheoretical Model 
Cardiac Rehabilitation 
Recently,  Bock
96 
measured the components of the TIM and  physical  activity by  self-
report  in  62  cardiac  patients  at  the  beginning  and  end  of  a  12  week  phase  II 
supervised  exercise  programme  and  at  three  months  follow  up.  At  the  beginning  of 
phase  II,  43%  of  participants  were  in  the  action  and  maintenance  stages  (i.e. 
accumulating a weekly minimum of 30 minutes of moderate activity on  most days). At 
the end of the  programme,  96%  of participants were  in  the  action  and  maintenance 
stages and  self-reported physical  activity had significantly increased.  Moreover,  there 
were significant increases in  exercise self-efficacy, the use of behavioural processes, 
and a significant reduction in the perceived barriers to exercise, with no change in the 
use  of experiential  processes  or perceived  benefits  of exercise.  Three  months  after 
programme  completion,  the  proportion  of  patients  in  the  action  and  maintenance 
stages  had  decreased  to  80%  and  nearly  50%  of  participants  had  reduced  their 
physical  activity  compared  to  the  end  of  the  programme.  Individuals  who  had 
regressed at the  ~ month follow-up had significantly lower scores for self-efficacy, use 
of behavioural processes,  and  more negative decisional balance scores at the end  of 
the programme compared to participants who remained physically active at 3 months. 
Thus,  maintenance of exercise behaviour after completion  of a cardiac rehabilitation 
exercise programme appears to be associated with changes in self-efficacy, decisional 
balance  and  behavioural  processes.  The  findings  suggest  that  enhancing  these 
components  of  the  TIM  may  promote  maintenance  of  physical  activity  after 
programme completion.  However,  there is  limited  research  investigating the effect of 
interventions  based  on  this  model  to  improve  maintenance  of  physical  activity  in 
cardiac rehabilitation. 
General Population 
Interventions  based  on  the  TIM  have  been  shown  to  be  effective  in  improving 
adoption  and  maintenance  of  physical  activity  In  the  general 
population.60;74;77;165;166;166;167;167;168;168  These  Interventions  use  the  concept of matching 
treatment  to  the  individual's  stage  of  change  for  exercise  behaviour.  Marcus 
randomised  194 sedentary adults to  receive  either an  individualised,  stage-matched 
intervention  or a standard  intervention  over a 6-month  period.
167 
The  stage-matched 
intervention  involved  providing  participants  with  individualised  feedback  about  their 
physical activity behaviour and stage-matched self-help manuals, which were designed 
61 to enhance the components of the TIM. The standard intervention involved providing 
participants with standard self-help booklets to promote physical activity, developed by 
the American Heart Association. A significantly greater proportion of participants in the 
stage-matched  group  were  regularly  active  and  had  reached  the  action  stage 
compared  to  individuals  receiving  standard  treatment  at  6 months.  In  addition  self- , 
reported physical activity had  increased significantly more in the stage-matched group 
compared  to  the  standard  group  at  6  months.  In  a  follow-up  to  this  study,  a 
significantly  greater proportion  of participants  who  had  received  the  stage-matched 
intervention  were  regularly  active  and  were  in  the  action  or  maintenance  stages  6 
months after the intervention period compared to subjects who  received the standard 
intervention.
168  These  findings  suggest that an  intervention tailored  to  an  individual's 
stage of exercise behaviour change was more effective than a standard intervention in 
improving  adoption  and  maintenance  of  physical  activity  in  a  group  of  sedentary 
healthy adults. 
In  summary,  the transtheoretical  model  proposes  that  by  identifying  an  individual's 
stage  of exercise  behaviour  change,  key  components  such  as  the  processes  of 
change,  exercise self-efficacy and decisional balance can  be influenced to encourage 
stage progression and  relapse  prevention.  For example,  maintaining  physical  activity 
and  preventing  relapse  may  require  continued  use  of  behavioural  processes  and 
enhancing self-efficacy. 
Overall,  several  theories  have  been  used  to  understand  and  explain  adherence  to 
exercise in healthy subjects and in cardiac rehabilitation settings. These theories have 
identified  a  number of factors  influencing  participation  in  physical  activity  including: 
social support, exercise self-efficacy, perceived behavioural control, perceived benefits 
of exercise, perceived barriers to exercise, ability to cope with high risk situations,  and 
use  of cognitive  and  behavioural  processes.  In  addition,  the  evidence  suggests that 
interventions  based  on  theoretical  models  of  behaviour  change  such  as  social 
cognitive  theory,  the  relapse  prevention  model  and  the  transtheoretical  model  are 
effective  in  increasing  and  maintaining  physical  activity  in  the  general  population. 
Effective  compliance  enhancing  strategies  include;  goal  setting,  decision  balance 
sheets,  enhancing  exercise  self-efficacy  and  social  support,  self-monitoring,  written 
agreements,  relapse  prevention  training,  and  enhancing  the  use  of  cognitive  and 
behavioural processes. In contrast, there is little research on the effect of theory-based 
62 interventions to encourage maintenance of physical activity after completion of formal 
cardiac rehabilitation. 
Physical Activity Counselling 
Recent cardiac rehabilitation guidelines9 by the American Heart Association and the 
American Association of Cardiovascular and  Pulmonary Rehabilitation  recommend 
that physical activity counseling should be a core component of cardiac rehabilitation 
programmes to promote an  active  lifestyle for patients with  CHD.  Physical  activity 
counselling should include an  evaluation of the individual's current physical  activity 
level, stage of change, self-efficacy, barriers to increasing physical activity and social 
support in  making positive changes.  Interventions should include providing support, 
advice  and  counselling  about  physical  activity  needs,  and  set  goals  to  increase 
physical activity that include 30 minutes per day of moderate physical activity on  ~5 
days  a  week.  In  addition,  patients'  daily schedules should  be  explored  in  order to 
suggest  how to  incorporate  physical  activity  into  their  daily  routine;  e.g.  parking 
farther away from. entrances, walking up 2 or more flights of stairs and walking for 15 
minutes during lunch breaks. 
Physical  activity  counselling  is  based  on  the  transtheoretical  model  of  behaviour 
change and social cognitive theory.  In addition, this approach is closely linked with the 
1995  physical  activity  recommendations  of accumulating  30  minutes  of  moderate 
intensity physical  activity  on  most  days  of the  week.  Thus,  these  interventions  use 
stage-matched  strategies  to  encourage  participants  to  integrate  moderate  intensity 
physical  activity  into  their  daily  lives.  Physical  activity  counselling  has  produced 
improvements  in  stage of exercise  behaviour change  and  physical  activity  levels  in 
initially sedentary healthy adults.169-173 
Exercise Consultation 
In  1995,  Loughlan  and  Mutrie  174  developed  a  set  of  guidelines  on  exercise 
counselling  of  sedentary  adults.  This  intervention,  known  as  the  exercise 
consultation  is a client-centred one to one counselling approach.  It  is  based on the  , 
transtheoretical  model  and  social  cognitive  theory  and  comprises  strategies  to 
increase  and  maintain  physical  activity.  Several  randomised-controlled  trials  have 
investigated the effect of the exercise consultation on  physical activity adoption and 
adherence.  Loughlan  and  Mutrie  175  showed  that  the  exercise  consultation  was  as 
63 effective as standard fitness assessments in increasing physical activity at 3 months. 
Though  these  initial  increases  in  activity  were  not  maintained  at  6  months  in  the 
fitness  assessment group,  the exercise  consultation  group were  significantly  more 
active  at  6  months  compared  to  baseline.  In  a similar study,  Lowther  and  Mutrie 
reported that participants who had received an exercise consultation remained more 
active  compared  to  participants  receiving  the  fitness  assessment,  who  had 
regressed  to  baseline  values  at  1-year fo"ow_up.176  Kirk  et  al  found  in  a group  of 
sedentary  people  with  type  2  diabetes  that  an  exercise  consultation  significantly 
increased physical activity assessed by self-report and  accelerometry from  baseline 
to  six  months  compared  to  standard  exercise  information. 177  In  addition,  these 
improvements were  maintained from  six to  12  months  in  the  exercise consultation 
group.  Results  from  these  trials  suggest that  the  exercise  consultation  may  be  a 
successful intervention for long-term maintenance of physical activity.17s;176 
The  exercise  consultation  intervention  was  initially  aimed  at  sedentary  individuals, 
however  recently  strategies  to  prevent  relapse  were  incorporated  into  the 
consultation procedure to  enhance maintenance of physical  activity.  A pilot study178 
demonstrated  that  the  exercise  consultation  significantly  improved  short-term 
exercise adherence during phase IV cardiac rehabilitation in  a group of patients who 
had completed a phase "I supervised exercise programme. 
SUMMARY OF SECTION TWO 
In  summary,  theoretical  models  of  behaviour  change  have  identified  a  number  of 
factors  that  influence  participation  in  physical  activity  in  the  general  population  and 
cardiac rehabilitation settings.  Furthermore, interventions based on theoretical models 
such  as  the  TIM,  SCT  and  relapse  prevention  are  effective  in  increasing  and 
maintaining physical activity. Current traditional phase III  rehabilitation programmes do 
not  facilitate  independent  exercise  after  programme  completion.  However,  the 
research  is  limited  on  effective interventions to  encourage  long-term  maintenance of 
physical  activity  after  completion  of  cardiac  rehabilitation  exercise  programmes. 
Physical  activity counselling  and  exercise  consultation,  based  on  the  TIM, SCT  and 
relapse  prevention  training,  use  evidence-based  strategies  to  increase  and  maintain 
physical activity.  In  addition,  these intervention are closely linked to the  1995 physical 
activity  guidelines,  thus  encourage  individuals to  integrate moderate  intensity  activity 
into  their  daily  lives,  which  may  overcome  the  many  barriers  associated  with 
64 supervised  exercise  programmes.  A  pilot  study  found  that the  exercise  consultation 
improved short-term maintenance of physical activity following  completion of a phase 
III  exercise programme.
178  However,  the long-term effect of the exercise consultation 
on maintenance of physical activity after programme completion has not been studied. 
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MEASUREMENT OF PHYSICAL ACTIVITY 
The primary aim  of this study is to  evaluate the effect of an  exercise consultation  on 
maintenance  of  physical  activity  following  completion  of  a  phase  III  cardiac 
rehabilitation  exercise  programme.  Therefore,  to  detect changes  in  this  variable  it  is 
important to  accurately  measure  physical  activity.  This  section  reviews  the  methods 
that  have  been  commonly  used  to  measure  physical  activity.  This  review  was  then 
used to select the  most appropriate  methods to  measure these  outcomes  based  on 
the requirements of the study. 
Components of Physical Activity 
Physical  activity  is  a  complex,  multidimensional  behaviour,  which  is  difficult  to 
measure.  Physical  activity  has  been  defined  as  "any  bodily  movement  produced 
skeletal muscles that results in energy expenditure.,,182 Therefore, physical activity can 
be  quantified  by  measuring  energy  expenditure,  either  directly  (e.g.  using  doubly 
labelled water)  or indirectly (e.g.  measuring bodily movement using  motion sensors). 
Physical  activity  has  three  dimensions;  frequency,  intensity  (light,  moderate  or 
vigorous) and duration, which are associated with health and fitness.? Physical activity 
can  be  performed in  a number of different settings including  leisure-time,  housework, 
and  occupation. 182  Although  exercise  is  often  used  interchangeably  with  physical 
activity,  it  is  actually  a subcategory  of physical  activity.  Exercise  is  physical  activity, 
which  is  planned,  structured  and  undertaken  to  improve  or  maintain  one  or  more 
components of physical fitness. Physical fitness has been defined as a set of attributes 
(e.g.  cardiorespiratory  fitness,  muscle  strength  and  flexibility)  that  people  have  or 
achieve that  relates  to  the  ability to  perform  physical  activity.  Although,  more  active 
people tend to  be fitter,  physical fitness and the ability to improve fitness with training 
have a sizeable hereditary component and  are affected by gender,  ageing and  habits 
other than  physical  activity.183  Therefore,  measuring fitness to  quantify an  individual's 
physical  activity  has  its  limitations.  Overall,  physical  activity  involves  various 
components,  most or all  of which  may need to be  recorded to  accurately quantify an 
individual's  physical  activity  behaviour.  Accurate  measurement of physical  activity  is 
required to  determine the  proportion  of a study  population  meeting  current  physical 
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;8  and  to  examine  the  effectiveness  of  physical  activity 
interventions. 
Methods to Measure Physical Activity 
There are numerous methods available to  measure physical activity,  making it difficult 
for researchers to select the most appropriate method(s).  Physical  activity measures 
can  be  divided  into  subjective  (e.g.  recall  questionnaires,  and  activity  diaries)  and 
objective  methods  (e.g.,  doubly  labelled  water,  indirect  calorimetry,  pedometers, 
accelerometers and heart rate monitoring). The method selected to  measure physical 
activity in  intervention  studies  needs to  be  valid,  reliable,  and  responsive  to  change, 
without influencing an individual's behaviour. 
Validity is the extent to which  a method measures what it  is  designed to  measure. 184 
Testing  the  validity  of a  method  involves  comparing  it  with  another physical  activity 
measure,  known  as the criterion method.  In  addition,  the method  has to  demonstrate 
good reliability.184 A reliable method consistently provides the same results  under the 
same  conditions.  Reliability  of a  method  can  be  tested  by  repeatedly  measuring  a 
physical activity bout on the same subjects, this is known as test-retest reliability.  High 
reliability is important in  intervention studies to ensure that changes in  physical activity 
are caused by the intervention,  and  not because of variation  in  activity scores due to 
low  reliability.185  Finally,  to  obtain  a good  estimate  of an  individual's  physical  activity 
habits,  a  minimum  of 5  or 6  days  of recordings  are  required. 186  This  is  because 
physical  activity varies from day to  day,  and  measuring  physical  activity over several 
days reduces this variability. Furthermore, if the study population includes subjects that 
are working, then both week and weekend days must be sampled.
186 
A number of methods can be  used to measure physical activity,  which  are discussed 
below. 
Indirect Calorimetry 
I  ndirect calorimetry estimates energy expenditure by directly measuring oxygen uptake 
(V02)  and carbon dioxide production (VC02).183 This method can  be conducted in two 
ways;  using  a  whole  room  calorimeter  or  a  metabolic  cart.  Whole  room  indirect 
calorimeter is an  airtight room, which is usually equipped with a desk, chair, toilet, sink, 
TV, a bed and a stationary bike etc. Oxygen uptake and carbon dioxide production are 
67 measured from expired gas and  used to calculate energy expenditure.  A whole room 
calorimetry  accurately  measures  energy  expenditure,187  however  these  rooms  are 
expensive to build and operate, they are confining,  and  some types of activity cannot 
be performed, such as gardening or sports. Thus, whole room  calorimeters cannot be 
used to measure physical activity habits under free living conditions. 
Energy expenditure can  also  be  estimated  by  measuring  oxygen  uptake and  carbon 
dioxide  production  in  expired  air  using  a metabolic  cart. 183  With  this  procedure,  the 
subject wears a face mask or nose clip and mouthpiece. Stationary metabolic carts are 
used in the laboratory to estimate energy expenditure at rest,  during treadmill or cycle 
exercise,  and  other laboratory-based activities.  Portable metabolic carts  can  be  used 
to estimate the energy cost of field-based activities. However, portable systems cannot 
be  used  to  measure  habitual  physical  activity  in  free-living  conditions  due  to  the 
limitations of the equipment. 
Doubly Labelled Water (DLW) 
Doubly labelled water (DLW) can  be  used to measure total energy expenditure (TEE) 
for 1 to 3 weeks under free living conditions. 188  DLW consists of the stable isotopes of 
water 2H20  and H2
180, which is ingested by the subject as a liquid. Elimination of these 
isotopes  in  water  (e.g.  urine,  sweat  or  saliva)  and  CO2  is  analysed  using  mass 
spectrometry over several  days,  and  energy expenditure and  oxygen  uptake can  be 
estimated from  CO2  production  using  established equations.  Physical  activity  related 
energy  expenditure  is  calculated  by  subtracting  the  resting  metabolic  rate  and  the 
thermic  effect  of food  from  total  energy  expenditure.  The  DLW  method  accurately 
measures energy expenditure, therefore it is  considered to be the "gold standard" for 
measuring  energy expenditure  under free-living  conditions.
188 
However,  this  method 
has limited applicability for measurement of physical activity in intervention studies and 
epidemiology based trials of large populations because the stable isotope of water is 
expensive,  and  the  analysis  of samples  using  the  mass  spectrometer  is  costly  and 
complex.  Moreover,  as  DLW  measures  energy  expenditure,  it  does  not  provide 
information on physical activity patterns (i.e. intensity, duration or frequency). However, 
DLW  has  been  used  to  validate  other instruments  because  it  accurately  measures 
energy expenditure. 
Overall,  indirect calorimetry and doubly labelled water are frequently used as criterion 
68 methods  to  validate  other  physical  activity  measures,  such  as  motion  sensors  , 
questionnaires and heart rate monitors. 
Motion Sensors 
Motion sensors,  such as  pedometers and  accelerometers  are devices that measure 
physical activity by detecting motion or acceleration of a limb or trunk,  depending on 
the placement of the monitor on the body.189 
Accelerometers 
When a person moves, the limbs and body are accelerated, theoretically in  proportion 
to  the  muscular  forces  responsible  for  the  accelerations  and  thus  to  energy 
expenditure.
189 
Portable accelerometers measure these accelerations caused by bodily 
movement  in  either  one  (uniaxial)  or  three  (triaxial)  directions.  A  number  of 
accelerometers, varying  in  size,  cost and weight are commercially available,  such as 
the  Caltrac,  Computer  Science  and  Applications  and  the  Tritrac.  Accelerometers 
record  activity  counts,  which  are  the  product  of  the  frequency  and  intensity  of 
movement,  sampled  at  set intervals.  They have  a  large  memory capacity,  thus  are 
able to store minute by minute data for several weeks.  In  addition, the accelerometer 
recordings can be used to estimate oxygen uptake, energy expenditure, and the time 
spent  engaging  in  light,  moderate  and  vigorous  physical  activity  using  established 
regression equations. 
Uniaxial accelerometers 
Uniaxial  accelerometers  detect bodily  accelerations  in  the  vertical  (z)  direction,  and 
have  been  widely  used  in  research  to  assess  physical  activity.190  The  Computer 
Science and Applications (CSA) is a uniaxial accelerometer, which has been frequently 
used  in  physical  activity  studies  due  to  its  small  size,  lightweight,  ease  of  use, 
durability, large memory capacity and can be worn on the ankle, wrist or waist. Studies 
have found that the CSA accelerometer is very reliable for measuring physical activity. 
Melanson assessed the test-retest reliability (r=0.93 to 0.99) of the CSA accelerometer 
worn  on  the  waist,  ankle  and  wrist  by  colleding  CSA  recordings  during  treadmill 
walking and jogging on  two separate occasions in  a group of healthy subjects.  High 
correlation  coefficients,  ranging from 0.93 to  0.99 between CSA recordings collected 
during repeat testing were reported in this study.  In  addition, no significant differences 
were observed  between  CSA activity counts recorded  during  repeat testing  of field-
69 based  activities. 191  Fairweather  tested  the  inter-instrument  reliability  of  the  CSA 
accelerometer  by  attaching  CSAs  to  a  mechanical  accelerometry  system,  which 
simulated  body  movement.  A  minimal  difference  (3%)  was  observed  between  CSA 
accelerometers attached to this system.192 
The  validity  of the  CSA  accelerometers  to  measure  physical  activity  and  estimate 
energy  expenditure  has  been  studied  under  laboratory  conditions  in  adults  and 
h'ld  193-195  M  I  193  .. 
C  I  reno  e anson  assessed the validity of the CSA accelerometer worn  at all 
three attachment sites against direct measurement of V02 during treadmill walking and 
jogging  in  a group of young  adults.  The  study found  a significant increase  in  activity 
counts  from  the  monitors  attached  to  all  sites  with  increaSing  treadmill  speed. 
Furthermore,  significant linear correlations  (r > 0.80) were  observed  between  activity 
counts  and  measured  V02  and  energy  expenditure  during  walking  and  jogging.  In 
contrast,  there was  no  significant relationship between  activity  counts  and  measured 
V02  or energy expenditure for changes  in  the  gradient of the  treadmill  at  a constant 
speed. Therefore, the CSA accelerometer detected changes in treadmill speed but not 
gradient.  Other  studies  have  demonstrated  that  the  CSA  accelerometer  is  a  valid 
instrument  for  estimating  energy  expenditure  during  treadmill  walking  and  jogging 
under  controlled  laboratory  conditions.
190
;193-195  Freedson  developed  a  regression 
equation to estimate energy expenditure from activity counts recorded during treadmill 
walking  and  jogging  in  a  group  of young  adults.
195  The  study  found  no  significant 
difference  between  estimated  and  measured  energy  expenditure  during  treadmill 
exercise. Similarly, Trost found that the CSA accurately estimated energy expenditure 
during treadmill exercise in a group of children.
194 
The validity of the CSA to  measure physical activity and  estimate energy expenditure 
has also been  examined in  field  settings.
191
;196-199  Hendleman  191  reported a significant 
correlation (r = 0.77) between accelerometer recordings and oxygen uptake measured 
by  indirect  calorimetry  during  overground  walking  at  a range  of self-paced  speeds. 
These  accelerometer recordings  measured  during  overground  walking  were  used  to 
develop individual regression  equations to estimate oxygen  uptake.  These equations 
were  used  to  estimate  V02  from  activity  counts  recorded  during  golf,  washing 
windows,  vacuuming,  lawn  mowing,  dusting  and  planting  shrubs.  The V02  estimated 
from  activity counts was significantly lower than  measured V02  for all  activities.  The 
difference between measured and predicted V02 ranged from  30.5% for golf to 56.4% 
70 for planting shrubs. Other studies have found that the CSA significantly overestimated 
the energy cost (METs) of walking  196  and  significantly  underestimated the  metabolic 
cost of leisure, recreational and household activities. 191;196;197 
The CSA has been compared with DLW to measure total and  physical activity related 
d't  198;199  L  198  energy  expen  lure.  eenders  found  that  total  daily  energy  expenditure 
estimated from CSA recordings was significantly lower by 59%,  compared to energy 
expenditure  measured  using  the  DLW  method  in  a  group  of  13  healthy  women. 
Furthermore,  a  modest correlation  (r = 0.45)  between  measured energy expenditure 
and  activity  counts was  reported.  In  contrast,  Ekelund199  documented that  the  CSA 
accurately estimated total  and physical activity related energy expenditure in  a group 
of children.  However, a significant proportion (40% to  55%) of the variation in  energy 
expenditure was not explained by activity counts. 199 
In  summary,  strong  linear correlations  have  been  observed  between  activity  counts 
collected  at the  t~ree attachment sites  and  measured  V02 and  energy expenditure 
during level walking and jogging on a treadmill and overground walking.193-195 However, 
poor  to  modest  correlations  have  been  observed  between  activity  counts  and 
measured V02 and energy expenditure during uphill walking  on  a treadmill and field-
based  activities.191;196  Furthermore,  the  CSA  accelerometers  substantially 
underestimated  the  energy  cost  of household,  gardening  and  leisure  activities  and 
d·  d  f  I"  d't'  191'196-198  energy expen  Iture un  er  ree- Ivmg con  I Ions.  ' 
Triaxial accelerometers 
Human  movement is  multi-directional,  thus measuring  accelerations  in  three  planes 
may provide a more accurate assessment of physical activity and energy expenditure 
compared  to  measuring  movement  in  one  direction.
189 
The  Tritrac  is  the  most 
commonly  used  triaxial  accelerometer and  measures  accelerations  in  the  anterior-
posterior (x),  medio-Iateral (y),  and vertical (z) direction. The test-retest reliability of the 
200'  .  .  200-203  t  .  202 
Tritrac has  been  demonstrated at rest,  dUring  treadmill  exerCise,  s epping, 
and stationary cycling.202  However, a study assessing the inter-instrument reliability of 
the  Tritrac,  found  a  220/0  difference  in  activity  counts  between  two  monitors  during 
treadmill walking.  204 
Similar to the CSA,  the Tritrac is  able to detect changes in  treadmill  speed,201;205  but 
71 not  gradient.201 ;206  Studies  .  h  assessing  t  e  validity  of the  Tritrac  to  estimate  energy 
expenditure  during  laboratory-based  activities  have  reported  inconsistent 
f  d'  201'202'205'206  207 
In  Ings.  '  ,  ,  Sherman  found that compared to measured energy expenditure, 
the  Tritrac  accurately  estimated  energy  expenditure  at  rest  and  during  treadmill 
exercise at 3 different speeds at 0%  gradient in  a group of young  adults,  In  contrast  , 
other  researchers  observed  that  the  Tritrac  Significantly  overestimated  energy 
expenditure  during  treadmill  walking  at  0%  gradient,201;202  and  significantly 
underestimated  energy  expenditure  during  treadmill  walking  at  an  incline,  stepping, 
t  t·  I'  d  I'  .  201'202'206  S a lonary  cyc lng,  an  s Ideboardlng.  '  ,  These  conflicting  findings  indicate  that 
estimating  energy  expenditure  with  the  Tritrac  may  depend  upon  the  activity 
performed,  or the  placement  of the  Tritrac;  on  the  hip201;202  compared  to  the  lower 
back.205 
Chen  187  evaluated  the validity  of the  Tritrac to  estimate  energy expenditure  using  a 
whole  room  calorimeter,  thus  simulating  conditions  that  were  close  to  free  living. 
Compared  to  measured  energy expenditure,  the  Tritrac  significantly  underestimated 
total  and  physical  activity  energy  expenditure.  The  Tritrac  manufacturer's  prediction 
equation  was  used  to  estimate  energy  expenditure  from  accelerometer  recordings, 
However,  Chen  discovered that the  estimations  of total  and  physical  activity  energy 
expenditure were significantly improved when their own prediction equation was used. 
The investigators concluded that the inaccurate estimates of energy expenditure from 
the Tritrac were due to the equation used to predict energy expenditure. 
The validity of the Tritrac to measure physical activity and estimate energy expenditure 
has  been  tested  in  under free-living  conditions. 191;198  Compared  to  DLW,  the  Tritrac 
significantly underestimate energy expenditure by 35%.198 Furthermore, only a modest 
correlation was found between measured energy expenditure and Tritrac recordings (r 
=  0.54).  Similarly,  Hendelman  191  reported that the Tritrac significantly underestimated 
the  energy cost  of various  household  and  leisure  activities,  The  difference  between 
measured  and  predicted  METs  ranged  from  32.1 %  for  golf to  53.1 %  for  planting 
shrubs. 
Limitations of  accelerometers 
There are limitations of accelerometers for measuring  physical  activity.  Firstly,  these 
devices  are  designed  to  measure  acceleration  during  bodily  movement,  thus  static 
72 work  such  as  lifting  objects  cannot  be  accurately  quantified  by  accelerometers,  In 
addition,  activities that increase energy expenditure without a proportional increase in 
bodily  acceleration  such  as  walking  uphill  will  not  be  detected  by  accelerometers,193 
These instruments cannot be worn  in  water,  thus will  not be  able to  record  swimming 
or  other water  activities.  Additionally,  accelerometers  may  not  record  upper  body 
movement,  unless  they  are  worn  on  the  wrist.  Overall,  as  accelerometers  cannot 
detect all  types of physical activity,  they will  be  unable to accurately estimate energy 
expenditure in free-living conditions. Additionally, the inaccurate estimations of oxygen 
uptake  and  energy  expenditure  from  accelerometers  may  be  due  to  the  equations 
used to predict these parameters from accelerometer recordings. The equations were 
developed from  accelerometer readings  and  oxygen  uptake recorded  during  walking 
and jogging under controlled laboratory conditions.  However, the relationship between 
activity  counts  and  oxygen  uptake  under  laboratory  conditions  differs  from  the 
relationship in  field settings.  For example,  a lower correlation between oxygen uptake 
and  activity  counts  was  observed  for  overground  walking  compared  to  treadmill 
walking. 191  Furthermore,  the  relationship  between  accelerometer counts  and  oxygen 
uptake or energy expenditure may be specific to a given type of activity.  For example, 
a stronger relationship between activity counts and V02 was observed for walking  193-195 
d  th  t· 't'  (  d'  d  h  k)  191'196'198  I  dd't'  compare  to  0  er  ac IVIles  e.g.  gar  emng  an  ousewor.'"  n  a  lion, 
Hendelman  191  found that the GSA and  Tritrac did  not accurately estimate the energy 
cost of various household, gardening and leisure activities using regression equations 
developed  during  overground walking.  Thus,  researchers  have  recommended  using 
the  raw  output from  accelerometers  (i.e.  activity  counts)  to  quantify  physical  activity 
rather than converting the accelerometer readings to energy expenditure. 
Comparison of  the CSA and the Tritrac 
It  has been  proposed that measurement of bodily movement in  3 directions is  better 
than  measuring  acceleration  in  one  direction.  Therefore,  studies  have  compared 
triaxial  and  uniaxial  accelerometers to  determine whether one  instrument is  superior 
for measuring  physical  activity.191;198;203;208  A  slight  improvement  in  the  estimation  of 
V02 and  energy  expenditure was  observed  with  the  Tritrac  compared  to  the  GSA, 
.  198;208  I 
although  both  monitors  still  significantly  underestimated  energy  expenditure,  n 
contrast,  Welk203  found  that  the  GSA  accurately  estimated  METs  during  treadmill 
walking at 3 different speeds on the level, whereas the Tritrac did not.  Finally,  another 
study found  that the Tritrac and  the GSA underestimated the  energy cost  of various 
73 leisure  and  household  tasks  by  a  comparable  amount. 191  Although  there  is  some 
evidence to suggest that the Triaxial  accelerometer may  provide  a better estimate of 
energy expenditure,  these findings  are  inconsistent and  both  types  of accelerometer 
do  not  accurately  estimate  V02  and  energy  expenditure  under  free-livin 
d' .  191'198'208  g 
con  Itlons.  "  Furthermore,  the  CSA  accelerometer  has  some  advantages 
compared  to  the  Tritrac for  measuring  physical  activity  under free-living  conditions. 
The CSA is  smaller,  lighter,  less  expensive  and  more compact than  the  Tritrac,  and 
can be worn on the waist,  ankle or wrist, whereas the Tritac can  be  positioned on the 
waist or lower back.  One study found that 20% of elderly subjects did not comply with 
wearing  the  Tritrac  for  at  least  3  days.20o  Therefore,  the  CSA  may  allow  for  less 
obtrusive data collection and better compliance. 
Pedometers 
Pedometers  are  small,  inexpensive  and  are  designed  to  count  steps  during 
locomotion.189  They contain  a horizontal,  spring-suspended  lever arm  that  moves  up 
and down with vertical acceleration of the body during locomotion. With each step, the 
lever arm  makes mechanical contact and  one step  is  recorded.  The output from  the 
pedometer is  in  total  steps.  Although,  some  pedometers  can  estimate total  distance 
walked, if stride length is provided, or they can estimate energy expenditure. 189 
Bassetf09  reported that the  Yamax Digi-walker was very  accurate for counting  steps 
and estimating total distance during self-paced overground walking. Hendelman  191  also 
tested the utility of the Digi-walker to assess moderate intensity overground walking. 
Pedometer  recordings  were  highly  correlated  with  actual  steps  counted  (r=0.84), 
walking speed (r=0.86) and V02 (r = 0.75).  However,  pedometers underestimate step 
frequency at slow walking speeds, as the vertical acceleration of the body during slow 
walking  may  be  too  low  to  be  captured  by  the  instrument. 191;209  In  addition, 
pedometers  underestimate the total  distance walked  at  fast walking  speeds,  despite 
accurately counting step frequency.209 This  is because stride length tends to increase 
at  fast walking  speeds.  Therefore,  estimating total  distance  walked  from  pedometry 
recordings introduces measurement error.  In addition, pedometers cannot differentiate 
.  't  f  t 189  between walking  and  running,  therefore  do  not  reflect the  Intensl y  0  movemen. 
Furthermore,  pedometers  do  not  accurately  assess  energy  expenditure  under free-
living  conditions.196-198  Leenders  198  found  that  the  Digi-walker  significantly 
underestimated physical activity energy expenditure by 59% when compared to energy 
74 expenditure assessed  by  DLW.  Additionally,  other studies  reported  that  pedometers 
significantly  overestimated  the  energy  cost  of  walkl'ng 196  d  .  'fi  an  slgnl Icantly 
underestimated the energy cost of various moderate intensity activities.196;197 
Montoye  189  stated that "pedometers were designed to  count steps  in  locomotion  and 
should  not  be  expected  to  measure  other  kinds  of  activities  or  estimate  energy 
expenditure." In agreement, the literature suggests that pedometers may be useful for 
measuring walking behaviour by  counting steps.  However,  they can  be  inaccurate at 
very slow walking speeds,  may not accurately measure total  distance walked  at very 
fast walking  speeds,  and  provide  inaccurate estimates  of energy  expenditure  under 
free-living  conditions.  These  limitations  of the  pedometer  make  it  less  suitable  for 
measuring habitual physical activity, unless walking is the predominant form of activity. 
Heart Rate Monitoring 
There  is  a linear relationship  between  heart rate  and  oxygen  uptake during  exercise 
under  laboratory ,conditions.21o  Therefore,  monitoring  heart  rate  has  been  used  to 
assess  physical  activity  by  estimating  V02 and  energy  expenditure.  Advantages  of 
heart  rate  monitoring  include  their  ability  to  measure  the  frequency,  intensity  and 
duration of physical activity.  In  addition, they are relatively inexpensive,  simple to use, 
robust,  and versatile in  a wide variety of field settings, non-intrusive and well  tolerated 
by  subjects.21o  However,  there  are  limitations  of  assessing  physical  activity  by 
monitoring heart rate.  Factors such as emotional stress, high ambient temperature and 
high humidity will raise the heart rate with little effect on  oxygen uptake. 211  In addition, 
arm exercise elicits a higher heart rate than leg exercise even though the oxygen cost 
is  the  same,  because  of the  smaller muscle mass  involved  with  arm  only  activity.197 
Individual variations in  age,  medication (e.g.  beta-blockers),  fitness  level  and  gender 
can also affect the relationship between heart rate and oxygen uptake (HR_V02 ).211 
These  individual  differences  in  the  HR-V02  relationship  resulting  from  variations  in 
age,  medication,  gender  and  fitness  can  be  overcome  by  establishing  a  HR-V02 
calibration  curve  for  each  individual.  211  This  involves  simultaneously  recording  an 
individual's  heart  rate  and  V02 responses  to  exercise  at  different  intensities  under 
laboratory conditions.  A  HR-V02 calibration  curve  is  established  for  each  individual, 
which is then used to estimate V02 and energy expenditure from heart rates recorded 
under  free  living  conditions. 197  Using  this  method,  Racette
212 
found  that  heart  rate 
75 monitoring  produced  similar  estimates  for total  and  physical  activity  related  energy 
expenditure compared to DLW.  However,  other investigators have reported that heart 
rate  monitoring  significantly  overestimated  the  oxygen  cost  of  various  field-based 
activities.  197;213 
The relationship between heart rate and V02 is  poor at low levels of exercise 204  thus  ,  , 
the HR FLEX method was developed to overcome this limitation.214;215  This technique 
involves monitoring each subject simultaneously for heart rate  and V02 at rest,  during 
sedentary  activity  and  exercise,  resting  metabolic  rate  is  also  obtained.  This 
information  is  then  used  to  develop  the  individual's  HR-V02  calibration  curve.  The 
FLEX  HR  is  determined  by  taking  the  highest  heart  rate  recorded  from  rest  and 
sedentary activity and  the lowest heart rate recorded during light exercise.  Above the 
FLEX HR value, there is a strong relationship between HR and V02, below it they are 
poorly correlated. During heart rate monitoring of physical activity in the field,  if a given 
heart rate is  below the FLEX HR then energy expenditure is  determined from  resting 
metabolic  rate.  Whereas,  if a  given  heart  rate  is  above  the  FLEX  HR  then  energy 
expenditure  is  estimated  using  the  calibration  curve. 216  Studies  have  reported  no 
significant difference between measured and  estimated energy expenditure using the 
FLEX HR  method  in  a group  of children215  and  adults.214  However,  there  are  some 
drawbacks  of the  FLEX  HR  method  to  estimate  energy  expenditure.  Firstly,  the 
calibration test and the data analysis is time consuming and costly.  Secondly, the HR-
V02 relationship  derived  from  activities  in  a  controlled  laboratory  setting  may  not 
accurately represent the relationship in free-living  activity.211  Finally,  heart rate can  be 
affected by factors other than physical activity, as previously discussed. 
Simultaneous use of heart rate monitoring and accelerometers 
Heart  rate  monitoring  and  accelerometers  have  limitations  for  measuring  physical 
activity  and  estimating  energy  expenditure.  However,  Strath  197  found  that  the 
simultaneous use of heart rate and motion sensors improved the estimation of V02 of 
selected  field-based  activities,  compared  with  heart  rate  monitoring  and 
accelerometers  independently.  This  study established  an  individual  calibration  curve 
between  HR  and  V02 for both  arm  and  leg  exercise  in  the  laboratory.  In  the  field 
setting, the activity monitor was used to differentiate between arm and  leg  movement 
and  heart rate  was  used to  estimate V02 from  the  corresponding  calibration  curve. 
This differentiation allowed the investigator to  predict V02 from  an  individualised  arm 
76 or leg  HR-V02 calibration curve,  as  the  relationship  between  HR  and V0
2  differs for 
d  I  .  211 
arm  an  eg  exercise.  Another  advantage  of  this  technique  is  that  the 
accelerometers can differentiate between an increase in heart rate caused by physical 
activity  and  that  caused  by  other factors.  The  simultaneous  use  of heart  rate  and 
accelerometers to measure physical activity could be a promising method to measure 
physical activity, however this method is very time-consuming. 
In  summary, the objective methods that could be  used to  measure physical activity in 
this  study  were  reviewed.  Although  motion  sensors  and  heart  rate  monitors  have 
limitations,  an  objective method was selected because they eliminate the subjectivity 
associated  with  self-report  methods.  An  accelerometer  seemed  to  be  the  most 
appropriate  instrument  to  use  in  this  study  for  the  following  reasons.  Firstly, 
accelerometers have a large memory capacity, which  is  important because at  least 5 
days of physical activity should be recorded to obtain a good estimate of an individual's 
physical activity behaviour.
186 Heart rate monitoring was not selected, as it requires the 
development of individual calibration  curves,  which  is  very time-consuming,  whereas 
analysing  accelerometer  recordings  is  relatively  quick  and  simple.  Additionally, 
accelerometers are reliable, which is  important in  an  intervention study to ensure that 
changes  in  physical  activity  are  a  result  of the  intervention,  and  not  because  of 
variation  in  activity  scores  due  to  low  reliability.  As  previously  discussed, 
accelerometers cannot record all types of activity under free-living conditions, however 
there were limitations to all other objective methods that could have been used in this 
study. The GSA accelerometer was chosen instead of the Tritrac because it is smaller, 
lighter,  and  more compact than  the Tritrac,  which  may allow for less obtrusive  data 
collection and better compliance. One study reported that 20% of the study sample did 
not comply with wearing the Tritrac for at least 3 days.39  In  addition, the GSA is  less 
expensive  than  the  Tritrac.  Finally,  the  GSA  is  similar to  the  Tritrac  for  measuring 
physical  activity.  Schutz recommended  using  multiple  methods to  measure  physical 
activity as no single current technique is able to quantify all aspects of physical activity 
under  free  living  conditions.
217  Thus,  a  self-report  method  was  selected  to  gain 
additional information on patterns of physical activity. 
Self Report 
Numerous self-report  instruments  have  been  developed  to  assess  physical  activity. 
Self-reports  include  self-administered  or  interviewer-administered  recall 
77 questionnaires,  activity  logs  or diaries.  They  are  practical  for  use  in  field  studies  as 
they  are  relatively  inexpensive  and  require  less  equipment  compared  to  objective 
218 
measures.  Furthermore,  some  self-reports  measure  the  dimensions  of  physical 
activity  (type,  frequency,  intensity,  and  duration),  therefore  an  individual's  pattern  of 
physical  activity can  be examined.  This information  can  also  be  used  to  determine if 
individuals are  meeting  current physical  activity recommendations. 219  However,  there 
are limitations to self-report methods. They are subjective, therefore can  be influenced 
by the  subject's perceptions  and  emotions.  In  addition,  subjects  may  not  recall  their 
activities  accurately,  and  social  desirability  bias  can  lead  to  over-estimation  of  the 
duration or intensity of activities. Recall questionnaires have an advantage over activity 
diaries and  activity logs,  as  they are  less time consuming  and  do  not affect physical 
activity behaviour (unless subjects know in advance that they will be completing one). 
Recall Questionnaires 
Recently,  Sallis  reviewed  the  validity,  reliability  and  content  of numerous  self-report 
questionnaires  th.at  have  been  frequently  used  over  the  past  decade  to  measure 
physical  activity  in  adults.219  The  components  of  physical  activity  measured  by  the 
questionnaires varied widely. The majority of self-reports measured the dimensions of 
physical  activity  (Le.  duration,  frequency,  and  intensity);  some  assessed  both 
moderate and vigorous intensity activities.  Leisure physical activity was  included in  all 
self-reports,  whereas,  assessment  of household  and  occupational  activity  was  less 
common. A few questionnaires measured long-term habitual physical activity over the 
previous year,  whereas others assessed recent or usual activity.  All  of the self-report 
questionnaires reviewed demonstrated modest to high levels of test-retest reliability.219 
However,  the  test-retest  correlation  coefficients  tended  to  be  higher  for  total  and 
vigorous  physical  activity compared  to  moderate  physical  activity.  The  validity  of the 
questionnaires for measuring physical activity was  evaluated by comparing them with 
motion  sensors  and  heart  rate  monitoring.  In  general,  low  to  moderate  correlation 
coefficients  were  observed  between  self-report  measures  and  objective  methods, 
ranging  from  0.14 to 0.50.  However,  motion  sensors and  heart rate  monitoring have 
limitations for measuring physical activity,  therefore they are  inadequate for use  as  a 
criterion method. Doubly labelled water accurately measures total and  physical activity 
related energy expenditure, thus has  been  used to validate questionnaires.  However, 
DLW  does  not  measure  the  intensity,  frequency  and  duration  of  physical  activity, 
therefore this method cannot be  used to  validate the various components of physical 
78 activity measured by self-report questionnaires.  In  general,  determining the validity of 
self-report questionnaires is difficult due to the lack of an acceptable criterion method. 
In summary, there are numerous questionnaires that can  be used to measure physical 
activity,  each  demonstrating  varying  levels  of  reliability  and  validity.  Recall 
questionnaires  are  useful  in  assessing  habitual  physical  activity,  as  they  are 
inexpensive, easy to use and do not alter physical activity behaviour.  In addition,  unlike 
accelerometers,  they  can  provide  information  on  mode,  intensity,  duration  and 
frequency  of physical  activity  and  whether  an  individual  is  meeting  current  physical 
activity  recommendations.  For  these  reasons,  it  was  appropriate  to  use  a  recall 
questionnaire to assess physical activity in this study.  The  seven-day physical activity 
recall
220 
was  selected,  as  it  measures  all  dimensions  of  physical  activity  (i.e.  type, 
frequency,  duration  and  intensity),  and  measures  physical  activity  during  both 
occupation and leisure time.  In addition, the questionnaire measures recent,  instead of 
usual activity, which is important in an intervention study to assess changes in physical 
activity.  Physical activity patterns vary from day to day and from weekday to weekend, 
therefore  the  questionnaire  assesses  physical  activity  behaviour  for  seven  days. 
Finally,  the  instrument  is  administered  in  an  interview  format,  which  may  generate 
more accurate and  reliable  information than  self-administered questionnaires.221  This 
is  because  some  subjects  find  it  difficult  to  recall  physical  activity  or  classify  the 
intensity  level  of various  activities.  Furthermore,  individuals  may  not  always  define 
what  they  are  doing  as  physical  activity,  for  example  housework.  Therefore,  the 
interviewer can advise the subject and use prompts to facilitate recall. 220 
Stanford Seven-Day Physical Activity Recall 
The Stanford Seven-Day Physical Activity Recall  (7DPAR)220 has been widely used  in 
research  to  quantify  physical  activity.  This  instrument  is  an  interview  administered 
questionnaire that measures the  time spent  in  sleep  and  light,  moderate,  hard  and 
very hard intensity physical activity for seven days. An estimate of energy expenditure 
can  be  calculated from the time spent in  various intensities of physical  activity,  using 
established MET values for each  intensity category.  The  reliability  and  validity  of the 
seven-day recall has been reviewed by various investigators.218;219;222;223 The seven-day 
recall  demonstrated  high  test-retest  reliability  (r-0.7  to  0.9)  for  estimating  energy 
.  223-225 
expenditure when  the  questionnaire was  administered  over a two-week  period. 
Other studies have observed modest test-retest correlation coefficients for the recall of 
79 moderate,  hard,  very  hard  and  total  physical  activity.219;222;226-228  However,  the  time 
interval  between  questionnaire  administrations  ranged  from  2  weeks  to  1  th  mon  , 
therefore the reliability estimates reflect both the ability of the  individual to  recall  their 
activity  and  actual  changes  in  physical  activity.  Studies  have  reported  poorer  test-
retest reliability for the recall of moderate intensity physical activity compared to recall 
of  total,  hard,  very  hard  and  occupational  physical  activity.219;222;226;227  Vigorous 
activities tend to be planned or structured, thus individuals are more likely to accurately 
recall  these  types  of activity.  Whereas,  it  is  more  difficult  to  accurately  recall  and 
categorise the intensity of moderate activities that are part of normal daily life.  229 
The validity of Stanford Seven-Day Recall  (7DPAR) to  measure physical  activity and 
estimate  energy  expenditure  has  been  tested.  Studies  have  found  that  energy 
expenditure estimated by the 7DPAR was similar to energy expenditure measured by 
DLW in  a group of obese212  and  normal weight women. 198  In  contrast,  other studies 
have  found  that  energy  expenditure  estimated  by  the  7DPAR  was  significantly 
overestimated  by.  11
0
/0230  to  30%231;232  compared  to  DLW.  Leenders  reported  high 
correlation coefficients (r=0.82 - 0.94) between energy expenditure estimated from the 
7DPAR  and  accelerometers  recordings  (CSA  and  Tritrac).233  Furthermore,  the 
questionnaire and accelerometers similarly estimated the time spent in light, moderate, 
hard,  very hard  and total  physical  activity.  In  contrast,  Duncan found that sedentary, 
middle aged subjects significantly overestimated the time spent in  moderate intensity 
activity  measured  by  the  questionnaire  compared  with  actual  moderate  activity 
determined by heart rate monitoring.223 Other studies have observed lower correlations 
for moderate intensity activity compared to  hard,  very hard  intensity and  total activity 
between the 7DPAR and accelerometers.219;222;227;228;234  The 7DPAR has been used to 
assess  physical  activity  levels  of individuals  participating  in  exercise-based  cardiac 
rehabilitation. These studies found a significant increase in  physical activity measured 
by the questionnaire after cardiac rehabilitation. 89;93;96  In addition, these changes were 
confirmed  by  a  concomitant  increase  in  exercise  capacity.89;93  In  addition,  physical 
activity intervention trials in the general population have found  Significant increases in 
physical activity measured by the questionnaire and accelerometers. Thus, the seven-
day physical  activity  recall  seems to  be  responsive  to  the  effect of interventions  to 
increase physical activity. 
80 Cardiorespiratory Fitness 
Cardiorespiratory fitness and the ability to improve fitness with exercise training has a 
sizeable  hereditary  component  and  can  be  affected  by  factors  other than  physical 
activity.  Therefore,  using  fitness  as  an  indicator  of  an  individual's  physical  activity 
behaviour has its limitations.  On  the other hand,  the improvement in  aerobic capacity 
and  submaximal  endurance capacity with  cardiac  rehabilitation  exercise  training  has 
been  well  documented.  Furthermore,  studies  have  shown  that  both  physical  activity 
and exercise capacity tend to decline in the long-term following completion of exercise-
based cardiac rehabilitation.  The  aim  of this  study was to  investigate the effect of an 
exercise consultation on maintenance of physical activity following completion of phase 
III exercise training, thus it was appropriate to assess cardiorespiratory fitness. 
Exercise Capacity 
Maximal oxygen uptake (V02max) is the criterion measure of exercise capacity.83;235 
V02max is  the  highest oxygen  uptake attainable during  a progressively increasing 
exercise  test,  as  demonstrated  by  a  plateau  in  oxygen  uptake  despite  further 
increases  in  work rate.  V02 max  is  equal  to  maximal  cardiac output  and  maximal 
arteriovenous oxygen difference, thus represents the capacity of the cardiovascular 
system to supply oxygen to exercising skeletal muscles and the potential for oxygen 
extraction by the exercising muscle. However, most cardiac patients fail to achieve a 
"true" V02max as  they are often limited by cardiac symptoms and  may be reluctant 
to push themselves to their maximal capacity.236 Thus, peak V02, the rate of oxygen 
uptake  at  the  highest  level  of  exercise,  is  more  relevant  when  discussing  the 
exercise capacity of individuals with CHD. 
Accurate  assessment  of exercise  capacity  (i.e.  peak V02)  is  achieved  with  direct 
analysis of expired gases during  a progressively increasing exercise test.  The type 
of  exercise  testing  protocol  used  influences  the  measurement  of  peak  oxygen 
uptake.237  In  clinical  practice,  the  Bruce  protocol  (or modified  Bruce)  is  the  most 
d·  t'  t  83;236;237 
commonly  used  exercise  testing  treadmill  protocol  for  car  lac  pa len s. 
However,  this  protocol  has  been  criticised  because  of  its  large  and  unequal 
increases in  work rate  every three minutes.  It  is  thought that some  patients will  be 
unable to tolerate these large and  unequal  increases in  exercise intensity, thus will 
83'236'237  dd't'  I  d  nequal  terminate  the  exercise  test  prematurely.  "  In  a  I lon,  arge  an  u 
increments  in  work  rate  leads  to  difficulties  in  interpreting  gas-exchange 
81 measurements (e.g.  lactate threshold) and causes inaccurate estimates of exercise 
capacity.83  Protocols with  smaller,  more frequent uniform work  rate  increments  are 
recommended, which are preferred and better tolerated by patients and  produce an 
accurate assessment of peak V02.83;236;237  The exercise testing protocol should also 
be individualised,  as cardiac patients exhibit a wide  range of exercise capacities.237 
For  example,  exercise  testing  protocols  with  small  work  rate  increments  to 
accommodate patients with poor exercise capacity result in  very long tests for fitter 
patients, which may produce unrepresentative values for peak V02 as  subjects may 
terminate the test prematurely due to  boredom. The optimal exercise test duration is 
8 to 12 minutes, thus the work load increments should be adjusted for each patient's 
capabilities to achieve this test duration.83;236;237 
Submaximal Endurance Capacity 
Estimating  the  lactate  threshold,  the  exercise  V02 at  which  the  concentration  of 
lactate  in  arterial  blood  increases  above the  resting  value,83  during  a progressive 
exercise  test  can  be  used  as  an  indicator of submaximal  endurance  capacity.  A 
range of techniques have been used to estimate the lactate threshold, including both 
direct measurements and indirect estimation. Direct measurement of lactate requires 
serial  blood  sampling during exercise testing,  which  is  invasive and  uncomfortable 
for patients.83  However, the lactate threshold can be estimated noninvasively as the 
increase in lactate during exercise causes profound alterations in ventilation and gas 
exchange.  The  V-slope  and  ventilatory  equivalent  techniques  are  common  and 
reliable methods for indirectly detecting the lactate threshold. 83 
The V-slope method for estimating the lactate threshold is  illustrated in  Figure 4.  As 
work rate increases during an  incremental exercise test, there is a linear increase in 
oxygen uptake (V02) and carbon dioxide output (VC02). Above the lactate threshold, 
the increase in lactic acid production causes carbon dioxide output to increase more 
rapidly than  oxygen  uptake.  When these V02  and  VC02  are  plotted  against each 
other, the relationship is composed of two linear components, the lower of which has 
a  slope slightly  less than  1.0,  whereas the  upper component has  a slope  steeper 
than 1.0. The intercept of these two slopes defines the oxygen uptake above which 
VC02 increases faster than V02  and  signals  the  increased  concentration  of lactic 
acid.  The increase  in  VC02 in  excess  of that derived  from  aerobic  metabolism  is 
generated from the buffering of lactic acid. 
82 The  ventilatory  equivalent  method  is  illustrated  in  Figure  5  Above  the  lactate 
threshold,  minute  ventilation  (VE)  increases  proportionally  with  the  increased  CO2 
output.  Thus,  VE  retains  a  constant  relationship  with  VC02  (VENC02  appears 
constant  or  decreases  slightly),  whereas  VE  increases  relative  to  V02  (VEN02 
increases).  Similarly, the end  tidal  pressure of oxygen  (PET02)  increases, whereas 
the  end  tidal  pressure of carbon  dioxide  (PETC02)  remains  constant at  the  lactate 
threshold. This method is frequently used to verify estimation of the lactate threshold 
by  the  V-Slope  method.  Beaver  found  that  the  values  obtained  by  the  V-slope 
method  agreed  closely  with  those  obtained  by  direct  measurement  of the  lactate 
threshold.
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Figure 4 The V-Slope technique to estimate the lactate threshold. 
Below the  lactate threshold,  there  is  a linear increase  in  V02  and  VC02·  Above  the 
lactate threshold, VC02  increases more rapidly than V02 due to increased lactic acid. 
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Figure 5 Ventilatory equivalent method to estimate the lactate threshold. 
At  the  lactate  threshold,  VEN02  and  PET02  increase,  whereas  VENC02  and  PETC02 
remain constant or decreases slightly. 
VEN02 =  ventilatory  equivalent  for  oxygen  uptake,  VENC02  =  ventilatory  equivalent for 
carbon  dioxide  output.  PET02 =  End  tidal  O2  partial  pressure,  PETC02 =  End  tidal  VC02 
partial pressure. 
84 SECTION FOUR 
MEASURING ANXIETY, DEPRESSION AND QUALITY OF LIFE 
Anxiety  and  depression  are  commonly  experienced  psychological  problems 
encountered by  patients following  cardiac events.
2  Evidence shows that moderate to 
severe depression following an MI  is a significant predictor of cardiac mortality over the 
subsequent 6 to  18  months.
1oo
;101  In  addition,  patients  suffering  from  psychological 
distress have demonstrated poorer quality of life, increased severity of chest pain,  poor 
compliance  to  lifestyle  changes  and  increased  use  of  health  services  compared  to 
non-distressed  patients.
102  Therefore,  a goal  of  cardiac  rehabilitation  is  to  limit the 
psychological effects of cardiac illness and to enhance quality of life. 
1 Beneficial effects 
of exercise-based cardiac rehabilitation on quality of life,  anxiety and depression have 
been reported.  However, some studies have found that improvements in quality of life 
achieved  during  cardiac  rehabilitation  diminish  after  programme  completion,  which 
may  be  a  result  of  poor  compliance  to  lifestyle  changes  in  the  long-term.  Thus, 
measurement  of quality  of  life,  anxiety  and  depression  were  important  secondary 
outcomes of this study. 
Anxiety and Depression 
National  guidelines for cardiac rehabilitation
2  have  recommended  using  the  Hospital 
Anxiety  and  Depression  Scale  (HADS)  to  measure  anxiety  and  depression.  This 
instrument is easy to administer, simple to score and  has been widely used in cardiac 
rehabilitation settings to screen patients for symptoms of psychological distress, and to 
evaluate psychological outcomes of cardiac rehabilitation. 
The Hospital Anxiety and Depression Scale 
The Hospital Anxiety and  Depression  Scale  is  a self-report instrument developed  by 
Zigmond  and  Snaith  (1983) to measure states of anxiety and  depression  in  medical 
patients.239  Symptoms  relating  to  serious  mental  disorders  were  excluded  from  the 
instrument,  which  is  thought  to  make  the  scale  more  sensitive  to  mild  forms  of 
psychological  distress.  Furthermore,  the  investigators  omitted  physical  symptoms  of 
psychological distress such as insomnia, loss of energy or weight loss, which may be a 
85 direct consequence of a  medical illness (e.g.  MI)  rather than related to depression or 
.  t  240  Th  . 
anxle y.  e  Instrument measures states  of anxiety and  depression  over the  past 
week,  therefore it is  sensitive to change but is  not limited to  an  immediate stressful 
situation.240 
The HADS is a reliable and valid instrument for measuring anxiety and depression in 
medical  patients  and  patients  with  CHD.241  Visser  found  that  the  anxiety  and 
depression scales were very reliable over a two week period in a group of patients who 
had  suffered  an  MI  in  the  previous  6  to  24  months.242  It  is  fundamental  that  the 
questionnaire  items  that  compose  a  scale  are  related  to  one  another,  known  as 
internal  consistency.  A  Cronbach's  alpha  coefficient  of  0.7  or  above  is  taken  as 
evidence  of  internal  consistency.  Johnston  reported  cronbach's  alpha  coefficients 
exceeding 0.80 for the HADS anxiety and depression scales at three time periods over 
12 months following myocardial infarction.243  The validity of a psychological instrument 
can  be  examined  by  comparing  the  questionnaire  with  relevant  psychometric 
properties  of  oth~r instruments  (i.e.  concurrent  validity).  A  recent  review  observed 
moderate to high correlations ranging from 0.6 to 0.8 between the HADS anxiety and 
depression subscales and other self-assessment instruments.244  The HADS is  able to 
detect  anxiety  disorders  and  depression  in  medical  populations  compared  to  gold 
standard diagnostic instruments.241 ;244  In addition, the prevalence of moderate anxiety 
and  depression  estimated  using  the  HADS  in  a  sample  of  the  general  adult  UK 
population  was  similar  to  findings  from  epidemiology  studies  that  employed  well-
validated  classification  systems.245  Finally,  it  is  expected  that  patients  who  have 
experienced a myocardial infarction will  have higher levels of anxiety and depression 
compared to the general healthy population. Visse(42 reported higher scores on HADS 
anxiety and depression subscales for a group of post MI  patients compared to healthy 
controls.  Studies have  shown that the  HADS is  responsive to the effects of cardiac 
b  I
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rehabilitation for up to one year after the  ase me assessmen . 
Quality of Life 
Evaluating  the  effect  of cardiac  rehabilitation  on  quality  of  life  should  include  the 
assessment of physical  function,  psychological  well-being  and  social  functioning.
248 
Instruments designed to measure quality of life  can  be  divided  into two categories: 
generic and disease-specific. Generic questionnaires provide a broad assessment of 
the health status of an  individual and  allow comparisons between groups of patients 
86 with  different conditions  and  general  populations,  however a main  concern  of these 
instruments  is  their lack  of sensitivity  to  measure  change  over time. 248  In  contrast, 
disease-specific  instruments  assess  the  effects  of  a  particular  disease  on  health 
status,  which  may  improve  the  sensitivity  of  the  measurement.  However  a 
I 
disadvantage of disease-specific instruments is that they may be  less comprehensive 
in  covering  the  multiple  dimensions  of  health  status.  Due  to  the  advantages  and 
disadvantages of both types of questionnaire, ideally both disease-specific and generic 
instruments  should  be  used  to  measure  quality  of  Iife.246  However,  a  number  of 
methods were  being  used to  measure the  primary  outcomes  of this  study  I  thus  the 
addition of two quality of life questionnaires may have burdened the patients potentially 
affecting patient recruitment and compliance to the study. A generic questionnaire was 
selected to measure quality of life in this study for the reasons discussed below. 
A  variety  of valid  and  reliable  generic  and  disease-specific  instruments  have  been 
used to measure quality of life in cardiac rehabilitation.  In addition, a systematic review 
identified  a  number of instruments  that  were  responsive  to  cardiac  rehabilitation. 246 
Thus,  no agreement has been reached regarding the most appropriate questionnaire 
to  measure  quality  of  life  in  cardiac  rehabilitation  settings.2  Recently,  Hevey247 
examined the responsiveness of nine disease-specific and generic instruments, which 
are commonly used to assess quality of life in cardiac rehabilitation. The study sample 
was  comprised  of  patients  who  had  experienced  aMI,  CABG  or  PTCA.  Results 
showed  that  most  of  the  disease-specific  questionnaires  (i.e.  Quality  of  Life  after 
Myocardial Infarction, Quality of Life Index Cardiac Version III, and Cardiac Depression 
Scale) were not responsive to the effects cardiac rehabilitation.  The exceptions were 
two subscales of the Heart Patient's Psychological Questionnaire: feelings of disability 
and  despondency.  However,  the  English  version  of this  questionnaire  has  not  been 
validated.247  In  contrast,  a  number  of  generic  questionnaires  were  responsive  to 
cardiac rehabilitation. These included the Global Mood Scale, the depression scale of 
the HADS and five out of eight subscales of the Short-Form 36. 
Similarly, Smith249 showed that the Short-Form 36 was more responsive to 6 weeks of 
cardiac  rehabilitation  than  two  disease-specific  measures;  the  Quality  of  Life  after 
Myocardial Infarction and the Quality of Life Cardiac Version III.  There are  other valid 
and reliable disease-specific instruments available, such as the Cardiac Quality of Life 
Inventory,  and  the  Multidimensional  Index  to  Life  Quality,  however  their 
87 responsiveness  to  cardiac  rehabilitation  has  not  been  assessed.  In  contrast,  the 
Seattle Angina Questionnaire is  more responsive than the Short-Form  36,250  however 
this  disease-specific instrument does  not provide  a broad  measure of quality  of life. 
Another reason  for choosing  a generic questionnaire was  the  fact  that  many  of the 
disease-specific  questionnaires  tend  to  focus  on  a  specific  cardiac  condition  (e.g. 
Quality of Life after MI,  Angina Pectoris Quality of Life  Questionnaire),  and would  not 
be  appropriate for the  heterogeneous population  (i.e.  MI,  CABG  and  PTCA)  included 
in  this  study.  In  addition,  McGhee246  suggested  that  if  both  a disease-specific  and 
generic  measure  were  shown  to  have  equal  responsiveness,  then  it  may  be 
preferential  to  use  a generic  measure  as  this  allows  comparison  with  other  patient 
groups and normative data for the general population. 
The most commonly used generic instruments to  measure  quality of life  in  coronary 
heart disease are the Nottingham Health Profile, the Short-Form 36 and the Sickness 
Impact Profile.251  The  Sickness  Impact  Profile  was  not feasible  for use  in  this  study 
because it takes patients approximately 20 minutes to complete the 136 questionnaire 
items.242  Although,  the  Nottingham  Health  Profile  has  demonstrated  acceptable 
reliability and validity in  patients with heart disease,252  major ceiling effects (maximum 
possible score)  have  been  reported. 251;253  Dempste~51 found  that  16%  to 62%  of MI 
patients achieved the maximum possible score on all NHP domains at the beginning of 
a cardiac rehabilitation programme. Thus,  the Short-Form 36  (SF-36) was selected to 
measure quality of life in this study for the following reasons. 
The Short-Form 36 (SF-36) 
The  SF-36  demonstrates  good  content  validity,  as  it  measures  quality  of  life 
dimensions that are important in  cardiac rehabilitation,  for example physical function, 
social  function  and  psychological  wellbeing.248  Secondly,  the  validity,  internal 
consistency and  test-retest reliability  of the  instrument has  been  established  among 
patients with CHD. An acceptable level  of internal consistency has been found  for all 
SF-36  subscales  in  cardiac  rehabilitation  participants,249;254  patients  with  stable 
coronary  heart  disease,255  and  patients  who  had  suffered  an  MI  in  the  previous  4 
years,z53  In  addition,  Jette found  that  all  SF-36  scales,  except Role  Emotional,  were 
very  reliable  over  a  two  week  time  interval  in  a  group  of  cardiac  rehabilitation 
participants.254  High levels of agreement have been observed between SF-36 domains 
253  S  I  A  .  and  relevant  scales  on  the  Nottingham  Health  Profile,  the  eatt e  nglna 
88 Questionnaire,  and the Chronic Heart Failure Questionnaire.256  Dougherty reported  a 
significant  correlation  between  the  physical  limitations  scale  of  the  Seattle  Angina 
Questionnaire  and the  physical  function  domain  of the  SF-36  in  a sample  of stable 
angina  patients.
257 
Furthermore,  the  disease  perception  scale  of the  Seattle  Angina 
Questionnaire correlated significantly with  both the  energy and  general  health  scales 
of the SF-36 in this group. 
Studies have reported significantly poorer scores  on  all  SF-36 subscales for post MI 
patients
258 
and patients with stable coronary heart disease256 compared to age and sex 
adjusted normative data for the general population. In addition, scores on all of the SF-
36  scales  were  significantly  poorer  for  cardiac  patients  who  were  experiencing 
symptoms  of  angina  or  breathlessness  compared  to  those  who  were 
asymptomatic.253;255  Among post MI  patients,  increasing frequency of chest  pain  was 
significantly  associated  with  lower  scores  on  all  physical  health  domains,  with  no 
differences for role emotional or mental health. On the other hand, some studies have 
reported that all  of the SF-36 subscales,  except bodily  pain255  were  unable to  detect 
differences  in  the  severit/55;257  and  frequenc/55  of  angina  in  patients  with  stable 
coronary  artery  disease.  However,  similar  findings  were  observed  for  two  disease-
specific instruments.  In  addition,  floor and  ceiling  effects were  reported  for the  Role 
Physical  and  Role  Emotional  SF-36  subscales  among  patients  with  stable  coronary 
artery  disease,  post  MI,  and  those  at  the  beginning  of  cardiac  rehabilitation?53;255 
Consequently,  the SF-36 was revised to  reduce the floor and  ceiling  effects of these 
subscales.259  The  authors  reported  that  the  Role  Physical  and  Role  Emotional 
subscales of the SF-36 version II  demonstrated greater internal consistency and fewer 
floor and ceiling effects compared to the original questionnaire, which may improve the 
instrument's responsiveness.259  Normative values for the SF-36 version  II  are available 
for a UK general population.259 
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AIMS 
The benefits of exercise-based cardiac rehabilitation  are  well  documented.  However  , 
evidence suggests that  physical  activity  is  not  maintained  in  the  long-term  following 
completion  of these  programmes.  Therefore,  interventions  are  required  to  improve 
maintenance of physical  activity  after programme  completion.  Exercise  consultation , 
based  on  the  established  behaviour  change  theories  is  effective  in  encouraging 
promotion and  maintenance of physical  activity in  patients with  Type  II  diabetes  and 
the general  population for 6 to  24  months.  In  a pilot study,  the exercise consultation 
improved  short-term  maintenance of physical  activity after completion  of a phase  III 
exercise programme. 
Primary Aim 
The  primary  aim 'of this  randomised-controlled  trial  was  to  evaluate  the  effect  of  an 
exercise  consultation  (experimental  condition)  compared  with  standard  exercise 
information  (control condition)  on  maintenance of physical  activity six  and  12  months 
following completion of a phase III cardiac rehabilitation exercise programme. 
Secondary Aim 
The  secondary  aim  was  to  determine  the  effect  of  an  exercise  consultation 
(experimental) compared with standard exercise information (control) on  maintenance 
of cardiorespiratory fitness, the use of processes of exercise behaviour change, quality 
of life, anxiety and depression, blood lipids and clinical outcomes at six and  12 months 
in phase IV cardiac rehabilitation. 
The Research Objectives are: 
1)  To  describe  the  baseline  demographic  and  clinical  characteristics  of  the 
experimental and control group. 
2)  To  describe the  baseline  physical  activity  behaviour  of the  study  sample  (n=70) 
using  the  CSA  accelerometer,  190  the  Stanford  Seven-Day  Physical  Activity 
Recall220 and the Stage of Exercise Behaviour Change.
26o 
As subjects had recently 
90 completed a phase III exercise programme, it was hypothesised that they would be 
physically active at baseline. 
3)  To determine the effect of the exercise consultation (experimental) compared with 
standard exercise information (control) on the following: 
a)  Maintenance  of  physical  activity  measured  using  the  Stage  of  Exercise 
Behaviour Change,260  the CSA accelerometer190  and  the Stanford Seven-Day 
Physical Activity Recall. 220 
b)  Maintenance  of  cardiorespiratory  fitness,83  including  exercise  capacity  and 
submaximal endurance capacity. 
c)  The use of the experiential and  behavioural  processes of exercise behaviour 
change.16o 
d)  Anthropometric variables including weight, body mass index and the proportion 
of patients who were overweight and obese. 
e)  Blood  lipids  including  total  cholesterol,  triglycerides,  LDL  cholesterol,  HDL 
cholesterol and the ratio of total cholesterol to HDL cholesterol. 
f)  Psychological functioning  including  anxiety and  depression,  and  quality of life 
measured using the Hospital Anxiety and  Depression Scale
240 
and the  Short-
Form 36 version 2,261  respectively. 
4)  To report the incidence of total  and cardiovascular mortality,  and  the number of 
cardiac hospital readmissions (e.g. MI,  UAP, CABG and PTCA) in the experimental 
and control group. 
91 CHAPTER THREE 
METHODS 
Participants 
Men  and women who  had  experienced  a myocardial  infarction  (MI),  unstable  angina 
(UAP)  or had  undergone  coronary  artery  bypass  grafting  (CABG)  or  percutaneous 
transluminal  coronary  angioplasty  (PTCA)  and  were  attending  a phase  III  hospital-
based cardiac rehabilitation exercise programme were candidates for inclusion  in the 
study.  Patients  were  excluded  if  any  of the  following  criteria  were  present:  (1)  on 
waiting  list for cardiac investigation  (Le.  angiography),  (2)  on  waiting  list for coronary 
artery  bypass  surgery  (CABG)  or  percutaneous  transluminal  coronary  angioplasty 
(PTCA),  (3)  attended  less  than  70%  of the  phase  III  exercise  programme.  Subjects 
were recruited  from  the  phase  III  exercise  programme from  August  2000  to  August 
2001.  Eligible subjects who were attending weeks 6 to  11  of the exercise programme 
were given  information  on  the  study.  Subjects who  agreed  to  participate  in  the  trial 
received  an  appointment  for  a  baseline  assessment.  Baseline  assessments  were 
carried out within one month of patients completing the phase III exercise programme. 
All  assessments were conducted in the cardiology department at the Royal Alexandra 
Hospital. The study was approved by the Argyll and Clyde Research Ethics Committee 
(Appendix A)  and all patients provided written informed consent before participation in 
the study (Appendix B). 
Phase III Cardiac Rehabilitation Programme 
The phase III cardiac rehabilitation programme was based at a district general hospital 
(Royal  Alexandra  Hospital)  in  the  West  of  Scotland.  The  programme  involved 
supervised  exercise  training,  education  sessions,  medical  evaluation,  psychological 
support  from  specialist  nurses  and  access  to  a clinical  psychologist.  The  exercise 
programme  involved  two  exercise  classes  each  week  for  11  weeks.  Each  class 
included a 15  minute warm-up with flexibility exercises,  20  minutes  of circuit training, 
and  a  10  minute  cool  down  period  with  flexibility  exercises.  Participants  were  also 
encouraged to participate in physical activity at home on days they were not attending 
the  exercise  programme.  Information  booklets  on  physical  activity  and  CHD  were 
available in the gymnasium where the phase III classes took place. 
92 Sample size 
Physical activity measured using the CSA accelerometer190  was  used to estimate the 
number of participants needed to detect a true difference in  this variable between the 
experimental and control groups. The following equation was used n = 2(a+ p)2 s2/d2, s 
=  standard deviation and d =  difference between the groups, and the values selected 
for alpha (a) and beta (p) were 5% and 10% respectively.262 
No randomised controlled trials have evaluated the  effect of exercise-based cardiac 
rehabilitation on physical activity measured objectively using accelerometers. However, 
a  pilot study compared the effect of an  exercise  consultation  with  standard  care on 
physical activity measured using CSA accelerometers in a group of people with type II 
diabetes.263  Thus, the difference between the experimental and  control group for the 
mean change in total activity counts/week measured with the CSA accelerometer was 
used  to  calculate  the  sample  size  (baseline  mean  = 1813893,  mean  difference 
between groups  .=  409780,  SO  = 444779). A  minimum of 25  patients in  each group 
was  required  to  have  a  90%  power  of  detecting  a  true  difference  of  409780 
counts/week  (22%»  with  a  Significance  level  of  5%.  However,  70  patients  were 
recruited to allow for potential dropout from the study. 
Baseline Assessment 
Visit One: Total duration 60 minutes 
Patients attended the first visit within one month of completing the phase III exercise 
programme. Written informed consent was obtained from participants. The following 
data  were  collected  by self-report  and  reviewing  medical  records:  demographics, 
socio-economic status264  and occupation,  medical history,  medication and  smoking 
261  Th 
status. Quality of life was measured using version 2 of the UK Short Form 36.  e 
Hospital Anxiety and Depression scale240  was used to assess psychological distress. 
Weight (kg) and height (m) were recorded and used to determine body mass index 
(8MI).  An  incremental  exercise  test  with  expired  gas  analysis  was  performed  to 
assess  cardiorespiratory  fitness.83  Patients  were  given  a  Computer  and  Science 
Applications  (CSA)  accelerometer190  to  objectively  measure  their  physical  activity 
behaviour for a minimum of seven days. The monitor was attached to the subject's 
93 right ankle. Individuals wore the accelerometer during all waking hours and recorded 
the time  (see  Appendix  D)  that  the  monitor was  attached  and  removed  each  day 
until they returned for the  second visit.  Additionally,  subjects were  asked to  record 
the  activities  they  engaged  in  over  the  following  week  that  were  at  least  of  a 
moderate  intensity,  defined  as  effort  similar to  a  brisk  walk.  The  physical  activity 
recording sheet is shown in Appendix E. 
Visit 2: Total duration 45 minutes 
Approximately eight days after visit one,  subjects returned for visit two.  Patients were 
asked  to  fast  for  12  hours  prior to  the  visit  and  a  blood  sample  was  obtained  to 
measure  total  cholesterol,  triglycerides,  HDL  cholesterol  and  LDL  cholesterol.  The 
CSA  accelerometer  was  returned  and  the  Stanford  Seven-Day  Physical  Activity 
Recall,220  and  the  t  d  f'  260  S ages  an  processes  0  exercise  behaviour  change 
questionnaires  were  completed.  Thus,  data  collected  with  the  accelerometer 
corresponded  with  information  obtained  from  the  seven-day  physical  activity  recall. 
Participants wererandomised (refer to  randomisation  procedure) to  the experimental 
or control group. All participants received standard exercise information. Patients in the 
experimental  group  received  an  exercise  consultation,174  which  was  delivered  either 
during the  second  visit  or in  a third  visit  depending  on  what was  convenient for the 
patient and the researcher. 
Six and 12 Month Assessment 
All outcome measures recorded at baseline were repeated at six and  12 months. The 
experimental group received a further exercise consultation  174 at six months. 
Randomisation 
Participants were randomly allocated to the experimental or control group following the 
baseline assessment.  Patients remained in the same allocation group throughout the 
study period.  A  blocked  randomisation  procedure was  used  to  ensure two  groups of 
equal  size.  Block  sizes  of  10  and  20  were  used  with  an  allocation  ratio  of  one 
experimental to one control.  For each block,  a blinded research assistant generated a 
random  sequence of numbers. This same individual then marked cards with  "control" 
or "experimental" by allocating odd numbers to the control condition and even numbers 
to  the  experimental  condition.  These  cards  were  placed  in  sequentially  numbered 
opaque envelopes, which were then sealed.  These envelopes were then  allocated to 
94 participant  t'"t  s a  VISI  two and were opened by the principal researcher after the baseline 
measures had been recorded. 
Experimental Group 
Patients in the experimental group received an exercise consultation  174 delivered after 
the baseline and 6 month assessments. In addition,  patients received a support phone 
call three months and nine months after the baseline assessment. 
Exercise Consultation at Baseline 
All  exercise consultations were conducted in  accordance with  guidelines published by 
Loughlan  and  Mutrie.
174 
The  researcher  was  trained  in  the  exercise  consultation 
process  in  a one-day  course  (BASES  workshop,  Dr  Nanette  Mutrie,  30th  November 
1998)  and  through  the  use  of  an  Exercise  Consultation  video.
265  In  addition,  the 
researcher had previously conducted a pilot study to tailor the exercise consultation to 
cardiac patients who had  recently completed a phase  III  exercise programme.
178  The 
consultation involved an individualised, one to one counselling session lasting between 
20  and  30  minutes.  Consultations were  conducted  in  a private  room  containing  two 
comfortable  chairs.  Excellent  communication  and  counselling  skills  are  required  to 
effectively  conduct  a  consultation.  The  researcher  achieved  this  through  an  open 
posture (e.g.  avoid crossing arms or legs),  leaning towards the client,  appropriate eye 
contact  and  a  relaxed  style  to  put the  participant  at  ease  and  convey  interest  and 
attention.  Counselling  skills,  including  empathy  (Le.  understanding  the  client's  goals 
and needs),  parroting (i.e.  repeating the key words and  phrases that the client used) 
and paraphrasing (i.e.  summarising what the participant has said) were used to show 
the participant that the researcher had listened carefully and  had  understood what he 
or  she  had  said.  The  exercise  consultation  is  a  client-centred  approach,  thus  the 
researcher avoided preaching,  lecturing or providing solutions for the client.  However, 
the researcher could offer suggestions,  such as  how to  overcome a certain  barrier to 
activity, but watched for reactions to them, such as non-verbal clues. 
As  the  participants  had  recently  completed  a phase  III  exercise  programme,  it  was 
thought that participants would be either regularly physically active (Le.  in the action or 
maintenance stage of change) or doing some activity but not enough to  meet current 
physical activity guidelines (i.e. preparation stage). Physical activity guidelines included 
accumulating  at  least 30  minutes  of moderate intensity  activity  on  most days  of the 
95 week
8 
or engaging in  a minimum of three 20 minute sessions of moderate to vigorous 
intensity exercise per week.
6 
The aim  of the  consultation was  to  ensure that patients 
were regularly  physically active and  to  encourage them  to  remain  regularly  active  by 
preventing relapse. 
The strategies used to  increase and  maintain physical  activity were;  previous  activity 
history, decisional balance, problem solving barriers to physical activity, social support, 
goal  setting  and  preventing  relapse.  A copy  of the sheet that was  used to  guide the 
exercise consultation is included in Appendix C. 
The  consultation  began  by  reviewing  the  participant's  stage  of exercise  behaviour 
change and  current physical  activity behaviour using  information collected  during  the 
baseline assessment (Le.  from  the  Stanford  Seven-Day  Physical  Activity  Recall  and 
the  Stage  of  Exercise  Behaviour  Change  questionnaire).  This  was  followed  by  a 
discussion  on  the  participant's  past and  present  activities  to  discover their  likes  and 
dislikes  (e.g.  if  t~e patient  enjoyed  exercising  in  a  group  setting  then  they  were 
encouraged  to  attend  exercise  classes  in  the  community).  Clients  completed  a 
decisional  balance  sheet,  which  involved  comparing  the  perceived  pros  and  cons  of 
participating in  physical activity. Patients were encouraged to identify the benefits they 
had  gained  by  attending  the  phase  III  exercise  programme.  Examples  of  benefits 
included  increased  fitness,  improved  wellbeing,  increased  confidence  and  weight 
management.  The  researcher educated  the  patient  on  the  importance  of remaining 
active  in  phase  IV to  maintain these benefits. At this point,  the  researcher described 
the recommended amounts of physical activity required to improve and maintain health 
and  fitness,  and  suggested  ways  to  achieve  these  recommendations.  Then 
participants thought of additional  benefits that they would  gain  by remaining  active  in 
the long-term. Examples included preventing another heart attack, improved quality of 
life,  living  longer,  and  controlling  weight.  Patients  were  asked  to  identify  possible 
barriers that may prevent them from remaining active in  phase IV.  For example,  many 
patients' return to work after completing  phase  III  exercise training,  thus  lack of time 
may be  a potential  barrier to  activity  in  phase  IV.  The  aim  of the  decision  balance 
sheet was to help the participant realise that the benefits of increasing and maintaining 
activity outweighed the  barriers.  This  is  an  effective technique for improving  exercise 
adherence.149 This followed with  a discussion on  ways to  overcome potential  barriers 
to activity in  phase IV.  Possible solutions to time constraints included using the stairs. 
96 walking part or the entire journey to work or taking a brisk walk at luncht'  Ime. 
Social  support  is  a  major  determinant  of  adherence  to  exercise  in  cardiac 
rehabilitation. Thus, an important part of the consultation was to encourage patients to 
seek  support for their activity  plan.  For example,  family  or  friends  could  engage  in 
some  activity  with  the  patient  or praise  them  for continuing  with  an  active  lifestyle. 
Alternatively, joining a group exercise programme provided  a supportive environment 
for some individuals.  Clients received  information on  local exercise opportunities that 
were  suitable for phase IV cardiac patients.  For example,  patients could  attend  GP 
exercise  referral  schemes  called  "Living  Plus"  located  in  the  surrounding  leisure 
centres. These schemes involved group exercise classes and gym-based programmes 
lasting  10 weeks.  Following completion  of these programmes,  maintenance exercise 
classes called "Fit for Life" were available. In addition, patients and their partners could 
attend  a  community  exercise  programme,  which  took  place  in  the  evening  once  a 
week.  BACR  phase  IV maintenance exercise  programmes were  not  available  in  the 
surrounding area !--Intil near the end of the study. 
Relapse  prevention  training  150  was  an  important  component  of  the  exercise 
consultation  process as  patients had  recently  completed  phase  "I.  Participants were 
asked to identify high-risk situations that may cause a lapse from activity, for example 
bad weather or illness.  These lapses can  accumulate and  may lead  to  a return  to  a 
sedentary  lifestyle.  Thus,  the  researcher helped  the  patient to  acquire  strategies  to 
cope  with  these  situations,  for example  having  an  alternative  indoor  activity  in  bad 
weather, thereby reducing the likelihood of a lapse in  activity and an  overall decline in 
physical  activity.  Finally,  the  client  was  encouraged  to  set  short-term  (1  month), 
intermediate (3 month) and long-term (6-month) specific activity goals. The researcher 
assisted the client with the goal setting to ensure that the goals were  acceptable and 
achievable  met the  client's  needs  and  accounted  for factors  discussed  during  the  , 
consultation  such  as  solutions to  barriers,  likes and  dislikes,  and  relapse  prevention 
strategies. Participants were given a copy of the activity goals to take away with them. 
Exercise Consultation at Six Months 
Information recorded during the baseline exercise consultation was reviewed in the six-
month  consultation.  For example,  participants  were  asked  if they  had  achieved  the 
activity goals set at baseline. If clients did not achieve their goals, then the reasons for 
97 this were explored and new goals were set. Additionally,  clients received feedback on 
their level of physical activity and cardiorespiratory fitness collected during the baseline 
and  six-month assessments.  Specifically, the researcher informed participants  if they 
had improved, maintained or declined over the past 6 months in terms of their physical 
activity levels and fitness. If the patient's activity and fitness had declined from baseline 
to  six  months,  then  the  reasons  for this  deterioration  were  explored.  For  example, 
clients were  asked  if they had  encountered any  barriers to  activity or risky  situations 
that had caused a lapse or relapse from activity over the past six months. Participants 
who  had  maintained  or  increased  their  activity  from  baseline  to  six  months  were 
praised  by  the  researcher  and  instructed  to  "keep  up  the  good  work".  However, 
barriers  to  activity,  problem  solving  barriers,  goal  setting  and  relapse  prevention 
strategies  were  briefly  discussed  with  all  patients  to  ensure  they  had  acquired  the 
necessary skills to help them remain active over the next six months. 
Support Phone Calls 
The  exercise  consultation  also  included  two  support  phone  calls,  which  were 
delivered three months after the baseline and six-month exercise consultations. The 
notes  recorded  during  the  exercise  consultations  were  used  to  guide  the  phone 
calls.  The phone calls lasted approximately 1  0 minutes and  involved discussing any 
problems the patients were experiencing  in  achieving their activity goals,  attending 
community exercise programmes, and remaining active. 
Control Group 
Subjects in  the control  group also  received  two  phone  calls,  delivered  three  months 
after the baseline and six-month assessments, to maintain equal contact time between 
the experimental  and  control  groups and  to  limit dropout from  the  study.  The  phone 
calls lasted approximately five to 10 minutes and the topics discussed were unrelated 
to exercise and included asking patients if they had attended their GP, any problems in 
relation  to  cardiac  symptoms,  medication  or  blood  pressure.  This  is  not  standard 
management of patients in phase IV cardiac rehabilitation. 
Standard Exercise Information 
All study participants in the control condition and the experimental condition received a 
leaflet  entitled  Physical  Activity  and  your  Heart
266 
published  by  the  British  Heart 
98 Foundation after the baseline and six month measurements  P  t'  t  .  .  .  a len s normally receive 
this booklet in phase I and on  completion of phase III. The leaflet included information 
on  the  benefits  of  regular  physical  activity,  CHD  risk  factors,  physical  activity 
recommendations and examples of how to become more active. 
Primary Outcome Measures 
Physical Activity 
Stages of  Exercise Behaviour Change 
The stages of exercise  behaviour change  156  are:  Precontemplation  (inactive  and  no 
intention to  change),  Contemplation  (inactive,  but  intending  to  change  in  the  next 6 
months),  Preparation  (engaging  in  some activity,  but  not regularly),  Action  (regularly 
physically active,  but only began  in  the past 6  months),  and  Maintenance (regularly 
active  for more than  six  months).156  Patients  in  action  or maintenance  are  meeting 
guidelines6 ;8 for regular physical activity. 
The  method  used  to  assess  the  stages  of  exercise  behaviour  change  has  been 
validated  against  subjective  and  objective  measures  of physical  activity.  96;144;157-159 
Studies  have  reported  an  increase  in  self-reported  physical  activity  and 
cardiorespiratory fitness with advancing stage of change in  healthy adults and cardiac 
rehabilitation participants.96;144;157-159  The original stages of exercise behaviour change 
questionnaire  developed  by  Marcus  160  in  1992  defined  regular  physical  activity  as 
"exercising at least three time per week for 20 minutes." The reliability and validity of 
this  questionnaire  has  been  demonstrated.157;267  However,  Loughlan  and  Mutrie260 
modified this questionnaire to include the 1995 physical activity recommendation (i.e. 
30 minutes of accumulated  moderate activity on  five days per week).  The validity of 
the  modified  questionnaire  has  been  demonstrated  in  the  general  population.
268 
Lowther and Mutrie268  found that subjects in  the action and  maintenance stages (i.e. 
meeting the definition of regular physical activity) reported  significantly more physical 
activity compared to those in  preparation and  contemplation.  In  addition, those in  the 
preparation  stage  participated  in  significantly  more  physical  activity  compared  to 
subjects  in  the  contemplation  stage.  Similarly,  a  recent  study  used  both  physical 
activity recommendations to assess the stage of exercise behaviour change of a group 
99 of patients  before  and  after  participation  in  12  weeks  cardiac  rehabilitation. 96  The 
modified stage of exercise behaviour change questionnaire,260 which included the two 
physical activity recommendations was selected for use in this study. 
The questionnaire
260 
included a clear description of each  stage of exercise behaviour 
change  and  regular  physical  activity  was  based  on  the  current  physical  activity 
recommendations
6
;s  (i.e.  a  minimum  of  20  minutes  of  continuous,  moderate  to 
vigorous exercise on three days per week or accumulating a minimum of 30 minutes of 
moderate  physical  activity on  five  days  per week.  Based  on  this  definition,  subjects 
selected the stage of change that described their physical  activity behaviour over the 
past six months. At the baseline assessment only,  the stage of change questionnaire 
measured  individuals  physical  activity  behaviour over the  past  two months,  as  they 
had  suffered a cardiac event in  the preceding  six  months,  but  had  attended  cardiac 
rehabilitation classes in the past two months. 
Stanford Seven-Day Physical Activity Recall 
The  reliability  and  validity  of  the  Stanford  Seven-Day  Physical  Activity  Recall220 
(7DPAR)  was  discussed  in  Chapter  One.  The  7DPAR  was  administered  in  a 
structured  interview format  by  the  same  researcher throughout  the  study  period.  A 
standardised interview process was followed222 to  limit the interviewer's bias,  minimise 
guessing  and  over- or underestimating  a  participant's  physical  activity.  Gross found 
that individuals trained in the standardised interview process reliably administered and 
scored the seven-day physical activity recall. 225 The researcher performed a number of 
practice sessions conducting and scoring the questionnaire with  cardiac rehabilitation 
participants before commencing the study. 
Subjects  were  asked  to  recall  the  duration  spent  sleeping  and  participating  in 
moderate, hard and very hard intensity physical activity for each of the previous seven 
days. Participants were reminded that they had been wearing the CSA accelerometer, 
and were asked to recall the duration and  intensity of their activities as  accurately as 
possible and to report the activities they actually engaged  in  over the previous week 
instead  of activities  they would  normally  do.  Information  from  the  activity  recording 
sheet (Appendix E)  administered during visit one was used to assist patients with their 
recall.  To  further  assist  with  recall,  subjects  were  asked  to  recall  activities  in  the 
morning,  afternoon  and  evening  for  each  of the  seven  days,  beginning  with  the 
100 previous day.  After each day of recall  and  at the end  of the  interview,  the  participant 
was asked if there was any activity that they may have overlooked or forgotten.  During 
the interview,  prompts were used to  help partiCipants recall their activity.  For example, 
general  questions like  "Did  you  do  any housework or gardening  that  was  similar in 
intensity  as  a  brisk  walk?"  or "How  do  you  get  to  and  from  work?"  were  asked. 
Classifying the intensity level of activities is the most difficult and ambiguous part of the 
interview process. Thus, subjects were instructed that moderate intensity activities are 
similar to a brisk walk,  very hard intensity activities are equivalent to  running  and  hard 
activities  are  in  between  brisk  walking  and  running  (e.g.  a  brisk  walk  uphill). 
Physiological  symptoms,  such  as  perceptions of sweating,  heart  rate,  and  breathing 
were not used to  define intensity because they vary  greatly  by  age,  weather,  fitness 
level,  cardiac  medication  and  condition.  In  addition,  subjects  were  shown  a  list  of 
activities  in  each  intensity  category.  Patients  were  instructed  that  light  intensity 
activities  were  not included  in  the  questionnaire,  such  as  desk work,  standing,  light 
housework  (e.g.  ironing,  washing  dishes  etc),  strolling,  and  walking  for  less  than  5 
minutes  (e.g.  shopping).  Subjects  were  asked  about  the  duration  of  each  activity 
excluding breaks (e.g. being at the swimming pool for 1 hour but only swimming for 30 
minutes was  recorded  as  30  minutes,  not  1 hour).  The  information  recorded  by  the 
seven-day recall was summarised as follows: the number of minutes each day spent in 
sleep,  and  moderate,  hard  and very  hard  intensity  activity was  totalled  for the week. 
Minutes spent  in  light  intensity activity per week was  determined  by  subtracting the 
time in  sleep,  and  moderate to very hard activity from  10080 minutes.  Total  physical 
activity per week was calculated by summing the duration of moderate, hard and very 
hard activities per week. 
Total  weekly  energy  expenditure  can  be  estimated  by  multiplying  the  time  spent  in 
sleep (1  MET), light (1.5 METs), moderate (4 METs), hard (6 METs) and very hard (10 
METs) activities  per week by  their corresponding  MET value.  However,  total  energy 
expenditure was not determined in this study for the following reasons.  The fixed MET 
values  for estimating  energy  expenditure  were  derived  from  young  adults.  Duncan 
found that actual MET values for moderate,  hard and very hard intensity activity were 
3.8,  5.3  and  6.2,  respectively  in  a group of sedentary middle  aged  adults,  which  are 
lower than the fixed MET values used by the recall. 223  Furthermore,  Duncan reported 
that  the  average  aerobic  capacity  of the  study  group  was  7.3  METs,  thus  these 
individuals would  be  unable to perform  very  hard  activity (10  METs  according  to  the 
101 recall) as it would require 137% of their aerobic capacity.  Therefore, fixed MET values 
used  by  the  7DPAR  to  estimate  energy  expenditure  may  not  be  appropriate  for 
individuals with  low exercise capacities.  In  addition,  several  studies  reported  that the 
seven-day recall significantly overestimated energy expenditure compared to  DLW.230-
232 Th  .  t  us, mlnu es per week in various physical activity intensities were used instead. 
Computer Science and Applications Accelerometer 
The Computer Science and Applications accelerometer (CSA)  model 7164 (Shalimar, 
Florida)  is  small  (5.1  x  3.8  x  1.5  cm),  lightweight  (42.6  g),  measures  dynamic 
movement  in  one  direction  and  can  be  worn  on  the  waist,  ankle  or  wrist. 190  This 
instrument is  illustrated  in  Figure  6.  The  CSA  measures  vertical  movement  using  a 
piezoelectric bender, which generates a signal in response accelerations during bodily 
movement. The signal generated is  proportional to the magnitude of the acceleration. 
Thus,  greater  accelerations  produce  higher  signals.  The  acceleration  signal  is 
digitised,  and  these values  are  summed  over a one-minute time  interval  (epoch).  At 
the end  of each  ~poch, the summed value  is  expressed  as  an  activity  count  and  is 
stored in the memory. Each activity count represents the sum  of accelerations during 
one minute. Thus,  the  greater the  intensity of activity  (i.e.  in  terms  of the  magnitude 
and  frequency  of accelerations)  the  higher  the  activity  count.  The  CSA  measures 
accelerations ranging in  magnitude from 0.05 to 2 GiS in the vertical (z) direction. The 
instrument detects movements that occur within a frequency response from 0.25 to 2.5 
hertz  so  that  normal  human  movement  is  detected  and  nonphysiological  motion  is 
filtered  out.  The  reliability and  validity of the  CSA for measuring  physical  activity was 
discussed in  Chapter One.  However,  a pilot stud/69  was  conducted  to  examine  the 
relationship between CSA accelerometer counts and V02  during daily living activities in 
15  cardiac  patients  recruited  from  a  phase  III  hospital-based  programme.  Patients 
walked  at three  self-selected  speeds  (slow,  normal  and  brisk)  and  performed  other 
daily  living  activities  (i.e.  carrying  loaded  shopping  bags  and  pushing  a  loaded 
shopping  trolley  at the  normal walking  pace).  During  each  activity,  steady state V02 
(ml/kg/min)  was  measured  using  a  portable  metabolic  system  (Cosmed  K4b
2
)  and 
activity  counts/minute were  recorded  using  CSA accelerometers  worn  on  the  waist, 
ankle  and  wrist.  This  study  found  that  V02  (ml/kg/min)  and  activity  counts/minute 
Significantly  increased  as  walking  speed  increased.  In  addition,  V02 (ml/kg/min)  for 
carrying  shopping  bags  and  pushing  shopping  trolley  were  similar  and  significantly 
higher than normal walking. In contrast, activity counts/minute recorded during carrying 
102 shopping bags and pushing shopping trolley were not significantly higher compared to 
normal  walking.  Similar results  were  obtained  for CSA  accelerometers  worn  on  the 
wrist  and  ankle.  Findings  from  this  study  suggest that  changes  in  V02 during  daily 
living  activities  are  not always  reflected  by  changes  in  accelerometer counts.  Thus, 
CSA accelerometers do not accurately record all types of activity. 
The CSA was operated according to the manufacturer's instructions. 19o The instrument 
was initialised to begin recording at visit one and the monitor was  instructed to collect 
data  in  one-minute  time  intervals  (Le.  epochs),  thus  output  from  the  CSA  was  in 
activity counts per minute. The CSA was attached to the right ankle with a Velcro strap 
above the anklebone with the orientation of the notch toward the knee,  as specified by 
the manufacturer. Although most studies using CSA accelerometers have attached the 
monitor to the waist,  the ankle was  chosen  as the  attachment site  in  this  study.  This 
was  because during  pilot  studies,263;269  subjects  reported  that monitors attached to  a 
belt  and  worn  on  the  waist  frequently  became  loose  and  turned  upside  down. 
Participants were .instructed to wear the monitor during all waking hours except during 
bathing  or  other water  activities.  Subjects  recorded  the  time  that  the  monitor  was 
attached and removed each day, to ensure that the monitor was being worn during all 
waking hours.  The recording  sheet is  shown  in  Appendix  D.  In  addition,  participants 
were asked to ensure that the orientation and  placement of the monitor on the ankle 
was  held  constant  from  day  to  day  in  order  to  obtain  accurate  repeatable  data. 
Participants  wore  the  accelerometer  for  a  minimum  of  seven  days,  so  that  the 
accelerometer data would correspond with the information obtained from the Stanford 
Seven  Day  Physical  Activity  Recall.  The  monitor was  returned  at  visit  2  and  data 
recorded by the accelerometer were downloaded to  a desktop computer using a CSA 
reader interface unit connected to the PC serial port.  Data were exported to excel and 
activity counts per minute for the seven-monitored days were summed to produce total 
activity counts per week. Activity counts were not used to estimate energy expenditure 
or the time  spent in  various  intensity  categories  due  to  limitations  of the  equations 
used to predict these variables from accelerometer readings.  Due to the small number 
of monitors available for use in  the  study,  it  was  not possible to  use the  same  CSA 
monitor on the same individual at each of the three measurement periods. 
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Cardiorespiratory Fitness 
Cardiorespiratory  fitness,  specifically  exercise  capacity  and  submaximal  endurance 
capacity, was measured using  a cardiopulmonary exercise test.  This test was  carried 
out on a motorised treadmill (Quinton 65) with gas exchange and ventilatory variables 
being  analysed  breath  by  breath  using  the  Cosmed  K4b2 (Cosmed,  Italy). All  tests 
were performed in the same laboratory. 
Cosmed K4b
2 
The  Cosmed  K4b2 (Cosmed,  Italy)  is  a breath  by  breath  portable  metabolic system, 
illustrated  in  Figure  7.  The  Cosmed  K4b2  is  valid  for  measuring  gas  exchange 
variables across a wide range of exercise intensities.270;271  In  addition,  a recent study 
found no significant difference between the Cosmed  K4b2 and  a stationary metabolic 
cart  for  measuring  gas  exchange  during  treadmill  exercise  in  a  group  of  cardiac 
patients  attending  phase  "I  exercise  programmes.272  Although  the  reliability  of the 
Cosmed K4b2 has not been  assessed, the earlier model  (Cosmed K4)  was  shown to 
be  reliable.273  The portable unit of the Cosmed  K4b2 contains the oxygen  and  carbon 
dioxide  analysers,  sampling  pump,  UHF  transmitter,  barometric  sensors  and 
electronics and is powered by a rechargeable battery.274 The total system weighs less 
than 1 kg. The oxygen analyser has a measurement range of 7-24% O2, and accuracy 
to 0.02% O2. The carbon dioxide analyser has  a measurement range  of 0 - 8%  CO2 
and  accuracy to 0.01 %  CO2. The O2 and CO2  analysers  have a rapid  response time 
and  are  thermostated  and  compensated  for  variations  in  barometric  pressure, temperature,  and  environmental  humidity.  The  flowmeter  contains  a  bi-directional 
digital  turbine  that  measures  respiratory  flow  with  a  flow  range  capacity  up  to  20 
litres/sec and a wide ventilation range between 0 to 300 IImin with accuracy to ±2%. 
The  flowmeter  is  fixed  to  a  soft facemask  (Hans-RUdolph,  Kansas  City,  MO),  that 
covers the subject's mouth and nose. The masks are  available in  different sizes and 
have  two  inspiratory  valves  to  reduce  inspiratory  resistance.  A  Permapure  tube 
connected to the flowmeter and the portable unit is used to sample oxygen and carbon 
dioxide in expired air. 
The manufacturer recommended that the portable unit (connected to the charger unit) 
was warmed up for at least 45 minutes before use.274  Before each exercise test,  the 
following calibrations were performed, according to the manufacturer's guidelines,274 to 
ensure accurate and reliable readings. The system automatically performs a room air 
calibration  by  sampling  room  air to  update  the  CO2 analyser  baseline  and  the  O2 
analyser gain to match the readings with predicted atmospheric values (20.93% for O2 
and  0.03%  for CO2).  The  reference  gas  calibration  involves  sampling  a  gas with  a 
known composition (Le.  16% O2 and 5% CO2, balance N2 ) from  a calibration cylinder 
and  updating  the  baseline  and  the  gain  of the  analysers  to  match  the  measured 
readings with the predicted values.  The output pressure from the calibration cylinder 
was  set  between  300  to  500  Kpa  to  ensure that  room  air was  not  mixed  with  the 
reference gas, which would affect the calibration. The delay calibration measures the 
time necessary for the gas  sample to  pass  through  the  sampling  line  before  being 
analysed.  The  turbine  calibration  consists  of  measuring  the  volume  of  a  3  litre 
calibration  syringe  and  updating  the  gain  of the  flowmeter  in  order  to  match  the 
predicted  value.  The  calibration  results  were  viewed  to  ensure  that  the  measured 
values were within the acceptable range of the predicted values. 
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Exercise Testing Protocol 
An  individualised  exercise  testing  protocol
275  was  devised  to  accommodate  each 
patient's  capabilities  and  to  achieve  an  optimal  exercise  test  duration  of  8  to  12 
minutes (excluding the 3 minute warm-up phase) for reasons  previously discussed in 
Chapter One.  The  protocol  consisted  of:  1)  2 minutes  at  rest;  2)  3 minute warm-up 
phase, which involved gradually increasing treadmill speed to  achieve a brisk walking 
pace  (range  1-3.3mph),  at  0%  gradient;  and  3)  incremental  phase,  which  involved 
increasing  treadmill  gradient  by  1  %,  1.5%  or  2%  each  minute  until  the  test  was 
terminated.  However,  if  after  five  minutes  of  incremental  exercise,  the  respiratory 
exchange ratio  (RER) values were less than 0.90  and there were  no  ischaemic ECG 
changes, the treadmill speed was increased by 0.3 to 0.5mph per minute to achieve a 
fast walk or jog,  (the gradient did  not change). Once a fast walk or jog was  achieved, 
the speed did not changed and the gradient was increased by  1.5% to 2%  per minute 
until the test was terminated. 
Exercise Testing Procedure 
An  established  procedure  for  conducting  cardiopulmonary  exercise  tests  was 
followed. 83  Patients were advised to wear comfortable clothes and shoes, to adhere to 
his or her usual medical regimen,  to eat a light meal  no  less than  2 hours before the 
test,  and to  avoid cigarettes and caffeine for at least 2 hours  A full  explanation of the 
106 exercise  test  procedure  was  given  to  standardise  the  response  to  the  test  and  to 
reduce the patient's anxiety. 
A cardiac technician fitted each patient with  a 12  lead  ECG  and  an  automated  blood 
pressure cuff. A resting  12 lead ECG and  a blood pressure reading was obtained with 
the subject in  a seated position. A heart rate belt was fixed to the patient's thorax and 
the  heart  rate  probe  was  attached  to  the  harness.  The  K4b2 portable  unit  and  the 
battery were fixed to the back plates of the harness worn by the patient. The facemask 
was  attached  to  the  participant  with  a  nylon  mesh  hairnet  and  velcro  straps.  The 
researcher ensured that the facemask fitted well and was fixed  securely to prevent air 
leakage.  The ambient humidity was  determined using  a hygrometer and  entered  into 
the  portable  unit  along  with  physical  characteristics  of the  participant  (age,  weight, 
height,  and  gender).  After performing  a room  air calibration,  the  portable unit began 
recording gas exchange data.  The data recorded by the portable unit was transmitted 
breath  by  breath  to  a laptop allowing  the  data to  be  displayed  in  table  and  graphic 
formats. 
Patients performed a practice walk on the treadmill to familiarise themselves with the 
treadmill and the equipment. Then subjects were seated and remained in this position 
until values for ventilation and  RER returned to resting levels (i.e.  ventilation below 10 
IImin  and  RER  less  than  0.85)  to  ensure  that the  patient  was  not  hyperventilating, 
which  may  affect  the  estimation  of the  lactate  threshold.  During  the  exercise  test 
patients received  standardised encouragement from  the  cardiac technician,  who  was 
blinded to group allocation, to maximise exercise performance.  Throughout the test,  a 
12  lead  ECG  was  monitored  continuously  and  blood  pressure  readings  were  taken 
every  3  minutes.  The  patient  could  terminate  the  test  by  symptoms  of  chest  pain, 
fatigue,  and  breathlessness.  The  supervising  cardiac technician  could  also  stop  the 
test  in  the  event  of  significant  ECG  changes  (~2mm ST  depression),  significant 
arrhythmia  or a fall  in  blood  pressure.  The  following  data  were  obtained  breath  by 
breath:  oxygen  uptake  (V02 mllmin),  V02 per  kg  (V02  ml/kg/min),  carbon  dioxide 
output  (C02 ml/min),  respiratory  frequency  (Rf breath/min),  tidal  volume  (VT  litres), 
heart  rate  (HR  beats/min),  ventilation  (VE  I/min),  respiratory  exchange  ratio  [RER 
(VC02N02)]  ventilatory  equivalent  for  O2 (VEN02 )  ,  ventilatory  equivalent  for  CO2 
(VENC02 ),  oxygen pulse (V02/HR ml/beat), end tidal partial pressures of O2 (PET02) 
and CO2 (PETC02). On test completion, data were downloaded from the portable unit 
107 to the laptop and then exported to an excel spreadsheet for data management. 
Data Analysis 
Data were managed in  excel in  the following way.  Graphs were drawn for V0
2
,  VC0
2 
and  VE  versus  time.  Outlying  points  caused  by  the  patient  talking,  coughing  or 
abnormal breathing patterns (e.g.  patient taking a deep breath) were deleted from the 
data sheet as they could affect the detection of the lactate threshold.  The edited data 
was then used to determine exercise capacity and submaximal endurance capacity. 
Exercise Capacity 
Exercise  capacity  was  determined  by  calculating  the  following  variables  at  peak 
exercise: 
1.  Peak exercise duration (excluding the three minute warm-up phase) 
2.  Peak V02 ml/min (average V02 for the last 30 secs of the exercise test) 
3.  Peak V02 mllkg/min (average V02 for the last 30 secs of the exercise test). 
4.  Peak oxygen pulse  (V02/HR  ml/beat)  was  calculated  from  peak  V02  divided  by 
peak heart rate (highest heart rate measured by the K4b
2 and ECG). This variable 
measures  the  amount  of oxygen  carried  in  each  stroke  volume,  and  gives  an 
index of cardiac function. 
5.  Peak respiratory exchange ratio (RER) is the ratio of VC02N02  at peak exercise 
and was used as an indicator of exercise effort. An RER greater than 1.15 at peak 
exercise indicates a maximal effort.  83 
Submaximal Endurance Capacity 
Submaximal endurance capacity was  determined  by  estimating  the  lactate threshold 
using the V-slope and ventilatory equivalent methods, which were previously described 
in  Chapter  One.  The  V-slope  and  ventilatory  equivalent  methods  were  carried  out 
using  an  established  procedure?76  Breath  by  breath  values for V02,  VC02,  VEN02, 
VEVC02, PET02,  and PETC02 were averaged (Le. 4, 6 and 8 breath averages), which 
makes it easier to estimate the threshold.  For the V-slope method,  a graph  of VC02 
versus  V02  graphs  was  drawn  and  the  lactate  threshold  was  estimated  by  visual 
inspection  of the  V02  at  which  a  breakpoint  in  the  VC02N02  relationship  is  first 
evident.  For  the  ventilatory  equivalent  method,  graphs  of  V02  versus  VEN02, 
VENC02,  PET02,  and PETC02 were drawn. The lactate threshold was determined by 
the  V02  at  which  an  increase  in  VEN02  and  PET02  occurs  with  no  change  or  a 
108 decrease in VENC02 and PETC02. These methods are demonstrated in Chapter One. 
Secondary Outcome Measures 
Psychological Functioning 
Quality of  Life 
Quality of life was assessed using version  2 of the  UK Short Form-36. 261  It  is  a self-
administered  generic  instrument  containing  36  items  that  measure  the  following  8 
dimensions of general  health:  physical  functioning  (PF),  social  functioning  (SF),  role 
limitations due to physical problems (RLP),  role limitations due to emotional problems 
(RLE), pain (P), energy/vitality (EV), mental health (MH) and general health perception 
(GHP).  Scores for each dimension are obtained by reverse scoring, where necessary 
and  summing responses.  Raw scores can  then  be transformed on  to  a scale from  0 
(worst possible health) to 100 (best possible health). 
The  validity,  reliability  and  responsiveness  of the  SF-36  to  assess  quality  of  life  in 
cardiac  patients  ~as been  demonstrated  (Chapter  One).  In  1999,  version  2 of this 
questionnaire  was  developed  to  overcome  some  of the  problems  with  the  original 
instrument.  259 The wording and layout of the SF-36 was modified and the responses to 
the two role functioning domains were changed from  dichotomous scales  (yes/no) to 
five point response categories to reduce ceiling and floor effects for these dimensions. 
In  addition,  minor modifications to  the wording  of six  items were  made  to  make the 
questionnaire acceptable in the British context. The UK SF-36 version 2 demonstrated 
greater  internal  consistency  and  fewer  floor  and  ceiling  effects  compared  to  the 
original  questionnaire,  which  may  improve  the  responsiveness  of the  instrument.
259 
Normative values for this version are available for a UK general population.
259 
Anxiety and Depression 
Anxiety  and  depression  was  assessed  by  the  Hospital  Anxiety  and  Depression 
Scale.
240 The validity, reliability and responsiveness of the HADS for measuring anxiety 
and depression in medical patients, including individuals with CHD has been discussed 
(Chapter One).  The  Hospital  Anxiety  and  Depression  Scale  (HADS)  is  a brief,  self-
report questionnaire that measures the states of anxiety and depression over the past 
week.  The  questionnaire  is  divided  into  anxiety  and  depression  subscales  both 
containing 7 items, each item is rated on a 4 point scale from 0 to 3,  giving total scores 
ranging  from  0 to  21  for each  subscale.  The  HADS  scores  can  be  used  to  classify 
109 individuals into normal (0-7),  mild  (8-10),  moderate (11-14)  and  severe  (15  or above) 
cate~ories for  anxiety  and  depression.
245  In  addition,  it  has  been  suggested  that  a 
HADS  score  of  2  8  for  both  subscales  identifies  possible  cases  of  psychological 
distress in the general population and medical patients. 239 
Processes of  Exercise Behaviour Change 
The  processes  of change  for exercise  behaviour
160  are  strategies  that  people  use 
when  changing  their exercise  behaviour.  There  are  five  experiential  (consciousness 
raising,  social  liberation,  dramatic  relief,  environmental  re-evaluation,  self  re-
evaluation)  and  five  behavioural  processes  (helping  relationships,  stimulus  control, 
counter  conditioning,  self-liberation,  reinforcement  management),  see  Table  6  for 
definitions.  The  ten  processes  were  assessed  using  a 40  item  questionnaire  that 
asked  participants  to  indicate  on  a 5 point  likert  scale  ranging  from  1 (never)  to  5 
(repeatedly)  how frequently  in  the  past  month they  had  used  or thought about each 
process.
160 The internal consistency for each process and the validity of the processes 
of change questionnaire has  been  demonstrated.
160
;277  Several studies have used the 
questionnaire  to  measure  process  use  in  cardiac  rehabilitation  populations.
96
;144;161 
Recently,  Bock  reported  significant  increases  in  the  use  of  behavioural  processes 
following participation in a 3 month cardiac rehabilitation exercise programme.
96 
Lipids 
A  12  hour  fasting  blood  sample  was  obtained  and  analysed  to  determine  total 
cholesterol,  high-density cholesterol  (HDL-C),  low-density  cholesterol  (LDL-C)  and 
triglycerides. The blood samples were analysed by the biochemistry laboratory at the 
Royal  Alexandra  Hospital.  The  concentration  of total  cholesterol,  tryglycerides  and 
HDL  cholesterol  in  serum  was  directly quantified  by  enzymatic  methods  using  an 
automated  clinical  chemistry  analyser  (Hitachi  917,  Roche  Diagnostics  Ltd).  LDL 
cholesterol  was  calculated  using  the  Friedewald  equation.
278 
The  accuracy  and 
reliability of the biochemistry laboratory for measuring total cholesterol, triglycerides, 
HDL  cholesterol  and  LDL  cholesterol  is  tested  throughout  each  day  by  analysing 
control samples and monthly by analysing reference samples supplied by a UK-CDC 
Network Laboratory at the Glasgow Royal  Infirmary. The difference between values 
measured  by the laboratory and  target values  were  within  acceptable  limits  (i.e.  ± 
5%). 
110 Smoking Status at Baseline 
Smoking status at baseline was  assessed by  asking patients if they were  a current 
smoker, an ex smoker or a non-smoker. 
Social Class at Baseline 
Social  class  at  baseline  was  determined  using  the  new  National  Statistics  Socio-
Economic Classification
264 
(NS-SEC), which  replaces the two  previous classifications'  , 
Social Class based on Occupation (SC) and Socio-economic Groups (SEG). The SEC 
has been thoroughly tested and validated using the Labour Force Survey and a variety 
of national  datasets  (e.g.  health,  mortality  and  employment).264  The  SEC  has  a full 
version,  which  involves  14 functional  classes  based  on  occupation  and  employment 
status.  In  addition,  the full  version  can  be  collapsed  into  9,  8,  5 or 3 socio-economic 
classes for analytical purposes. The full version of the SEC is very similar to the SEG, 
whereas the collapsed versions of the SEC resemble the SC.  Thus,  all three methods 
are closely related. 
The  new  classification  (SEC)  groups  individuals  according  to  both  occupation  and 
employment status.264 Therefore, information was collected on the patient's occupation 
and employment status (i.e. self-employed with 25 plus employees, self-employed with 
less  than  25  employees,  self-employed  with  no  employees,  and  employee).  In 
addition,  information  was  collected  on  employees  with  managerial  or  supervisory 
status (i.e.  manager with  25 plus  employees,  manager with  less than  25 employees, 
supervisor/foremen and  employee).  Unemployed and  retired  individuals were  classed 
using  their last  main job.  In  the  five  and  three  class  versions,  individuals  who  have 
never worked  were  allocated to working  class.  Women  who  had  never worked  and 
were married were classified using their husbands' occupation and employment status. 
The  three-class  version,  which  categorises  individuals  into  Managerial/Professional, 
Intermediate and Working Class, was used to determine social class in this study. 
Mortality and Morbidity 
Total  and  cardiovascular  mortality  was  recorded  by  reviewing  patient's  medical 
records.  The  number  of cardiac  hospital  re-admissions  (e.g.  MI,  UAP,  receiving 
PTCA or CABG) was recorded by reviewing  medical records and  asking  patients at 
the six and 12-month follow-up visits. 
111 Figure 8 Summary of Study Design 
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12 month Assessment  1 Statistical Analysis 
Analyses  were  performed  using  computer software  packages  Minitab  version  13.30 
and SPSS version 11.0. Normality of all data were assessed by examining histograms, 
boxplots  and  normal  probability  plots  of  the  data.  In  addition,  comparisons  of 
descriptive statistics were used to assess the normality of the data; such as mean and 
median,  minimum  and  maximum  values,  and  upper  and  lower  interquartile  ranges. 
Normally distributed data are  expressed  as  mean  ± standard  deviation  (SO);  median 
and  interquartile range  (IQR) are used for data that are  not normally distributed.  The 
General  Linear  Model  (GLM)  repeated  measures  statistical  test  was  considered  to 
determine  the  effect  of  the  exercise  consultation  (experimental)  compared  with 
standard  exercise  information  (control)  on  the  dependent  variables  (e.g.  physical 
activity) from baseline to six and 12 months. The GLM test is based on the assumption 
that the data come from  normal distributions within the groups and that the variances 
of these distributions are the same.  Normal probability plots of the  residuals,  plots of 
residuals  versus  fitted  values  and  the  8artletts test  of equal  variance  were  used  to 
check  these  assumptions.  However,  results  of  these  tests  suggested  that  the 
assumption of normality and equal variance were not met for the following dependent 
variables (i.e.  physical activity,  lipids,  quality of life,  processes of change,  anxiety and 
depression).  In  addition,  performing  normality  and  equal  variance  tests  on  log  and 
square root transformed data suggested that the transformed data did not meet these 
assumptions.  Therefore,  using  GLM  repeated  measures  to  analyse  the  data  was 
rejected. 
The following statistical tests were performed instead.  Normally distributed data were 
analysed  using  paired  student's t tests  for within  group  analyses  and  two  sample  t 
tests  for  between  group  analyses.  Data  that  was  not  normally  distributed  were 
analysed  using  Wilcoxon  signed  rank  tests  for  within  group  differences  and  Mann 
Whitney  tests  for  differences  between  groups.  Ninety  eight  percent  confidence 
intervals were used to quantify the between and within group differences.  Ninety eight 
percent confidence limits were used to control for Type 1 errors due to the number of 
comparisons  being  conducted.  Categorical  data  are  reported  as  number of patients 
and proportions and analysed using chi square tests and Fisher's exact tests. Dr Lilian 
Murray, Statistician, University of Glasgow provided statistical advice. 
113 CHAPTER FOUR 
RESULTS 
Flow of Participants Through the Study 
Figure  9  demonstrates the  flow  of participants  through  each  stage  of the  study.  In 
total,  85  patients were  invited to  participate in  the  study,  and  15  patients  refused  to 
take part.  Therefore,  70  patients were  assessed  at  baseline and  then  randomised  to 
the  experimental  or  control  group.  At  baseline,  all  patients  received  the  allocated 
intervention  or  standard  care.  Ninety  three  percent  (65nO)  of  the  sample  were 
assessed at six months (n=32 experimentals and n=33 controls). Two control patients 
were lost to follow-up at six months;  one  patient died  and  one  patient received  non-
cardiac surgery. Three experimental patients were lost to the six month follow-up;  one 
patient  received  CABG,  one  patient  could  not  be  contacted  and  one  patient  was 
suffering from depression. Ninety four percent (66nO) of the sample were assessed at 
12 months (n=33 'experimentals and n=33 controls).  In the control group, two patients 
had died at 12 months.  In the experimental group, one patient could not be contacted 
and  one  patient  was  suffering  from  depression  at  12  months.  In  addition,  the  two 
patients who received surgery at six months, thus were lost to the six-month follow-up, 
returned  for  the  12  month  assessment. 
11-+ Figure 9 Flow of participants through the randomised controlled trial 
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115 Baseline Demographic and Clinical Characteristics 
Table  7  displays  the  baseline  demographic  and  clinical  characteristics  of  the 
experimental  and  control  groups.  The  experimental  and  control  groups  were 
comparable for age  (95%CI  -3.1,  7),  and  gender (X
2=1.4,  p=0.23).  However,  mean 
weight  (kg)  of the  experimental  group  was  significantly  greater  compared  to  the 
control  group  (95%CI  -13.8,  -0.1).  In  addition,  there  was  trend  for  a greater  mean 
body mass index in  the experimental group compared to the control group (95%CI -
3.1,  0.2). As shown in Table 7,  the majority of patients in  both  groups were male and 
had  suffered  a  myocardial  infarction.  A  small  number  of  experimental  and  control 
patients were  current  smokers,  had  suffered  a previous  MI  or were  diagnosed  with 
type  II  diabetes  mellitus.  Most  of  the  patients  in  each  group  were  married  or 
cohabiting.  The majority of patients in the experimental and control groups were either 
employed  or  retired.  Within  each  group,  a  comparable  number  of  patients  were 
employed  or  retired.  In  the  experimental  group,  46%  (16/35)  were  in  the 
managerial/professional  social  class  and  37%  (13/35)  were  working  class.  Similarly, 
43% (15/35) of the control group were in the managerial/professional social class and 
29% (10/35) were working class. 
116 Table 7 Baseline Demographic and Clinical Characteristics of Study Groups 
Characteristic  Experimental  Control 
(n =  35)  (n =  35) 
Mean age + SO, y  59.0 ± 9.7  60.9 ± 11.3 
Males, n (%)  30 (86)  26 (74) 
Mean weight ± SO, kg  86.0 ± 13.9  79.1  ± 14.7 
Mean 8MI ± SO, kg/m
2  28.5 ± 3.5  27.0 ± 3.5 
Cardiac diagnosis, n (%) 
MI  22 (62.9)  24 (68.6) 
CABG  8 (22.9)  6(17.1) 
PTCA  4 (11.4)  3 (8.6) 
UAP  1 (2.9)  2 (5.7) 
Smoking status, n (%) 
Current Smoker  2 (5.7)  4 (11.4) 
Previous Smoker  22 (62.9)  21  (60.0) 
Non Smoker  11  (31.4)  10 (28.6) 
Previous MI, n (%)  7 (20.0)  6 (17.1) 
Diabetes Mellitus, n (%)  4(11.5)  5 (14.3) 
Marital status, n (%) 
Married/cohabiting  29 (82.9)  28 (80.0) 
Widowed/divorced/single  6(17.1)  7 (20.0) 
Employment status, n (0/0) 
Employed  16 (45.7)  16 (45.7) 
Retired  16 (45.7)  15 (42.9) 
Unemployed  3 (8.6)  1 (2.9) 
Unable to work due to illness  0  3 (8.5) 
Socio-economic class, n (%) 
Managerial/Professional  16 (45.7)  15 (42.9) 
Intermediate 
6(17.1)  10 (28.6) 
13 (37.1)  10(28.6) 
Working 
BMI = body mass index; MI = myocardial infarction; CABG = coronary artery bypass graft; 
PTCA = percutaneous transluminal coronary angioplasty; UAP = unstable angina pectoriS. 
11-:' A  similar  number  of  exp·  tid  enmen a  an  control  subjects  were  taking  the  cardiac 
medications  described  in  Table  8.  As  shown  in  Table  8  74°1  (26/35)  f  .  . 
,10  0  patients  In 
each  g~oup were taking  beta-blocker medication.  Only  one  patient from  the  sample 
population  was  not  prescribed  anti-platelet  medication,  this  patient  was  taking  anti-
coagulent therapy instead. In addition, 89% (31/35) of patients in the control group and 
100
% 
of those in  the experimental group were taking  lipid-lowering medication.  Forty 
percent (14/35) of the control  group and  26%  (9/35)  of the experimental group were 
prescribed oral nitrates or nitrate patches for angina. 
Table 8 Proportion of Patients Taking Cardiac Medication at Baseline 
Cardiac Medication 
Beta blocker 
Lipid lowering 
Anti-platelet 
ACE inhibitor 
Nitrate
a 
Calcium channel blocker 
Anti-coagulent 
Diuretic 
Experimental 
(n =  35) 
26 (74.3) 
35 (100) 
34 (97.1) 
19 (54.3) 
9 (25.7) 
12 (34.3) 
1 (2.9) 
6(17.1) 
Control 
(n =  35) 
26 (74.3) 
31  (88.6) 
35 (100) 
19 (54.3) 
14 (40.0) 
10 (28.6) 
0 
6(17.1) 
a Nitrate includes oral nitrate and nitrate patch, nitrate spray is not included. 
Note. Values represent number of patients and percentages in parentheses. 
PhYSical Activity at Baseline 
This  section  describes  the  baseline  physical  activity  level  of the  total  study  sample 
(n=70). 
Physical  activity  was  measured  objectively  using  the  CSA  accelerometer,190  and 
subjectively using the Stanford Seven-Day Physical Activity Recall
220 
and the Stage of 
Exercise Behaviour Change.
22o The Seven-Day Recall measures the duration of sleep, 
and  light,  moderate,  hard,  very  hard  and  total  physical  activity  in  minutes per week. 
Total  physical  activity is  the  sum  of moderate,  hard  and  very  hard  intensity physical 
activity. The stages of exercise behaviour change are:  Precontemplation (inactive and 
no intention to change), Contemplation (inactive,  but intending to change in the next 6 
118 months),  Preparation  (engaging  in  some activity,  but  not  regularly),  Action  (regularly 
physically  active,  but  only  began  in  the  past  6 months),  and  Maintenance  (regularly 
active for more than  six months).  Patients  selected  the  stage  of exercise  behaviour 
change that described their physical activity behaviour over the previous two months at 
baseline.  Patients  in  the action  or  maintenance stages  considered  themselves  to  be 
regularly physically active. 
Stage of  Exercise Behaviour Change 
There  were  no  study  patients  in  the  precontemplation  or  contemplation  stages  of 
change at baseline.  Results revealed that 17.1 % (12nO) of the study sample were  in 
preparation, 45.7% (32/70) were in  action and  37.1 % (26/70) were in  maintenance at 
baseline.  Thus,  83%  of the  sample  population  were  regularly  physically  active  at 
baseline.  This  is  because  physical  activity  was  measured  within  one  month  of the 
study sample completing an 11-week phase III exercise programme. 
Computer Scienc.e and Applications (CSA) Accelerometer 
CSA  accelerometer  counts/week  at  baseline  were  not  normally  distributed,  thus 
median  and  interquartile  range  values  are  reported.  In  the  total  group,  median 
accelerometer counts/week at baseline were 4025432 (3034626,5095810). 
Stanford Seven-Day Physical Activity Recall 
Baseline physical activity in  minutes per week measured  by the  Stanford  Seven-Day 
Recall were not normally distributed,  thus  median  and  interquartile range values  are 
stated.  Only two patients reported  participating in  very  hard intensity physical activity, 
thus  hard  and  very  hard  intensity  categories  were  combined  to  produce  a vigorous 
intensity activity category.  Table 9 reports median values for total,  moderate, vigorous 
and  light intensity physical  activity  in  minutes/week at  baseline  for the  study  group. 
Subjects  participated  in  248  minutes/week  of  moderate  intensity  activity  and  26 
minutes/week of vigorous intensity activity.  Total physical  activity, which was the sum 
of moderate and vigorous intensity activity, was 288 minutes/week at baseline. 
119 Table  9  Baseline  Physical  Activity  (mins/week)  Measured  by  the  Seven-Day 
Physical Activity Recall 
Physical Activity Category 
Total
a 
Moderate 
Vigorous 
Median (IQ Range) 
288 (192, 460) 
248 (142,381) 
26 (0, 82) 
Light  6029 (5560, 6282) 
a Total activity is the sum of moderate and vigorous intensity activity. 
Note. Values represent median and interquartile (IQ) range. 
Effect of an Exercise Consultation on Physical Activity 
Stage of  Exercise Behaviour Change 
There  were  no  experimental  or  control  patients  in  the  precontemplation  or 
contemplation stages at baseline, six and 12 months. Table 10 shows the proportion of 
patients  in  the  preparation,  action  and  maintenance  stages  of  exercise  behaviour 
change at each time period by group. Subjects in the action and  maintenance stages 
are  considered  to  be  regularly  physically  active.  Therefore,  the  action  and 
maintenance stages were combined to produce an  action/maintenance category.  Chi 
square tests and Fisher's exact tests were used to compare the number of patients in 
the preparation stage versus the action/maintenance category between and within the 
experimental and control groups. 
Table  10  shows that 88%  of the  experimental  group  and  77%  of the  control  group 
were  in  action/maintenance  at  baseline,  chi  squared  analysis  reveals  that  this 
difference was  not significant (x2=1.6,  df=1,  p=O.2).  Thus,  the  majority  of patients  in 
both groups were regularly active at baseline. At six months, 84% of the experimental 
group  and  690/0  of  the  control  group  were  in  the  action/maintenance  stage,  this 
difference was not significant (X
2=2.2, df=1,  p=0.1). At 12 months, a greater proportion 
of the experimental group (85%) were in the action/maintenance category compared to 
the  control  group  (67%),  chi  square  analysis  shows  that  this  difference  was  not 
statistically significant (X
2=3.0, df=1,  p=O.08). 
120 Chi  square  analysis  revealed  that  the  number  of  control  patients  who  were  in  the 
action/maintenance category did  not  significantly change  at  six  (X2=0.6,  df=1,  p=OA) 
and  12 months (X
2
=0.9,  df=1,  p=O.3) compared with baseline.  Similarly, Fisher's exact 
tests  found  that  the  number  of  experimental  patients  in  the  action/maintenance 
category was  similar at six months (p=0.73)  and  12  months  (p=0.73)  compared  with 
baseline. Thus, the number of regularly active patients in the experimental and control 
group did not significantly change at six and 12 months compared to baseline. 
Table 10 Proportion of Patients in the Preparation, Action and Maintenance Stages 
of Change at Baseline, Six and 12 Months by Group 
Stage of Change  Experimental Group  Control Group 
Baseline 
Preparation  11 % (4/35)  23% (8/35) 
Action  51 % (18/35)  40% (14/35) 
Maintenance  37% (13/35)  37% (13/35) 
Six months 
Preparation  16% (5/32)  31  (10/32) 
Action  19% (6/32)  7% (2/32) 
Maintenance  65% (21/32)  62% (20/32) 
12 months 
Preparation  15% (5/33)  33% (11/33) 
Action  6% (2/33)  3% (1/33) 
Maintenance  79% (26/33)  64% (21/33) 
Note. Values in parentheses represent number of patients. 
Change in Stage of  Exercise Behaviour from Baseline to Follow-up 
The change in stage of exercise behaviour from baseline to six and 12 months in each 
group was determined by  the following  method.  Patients were  categorised  into  four 
groups:  progression  (progressed  from  preparation  to  action  or  maintenanc~), 
regression  (regressed  from  action  or  maintenance  to  preparation),  stable  a~tlve 
(remained  in  action  or  maintenance)  and  stable  inactive  (remained  in  preparation). 
Table  11  shows the  number of patients  in  each  category  at  six  and  12  months  by 
group. 
121 Table 11  Change in Stage of Exercise Behaviour from Baseline to Follow-up by Group 
Category  0  6M  0-12M  6-12M 
Experimental  Control  Experimental  Control  Experimental  Control 
n = 32  n = 32  n = 33  n = 33  n = 32  n =  32 
Progression  1  3  2  4  3  4 
Regression  3  5  3  7  2  6 
Stable Active  26  19  26  18  25  17 
Stable Inactive  2  5  2  4  2  5 
Note. Values represent number of patients. 
Table 11  shows that few patients in  both  groups were in the progression,  regression 
and stable inactive categories. Therefore, the progression and stable active categories 
were combined, as these patients were regularly physically active,  in order to conduct 
chi-square  analysis.  Similarly,  the  stable  inactive  and  regression  categories  were 
combined, as these patients were not regularly active.  Figure 10 shows the proportion 
of patients in  eac~ group who were regularly physically active at follow-up compared to 
baseline.  From  baseline  to  six  months,  69%  of the  control  group  and  84%  of the 
experimental  group  had  progressed  to  action/maintenance  or  remained  in 
action/maintenance (Figure 10), thus were regularly active (x
2
=2.2, df=1, p=0.1). From 
baseline  to  12  months,  a  greater  number  of  patients  in  the  experimental  group 
compared  to  the  control  group  had  remained  regularly  active  or  become  regularly 
active,  see  Figure  10  (X2=3.0,  df=1,  p=0.08).  From  six  to  12  months,  a significantly 
greater proportion  of experimental  patients  had  remained  in  action/maintenance  or 
progressed to action/maintenance than controls, see Figure 10 (x
2
=4.3, df=1, p=0.04). 
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Figure 10 Change in stage of exercise behaviour from baseline to six and 12 
months  by  group.  Bars  represent  the  proportion  of  patients  remaining  In 
action/maintenance stage or progressing from preparation to action/maintenance. 
Computer Science and Applications (CSA) Accelerometer 
Two  control  patients  refused  to  wear  the  accelerometer  at  12  months.  In  the 
experimental gro~p, one accelerometer malfunctioned and one patient refused to wear 
the accelerometer at six months.  At  12  months,  one  accelerometer malfunctioned in 
the experimental group. 
GSA accelerometer data were not normally distributed, thus non-parametric tests were 
used to analyse the data. Table 12 reports medians and interquartile ranges for weekly 
GSA accelerometer counts  at  baseline,  six  and  12  months  in  the  experimental  and 
control  group.  Figure  11  and  Table  13  demonstrates the  median  change  in  weekly 
GSA accelerometer counts from baseline to follow-up in the two groups. 
A  Mann Whitney test revealed that GSA accelerometer counts  per week at  baseline 
were similar between the experimental and  control group (98%CI -856002, 889959). 
In the experimental group, accelerometer counts increased by  1.9% (76431/3999309) 
from baseline to six months,  0.8% (33619/4257833) from  six to  12 months, and 2.2% 
(86575/3999309) from  baseline to  12  months. However,  Wilcoxon  signed  rank tests 
revealed  that  the  change  in  weekly  accelerometer  counts  was  not  significant  from 
baseline  to  follow-up  in  the  experimental  group  (Table  13).  In  the  control  group, 
accelerometer  counts  decreased  by  5.2%  (-215141/4105603)  from  baseline  to  six 
months,  3%  (-109691/3621195) from  six  to  12  months,  and  8%  (-328116/4105603) 
from baseline to 12 months. Similar to the experimental group, there was no Significant 
123 change in weekly accelerometer counts from baseline to follow-up in the control group, 
reported  in  Table  13.  Furthermore,  Mann  Whitney  tests  found  that  the  difference 
between the groups for the change in weekly accelerometer counts was not significant 
from  baseline  to  six  months  (98%CI  -1143720,  607430),  baseline  to  12  months 
(98%el -1131128, 366473) and six to 12 months (98%CI -861968,647527). 
Table 12 CSA Accelerometer Counts at Baseline, Six and 12 Months by Group 
Time  Experimental group  Control group 
(months)  Median (IQ Range)  Median (IQ Range) 
0  3999309(2652408,5105019)  4105603(3089611,4779881) 
6  4257833(3074216,5556053)  3621195(3008800,5063930) 
12  4221539(2640305,5600396)  3674479(2746242,5035637) 
Note. The values represent median and interquartile (IQ) range. 
Experimental group: n=35 at baseline, n=33 at six months, n=31  at 12 months. Control 
group: n=35 at baseline, n=31  at six months, n=31  at 12 months. 
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Figure 11  Median values for CSA accelerometer counts/week at baseline, six and 
12 months in the experimental and control groups. 
124 Table 13 Change in CSA Accelerometer Counts from Baseline to Follow-Up 
Time Period  Experimental group  Control group 
Baseline  6 months  (-705643,  860599)  (-680366,  349212) 
Baseline - 12 months  (-381927,  504719)  (-906564,  268168) 
Six months - 12 months  (-737184,  671240)  (-514984,  303570) 
Note. Values represent 98% confidence intervals for the change 
Stanford Seven Day Physical Activity Recall 
The Stanford Seven Day Physical Activity Recall measures minutes of sleep, and light, 
moderate,  hard,  very  hard  and  total  physical  activity  over the  previous  week.  Total 
activity is the sum of moderate, hard and very hard intensity physical activity. 
Physical  activity  data was  not collected  at  six  months  for one  patient  in  the  control 
group.  Physical  activity data was  not normally distributed,  therefore  non-parametric 
tests were  used  to  detect  between  and  within  group  differences  for  each  physical 
activity variable.  Table  14 reports  median  values  for total  physical  activity,  vigorous, 
moderate and light intensity activity, and sleep in minutes/week at baseline, six and 12 
months by group. 
Table 14 Physical Activity (mins/week) by Group at Baseline and FollOW-Up 
PAa (mins/week)  Baseline  6 months  12 months 
Total
b 
Experimental  300 (195, 470)  330 (188, 664)  360 (208, 590) 
Control  275 (175, 460)  235 (110, 369)  205 (68,  310) 
Vigorous 
Experimental  56 (5,  100)  73.5 (16, 250)  65 (0,  178) 
Control  10 (0, 40)  0(0,44)  o  (0,  0) 
Moderate 
Experimental  250 (115, 382)  235 (120, 489)  215 (98,  371) 
Control  240 (145, 375)  222 (11 0, 311)  190 (68, 282) 
Light 
Experimental  6120 (5615, 6460)  6028 (5629, 6402)  5940 (5535, 6478) 
Control  5885 (5584, 6240)  6000 (5671,6390)  6082 (5875,6410) 
125 Sleep 
Experimental  3645 (3315, 3870)  3660 (3454, 3870)  3720 (3383, 4095) 
Control  3825 (3645, 4230)  3720 (3428, 4035)  3750 (3473, 3968) 
a PA  Physical Activity b Total - moderate + vigorous intensity PA. 
Note. Values represent median and interquartile (IQ) range. 
Experimental group:  n=35 baseline,  n=32  at  six  months,  n=33  at  12  months.  Control 
group: n=35 baseline, n=32 at six months, n=33 at 12 months. 
Total Physical Activity 
Table  14 shows that total  physical  activity at  baseline  was  300  minutes/week  in  the 
experimental  group  and  275  minutes/week  in  the  control  group,  there  was  no 
significant between group difference (98%CI  -120,  100).  The  change  in  total  activity 
(minutes/week)  from  baseline to  six  and  12  months  in  the  experimental  and  control 
group is shown in Figure 12 and Table 15. Wilcoxon signed rank tests found that there 
was  no significant change  in  total  activity from  baseline to  six  and  12  months  in  the 
experimental  group,  thus total  activity  was  maintained  over  the  study  period  in  this 
group  (Figure  12,  Table  15).  In  the  control  group,  total  activity  did  not significantly 
change from  baseline to six  months.  In  contrast,  total  activity significantly decreased 
by  115 minutes/week from  baseline to  12 months and  63  minutes/week from  6 to  12 
months in the control group.  In addition, the between group difference for the change 
in  total activity was  borderline significant from  baseline to  6 months (108  mins/week; 
98%CI -272,  25), was significant from  baseline to  12 months (130 mins/week; 98%CI 
-295, -20) and was not significant from 6 to 12 months (75 mins/week; 98%CI-178, 40). 
Figures 11  and  12 show that the change in CSA accelerometer counts/week and total 
physical activity (minutes/week) from baseline to six months appear to track each other 
in both groups. In contrast, from six to 12 months Figures  11  and  12 illustrate a further 
increase  in  total  physical  activity  (minutes/week)  in  the  experimental  group  and  a 
further  decrease  in  the  control  group,  whereas  CSA  accelerometer  counts/week 
showed no further change from six to  12 months in either group. Thus,  the change in 
total activity and weekly accelerometer counts do  not track each  other from  six to  12 
months in either group. 
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Figure 12 Total  physical activity (PA)  in  minutes/week at baseline,  six and  12 
months in the experimental and control group 
Table 15 Median Change in Total Physical Activity (mins/week) from Baseline to 
Six and 12 Months by Group 
Total PA
a (mins/week)  Experimental Group  Control Group 
Baseline - 6 months  47 (-43,  191)  -55(-178,45) 
Baseline - 12 months  23 (-63,  154)  -115 (-228, -28) 
6 months - 12 months  3 (-128,95)  -63 (-126,  -5) 
a PA =  Physical Activity.  Note.  Values represent median change and 98% confidence 
interval for the change. Significant changes are represented in italics. 
Moderate Intensity Physical Activity 
Moderate  intensity  activity  at  baseline  was  similar  (98%CI  -85,  110)  between  the 
experimental group (250mins/week) and the control group (240 mins/week), as shown 
in Table 10. The change in  moderate intensity activity (minutes/week) from baseline to 
follow-up in the experimental and control group is displayed in Figure 13 and Table 16. 
In  the experimental group, there was  no  significant change  in  moderate activity from 
baseline to six  and  12  months,  therefore moderate  intensity activity was  maintained 
over the study period (Figure 13, Table 16). In the control group, moderate activity did 
127 not  significantly  change  from  baseline  to  SIX  months.  In  contrast,  there  was  a 
significant  decrease  in  moderate  activity  by  83  minutes/week  from  baseline  to  12 
months  (Figure  13,  Table  16).  In  addition,  there  was  a  trend  for  a  decrease  in 
moderate  activity  by  48  minutes/week  from  six  to  12  months  in  the  control  group 
(Figure 13,  Table 16), However, the difference between the  groups for the  change  in 
moderate  activity  was  not  significant  from  baseline  to  six  months  (60  mins/week; 
98
% CI  -190, 39),  baseline to  12 months (75  mins/week; 98%CI -198, 30)  and  six to 
12 months (22 mins/week; 98%CI -99, 68), 
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Figure  13  Moderate  intensity  physical  activity  (PA)  in  minutes/week  at 
baseline, six and 12 months in the experimental and control group 
128 Table  16  Median  Change  in  Moderate  Physical  Activity  (mins/week)  from 
Baseline to Six and 12 Months by Group 
Moderate PA
a (mins/week)  Experimental Group  Control Group 
Baseline  6 months  35 (-60, 113)  -47 (-149, 49) 
Baseline - 12 months  -10 (-90,83)  -83 (-175, -14) 
6 months - 12 months  -30 (-120, 39)  -48 (-92, 2) 
a PA - Physical Activity. Note.  Values are median change and 98% confidence interval 
for the change. Significant changes are represented in red text. 
Vigorous Intensity Physical Activity 
The change in  vigorous intensity activity from  baseline to follow-up by group is shown 
in  Figure 14 and Table 17. There was a trend for baseline vigorous intensity activity to 
be higher in the experimental group compared to the control group (98%CI -61, 0). At 
baseline,  vigorous  activity  was  56  minutes/week  in  the  experimental  group  and  10 
minutes/week in the control group, see Table 14. Vigorous activity did  not significantly 
change from baseline to follow-up in the experimental group (Figure 14, Table 17).  In 
the  control  group,  vigorous  activity did  not  significantly change  from  baseline  to  six 
months, however there was a trend for a decrease in vigorous activity from baseline to 
12  months  and  six  months  to  12  months  (Figure  14,  Table  17).  Between  group 
differences for the change in  vigorous activity was non-significant from baseline to six 
months (98%CI -90, 20) and six to 12 months (98%CI -90, 30).  However, there was a 
bordeline significant difference between the groups for the change in vigorous activity 
from baseline to 12 months (45 mins/week; 98%CI -110, 0). 
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Figure 14 Vigorous physical activity (PA)  in mins/week at baseline, six and 12 
months by group 
Table 17 Median Change in Vigorous Activity (mins/week) from Baseline to Six 
and 12 Months by Group 
Vigorous PA
a (mins/week) 
Baseline - 6 months 
Baseline - 12 months 
6 months - 12 months 
Experimental Group 
31  (-21,  117) 
35(-15,112) 
o  (-68, 65) 
Control Group 
0(-20, 22) 
-8 (-40, 0) 
-5 (-40, 0) 
a PA = Physical Activity.  Note.  Values represent median change and  98%  confidence 
interval. 
Light Intensity Physical Activity 
Light intensity activity per week at baseline was not significantly different between the 
experimental and control group (98%CI -485, 65). There was no significant change in 
light  intensity  physical  activity  from  baseline  to  six  and  12  months  follow-up  in  the 
experimental group (Figure  15,  Table  18). In  the  control  group, light intensity activity 
did not significantly change from  baseline to  six months,  and  six to  12 months (Table 
18,  Figure  15).  In  contrast,  light activity  significantly  increased  by  205  minuteslweek 
from baseline to  12 months in  the control group. Furthermore, there was  a significant 
difference  between  the  groups  for the  change  in  light  activity  from  baseline  to  12 
months (290 minutes/week; 98%CI 50,  550). 
130 Table 18 Median Change in Light Activity (mins/week) from Baseline to Six and 
12 Months by Group 
Light PA
a (mins/week)  Experimental Group  Control Group 
Baseline  6 months  -20 (-249, 185)  95 (-95, 347) 
Baseline - 12 months  -70 (-308, 104)  205 (48, 388) 
6 months - 12 months  -21  (-185, 113)  71  (-90, 248) 
a  PA  Physical Activity. Note. Values  represent median  change  and  98%  confidence 
interval for the change.  Significant changes are represented italics. 
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Figure 15 Light intensity physical activity (PA) in minutes/week week at baseline, 
six and 12 months in the experimental and control groups 
Sleep 
Baseline minutes of sleep per week was higher in  the control group compared to the 
experimental group, this difference was not statistically significant (98%CI -30, 450) 
Sleep did not significantly change from baseline to follow-up in the either group (Table 
19). 
131 Table  19  Median  Change  in  Sleep  (mins/week)  from  Baseline  to Six  and  12 
Months by Group 
Sleep (minutes/week)  Experimental Group  Control Group 
Baseline  6 months  -44 (-233,  158)  -45 (-210,75) 
Baseline - 12 months  53 (-105, 248)  -90 (-233,  53) 
6 months - 12 months  60 (-38, 278)  o  (-143,  113) 
Note. Values represent median change and 98% confidence interval. 
Effect of an Exercise Consultation on Cardiorespiratory Fitness 
Cardiorespiratory  fitness,  specifically  exercise  capacity  and  submaximal  endurance 
capacity,  was  determined  by  cardiopulmonary  exercise  testing.  Cardiorespiratory 
fitness data was  normally distributed, therefore parametric tests were  used  to  detect 
differences between and within groups. 
Exercise Capacity 
Cardiorespiratory  variables  measured  at  peak  exercise  were  used  to  determine 
exercise  capacity.  In  the  control  group,  values  for  oxygen  uptake,  ventilation  and 
respiratory exchange ratio  (RER)  were  unavailable for one  patient at  baseline  as the 
portable  metabolic  system  malfunctioned.  In  the  experimental  group,  values  for 
oxygen uptake, ventilation and  RER were  unavailable for one  patient at baseline and 
three patients at six months as the portable metabolic system malfunctioned. 
Table 20  reports mean values for exercise capacity variables at baseline,  six and  12 
months  in  each  group.  The  mean  change  in  exercise  capacity  parameters  from 
baseline to follow-up by group is demonstrated in Table 21. 
132 Table 20 Exercise Capacity Variables by Group at Baseline, Six and 12 Months 
Baseline  6 months  12 months 
n  Mean ± SO  n  Mean ± SO  n  Mean ± SO 
Peak V02 ml/min 
Experimental  34  2287 ± 579  29  2129 ± 561  33  2118 ± 584 
Control  34  1950 ± 643  33  1817 ± 641  33  1774 ± 690 
Peak V02 ml/kg/min 
Experimental  34  26.9 ± 6.6  28  26.1  ± 6.9  33  25.1  ± 6.2 
Control  34  24.4 ± 6.5  33  22.5 ± 6.2  32  22.0 ± 6.1 
Exercise Time (sees) 
Experimental  31  513 ± 155  27  508 ± 166  29  532 ± 179 
Control  33  470 ± 226  32  481  ± 281  32  484 ± 264 
Peak VE 
Experimental  34  69.9 ± 17.8  29  68.6 ± 18.7  33  69.9 ± 20.9 
Control  34  61.1±20.0  33  57.9 ± 18.9  33  56.6 ± 19.3 
RER 
Experimental  34  0.94 ± 0.09  29  1.02 ± 0.12  33  1.04±0.10 
Control  34  0.93 ± 0.08  33  0.97±0.11  33  0.98 ± 0.12 
Peak HR 
Experimental  34  126.6±22.8  28  128.8±26.6  33  126.2±24.8 
Control  34  121.8±20.2  33  116.5±22.4  32  114.2±20.1 
Peak V02/HR 
Experimental  34  17.9±3.5  28  16.9±3.7  33  16.9±3.7 
Control  34  16.1±4.8  33  15.6±4.7  32  15.4±5.3 
V0
2 =  oxygen uptake; VE =  ventilation; RER =  respiratory exchange ratio, HR - heart rate; 
V02/HR = oxygen pulse. 
133 Table 21  Mean Change in Exercise Capacity Variables from Baseline to Six and 
12 Months by Group 
0  6 months  0-12 months  6 - 12 months 
Peak V02 ml/min 
Experimental  -82 (-169, 5)  -136 (-267, -5)  - 57 (-180,65) 
Control  -121  (-244,2)  -147 (-270,  -23)  -23(-121,75) 
Peak V02 ml/kg/min 
Experimental  -1.0 (-2.2, 0.2)  -1.8 (-3.2, -0.3)  -1.1  (-2.5,0.3) 
Control  -1.6 (-3.0,  -0.1)  -2.3 (-3.8, -0.8)  -0.6 (-2.0, 0.7) 
Exercise Time (secs) 
Experimental  -1.2 (-52, 50)  16 (-42, 75)  22 (-25,  70) 
Control  24 (-44,91)  25 (-44, 94)  -5 (-54, 44) 
Peak VE (11m in) 
Experimental  0.9 (-3.1, 4.9)  1.4 (-2.8,5.7)  -0.1  (-4.0,  3.8) 
Control  -1.9 (-6.7, 3.0)  -1.7 (-6.6, 3.2)  -0.05 (-3.2, 3.1) 
RER 
Experimental  0.07 (0.03,  0.11)  0.09 (0.06,  0.13)  0.02 (-0.01, 0.06) 
Control  0.05 (0.01,  0.10)  0.07 (0.03,0.11)  0.01  (-0.03, 0.06) 
Peak HR 
Experimental  0.5 (-4.5, 5.4)  -0.3 (-5.0, 4.5)  -1 .6 (-6.3,  3. 1  ) 
Control  -4.4 (-9.6, 0.82)  -5.6 (-10.6,  -0.7)  -1.8 (-4.8,1.3) 
Peak V02/HR 
Experimental  -0.6 (-1.5, 0.3)  -1.0 (-1.9, 0)  -0.3 (-1.4, 0.9) 
Control  -0.5 (-1.5, 0.5)  -0.5 (-1.3, 0.3)  o  (-0.9,  1.0) 
Note. Values represent median change and 98% confidence interval for the change. 
V02 =  oxygen uptake; VE =  ventilation;  RER =  respiratory exchange ratio,  HR =  heart 
rate; V02/HR =  oxygen pulse. Significant changes are represented in italics. 
Baseline mean peak V02  (mllmin) was higher in the experimental group compared to 
the control group, this between group difference was not statistically significant (98%CI 
--691,  17),  see  Table  20.  Peak V02  in  mllmin  decreased  by  3.6%  (82/2287)  in  the 
experimental  group  and  6.2%  (121/1950)  in  the  control  group  from  baseline  to  six 
months,  this  difference  was  near significant  (Table  21).  Furthermore,  there  was  a 
significant decrease in peak V02 mllmin by 5.9% (136/2287) in the experimental group 
13+ and 7.5% (147/1950)  in  the control group from  baseline to  12 months  (Table  21).  In 
contrast,  peak V02 mllmin did  not significantly change  from  six to  12  months  In the 
experimental  group  [2.7%  (57/2129)]  and  the  control  group  [1.3%  (23/1817)],  as 
displayed in Table 21.  Furthermore, the difference between the groups for the change 
in  peak V02  ml/min was  not significant from  baseline to  six  months  (98%CI  -185.3, 
108)  and  12  months  (98%CI  -186.6,  164.5),  and  six  to  12  months  (98%CI  -118.8, 
187.0). Thus, the decrease in  peak V02 from  baseline to  follow-up was  similar in  the 
experimental and control group. 
Table 20 shows that baseline peak V02 corrected for body weight was  26.9 (SO  6.6) 
ml/kg/min in the experimental group and 24.4 (SO 6.5) ml/kg/min in the control group, 
this  difference  was  not  significant  (98%CI  -6.24,  1.30).  Peak  V02  declined  from 
baseline  to  six  months  by  1  ml/kg/min  (3.7%)  in  the  experimental  group  and  1.6 
ml/kg/min  (6.5%)  in  the  control  group,  this  decline  was  borderline  significant  in  the 
experimental group and was significant in the control group (Table 21).  From  baseline 
to 12 months,  ex~rcise capacity significantly decreased by  1.8 ml/kg/min (6.7%) in the 
experimental group and 2.3 ml/kg/min (9.4%) in the control group (Table 21).  From six 
to 12 months, peak V02 decreased by  1.1  ml/kg/min (4.2%)  in the experimental group 
and 0.6 ml/kg/min (2.7%)  in the control group. This decrease in  peak V02  (ml/kg/min) 
from  six  to  12  months  was  borderline  significant  in  the  experimental  group.  Two 
sample  t  tests  revealed  that  the  decline  in  peak  V02  ml/kg/min  was  similar  in  the 
experimental and control groups from baseline to six (98%CI -2.4, 1.2) and  12 months 
(98 % CI  -2.5,  1.5) and  six to  12  months  (98%CI  -1.4,  2.4).  Figure  16  illustrates the 
decline  in  peak  V02  ml/kg/min  from  baseline  to  follow-up  in  the  experimental  and 
control groups. 
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Figure 16 Mean peak V02  (ml/kg/min) at baseline, six and 12 months follow-up 
by group. 
Exercise  duration  (seconds)  at  baseline  was  similar  between  the  groups  (98%CI  -
158.2, 72.7),  shown  in  Table 20_ Exercise duration  did  not significantly change from 
baseline to follow-up in the experimental group or the control group, as shown in Table 
21  and  Figure  17.  Furthermore,  there  was  no  significant  difference  between  the 
groups for the change in  exercise duration from  baseline to  six months (98%CI -58, 
107), baseline to 12 months (98%CI -79, 96),  and six to  12 months (98%CI -93, 39). 
Exercise duration at each time period by group is shown in Figure 17. 
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Figure 17 Mean exercise duration (sees) at baseline, six and 12 months follow-
up by group. 
Peak ventilation  at  baseline was  higher in  the  experimental  group  compared  to  the 
control group (Table 20), the between group difference was not statistically significant 
(9B%CI -19.B, 2.1).  Table 21  shows that peak ventilation did not significantly change 
from  baseline to six and  12 months follow-up  in  either group. Similarly,  the between 
group difference for the change in peak ventilation was not significant from baseline to 
six months (9B
% CI  -B.B,  3.4),  baseline to 12 months (9B%CI -9.4, 3.2) and six to 12 
months (9B%CI -4.B, 4.9). 
As reported in  Table 20,  baseline respiratory exchange ratio  (RER)  at  peak exercise 
was 0.93 in  the control group and 0.94 in the experimental group, the between group 
difference  was  not  significant  (9B%CI  -0.06,  0.04).  There  were  similar  significant 
increases in  peak RER from baseline to six and 12 months in  both groups (Table 21). 
In contrast, RER did not significantly change from six to 12 months in either group. 
Peak heart rate  at baseline was 126.6 bpm (SO  22.B)  in  the experimental group and 
121.B  bpm  (SO  20.2)  in  the control  group (9B%CI  -17.7,  B.1),  see Table  20.  In  the 
control  group,  there was a decline in  peak heart rate from  baseline to six months by 
4.4 bpm (9B%CI  -9.6, 0.B2)  and a significant decrease from baseline to 12 months by 
5.6 bpm (9B%CI -10.6, -0.7), as shown in Table 21.  In contrast, peak heart rate did not 
137 significantly change from baseline to  six and  12 months follow-up in the experimental 
group (Table 21). Two sample t tests  revealed  a greater decline  in  peak heart rate 
from baseline to  12 months in  the control  group compared to the experimental group 
(98%CI -12.0, 1.3). 
Table  20  shows  that  there  was  a trend  for baseline  peak V02/HR  (ml/beat)  to  be 
higher in  the  experimental group  compared  to  the  control  group  (98%CI  -4.3, 0.7). 
Peak oxygen pulse did not significantly change from baseline to  six and  12 months in 
the control group (Table 21). Similarly, there was no significant change in  peak oxygen 
pulse from baseline to six months and from six to  12 months in the experimental group 
(Table  21).  In  contrast,  there  was  a trend  for decline  in  peak  oxygen  pulse  in  the 
experimental group from baseline to 12 months. However, two sample t tests revealed 
no significant difference between the groups for the change in peak oxygen pulse from 
baseline to six (98%CI -1.2,1.4),12 months (98%CI -0.7,1.6) and six to  12 months 
(98%CI  -1.1,  1.8).  Peak  oxygen  pulse  at  baseline,  six  and  12  months  by  group  is 
illustrated in  Figur~ 18. 
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Figure 18 Peak oxygen pulse (V02/HR) in ml/beat at baseline, six and 12 months 
in the experimental and control groups 
138 Proportion of  Patients Taking Beta-blocker Medication 
Beta-blocker medication can  affect exercise capacity  in  terms  of peak V02  and  peak 
heart rate. Therefore, the change in beta-blocker medication from baseline to follow-up 
was  examined  to  determine  if  alterations  in  medication  could  have  influenced  the 
outcome of the exercise capacity variables. 
Figure  19  displays  the  proportion  of  patients  taking  beta-blocker  medication  at 
baseline,  six and  12  months  in  each  group.  At baseline,  74.3%  (26/35)  of patients in 
the  control  group  and  the  experimental  group  were  taking  beta-blocker medication. 
Figure 19 shows that the proportion of patients taking beta-blocker medication did not 
markedly change at six and  12 months in  either group.  Four control patients and  two 
experimental patients had their dose of medication changed  at  six months compared 
to  baseline.  In  addition,  three  controls  and  five  experimental  patients  had  their 
medication dose altered at 12 months compared to baseline. 
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Figure 19 Proportion  of patients taking  beta-blocker medication at baseline,  six 
and 12 months in both groups. 
139 Submaximal Endurance Capacity 
Submaximal endurance capacity was  determined by estimating the oxygen  uptake in 
mllmin at the lactate threshold (V02 L  T). The lactate threshold could not be detected at 
each time period for five control patients and  three experimental patients.  In  addition, 
data  was  unavailable  for  two  experimental  patients  at  6  months  as  the  portable 
metabolic system malfunctioned. 
Table 22  reports  mean values  for oxygen  uptake (ml/min)  at the  lactate threshold  at 
baseline, six and 12 months in each group. The mean change in V0
2 L  T from baseline 
to follow-up by group is demonstrated in Table 23. 
Oxygen  uptake  (ml/min)  at  the  lactate  threshold  (V02  L  T)  at  baseline  was  similar 
between  the  experimental  and  control  group  (98%CI  -257.0,  108.8).  In  the  control 
group, there was a trend for a decrease in V02 L  T by 52  ml/min from  baseline to  six 
months (Table 23).  However,  there was  no further significant change in V02 L  T from 
baseline to  12  months,  and  six to  12  months  in  the  control group (Table  23).  In  the 
experimental  group,  there was  a trend  for an  increase  in  V02  L  T by  47ml/min from 
baseline  to six  months  and  a significant  increase  by  81  ml/min  from  baseline  to  12 
months (Table 23). Although, there was no significant change in V02 L  T from six to 12 
months in  the experimental group. The difference between the groups for the change 
in  V02  L  T  was  significant  from  baseline  to  6  months  (98%CI  -185.4,  -12.6)  and 
baseline to 12 months (98%CI -216.7, -34.6).  Figure 20 demonstrates the V02  L  T at 
baseline, six and 12 months by group. 
Table 22 Oxygen Uptake at the Lactate Threshold (V02 L  T)  at Baseline, Six and 
12 Months by Group 
Time Period 
Baseline 
Six months 
12 months 
Experimental Group 
1251±273 
1274±267 
1332±278 
Note. Values represent mean ± SD. 
Control Group 
1177±311 
1140±285 
1132±316 
Experimental group:  n=30 baseline,  n=27 at six months,  n=30 at  12  months.  Control 
group: n=29 baseline, n=28 at six months, n=29 at 12 months. 
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Figure 20  Oxygen uptake (mllmin) at lactate threshold in  the experimental and 
control groups at baseline, six and 12 months 
Table 23  Mean Change in Oxygen Uptake (mllmin) at the Lactate Threshold from 
Baseline to Six and 12 Months by Group 
Time Period  Experimental Group  Control Group 
Baseline - Six months  47 (-14, 109)  -52 (-116,  12) 
Baseline - 12 months  81  (22, 140)  -45 (-118,28) 
Six months - 12 months  43 (-28, 113)  7 (-43, 57) 
Note.  Values  represent  median  change  and  98%  confidence  interval  for the  change. 
Significant changes are represented in italics. 
Effect of an Exercise Consultation on the Processes of Exercise Behaviour 
Change 
The  processes  of  change  are  strategies  that  individuals  use  when  changing  their 
exercise  behaviour.16o  The  five  experiential  processes  of exercise  behaviour change 
are  consciousness  raising  (CR),  social  liberation  (SL),  dramatic  relief  (DR), 
environmental  re-evaluation  (ER)  and  self  re-evaluation  (SR). The  five  behavioural 
processes are:  helping  relationships  (HR),  stimulus control  (SC), counter conditioning 
(CC),  self-liberation  (SO),  reinforcement  management  (RM).  A  description  of  each 
141 process  of exercise  behaviour  change  is  provided  in  Table  6,  Chapter  One.  The 
processes  of exercise  behaviour change  were  measured  using  a questionnaire,  the 
score for each process ranges from 4 to 20. 
Scores  for  the  processes  of change  were  not  normally  distributed,  therefore  non-
parametric tests were used to  analyse between and within group differences for each 
process of exercise behaviour change.  In the control group,  one patient at six months 
and one patient at  12 months did  not complete the  process of change questionnaire. 
In the experimental group, one patient at baseline, two patients at six months and one 
patient at 12 months did not complete the questionnaire. 
Experiential Processes 
The median values for the use of the experiential processes at baseline and follow-up 
in  the experimental and  control groups. The  use  of the five  experiential processes at 
baseline  was  similar between  the  experimental  and  control  groups  (Table  24).  The 
median  change  in  the  use of each  experiential  process  from  baseline  to  six  and  12 
months  follow-up  is  described  in  Table  25.  There  was  a  borderline  decrease  in 
consciousness raising from baseline to  12 months in  both groups. Social liberation did 
not significantly change from  baseline to follow-up in  either group.  Dramatic relief did 
not significantly change from baseline to six and  12 months in the experimental group, 
whereas there was a significant decrease in the use of this  process from  baseline to 
12  months  in  the  control  group.  Environmental  re-evaluation  did  not  significantly 
change  from  baseline  to  follow-up  in  the  control  group,  whereas  this  process 
significantly decreased from  baseline to  12  months  in  the  experimental group.  There 
was  a trend  for self re-evaluation  to  decrease  from  baseline  to  12  months  in  both 
groups.  In  addition,  there  was  a  trend  for  a  decrease  in  self  re-evaluation  from 
baseline to six months in the experimental group. However, the difference between the 
experimental and control group for the change experiential process use from  baseline 
to six and 12 months follow-up was not significant. 
1-+2 Table 24 Experiential Processes by Group at Baseline, Six and 12 Months 
Experiential Processes  Baseline  6 months  12 months 
CR 
Experimental  11  (9,  13.2)  12 (8,  13)  10 (8,  12) 
Control  11  (7,  14)  9.5 (7.2,  14.5)  10 (7.2, 12.8) 
SL 
Experimental  15 (12,  17)  14.5 (11.8,16)  14(11,17.8) 
Control  13 (11,  16)  13.5 (11,16)  13(10,15) 
DR 
Experimental  7.5(5,11)  7 (5,  9.2)  6.5 (5,  8) 
Control  8 (6,  12)  7 (5,  10)  6 (5,8) 
ER 
Experimental  12 (8,  13)  10(8, 12)  9 (7,  10) 
Control  10 (7,  13)  8.5 (6.2,  12)  8.5 (7,  11.8) 
SR 
Experimental  15 (11.5, 16)  13 (10.8,  15.2)  12 (10.2, 15.8) 
Control  13 (9,16)  12 (9,  15)  11  (9,  14) 
Note. Values represent median and interquartile range. 
CR = consciousness raising, SL = social liberation, DR =  dramatic relief, SR = self re-
evaluation, ER = environmental re-evaluation. 
Experimental group: n=34 baseline, n=30 at six months, n=32 at 12 months. Control group: 
n=35 baseline, n=32 at six months, n=32 at 12 months. 
143 Table 25  Median Change in  Experiential Processes  by  Group from  Baseline to 
Six and 12 Months 
Experiential Processes  0  6 months  0-12 months  6 -12 months 
CR 
Experimental  -0.5 (-1.5, 0.5)  -1.5 (-3, 0)  -1.0 (-2,  0.5) 
Control  -0.5 (-1.5, 0.5)  -1.0 (-2,  0)  -0.5 (-1.5, 0.5) 
SL 
Experimental  -0.5 (-2.5, 0.5)  -1  (-2.5,  1)  -0.5 (-1.5,  1) 
Control  0(-1.5,1.5)  -0.5 (-2,  1)  0(-1,1) 
DR 
Experimental  0(-1,1)  -0.5(-2,1)  -1  (-2,0.5) 
Control  -0.5 (-1.5, 0.5)  -1.5 (-2.5, -0.5)  -0.5 (-1.5, 0.5) 
ER 
Experimental  -1  (-2.5, 0)  -2 (-3,  -0.5)  -0.5 (-2, 0.5) 
Control  0(-1.5,1)  -0.5 (-2,  1)  -0.5 (-2,1) 
SR 
Experimental  -1.5 (-3, 0)  -1.5 (-3, 0)  0(-1,1) 
Control  0(-1.5,1)  -1  (-3, 0)  -0.5 (-2, 0.5) 
Note. Values represent median change and 98% confidence interval for the change. 
CR = consciousness raising, SL = social liberation, DR =  dramatic relief, SR = self re-
evaluation, ER =  environmental re-evaluation. 
Significant changes are shown in italics. 
Behavioural Processes 
Table 26 demonstrates the median values for the use of the behavioural processes of 
change at baseline and follow-up in  the experimental and  control groups. The use of 
four of the five behavioural processes of change at baseline were similar between the 
experimental  and  control  group  (Table  26).  In  contrast,  there  was  a  trend  for the 
experimental  group  to  use  counterconditioning  more  often  than  the  control  group 
(98°  loCI -4, 0). The change in the use of each behavioural process from baseline to six 
and 12 months follow-up is described in Table 27. There was a trend for a decrease in 
helping relationships from baseline to six in the control group. In  addition, there was a 
trend for helping relationships to decrease from baseline to 12 months in  both groups. 
Stimulus control and counter conditioning did not significantly change from baseline to 
144 six  and  12 months follow-up in  the  control  group.  However,  there was  a trend  for a 
decrease  in  the  use  of both  these  processes  from  baseline  to  12  months  in  the 
experimental  group.  There  was  no  significant  change  in  self-liberation  and 
reinforcement management from baseline to six and  12 months in either group. Mann 
Whitney tests found that difference between the groups for the change  in  the use of 
the five behavioural processes was not significant from baseline to six and 12 months. 
Table 26 Behavioural Processes by Group at Baseline, Six and 12 Months 
Behavioural Processes 
HR 
Experimental 
Control 
SC 
Experimental 
Control 
CC 
Experimental 
Control 
SO 
Experimental 
Control 
RM 
Experimental 
Control 
Baseline 
8 (6,  11) 
9 (6,  12) 
6 (5, 9) 
7 (4, 9) 
13.5 (10,  15.20 
11  (9,  13) 
10 (8,  12.2) 
10 (7,  13) 
10 (8,  12) 
9 (8,  11) 
6 months 
6.5 (4,10) 
7.5 (5,  11.8) 
6.5 (5,9) 
6.5 (5.2, 8.8) 
12.5 (9.8,  15) 
12 (10,  14) 
8.5 (7,  13) 
9 (7,  11) 
10 (7.8,12) 
10 (8,  12) 
Note. Values represent median and interquartile range. 
12 months 
7 (5, 9.8) 
6.5 (4,  11.8) 
6.5 (4.2,8) 
7 (5,  8) 
11.5(9,14) 
11  (9,13) 
8(7.2,11) 
9(7,11.8) 
9 (7,  11.8) 
10 (7,  12) 
HR = helping relationships, SC = stimulus control, CC = counter conditioning, SO = self-
liberation, RM = reinforcement management. 
Experimental group: n=34 baseline, n=30 at six months, n=32 at 12 months. Control group: 
n=35 baseline, n=32 at six months, n=32 at 12 months. 
145 Table 27 Median Change in Behavioural Processes by Group from Baseline to Six 
and 12 Months 
Behavioural Processes  0  6 months  0-12 months  6 -12 months 
HR 
Experimental  -1  (-2, 0.5)  -1.5 (-2.5, 0)  0(-1.5,1) 
Control  -1  (-2.5, 0)  -1.5 (-3, 0)  -0.5 (-2,  1.5) 
SC 
Experimental  -0.5 (-2, 0.5)  -0.5 (-1.5, 0)  -0.5 (-1, 0.5) 
Control  0(-1,1)  -0.5 (-1.5, 0.5)  o  (-1, 0.5) 
CC 
Experimental  -0.5 (-2.5, 0.5)  -1.5 (-2.5, 0)  -1  (-2, 0.5) 
Control  0.5 (-1, 1.5)  -1  (-2, 0.5)  -0.5 (-2, 0.5) 
SO 
Experimental  -0.5 (-2,  1)  -1  (-2, 0.5)  0(-1.5,1) 
Control  -0.5 (-2, 0.5)  -1  (-2, 0.5)  0(-1.5, 1.5) 
RM 
Experimental  -0.5 (-2, 0.5)  -0.5 (-2, 0.5)  0(-1,1) 
Control  0(-1,1)  -0.5 (-1.5, 0.5)  -0.5 (-1.5,  1) 
Note.  Values represent median change and 98% confidence interval for the change. HR 
=  helping relationships, SC =  stimulus control, CC =  counter- conditioning, SO =  self-
liberation, RM =  reinforcement management. 
Effect of an Exercise Consultation on Anthropometric Variables 
Weight and BodyMass Index 
Anthropometric data was normally distributed. Therefore, parametric tests were used 
to determine between and within group differences for weight and body mass index 
(8MI). Weight was not recorded for one control patient at 12 months, and two 
experimental patients (one subject at six months and one subject at 12 months). 
Mean  values  for  weight  and  8MI  at  baseline,  six  and  12  months  by  group  are 
displayed in  Figure 21  and Figure 22,  respectively.  The mean change in  weight and 
8MI from baseline to six and 12 months are reported in Table 28. 
146 There was trend for mean weight at  baseline to  be  higher in  the experimental group 
compared  to  the  control  group  (98%CI  -15.1,  1.2),  see  Figure  21 .  Figure  21  and 
Table 28 shows that mean weight did not significantly change from  baseline to six and 
12 months in either group. 
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Figure 21  Mean weight (kg) at baseline, six and 12 months by group. 
Experimental group:  n=35 baseline,  n=31  at 6 months,  n=32 at  12 months. Control 
group: n=35 baseline, n=33 at 6 months, n=32 at 12 months. 
Table 28 Mean Change in Weight and BMI from Baseline to Follow-Up by Group 
Variable  0-6  months  0-12 months  6 -12 months 
Weight (kg) 
Experimental  0.06 (-1.35, 1.48)  0.06 (-1.78,  1.90)  0.10 (-1.26,  1.45) 
Control  0.27 (-1.48, 2.02)  0.75 (-1.32, 2.82)  0.55 (-0.57,  1.67) 
BMI 
Experimental  0.01  (-0.48, 0.50)  0.01  (-0.60, 0.62)  0.03 (-0.39, 0.46) 
Control  0.14 (-0.46, 0.50)  0.28 (-0.44,  1.0)  0.16 (-0.22,0.55) 
Note. Values represent mean change and 98% confidence interval for the change 
Mean  BMI  at baseline was  27.01  kg/m
2  in  the  control  group and  28.48  kg/m
2 
in  the 
experimental group, the between group difference was borderline significant (98%CI -
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3.47, 0.52).  Mean 8MI did not significantly change from  baseline to six and 12 months 
in either group, as shown in Figure 22 and Table 28. 
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Proportion of Obese Patients 
The proportion of obese patients, defined as those with a BMI>30kg/m
2
,  in each group 
at  baseline,  six  and  12  months  was  calculated  and  is  displayed  in  Figure  23.  Chi 
square  analysis  found  that the  number of obese  patients  were  similar between  the 
experimental  group  and  the  control  group  at  baseline  (X
2=1 .30;  df =1,  p=0.26),  six 
months (X
2=0.97; df =1,  p=0.32) and  12 months (X
2=0.72; df =1,  p=0.40). At baseline, 
28.5% (10/35) of the experimental group and  17.1  % (6/35)  of the control group were 
obese,  as shown in  Figure 23.  The number of obese patients in the control group did 
not significantly change from  baseline to  six  (X
2=0.52;  df =1 , p=0.47) and  12 months 
(x
2=0.24;  df =1,  p=0.63).  Similarly,  in the experimental group there was  no  significant 
change in  the number of obese patients from  baseline to  six months (X
2
=0.36; df =1 , 
p=0.55) and 12 months (X
2=0.06; df=1, p=0.81). 
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Figure 23  Proportion of obese patients (BMI>30kg/m
2
)  in the experimental and 
control groups at baseline, six and 12 months. 
Proportion ot  Overweight Patients 
The proportion of overweight patients, defined as those with  a BMI>25kg/m
2
,  in  each 
group at  baseline,  six  and  12  months was  calculated  and  the  results  are  shown  in 
Figure  24.  A  similar  number of patients  in  the  experimental  group  and  the  control 
group were overweight at  baseline  (X
2=O.36;  dt =1,  p=O.55),  six  months  (X
2=O.27;  dt 
=1,  p=O.60)  and  12  months  (x
2=1.64;  dt =1,  p=O.20),  see  Figure  24. At  baseline, 
82.9%  (29/35) of the experimental group and 77.1 % (27/35)  of the control group were 
overweight. In the control group, the number of overweight patients did not significantly 
change from baseline to six months (X
2=O.03;  dt =1,  p=O.87)  and  12 months (x
2
=O.04; 
dt =1, p=O.83).  Similarly, there was no significant change in the number of overweight 
patients in the experimental group from baseline to six months (X
2=O.01;  dt=1 , p=O.91) 
and 12 months (X
2=O.28;  df=1,  p=O.60). 
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Figure  24  Proportion  of  overweight  patients  (BMI>25kg/m
2
)  in  the 
experimental and control groups at baseline, six and 12 months. 
Effect of an Exercise Consultation on Blood Lipids 
Non-parametric tests were used to analyse the between and within group differences, 
as the lipid data were not normally distributed. Cholesterol and triglyceride values were 
not recorded for one control patient and  one experimental patient at six months. LDL 
and HDL cholesterol values were not recorded at baseline for two control patients and 
two  experimental  patients.  Median  values  for  cholesterol,  triglycerides,  LDL 
cholesterol,  HDL cholesterol and cholesterol/HDL cholesterol ratio at baseline, six and 
12 months in the experimental group and the control group are displayed in Table 29. 
The  median  change in  lipid  values from  baseline to  six and  12 months by group are 
shown in Table 30. 
150 Table 29 Blood Lipid Levels by Group at Baseline, 6 and 12 Months 
Baseline  6 months  12 months 
Cholesterol 
Experimental  4.34 (3.81,4.79)  4.31  (3.69, 4.93)  4.51  (3.80, 5.97) 
Control  4.19 (3.86, 4.89)  4.50 (3.83, 4.82)  4.29 (3.98, 5.05) 
Trig  Iycerides 
Experimental  1.66 (1.23, 2.28)  1.65 (1.12, 2.06)  1.66 (1.26, 2.26) 
Control  1.50 (0.95, 1.98)  1.28 (0.97, 2.28)  1.44 (1.00, 2.21) 
LDL-C 
Experimental  2.51  (2.04, 2.76)  2.29 (1.96, 2.76)  2.31  (1.90,2.77) 
Control  2.30 (1.96, 2.89)  2.44 (1.89, 2.90)  2.39 (1.90, 2.83) 
HDL-C 
Experimental  1.10 (1.00,1.30)  1.20 (1.09, 1.40)  1.25 (1.08, 1.48) 
Control  1.20 (1.00, 1.40)  1.24 (1.08, 1.52)  1.24 (1.10, 1.56) 
ChoI/HDL-C 
Experimental  . 3.68 (3.08, 4.58)  3.49 (2.80, 3.98)  3.32 (2.94, 4.13) 
Control  3.42 (3.22, 4.49)  3.46 (3.11, 4.10)  3.47 (3.02, 4.09) 
Note. Values represent median and interquartile (IQ) range. 
151 Table  30  Median  Change  in  Blood  Lipid  Levels  from  Baseline  to  Six  and  12 
Months by Group 
0  6 months  0-12 months  6 - 12 months 
Cholesterol 
Experimental  0.07 (-0.20, 0.30)  0.14 (-0.11, 0.3S)  0.08 (-0.09,0.24) 
Control  0.03 (-0.30, 0.28)  0.08 (-0.3S, 0.34)  -0.04 (-0.23, 0.16) 
Trig  Iycerides 
Experimental  0.04 (-0.20, 0.28)  0.09 (-0.08, 0.30)  0.06 (-0.19, 0.36) 
Control  -0.08 (-0.33, 0.22)  0.07 (-0.14, 0.28)  0.08 (-0.09,0.22) 
LDL-C 
Experimental  -0.04 (-0.2S, 0.14)  -0.10 (-O.3S, 0.11)  0.02 (-0.20, 0.21) 
Control  0.01  (-0.23, 0.20)  -0.02 (-0.34, 0.21)  -0.02 (-0.22, 0.17) 
HDL-C 
Experimental  0.08 (-0.01, 0.19)  0.11  (0.04, 0.18)  0.02 (-O.OS, 0.09) 
Control  O.OS (-0.10, 0.12)  0.06 (-0.02, 0.14)  -0.01  (-0.06, 0.06) 
ChoI/HDL-C 
Experimental  -0.21  (-0.72, 0.06)  -0.21 ( -OA4, -0.02)  0.04 (-0.21, 0.32) 
Control  -0.16 (-0.46, 0.12)  -0.11  (-OAO, 0.11)  0.03 (-0.18, 0.23) 
Note. Values represent median change and 98% confidence interval for the change. 
Total Cholesterol 
Baseline  cholesterol  values  were  4.34  mmol/l  in  the  experimental  group  and  4.19 
mmol/l  in  the  control  group (Table  29),  which  are  below the  level  recommended  by 
national  guidelines  (i.e.  <  S mmol/l).  A  Mann  Whitney  test  revealed  that  baseline 
cholesterol  levels  were  similar  between  the  groups  (98%CI  -OA4,  0.S1).  Table  30 
demonstrates that cholesterol  levels did  not significantly change from  baseline to  six 
and 12 months in the experimental group or the control group. Similarly, there was no 
significant difference between the groups for the change in  cholesterol from  baseline 
to six months (98%CI -OAO, 0.32), baseline to 12 months (98
%
CI -0.41,0.28) and six 
to 12 months (98%CI-0.37, 0.14). 
Triglycerides 
Table  29  shows  that  baseline  triglyceride  concentrations  were  1.66  mmol/l  in  the 
experimental group and  1.S0 mmol/l in the control group, which  are within the normal 
152 range  (i.e.  <5.2  mmol/l).  Mann Whitney test revealed  that  baseline triglyceride  levels 
were  similar  between  the  groups  (98%CI  -0.58,  0.18).  Triglyceride  levels  did  not 
significantly  change  from  baseline  to  follow-up  in  either group  (Table  30).  Similarly, 
there was no  significant difference between the groups for the change in triglycerides 
from  baseline to  six  months  (98%CI  -0.45,  0.23),  baseline  to  12  months  (98%CI  _ 
0.29, 0.24) and six to 12 months (98%CI -0.31, 0.30). 
LOL Cholesterol 
Table  29  shows  that  median  values  for  LDL  cholesterol  were  similar  in  the 
experimental and control groups at baseline (98%CI -0.39, 0.47), and were lower than 
recommended targets (Le.  < 3 mmol/l) at baseline,  six and  12 months in  both groups. 
LDL cholesterol concentrations did not significantly change from baseline to six and 12 
months  in  either  group  (Table  30).  Similarly,  there  was  no  significant  difference 
between the groups for the  change  in  LDL-C  from  baseline to  six  months  (98%CI  -
0.22,0.29), 12 months (98%CI -0.24, 0.40) and six to 12 months (98%CI -0.29,0.24). 
HOL Cholesterol 
As  shown  in  Table  29  and  Figure 25,  baseline  HDL  cholesterol  concentrations were 
similar  (98
% CI  -0.1,  0.2)  in  the  experimental  group  (1.10  mmol/l)  and  the  control 
group  (1.20  mmol/l)  and  were  within  the  normal  range  (i.e.  >0.91  mmol/l).  In  the 
experimental  group,  there  was  a  trend  for  an  increase  in  HDL  cholesterol  from 
baseline by 0.08 at six months mmol/l and  a significant increase by 0.11  mmol/l at 12 
months (Table 30).  In contrast, HDL cholesterol did not significantly change from six to 
12 months.  In the control group, there was a trend for an increase in  HDL cholesterol 
from  baseline  by  0.05  mmol/l  at six  months  and  0.06  mmol/l  at  12  months,  with  no 
significant  change  from  six  to  12  months  (Table  30).  The  difference  between  the 
groups  for the  change  in  HDL  cholesterol  was  not  significant  from  baseline  to  six 
months  (98%CI  -0.14,  0.09),  12  months  (98%CI  -0.15,  0.06)  and  six  to  12  months 
(98% CI  -0.12, 0.07).  The  change  in  HDL-C  over the  study  period  in  each  group  is 
shown in Figure 25. 
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Figure 25 Median values for HDL cholesterol at baseline, six and 12 by group 
Total Cholesterol/HOL Cholesterol Ratio 
Table  29  and  Figure  26  shows  that  the  median  values  for  the  cholesterol/HDL 
cholesterol ratio at baseline and follow-up were below the recommended target of 5. A 
Mann  Whitney  test  revealed  that  baseline  values  were  similar  between  the  groups 
(98%CI -0.59, 0.42).  Table 30  indicates that the cholesterol/HDL cholesterol ratio did 
not  significantly  change  from  baseline  in  the  control  group. In  contrast, the  ratio  of 
cholesterol to  HDL significantly improved  from  baseline  to  six  and  12  months  in  the 
experimental  group,  with  no  significant  change  from  six  to  12  months  (Table  30). 
There was  no  significant between group difference for the change in  cholesterol/HDL 
cholesterol ratio from baseline to six months (98%CI -0.33, 0.48),  12 months (98%CI 
-0.16, 0.41) and six to 12 months (98%CI -0.36, 0.32). Figure 26 displays the change 
in cholesterol/HDL-C ratio over the study period in each group. 
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Figure 26 Median values for ratio of cholesterol to HDL-C at baseline, six and 12 
by group 
Proportion of  Patients Taking Lipid Lowering Medication 
Figure  27  displays  the  proportion  of  patients  taking  lipid-lowering  medication  at 
baseline,  six and  12  months  in  each  group.  At  baseline,  88.6%  of the  control  group 
and  100%  of  the  experimental  group  were  taking  lipid-lowering  medication.  The 
number  of patients  taking  lipid-lowering  medication  did  not  change  at  six  and  12 
months  in  either group,  see  Figure  27. Three  control  patients  and  five  experimental 
patients  had  their dose of medication  changed  at  six months  compared  to  baseline. 
Furthermore,  three  controls  and  seven  experimental  patients  had  their  medication 
dose altered at 12 months compared with baseline. 
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Figure 27 Proportion of patients taking lipid lowering medication at baseline, six 
and 12 months in the experimental and control group. 
Effect of an Exercise Consultation on Psychological Function 
Anxiety and Depression 
Anxiety  and  depression  was  measured  using  the  Hospital  Anxiety  and  Depression 
Scale.  The total score for the  anxiety and depression subscales ranges from  0 to  21 . 
The  scores  for  the  anxiety  and  depression  subscales  can  be  used  to  classify 
individuals  into  normal  (0-7),  mild  (8-10),  moderate  (11-14)  and  severe  (~15) 
categories. In addition, it has been suggested that individuals with HADS scores ~ 8 on 
the anxiety or depression subscales are psychologically distressed. 
HADS scores were not normally distributed,  thus  non-parametric tests  were  used  to 
analyse  the  between  and  within  group  differences.  Median  scores  for  anxiety  and 
depression  at baseline,  six and  12  months follow-up  in  the  experimental  and  control 
group are displayed in  Figure 28. The median scores for anxiety and depression were 
within  the  normal  range  (i.e.  0 - 7)  at  baseline,  six  and  12  months  in  both  groups. 
156 Mann  Whitney tests  revealed  that  baseline  scores  for  anxiety  and  depression  were 
similar between the groups, (98%CI -3, 1) and  (98%CI -1, 1), respectively. Wilcoxon 
signed rank tests found that anxiety and depression scores did not significantly change 
from baseline to six and 12 months follow-up in the experimental group and the control 
group (Table 31). From six to 12 months,  anxiety scores remained unchanged in  both 
groups, however there was a trend for a median increase in depression by 0.5 in  both 
groups (Table 31).  The difference between the groups for the  change  in  anxiety was 
not  significant  from  baseline  to  six  months  (98%CI  -2,  1),  baseline  to  12  months 
(98%CI -1, 2)  and  six to  12  months (98%CI -1, 1).  Similarly, the  difference between 
the  groups  for  the  change  in  depression  was  not  significant  from  baseline  to  six 
months (98%CI -1, 1). However, the increase in depression was greater in the control 
group compared to the experimental group from  baseline to  12 months (98%CI  0, 1) 
and six to 12 months (98%CI 0,  1). 
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Figure  28  Median  scores for anxiety and  depression  at baseline,  six and  12 
months in the experimental and control groups. 
Experimental group: n=35 baseline,  n=32  at  six months, n=33  at  12  months. Control 
group: n=35 baseline, n=33 at six months, n=32 at 12 months. 
157 Table 31  Median Change in Anxiety and Depression from Baseline to Six and 12 
Months by Group 
0  6 months  0-12 months  6 -12 months 
Anxiety 
Experimental  0(-1.5,1)  -0.5 (-1,  0.5)  o (-1,  0.5) 
Control  -0.5 (-1.5,  1)  0(-1.5,1)  o  (-0.5,  1) 
Depression 
Experimental  -0.5 (-1,0.5)  o  (-0.5, 0.5)  0.5 (0,  1) 
Control  o  (-1, 0.5)  0.5 (-0.5,  1.5)  0.5,  (0,  1.5) 
Note. Values represent median change and 98% confidence interval for the change 
Psychologically Distressed Patients 
Psychologically  distressed  patients  were  identified  as  those  having  a baseline  HAD 
score  ~ 8 on  the  anxiety  or depression  subscales.  At  baseline,  33%  (23/70)  of the 
sample  population  were  psychologically  distressed.  In  addition,  25%  (9/35)  of  the 
control  group  and  40%  (14/35)  of  the  experimental  group  were  psychologically 
distressed  at  baseline  (x
2  = 1.6,  df = 1,  P =  0.23).  Figure  29  displays  the  median 
scores for anxiety and  depression  at  baseline,  six  and  12 months  in  both  groups.  A 
Mann  Whitney test found  similar baseline  anxiety  scores  between  the  experimental 
and  control  groups  (98%CI  -1,  5).  Baseline  anxiety  scores  were  10  in  the  control 
group  and  9 in  the  experimental  group.  Thus,  distressed  individuals  in  both  groups 
were  mildly anxious.  Anxiety  scores did  not  significantly change  from  baseline to  six 
and  12 months in the control group and the experimental group (Figure 29, Table 32). 
Additionally, there was no significant difference between the groups for the change in 
anxiety from baseline to six months (98%CI -5, 5),  baseline to  12 months (98%CI -6, 
5) and six to 12 months (98
% CI --4, 3). 
Figure 29 shows that median scores for depression were within the normal range (i.e. 
less than  8)  at baseline,  six and  12 months in  both  groups. There was  no  significant 
difference  between  the  groups  (98%CI  -2,  5)  for  depression  scores  at  baseline. 
Depression scores did  not significantly change from  baseline to six  and  12 months in 
the experimental group and the control group (Table 32).  From six to 12 months, there 
was  no  significant change  in  depression  in  the  control  group,  however there  was  a 
borderline  increase  in  depression  from  six  to  12  months  in  the  experimental  group 
158 (Table 32). There was no difference between the groups for the change in  depression 
from baseline to six months (98%CI -2, 4),  baseline to  12  months (98%CI -2, 5)  and 
six to 12 months (98%CI -2, 6). 
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Figure 29  Median scores for anxiety and depression at baseline, six and 12 by 
group in patients who were psychologically distressed at baseline. 
Table 32  Median Change in Anxiety and  Depression by Group in  Patients Who 
Were Psychologically Depressed at Baseline 
0-6  months  0-12 months  6 -12 months 
Anxiety 
Experimental  -1.5 (-4,1.5)  -1  (-3,  1.5)  0.5 (-1,  2) 
Control  -1  (-6, 6)  -1.5 (-6, 4)  o  (-4, 4) 
Depression 
Experimental  0(-1.5,1.5)  o  (-1,  3)  0.5 (0,  1.5) 
Control  0.2 (-2, 4)  2.5 (-2,  6)  3 (-2, 6) 
Note. Values represent median change and 98% confidence interval for the change 
159 Non-Distressed Patients 
Patients with a baseline score less that 8 on the anxiety or depression subscales were 
classified  as  non-psychologically  distressed.  Figure  30  shows  that  anxiety  and 
depression scores were within the normal range at baseline, six and 12 months in both 
groups. Similar baseline scores were observed between the experimental and  control 
groups for anxiety (98%CI -2, 2)  and depression (98%CI -2, 2). Wilcoxon signed rank 
tests revealed that anxiety scores remained  unchanged from  baseline to  follow-up  in 
both  groups  (Table 33). In  addition,  there  was  no  significant difference  between  the 
groups for the change in anxiety from baseline to six months (98%CI -2, 1), baseline 
to 12 months (98%CI -1, 2)  and six to  12 months (98%CI  -1, 2). Depression did  not 
significantly change from baseline to six and  12 months in the experimental group, as 
displayed  in  Table  33.  In  the  control  group,  there  was  no  significant  change  in 
depression  from  baseline  to  six  and  12  months,  however  there  was  a  borderline 
significant increase in  depression by  0.5 from  six to  12  months. The  between  group 
difference for the change in depression was not significant from baseline to six months 
(98%CI -1, 1),  baseline to  12 months (98%CI -1, 1) and six to 12 months (98%CI -1, 
1  ). 
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Figure 30  Median scores for anxiety and depression at baseline, six and 12 by 
group in non-distressed patients at baseline 
160 Table 33 Median Change in Anxiety and Depression in Non-Distressed Patients 
o  6 months  0 -12 months  6 - 12 months 
Anxiety 
Experimental  0.5 (-0.5,  1)  0(-1,1)  -0.5 (-1.5, 0.5) 
Control  -0.5 (-1.5, 1)  0.5 (-1,  1.5)  0(-1,1) 
Depression 
Experimental  -0.5 (-1.5, 0.5)  o  (-1, 0.5)  0.5 (-0.5,  1) 
Control  o  (-1, 0.5)  o  (-0.5, 0.5)  0.5 (0,  1) 
Note. Values are median change and 98% confidence interval for the change 
Quality of  Life 
Quality of life was assessed at baseline, six and 12 months by the UK SF-36 version 2. 
This questionnaire assess the following 8 dimensions: physical functioning (PF),  social 
functioning (SF), role limitations due to physical problems (RLP),  role limitations due to 
emotional  problems  (RLE),  pain  (P),  energy/vitality  (EV),  mental  health  (MH),  and 
health perception· (HP).  For each dimension, the scale ranges from  0 (worst possible 
health) to  100 (best possible  health).  The  SF-36 data  were  not normally distributed, 
thus non-parametric tests were used to detect between and within group differences. 
Figure  31  displays  the  median  scores  for  the  SF-36  subscales  at  baseline  in  the 
experimental  and  control  group.  The  figure  shows  that  baseline  values  for  social 
functioning (SF) and role limitations emotional (RLE) were 100% in both groups, which 
indicates  best  possible  health.  Baseline  values  for  physical  functioning  (PF),  role 
limitations  physical  (RLP)  mental  health  (MH)  and  pain  (P)  were  high,  ranging  from 
800/0  to  90%  in  both  groups.  Scores  for energy/vitality  and  health  perception  were 
between 60% and  70% in  both groups.  There was  a trend for the median scores for 
physical functioning  (980/0CI  -10.0, -0.01)  and  pain  (98%CI  -11.1, 0)  to be  higher in 
the experimental group compared to the control group. Whereas, there was a trend for 
role limitations due to emotional problems to be higher in the control group compared 
to  the  experimental  group  (98%CI  0,  8.33).  In  contrast,  there  was  no  difference 
between the groups for social functioning (98%CI -0.01, 0.0),  role limitations physical 
(980/0CI  -12.5, 6.2),  mental  health  (98%CI  -10.0,  5.0),  energy/vitality (98%CI  -6.25, 
12.5) and health perception (98%CI-12.0, 10.0). 
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Figure 31  Median scores for SF-36 subscales at baseline by group. 
A  score  of  100 · indicates  best  possible  health.  Physical  functioning  (PF),  social 
functioning  (SF),  role limitations physical  (RLP),  role  limitations emotional (RLE), pain 
(P), energy/vitality (EV), mental health (MH) and health perception (HP). 
The  median  change  in  the  SF-36  subscales  from  baseline  to  follow-up  in  the 
experimental and control group is shown in Table 34.  Scores for four SF-36 subscales 
were maintained from baseline to  six and  12 months in the experimental group; these 
were physical function,  mental  health,  energy/vitality and  health  perception.  Similarly, 
there  was  no  significant  change  in  social  function,  role  limitations  due  to  physical, 
mental health and health perception from  baseline to six and  12 months in the control 
group.  From  baseline to  six months,  there was  a trend  for an  improvement in  social 
function  and  a deterioration  in  pain  in  the  experimental  group.  In  the  control  group, 
there  was  a  trend  for  a  decline  in  role  limitations  due  to  emotional  problems  and 
energy/vitality in the control group. From baseline to  12 months, there was  a trend for 
an improvement in three SF-36 subscales in the experimental group; these were social 
function, role limitations due to physical problems and role limitations due to emotional 
problems.  In  contrast,  there  was  a trend  for  a decline  in  physical  function  and  role 
limitations emotional in the control group. From six to 12 months, there was a trend for 
an  improvement  in  role  limitations  emotional  and  energy/vitality  in  the  experimental 
162 group, and a trend for an improvement in pain in both groups. 
Table 34 Median Change in Quality of life from Baseline to Follow-Up by Group 
SF-36 Subscales  0  6 months  0-12 months  6 -12 months 
PF 
Experimental  o  (-S.O, 2.S)  °  (-S.O,  2.S)  °  (-2.S,  2.5) 
Control  -2.S (-7.5, 2.5)  -5.0 (-10.0,0)  -2.5 (-7.5,2.5) 
SF 
Experimental  6.3 (0,  12.S)  °  (0,  12.5)  °  (0, 0) 
Control  °  (-6.3, 6.3)  °  (-6.3, 6.3)  °  (0,  0) 
RLP 
Experimental  °  (-6.3, 9.4)  6.3 (0,  12.5)  6.3 (-3.1,15.6) 
Control  °  (-9.4, 9.4)  °  (-9.4, 9.4)  °  (-9.4, 6.3) 
RLE 
Experimental  °  (-4.2, 8.3)  °  (0,  8.34)  0(0,4.16) 
Control  -4.2 (-16.7,0)  -4.2 (-8.3, 0)  °  (-8.3, 4.2) 
MH 
Experimental  o  (-2.5, 5.0)  1.5 (-2.5, 5.0)  °  (-2.5, 5.0) 
Control  o  (-5.0, 7.5)  °  (-2.5, 5.0)  °  (-2.5, 5.0) 
EV 
Experimental  o  (-6.3, 6.3)  3.1  (-3.1,9.4)  3.13 (0, 6.2) 
Control  -3.1  (-9.4, 0)  -3.1  (-9.4, 3.1)  °  (-6.3, 6.3) 
P 
Experimental  0(-11.1,0)  °  (-S.6, 5.6)  °  (0,  5.6) 
Control  o  (-11.1, S.6)  °  (-5.6, 5.6)  °  (0,  5.6) 
HP 
Experimental  -1.0 (-7.5, 5.0)  °  (-5.0, 7.5)  1.5 (-5.0, 7.5) 
Control  -2.5 (-8.0, 5.0)  -2.5 (-11.0, 6.0)  -2.0 (-10.0,6.5) 
Notes. Values are median change and 98% confidence interval for the change. 
A  score  of  100  indicates  best  possible  health.  PF  =  Physical  function,  SF =  Social 
function, RLP =  Role limitations physical, RLE = Role limitations emotional, P = Pain,  EV 
=  Energylvitality, MH = Mental health, HP =  Health perception. 
163 In  addition,  the  difference  between  the  groups for the  change  in  SF-36  dimensions 
from  baseline  to  six  and  12  months  was  examined.  These  findings  are  shown  in 
Figures 32,  33 and 34. There was a trend for a greater improvement in social function, 
role limitations due to emotional problems and energy/vitality from  baseline to  six and 
12  months  in  the  experimental  group  compared  to  the  control  group,  as  shown  in 
Figures 32 and 33.  From six to 12 months, there was a borderline significant difference 
between the groups for the change pain favouring the experimental group (Figure 34). 
·25  ·20  ·15  ·10  ·5  o  5  10  15  20 
98% Confidence Intervals 
Figure 32  98%  confidence intervals for the difference between the groups for the 
change in quality of life from baseline to six months. 
Red bars represent borderline significant differences between the groups for changes in 
SF-36  subscales.  Red  bars  skewed  to  the  right  indicate  an  advantage  to  the 
experimental group. 
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Figure 33 980/0 confidence interval for the difference between the groups for the 
change in quality of life from baseline to 12 months. 
Red bars represent borderline significant differences between the groups for changes 
in SF-36 subscales. Red bars skewed to the right indicate an advantage to the 
experimental grou·p. 
PF (-5, 5) 
SF (0, 0) 
-10  ·5  o  5  10  15  20  25 
98% Confidence Intervals 
Figure 34 98%  confidence intervals for the difference between the groups for the 
change in quality of life from six to 12 months. Red bars represent borderline 
significant differences between the groups for changes in SF-36 subscales. Red bars 
skewed to the right indicate an advantage to the experimental group, 
165 Clinical Outcomes from Baseline to Six and 12 Months 
In the experimental group,  one patient received  coronary artery bypass surgery, three 
patients  were  admitted  to  hospital  with  unstable  angina  and  subsequently  received 
angioplasty,  and one  patient was diagnosed with  Type 2 diabetes over the  12 month 
study period.  In  the  control  group,  two  patients  died  which  were  classed  as  sudden 
cardiac  deaths,  one  control  received  non-cardiac  surgery  and  one  patient  was 
diagnosed with Type 2 diabetes during the study period. Overall, cardiac mortality was 
5.70/0  (2/35)  in  the  control  group  and  0%  in  the  experimental  group.  However,  the 
revascularisation  rate  (i.e.  CABG  and  PTCA)  was  11.4%  (4/35)  in  the  experimental 
group and 0% in the control group. 
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DISCUSSION 
In  total,  85  patients  were  invited  to  participate  in  the  study,  15  of  these  patients 
declined to take part. 
Baseline  characteristics  of the  study  group  were  reported.  The  majority  of patients 
were  men  (800/0)  and  had  suffered  a myocardial  infarction  (65.8%).  Information from 
the  BACR  national  database  on  client  groups  taking  part  in  phase  III  cardiac 
rehabilitation  programmes  are  68%  MI  and  25%  female.
5  Thus,  the  study  sample 
appears  to  be  representative  of people  who  attend  phase  III  cardiac  rehabilitation 
programmes. 
Baseline Physical Activity of Study Sample 
This  study  investigated  the  effect  of an  exercise  consultation  on  maintenance  of 
physical  activity  following  completion  of a  phase  III  exercise  programme.  Baseline 
physical activity levels were assessed within one month of completing phase III. Thus, 
it  was expected  that  subjects would  be  physically  active  at  baseline.  We  found  that 
46%  of the  study  sample  were  in  the  action  stage  of  change,  and  37%  were  in 
maintenance  at  baseline.  Thus,  83%  of  patients  were  regularly  physically  active 
following completion of phase III. Similarly,  Bock
96  found that after completion of a 12-
week phase  II  supervised exercise  programme,  96%  of the  study group were  in  the 
action and maintenance stages, thus were considered regularly active. 
At baseline, patients participated in  a median 248 minutes/week of moderate intensity 
physical  activity,  26  minutes/week of vigorous activity and  288  minutes/week of total 
physical  activity  (Le.  moderate  and  vigorous  activity  combined)  measured  by  the 
7DPAR.  Thus,  patients  were  exceeding  the  1995  ACSM/CDC  physical  activity 
guidelines  of 150 minutes/week of moderate  intensity activity.s  Bock
96 
reported  that 
patients  participated  in  10.98  hours/week  of  moderate  to  vigorous  physical  activity 
measured by the 7DPAR after completion of a 12-week phase II exercise programme. 
Thus, there was a large difference between physical activity participation in the present 
study and the results reported by Bock. However, the 7DPAR was self-administered in 
167 Bock's study96 and was interview-administered in  the present study. Administering the 
questionnaire  in  an  interview  format  may  generate  more  accurate  and  reliable 
information than self-administering the 7DPAR,  as interviewing subjects can  minimise 
guessing and over-reporting physical activity participation.
221  In  addition,  subjects may 
mis-classify the intensity level of various activities.  For example,  in  the  present study 
some individuals classed ironing  in  the moderate intensity category  because it  made 
them  hot  and  tired,  when  ironing  is  clearly  a  light  intenSity  activity.  However,  the 
researcher could clarify if the patient thought that ironing was a similar effort to a brisk 
walk  (i.e.  definition  of  moderate  intensity),  whereas  determining  this  in  a  self-
administered format is not possible.  In a pilot study, we found that patients participated 
in  a median of 555  minutes/week (9.15 hours/week) of moderate to vigorous physical 
activity  shortly  after  completion  of  phase  111.178  The  Scottish  Physical  Activity 
Questionnaire
279 
(SPAQ),  a  self-administered  questionnaire,  was  used  to  measure 
physical  activity  in  the  pilot  study.  Results  of this  pilot  study  revealed  that  subjects 
reported  participating  in  5 to  6 hours  of gardening  or  decorating  at  a moderate  to 
vigorous intensity,_ however it is unlikely that these activities were exclusively moderate 
to vigorous intensity. Thus,  it is possible that individuals over-estimate physical activity 
participation  in  self-administered  questionnaires  more  than  interview-administered 
instruments.  An  alternative explanation for lower self-reported  physical  activity  levels 
after phase III  found  in this study compared to  other trials is that physical activity was 
monitored  objectively  using  accelerometers  over  the  same  sampling  period  as  the 
7DPAR.  Thus,  individuals may be  more likely to  report their activities  accurately and 
state the activities they actually performed instead of activities that they may normally 
do.  In  addition,  subjects  completed  an  activity  recording  sheet,  which  was  used  to 
assist patients with their recall and  prevent subjects from  over-estimating the intensity 
or duration of activities. 
The  CSA  accelerometers  recorded  a  median  of  4025432  activity  counts/week  at 
baseline in  the total  group.  As previously discussed,  CSA recordings  can  be  used to 
estimate energy expenditure or the time spent in various intensities of physical activity, 
which would  allow investigators to  interpret how active their subjects were.  However, 
studies  have shown  that accelerometers substantially underestimate the  energy cost 
of household, gardening and leisure activities and energy expenditure under free-living 
conditions. 191 ;196-198  Thus,  researchers have  recommended  using the  raw  output from 
accelerometers (i.e.  activity counts) to quantify physical activity rather than  converting 
168 the  data  to  estimate  energy  expenditure.  A  limitation  of  using  the  raw  data  from 
accelerometers is that it is not possible to describe how active the study sample was at 
baseline.  In  addition,  no  other  studies  have  measured  physical  activity  using 
accelerometers  after completing  exercise-based  cardiac rehabilitation.  Thus,  it  is  not 
possible to compare the accelerometer results from this study with findings from  other 
cardiac  rehabilitation  studies.  A  study  conducted  by  Kirk  et  al  measured  physical 
activity using the  7DPAR and  CSA accelerometers  in  a group  of sedentary  patients 
with type II  diabetes.
177 
Patients participated in 45 minutes/week of moderate intensity 
activity measured by the questionnaire, thus these patients were not meeting physical 
activity  guidelines.  In  addition,  CSA  accelerometer  readings  were  2908974 
counts/week in this inactive group of patients, which  is  much lower than the 4025432 
counts/week recorded in the current study. 
Effect of an Exercise Consultation on Physical Activity 
Physical  activity  was  measured  using  subjective  and  objective  methods.  There  are 
advantages  and.  limitations  to  using  each  method,  thus  researchers  have 
recommended  using  multiple  methods  to  measure  physical  activity  as  no  single 
technique is  able to quantify all  aspects of physical  activity.217 The 7DPAR measures 
the duration of moderate and  vigorous  intensity physical  activity,  thus  can  determine 
whether  individuals  are  meeting  current  physical  activity  recommendations. 
Accelerometers provide an objective measure of physical activity, however they do not 
give  meaningful  information on  patterns of physical  activity.  Although  accelerometers 
are able to detect if any changes occurred in physical activity over the study period. 
At baseline,  total  physical  activity was  300  minutes/week  in  the  experimental  group 
and 275 minutes/week in the control group. Thus, both of these groups were regularly 
physically  active  at  baseline.  No  significant  change  was  observed  in  moderate, 
vigorous and total physical activity measured by the 7DPAR from  baseline to  six and 
12 months in the experimental group.  Similarly, total activity counts/week recorded by 
the CSA accelerometer did not significantly change from  baseline to follow-up  in  the 
experimental group. These findings suggest that physical activity was maintained over 
the  study  period  in  the  experimental  group.  At  12  months,  the  experimental  group 
participated  in  360  minutes/week of moderate to  vigorous  intensity  physical  activity, 
thus were  clearly  exceeding  the  physical  activity  guidelines  of  150  minutes/week  of 
moderate intensity activity.8 In the control group, there was a non-significant decline in 
169 total and moderate intensity physical activity measured by the 7DPAR from  baseline to 
six months by  55  minutes/week and  47  minutes/week,  respectively.  In  addition,  total 
physical  activity  significantly  decreased  by  115  minutes/week  from  baseline  to  12 
months  and  63  minutes/week from  six to  12  months  in  the  control  group.  Similarly, 
there  was  a significant  decrease  in  moderate  intensity  activity  by  83  minutes/week 
from baseline to 12 months and a trend for a decrease by 48 minutes/week from six to 
12  months  in  the  controls.  These  results  show  a significant  decline  in  self-reported 
physical activity over the study period in the control group.  Despite a decrease in  self-
reported  physical  activity,  at  12  months  control  patients  were  participating  in  205 
minutes/week of moderate to  vigorous  activity,  thus  were  regularly  physically  active. 
Total  activity  counts/week  measured  by  accelerometry  decreased  by  5.2%  from 
baseline to six months, 8% from baseline to  12 months and 3% from six to 12 months , 
although  this  decline  was  not  significant.  Thus,  the  results  suggest  that  physical 
activity measured by self-report and CSA accelerometers declined from baseline to six 
months  in  the control  group.  In  contrast,  a further decrease  in  self-reported  physical 
activity was observed from six to  12 months,  however there was  no further decline in 
CSA accelerometer counts/week. Thus, findings from the CSA accelerometers did not 
parallel  the  decrease  in  self-reported  physical  activity  from  six  to  12  months  in  the 
control group. 
Results from the stage of change questionnaire support the results of the 7DPAR. At 
baseline,  the  majority of patients  in  the experimental  and  control  groups were  in  the 
action and  maintenance stages of change, thus were regularly physically active (88% 
experimental group vs  77%  control group), with  no significant difference between the 
groups.  At six months,  a similar number of patients  in  each  group were  in  action  or 
maintenance (84% experimental group vs 69% control group). However at 12 months, 
a  greater  proportion  of  the  experimental  group  were  regularly  physically  active 
compared to the control group, this difference was near significant (85% experimental 
group vs  67%  control group).  Furthermore, the  results show that a greater proportion 
of experimental patients compared to controls remained in  action and maintenance or 
progressed  to  action  or  maintenance  from  baseline  to  12  months  and  six  to  12 
months.  Overall,  the  results  show that  physical  activity  measured  by  self-report was 
maintained  in  the experimental group compared  to  the  control  group over the  study 
period. These findings suggest that the exercise consultation was more effective than 
standard  exercise  information  in  maintaining  self-reported  physical  activity  for  12 
170 months following completion of a phase III exercise programme. Results from the CSA 
accelerometers agree with the findings from the self-report method in the experimental 
group,  suggesting that physical  activity  was  maintained  in  this  group for  12  months 
after phase  III.  In  contrast,  although a decline in  physical  activity  measured  by  CSA 
accelerometers was observed over the study period  in  the control group,  this decline 
was not significant and did  not parallel the marked decrease in  self-reported physical 
activity. 
A significant decrease in self-reported physical activity from baseline to 12 months was 
observed in the control group. Similarly, a number of studies have reported a decline in 
physical  activity  following  completion  of  exercise-based  cardiac 
h  b'I't  t'  20'56'67"79'91'94-96'98  re  a  II a Ion.  '  ,  ,  "  ,  Bock measured physical  activity using the 7DPAR in  62 
cardiac patients before and  after a 12-week supervised  exercise  programme and  at 
three  months follow-up.96  On  programme completion,  the  time  spent  in  moderate to 
vigorous  intensity activity  had  increased significantly.  In  contrast,  three  months after 
rehabilitation,  ne,arly  50%  of  participants  had  reduced  their  physical  activity 
participation  compared  to  the end  of the  programme.  Furthermore,  16%  of patients 
had  regressed from the action/maintenance stage to  an  earlier stage of change.  The 
present study found that 33% of control patients regressed from action or maintenance 
to preparation or remained in the preparation stage from baseline to 12 months. 
The change  in  total  activity counts/week  measured  by  the  CSA accelerometer from 
baseline to  12 months did not parallel the decrease in self-reported physical activity in 
the  control  group.  Instead,  the  CSA accelerometer  results  suggested  that  physical 
activity  was  maintained  over  the  study  period  in  both  groups.  However,  CSA 
accelerometers  have  limitations,  which  could  explain  these  conflicting  findings. 
Accelerometers  cannot record  all  types  of activity  such  as  water activities,  activities 
that increase energy expenditure without a proportional increase in bodily acceleration 
(e.g.  walking  uphill)  and  activities  that  require  upper body  movement  (e.g.  washing 
windows)  unless  the  accelerometer  was  attached  to  the  wrist.  Modest  to  poor 
correlations  have  been  observed  between  activity counts  and  measured V02  during 
daily lifestyle activities (e.g.  housework, gardening and  leisure activities).191;196  Most of 
these  activities  required  modest  leg  movement  and  a large  amount  of  upper body 
work  which  would  not  be  detected  accurately  using  accelerometers  attached  the  , 
ankle.  In  contrast,  the 7DPAR would  be  able  to  record  these types  of daily  lifestyle 
171 activities. This reasoning is supported by poor to modest correlations ranging from 0.2 
to 0.46 between CSA activity counts/week and self-reported physical activity observed 
in  this study.  Thus,  the decrease in  self-reported physical  activity in  the control group 
could reflect a decline in  lifestyle physical activity, which would not be recorded by the 
accelerometers. In addition, it is possible that repeated use of the CSA accelerometers 
throughout  the  study  may  have  made  them  less  sensitive  to  measuring  physical 
activity  at  12  months  compared  to  baseline  and  six-month  measurement  periods. 
Results  show that the change  in  CSA  accelerometer counts/week  and  self-reported 
physical activity from baseline to six months appear to track each other in both groups. 
However,  despite  further  changes  in  self-reported  physical  activity  from  six  to  12 
months in  both groups, there was  no further change  in  CSA accelerometer readings. 
There are no  studies investigating the effect of repeatedly using CSA accelerometers 
on the reliability of these instruments for measuring physical activity. 
An alternative explanation for the discrepancy between the 7DPAR and CSA results is 
that the experimental group may have over-estimated the duration and/or intensity of 
their activities  at  six  and  12  months.  The  aim  of the  exercise  consultations  was  to 
encourage  patients  to  remain  regularly  active  following  completion  of the  phase  III 
exercise  programme.  Thus,  the  experimental  group  may  have  overestimated  their 
physical activity to  demonstrate to the researcher that they had  remained  active over 
the study period.  Conversely,  as  the  researcher was  not blinded to  group allocation, 
she could have unfairly influenced the information collected by the 7DPAR. However, a 
standardised interview process
222  was followed when  administering the questionnaire 
to limit the interviewer's bias. 
This  study  demonstrated  that  exercise  consultation  was  more  effective  than 
standard  exercise  information  in  maintaining  self-reported  physical  activity  for  12 
months after completion of a phase III  exercise programme.  Despite the decline in 
physical  activity  and  other  lifestyle  changes  following  completion  of  phase  III 
documented in several studies, there is  limited research on  effective interventions to 
encourage maintenance of physical activity in  phase  IV.  Brubaker
181 
randomized 31 
patients, who had completed a 12-week phase III supervised exercise programme to 
either  a  phase  IV  home-based  maintenance  programme  or  standard  care.  In 
addition,  a  comparison  group  (n  =  17)  who  attended  a  phase  IV  supervised 
maintenance programme after completion of phase  III  were randomly selected. The 
172 phase  IV home-based programme lasted  9 months  and  included  an  initial  physical 
activity  counselling  session  on  self-monitoring  exercise  intensity  and  daily  activity 
levels,  problem  solving  exercise  barriers,  and  regular telephone  contact to  discuss 
exercise  compliance,  feedback  on  exercise  levels  and  to  provide  support  and 
encouragement.  This  intervention  seems  to  be  similar to  the  exercise  consultation 
used in the present study. Standard care involved advice on continuing with exercise 
and  other  lifestyle  modifications.  The  comparison  group  attended  a  phase  IV 
supervised  maintenance  programme  for  9  months,  involving  supervised  exercise 
training  three  times  a  week  and  regular  counselling  on  exercise  compliance  and 
modification  of  other  risk  factors.  Exercise  capacity,  blood  lipids,  and  body 
composition were  assessed  before  and  after phase  III  and  at  9 months  follow-up. 
However,  physical  activity levels were  not assessed.  Results  revealed  comparable, 
significant improvements in these outcomes in  all  3 groups on  completion phase III. 
In  addition,  these  improvements  in  blood  lipids,  exercise  capacity  and  body 
composition  were  maintained  in  all  groups  at  9 months  follow-up.  These  findings 
suggest that a home-based exercise programme is just as effective for patients who 
cannot  attend  a phase  IV supervised  maintenance  exercise  programme.  Although 
the  standard  care  patients  received  no  further  intervention  in  phase  IV,  they  also 
maintained these changes, suggesting that follow-up testing alone may be sufficient 
to  maintain  lifestyle  changes  after  phase  III.  A  number  of  patients  stated  that 
knowing they were being reassessed at 12 months motivated them maintain lifestyle 
changes.  Thus,  it  is  possible that  assessing  physical  activity  and  cardiorespiratory 
fitness  at regular intervals in  the  present study could  have  encouraged  patients to 
remain  active  over  the  study  period.  Without  this  level  of  monitoring,  a  greater 
decline  in  physical  activity may  have  occurred  in  the  control  group over the  study 
period. In fact, several control patients stated that they were grateful for being invited 
to take part in  the  study as  it "encouraged them  to  keep  active after they finished 
phase III". 
Effect of an Exercise Consultation on Cardiorespiratory Fitness 
Measuring  exercise  capacity  and  submaximal  endurance  capacity  was  used  as 
indicators of cardiorespiratory fitness. 
Exercise Capacity 
Cardiorespiratory  variables  measured  at  peak  exercise  were  used  to  determine 
173 exercise capacity.  Exercise capacity parameters included peak oxygen uptake (V0
2
) , 
total  exercise duration,  peak ventilation  (VE),  peak  heart  rate  (HR),  peak  respiratory 
exchange ratio (RER) and peak oxygen pulse (V02/HR). 
Baseline peak V02 corrected for total body weight (mllkg/min) was similar between 
the  groups.  At  baseline  (i.e.  on  completion  of  phase  III),  peak  V02 was  26.9 
mllkg/min  (SO  6.6)  in  the experimental  group  and  24.4  mllkg/min  (SO  6.5)  in  the 
control  group.  It  is  difficult to  compare  baseline  results  in  the  present  study with 
other studies  reporting  exercise  capacity  values  on  completion  of exercise-based 
cardiac rehabilitation. This is because many studies have estimated peak V02 from 
treadmill  test  duration,20;46;127;85;35;41;58;88;47;66  which  can  overestimate  exercise 
capacity by up to 40%.57 In addition, several studies determined exercise capacity by 
measuring watts achieved during cycle testing. 36;37;50;51;53;55;56;67  Furthermore, findings 
from the present study cannot be compared with trials that directly measured peak 
V02 using  cycle  testing,  as  exercise capacity  is  10  to  15%  lower in  cycle  versus 
treadmill  testing. _  In  contrast,  a  few studies  have  assessed  exercise  capacity  by 
directly measuring peak V02 during treadmill testing.48;49;57;59;69;82;99;121;280;281  However, 
various  treadmill  protocols  were  used  in  these  trials,  which  influences  the 
measurement of peak oxygen uptake.237  Although, several of these studies reported 
similar values for peak V02 after three to five  months  of exercise training  as  the 
48'49'99'121'281  baseline results found in the present study.  '  ,  ,  , 
There was a trend for a decrease in  peak V02 (mllkg/min) in experimental group by 
3.7%)  and  a  statistically  significant  decrease  by  6.7%  in  the  control  group  from 
baseline  to  six  months.  From  baseline  to  12  months,  peak  V02  significantly 
decreased  by  6.7%  (1.Bmllkg/min)  in  the  experimental  group  and  9.4%  (2,3 
ml/kg/min) in  the control group. These findings suggest that exercise capacity was 
not  maintained  over  the  12-month  study  period  in  either  group.  There  was  no 
significant change in body weight from baseline to follow-up in either group and peak 
V02 (mllmin),  not corrected for total body weight,  also decreased significantly from 
baseline  to  12  months  in  the  experimental  and  control  group.  In  contrast  to  the 
decline  in  peak  V02,  total  exercise  duration  did  not  significantly  change  from 
baseline to six and 12 months in either group. 
174 Possible explanations for the  decrease  in  peak V02  observed  from  baseline  to  12 
months in both groups are discussed. Firstly, improvements in peak aerobic capacity 
with  exercise  training  may  be  partly  due  to  a  reduction  in  body  fat,  which 
overestimates the true improvement in exercise capacity with training. 280 Thus,  it has 
been  suggested that changes in  peak V02  corrected for lean  body mass should be 
used  to  assess  the  individual  effect  of  exercise  conditioning  alone. 28o  Body 
composition was not assessed in the present study,  but it is possible that changes in 
body composition could  have  partially caused  the decline in  exercise capacity after 
completion  of phase  III  exercise training.  Secondly,  the  decline  in  peak V02  could 
not be caused by a decrease in motivation during follow-up exercise tests compared 
with baseline,  as there was  no  significant change in total exercise duration over the 
study  period.  In  addition,  peak  respiratory  exchange  ratio  (RER),  an  indicator  of 
exercise effort,  did  not decrease in  either group over the  study period.  Finally,  it  is 
likely  that  the  decrease  in  peak  V02  reflects  a  decline  in  the  capacity  of  the 
cardiovascular  system  to  supply  oxygen  to  exercising  skeletal  muscles  and  the 
potential  for oxygen  extraction  by  the  exercising  muscle.  As  previously  discussed, 
improvements in  exercise capacity after training  in  CHD  patients is  primarily due to 
peripheral  adaptations  rather  than  central  (cardiac)  adaptations.
70
-
73  Peripheral 
changes reflect an  improvement in  the supply of oxygen to  active skeletal muscles, 
and enhanced oxygen extraction and utilisation by the exercising muscles. Thus, it is 
likely that a decrease in  peak V02  is  a result of a deterioration  in  these peripheral 
adaptations.  Peak  oxygen  pulse  (V02/HR  ml/beat)  was  calculated  in  the  present 
study,  which  measures  the  amount  of oxygen  carried  in  each  stroke  volume  and 
gives an  index of cardiac function.  There was  no  significant change in  peak oxygen 
pulse in  either group over the study period. This finding further supports the concept 
that a decline in  peak V02  was  not due deterioration in  cardiac function,  but rather 
due to negative changes in the skeletal muscles. 
This  study found  a decline  in  peak V02  by  6.7%  (1.Bml/kg/min)  in  the  experimental 
group  and  9.4%  (2.3  ml/kg/min)  in  the  control  group  from  baseline  to  12  months, 
suggesting that aerobic fitness decreased in both groups after completion of phase III. 
Other  studies  have  found  that  improvements  in  exercise  capacity  with  cardiac 
.  .  37;50;55;67 
rehabilitation  exercise training  decline  after programme  completIon.  As  these 
studies  did  not  directly  measure  peak  V02  during  treadmill  testing,  it  is  difficult  to 
compare the decline in  exercise capacity observed  in  the  present study with  findings 
175 from other trials.  Thus,  it  is  not clear whether the  magnitude of the  decrease in  peak 
V02  is  clinically  important.  However,  several  studies  have  reported  a  significant 
relation between exercise capacity and  mortality in  CHO patients. 91 ;282-285  Researchers 
have found  that  a low fitness  level  «  4  METs)  measured  before  entry  to  exercise-
based  cardiac  rehabilitation  is  a  significant  predictor  of  total  and  cardiac 
d  th  91 ;282;283;285  R  283 
ea  .  ecently,  Kavanagh  examined  the  relation  between  mortality  and 
peak V02 measured on entry to a cardiac rehabilitation exercise programme in  12169 
men after MI,  CABG and CHO.  The study found that estimated 15 year survival rates 
for patients with peak V02 values of <15,  15 to 22 and >22 mllkg/min were 65%,  81 % 
and 88%>,  respectively. Thus,  estimated  15 year prognosis was substantially lower for 
patients in  the least fit group «15 mllmg/min; 35%  mortality) compared to the middle 
group (15 to 22 mllkg/min, 19% mortality) and patients with the highest peak V02 (>22 
mllkg/min; 12%  mortality). Results from these studies suggest that a fitness level of 15 
mllkg/min, which is equivalent to 4 METs,  is an important cutoff for mortality risk.  Thus, 
it  may  be  that  a  decline  in  exercise  capacity  is  not  clinically  important  as  long  as 
patients  maintain. their exercise  capacity  above  15  mllkg/min  (4  METs)  in  the  long-
term.  Despite  a  decrease  in  peak  V02 over  12-months  in  the  present  study,  the 
average  peak  V02  values  at  12  months  were  25.1  (SO  6.2)  ml/kg/min  in  the 
experimental group and 22.0 (SO 6.1) ml/kg/min in the control group. 
These  studies  also  examined  the  relation  between  the  change  in  peak  V02 and 
mortality.282-284  Kavanagh  found  that  a  1  mllkg/min  advantage  in  peak  V02 was 
associated with a 9% improvement in prognosis. Vanhees282  investigated the relation 
between  mortality  and  the  change  in  peak  V02 with  exercise-based  cardiac 
rehabilitation in a group of MI  and CABG patients. Peak V02 increased by 33% after 
the three-month exercise programme. Thirty seven (9%)  patients died during the 6-
year  follow-up  period,  21  (5%)  died  from  cardiovascular  causes.  Total  and 
cardiovascular  mortality was  significantly  related  to  both  the  change  in  peak V02 
with  training  and  the  peak V02 after training,  which  was  independent  of age  and 
other  significant  covariates.  In  addition,  the  study  found  that  a  1  %  increase  in 
exercise capacity with training was associated with a 2%  reduction in  cardiovascular 
mortality,  which  was  independent from  the  exercise  capacity  before training.  Oorn 
also showed that an  increase in  exercise capacity reduces total  and  cardiovascular 
mortality.284  This  study found  that  each  1 MET  increase  in  exercise  capacity from 
baseline to the end of a three year trial of exercise-based cardiac rehabilitation was 
176 associated with a significant reduction in  all-cause and  cardiac mortality throughout 
the  19-year follow-up  period.  These  results  included  all  patients  who  increased 
exercise capacity by at least 1 MET,  regardless of initial exercise capacity level and 
group  assignment  (i.e.  control  group  or  rehabilitated  group).  Thus,  findings  from 
these studies suggest that small increases in exercise capacity have a marked effect 
on  survival. Thus,  it is  possible that the decline in  peak V02  by 6.7% (1.8 ml/kg/min 
or 0.5 METs) the experimental group and  9.4%  (2.3  mllkg/min or 0.7  METs)  in  the 
control  group  over  the  12  month  follow-up  period  in  the  present  study  may  be 
clinically relevant. 
Results revealed  that although there was  a decline  in  peak  aerobic capacity,  total 
exercise  duration  was  maintained  over  the  study  period  in  both  groups.  The 
following  reason  is  a  possible  explanation  for the  discrepancy  in  results  between 
peak V02  and total exercise duration.  Peak V02  measures aerobic capacity,  which 
represents the capacity of the cardiovascular system to supply oxygen to exercising 
skeletal muscles and the potential for oxygen extraction by the exercising muscle.  In 
contrast,  total  exercise  duration  measures  total  work  performed  without 
differentiating between aerobic and anaerobic metabolism. Thus, a decrease in peak 
V02 from baseline to 12 months indicates a decline in aerobic capacity.  It is possible 
that total exercise duration was  maintained over the study period  because patients 
performed  a  greater  amount  of work  anaerobically  at  12  months  compared  with 
baseline.  This  concept  is  supported  by  a significant  increase  in  RER  at  follow-up 
compared  with  baseline  in  both  groups,  which  may  indicate  greater  lactate 
production at peak exercise. 
Results  from  the  present  study  suggest  that  physical  activity  was  maintained  from 
baseline  to  12  months  in  the  experimental  group,  whereas  exercise  capacity 
significantly declined  over the  12  month  follow-up.  The following  reason  may  be  an 
explanation for the discrepancy in results between physical activity and fitness. Studies 
in  healthy  adults  suggest  that  to  maintain  initial  improvements  in  aerobic  fitness, 
exercise  must  be  continued  on  a  regular  basis,  as  a  significant  reduction  in 
cardiorespiratory  fitness  occurs  after  2  weeks  of  stopping  training.  Although  the 
minimal  level  of  exercise  necessary  to  maintain  fitness  is  not  known,  evidence 
suggests that missing an  exercise session periodically or reducing the frequency and 
duration of training will not adversely affect cardiorespiratory fitness as long as training 
177 intensity is  maintained.? A study found that if training  intensity remained  unchanged, 
cardiorespiratory fitness  was  maintained  for  up  to  15  weeks  when  the  duration  and 
frequency  of  training  was  reduced.  On  the  other  hand,  when  the  duration  and 
frequency  of training  was  held  constant  and  the  intensity was  reduced  there was  a 
significant  reduction  in  cardiorespiratory  fitness.  Thus  in  the  present  study,  it  is 
possible that the intensity of patients' physical  activity was  lower than  the  intensity of 
exercise training in phase III, which resulted in a decline in peak V02, whilst the level of 
physical activity was maintained. At the time of the study,  there were  few supervised 
exercise programmes available in the community for patients to  attend.  Thus,  most of 
the  patients  stayed  active  by  participating  in  moderate  intensity  activities,  such  as 
walking.  Alternatively,  experimental  patients  may  not  have  met  physical  activity 
guidelines  every  week throughout  the  12-month  follow-up  period,  which  may  have 
caused  the  decline  in  aerobic fitness.  Frequent  lapses  from  activity would  not  have 
been detected in the study, as physical activity was only measured three times over 12 
months. 
Submaximal Endurance Capacity 
Submaximal  endurance  capacity  was  determined  by  estimating  the  oxygen  uptake 
(mllmin)  at the  lactate threshold.  Oxygen  uptake  at  the  lactate  threshold  was  1251 
mllmin  in  the experimental  group and  1177  mllmin  in  the  control  group  at  baseline. 
These  results  are  comparable  to  other  studies  reporting  V02  values  at  the  lactate 
threshold  following  participation  in  exercise-based  cardiac  rehabilitation.
81
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Hambrecht found that V02  at L  Twas 1170 mllmin after 12 months of supervised and 
unsupervised  exercise.84  Although,  few  studies  have  evaluated  the  effect  of  the 
exercise-based  cardiac  rehabilitation  on  submaximal  endurance  capacity  by 
measuring the onset of the lactate threshold. 
Results  revealed  a  significant  increase  in  the  V02  at  the  lactate  threshold  from 
baseline to six and  12 months in the experimental group relative to the control group. 
From baseline to six months, there was a trend for an increase in V02 at the L  T by 47 
ml/min  (3.80/0)  in  the  experimental  group  and  a decline  by  52  mllmin  (4.4%)  in  the 
control group.  Furthermore, the lactate threshold significantly increased by  81  ml/min 
(6.50/0)  in  the experimental  group and  decreased by  45  mllmin  (3.8%)  in  the  control 
group from baseline to 12 months. Hambrecht reported a small but significant increase 
in V0
2 
at the L  T by 7%  (80 mllmin) after 12 months of supervised and  unsupervised 
178 exercise training. The magnitude of the increase in the L  T is very similar to the results 
observed in the experimental group in the present trial.  Hambrecht also found that V0
2 
at L  T  decreased by 90 ml/min (8%) in  the control group from baseline to  12 m  th  on  s, 
which is  greater than the decline observed  in  the control group in  the  present study. 
Other studies have found significant improvements in the lactate threshold after three 
t ·  th  f  .  ..  51 "75·81·82  o SIX  mon  s 0  exercise training,  ,  ,  ,  however they did not examine whether this 
beneficial effect was maintained after programme completion. 
These results indicate that the onset of the L  T was delayed in the experimental group 
compared to  the  control  group from  baseline to follow-up.  Hambrecht demonstrated 
that the change in the L  T significantly correlated with both changes in  physical activity 
related energy expenditure measured by questionnaire and peak V02.84  In the present 
study,  changes  in  L  T  may  be  a  result  of  continued  participation  in  moderate  to 
vigorous physical activity in the experimental group and a decline in  physical activity in 
the control group.  However,  peak aerobic capacity declined over the study  period  in 
both groups.  Studies that reported  increases in  the  L  T  after exercise-based  cardiac 
rehabilitation  also  found  significant  improvements  in  peak  aerobic  capacity.51;81;82;84 
This is  in  contrast to the  present study,  which found that peak V02  declined  in  both 
groups over the study period. 
The delayed onset of the  LT  is  beneficial to  the daily  lives  of cardiac  patients.  The 
lactate threshold  is  the exercise V02 at which the concentration  of lactate in  arterial 
blood increases above the resting value due to the supplementation of aerobic energy 
production  with  anaerobic  metabolism.83  Below the  lactate  threshold,  exercise  at  a 
given work rate  can be  sustained for a prolonged period  of time without fatigue  and 
with  relatively  little  stress  to  the  subject.  In  contrast,  work  rates  above  the  lactate 
threshold  lead  to  metabolic acidosis,  an  increased  ventilatory  response  and  muscle 
fatigue, thus exercise above this threshold cannot be sustained as long. Therefore, the 
delayed  onset  of the  lactate  threshold  enhances  an  individual's  ability  to  perform 
physical activity at a given work rate.  Proposed mechanisms for a delayed onset of the 
lactate threshold include improved oxygen supply to active skeletal muscles, increased 
oxidative capacity of mitochondria and delayed activation of type II  muscles fibres that 
function  anaerobically.83  However,  positive changes  in  these peripheral  mechanisms 
as an explanation for the increased L  T in the experimental group relative to the control 
group seems unusual  since peak aerobic capacity declined  in  both  groups over the 
179 study period, suggesting that negative changes occurred in peripheral mechanisms. 
In the present study,  the lactate threshold was  indirectly estimated  using the  V-slope 
and  ventilatory  equivalent  techniques.  These  methods  are  valid  and  reliable 
techniques for estimating  the  lactate threshold.
23s
;s3  However,  directly measuring  the 
concentration of blood  lactate during the exercise test would  have confirmed that the 
changes in the L  T in the experimental and control groups were due to changes lactate 
concentration. 
Effect of an Exercise Consultation on the Processes of Exercise Behaviour 
Change 
The  processes  of  change  are  strategies  that  individuals  use  when  changing  their 
exercise  behaviour.  The  frequency  of  using  the  five  experiential  processes 
(consciousness  raising,  social  liberation,  dramatic relief,  environmental  re-evaluation 
and self re-evaluation) did not significantly change from  baseline to six months and six 
to  12  months  in  either group.  From  baseline  to  12  months,  there  was  a significant 
decrease  in  the  use  of dramatic  relief  in  the  control  group  and  environmental  re-
evaluation  in  the  experimental  group.  The  use  of  the  five  behavioural  processes 
(helping  relationships,  stimUlus  control,  counter  conditioning,  self-liberation, 
reinforcement management) did  not significantly change from  baseline to follow-up  in 
either group.  Thus,  nine  out  of ten  processes  of change  remained  stable  over the 
study period in  both groups. The following  reasons may explain the  lack of change in 
process use observed  in  this study.  A meta-analysis  159  by Marshall and  Biddle found 
that the use of experiential and behavioural processes increased with advancing stage 
of change, with the largest increase occurring from precontemplation to contemplation 
and  preparation to  action.  Similarly,  Marcus found that the transition from  an  inactive 
stage  (i.e.  precontemplation  or  contemplation)  to  an  active  stage  (i.e.  preparation, 
action  or  maintenance)  was  associated  with  a  significant  increase  in  the  use  of 
experiential and behavioural processes.  In the present study, there were no patients in 
precontemplation  or  contemplation  (i.e.  inactive  stages)  at  baseline  or  follow-up. 
Secondly,  few patients  in  either group progressed  from  preparation  to  the  action  or 
maintenance stages. 
The  meta-analysis  also  found  minimal  change  in  the  use  of  experiential  and 
behavioural  processes  as  individuals  progressed  from  action  to  maintenance. 
180 Likewise, Marcus found that process use did not significantly change for subjects who 
remained  in  an  active stage (i.e.  preparation,  action  or maintenance).  In  the  present 
study, the majority of patients in  both groups remained in the action and maintenance 
stages  (i.e.  regularly  active)  throughout  the  study  period.  Marcus  also  reported  that 
subjects  who  relapse  over the  study  period  (regression  from  preparation,  action  or 
maintenance  to  either  contemplation  or  precontemplation)  reported  a  significant 
decline  in  the  use of all  behavioural  processes  and  1 experiential  process  (dramatic 
relief).  Similarly,  Bock found  that  individuals  who  had  regressed  three  months  after 
completion of a phase II programme had significantly lower scores for the frequency of 
using  behavioural  processes compared  to  participants who  remained  active  at  three 
months.  In  the  present study,  few patients  in  either group  regressed  from  action  or 
maintenance to the preparation stage of change.  In addition,  patients that did regress, 
moved  to  a  somewhat  active  stage  (i.e.  preparation),  whereas  in  Marcus's  study, 
patients relapsed from an active to inactive stage. 
It  would  have  beE3n  interesting  to  conduct  subgroup  analysis  to  determine  whether 
changes  in  process  use  occurred  in  patients that regressed  and  progressed through 
the stages of change during the study period.  However,  this  could  not be  carried  out 
due  to  the  small  number  of  patients  in  these  categories.  Overall,  the  exercise 
consultation compared to standard care had  little effect on the frequency of using the 
experiential and behavioural processes of change. This lack of change in  process use 
may be  because the  majority of patients  in  both  groups  remained  in  the  action  and 
maintenance  stages  of  change  throughout  the  study  period.  Although,  a  near 
significant difference was  observed in  the proportion of the experimental group in the 
action and maintenance stages of change at 12 months compared to the control group 
(85%  experimental  group  vs  67%)  control  group).  In  addition,  a significantly  greater 
proportion  of  patients  in  the  experimental  group  compared  to  the  control  group 
remained  regularly active or became regularly active from  baseline to  12 months and 
six  to  12  months.  However,  the  magnitude  of these  differences  were  probably  not 
sufficient to produce significant changes in process use. 
Results  from  the  present  study  and  previous  trials  suggest  that  maintenance  of 
physical activity does not require further changes in the use these processes. Findings 
from  previous  trials  suggest  that  continued  use  of  behavioural  processes  may  be 
important to prevent relapse. Therefore, interventions to maintain physical activity after 
181 completion  of  exercise-based  cardiac  rehabilitation  should  encourage  people  to 
increase the  frequency of using  the behavioural  processes  of change.  For example, 
encouraging  individuals  to  use  reminders,  rewards  or  seek  support  to  help  them 
remain  active  in  the  long-term.  These  strategies  are  incorporated  into  the  exercise 
consultation. 
Effect of an Exercise Consultation on Weight and 8MI 
There were no significant between or within group changes recorded  in weight or BMI 
over the  study period  in  either group.  At baseline,  28.5%  of the  experimental  group 
and 17.1 % of the control group were obese (BMI>30kg/m2 ).  In addition, the proportion 
of  overweight  patients  (BMI>25kg/m2)  in  the  experimental  and  control  group  was 
82.90/0  and 77.1%, respectively. The number of overweight and obese patients did not 
significantly  change  in  either  group  from  baseline  to  follow-up.  Thus  the  exercise 
consultation had no effect on body weight and body mass index compared to standard 
exercise information.  The following  reasons  are  possible explanations for the  lack of 
significant  changes  in  these  variables  observed  in  the  present  study.  A  systematic 
review found that the  majority of studies  reporting  improvements in  body weight and 
BMI  with  exercise-based  cardiac  rehabilitation  included  dietary  advice  in  addition  to 
exercise  training.
1  This  review  stated  that  exercise  only  rehabilitation  had  an 
inconsistent effect on  weight management.  Thus,  combining  dietary modification and 
exercise  training  is  recommended  to  optimise  weight  management.  In  the  present 
study,  the  intervention  did  not  include  advice  or  counselling  on  diet  in  addition  to 
physical activity, which may explain the lack of effect on weight and  8MI. However, all 
patients  participating  in  the  present trial  would  have  received  information  on  healthy 
eating in  phases I to  111.
3  In  addition,  overweight patients would  have  received dietary 
advice  for  weight  management  in  accordance  with  national  guidelines.
3 
Thus,  the 
majority  of participants  in  both  groups  may  have  been  on  a weight  reducing  diet. 
However,  this  study  did  not  attempt  to  encourage  patients  to  adhere  to  dietary 
changes  after  completion  of phase  III.  In  addition,  it  was  not  possible  to  assess 
whether patients  continued  to  make  dietary  changes  after  completing  phase  III  as 
eating habits were not measured.  It is also possible that changes in body composition, 
specifically  fat  mass  and  fat  free  mass  could  have  occurred,  which  would  not  be 
detected by measurement of body weight and BMI. 
182 Effect of an Exercise Consultation on Lipids 
No  significant  changes  in  total  cholesterol,  triglycerides  and  LDL  cholesterol  were 
observed  from  baseline  to  follow-up  in  either  group.  The  literature  suggests  that 
exercise programmes have little impact on blood lipids, unless patients have abnormal 
lipid levels before exercise training.
28 
In this study,  baseline levels for total cholesterol 
triglycerides  and  LDL  cholesterol  in  both  groups  were  in  the  normal  range 
recommended by SIGN,2 which may explain the lack of change in these variables over 
the study period. 
Evidence  suggests  that  a  combination  of diet,  exercise  training  and  lipid-lowering 
medication  produces  favourable  lipid  profiles  and  reaches  lipid  targets.9 Guidelines 
state  that  lipid  lowering  medication  should  be  prescribed  to  individuals  with  a  total 
cholesterol  ~ 5mmol/l  or LDL cholesterol  ~ 3  mmo1/1.
2
;115  Although,  results  from  the 
Heart  Protection  Study  indicate  that  all  CHD  patients  should  be  prescribed  lipid 
lowering medication irrespective of their initial cholesterollevel. 119 Patients participating 
in the present study would have had their lipid levels assessed in phase I and received 
lipid-lowering  medication  if  required.  In  addition,  blood  lipids  would  have  been  re-
assessed during  phase III  and  lipid  lowering  medication would  have  been  altered  if 
values were above national targets.  In  the present study,  88.6% of the control group 
and  100%  of  the  experimental  group  were  taking  lipid-lowering  medication  on 
completion of phase III, which did not significantly change at six and 12 months follow-
up.  In  addition,  lipid  levels  were within  normal  ranges  throughout the  study  period. 
Thus, the lack of change in lipid levels observed in this study may be because patients' 
blood lipids were very well controlled before entry to the trial. 
This  study did  find  an  increase  in  HDL from  baseline  to  follow-up  in  both  groups. 
However,  the  only  significant  improvement  in  HDL  occurred  from  baseline  to  12 
months in the experimental group. In  addition, there was a significant improvement in 
the  ratio  of total  cholesterol  to  HDL  from  baseline  to  six  and  12  months  in  the 
experimental group, whereas no significant change was recorded in the control group. 
A  meta-analysis28  reported that exercise-based cardiac rehabilitation  did  not improve 
HDL cholesterol compared with  usual care,  although this finding  was based  on  only 
three studies. Similarly, a systematic review observed that studies using exercise only 
rehabilitation or comprehensive rehabilitation documented inconsistent effects on HDL 
choletserol.1 Conversely, other studies61 ,121  have reported significant improvements in 
183 HDL  cholesterol  with  three  to  six  months  of  moderate  intensity  exercise  training. 
Brochu  121  found  a significant increase in  HDL cholesterol  by  8%  after a three  month 
exercise  programme,  with  no  change  in  the  other  lipid  levels.  In  the  present  study, 
HDL  cholesterol  increased  significantly  by  10%  (0.11  mmol/l)  in  the  experimental 
group and non-significantly by 5%  (0.06 mmol/l)  in the control  group from  baseline to 
12 months.  However,  the difference between the  groups for the change  in  HDL was 
not significant.  The median values for HDL  cholesterol were  within  the  normal  range 
(>0.91  mmol/l) in  both groups at baseline and follow-up.  Thus,  the clinical  importance 
of a 10% increase in  HDL cholesterol observed in the experimental group is not clear. 
It  is  likely that  patients with  low levels  of HDL  cholesterol  at  baseline  would  benefit 
more  from  a  10
%  increase  in  HDL  cholesterol  at  follow-up.  However,  subgroup 
analysis was not possible in this study due to the small number of patients. 
There is evidence to suggest that changes in HDL cholesterol may be influenced more 
by  changes  in  physical  activity than  fitness.  Brochu  121  found  no  association  between 
the  change  in  peak  V02  and  changes  in  coronary  risk  factors,  including  HDL 
cholesterol. Furthermore, Hambrecht
84 reported that improvements in lipids were more 
closely  correlated  with  increases  in  total  energy  expenditure  than  changes  in  peak 
V02. 
Effect of an Exercise Consultation on Psychological Function 
Anxiety and Depression 
Anxiety  and  depression  was  measured  using  the  Hospital  Anxiety  and  Depression 
Scale.  The scores for the anxiety and  depression  subscales  can  be  used  to  classify 
individuals  into  normal  (0-7),  mild  (8-10),  moderate  (11-14)  and  severe  (215) 
categories. 
At baseline,  median scores for anxiety were 6 in the experimental group and  5 in  the 
control group.  Similarly,  median depression scores at baseline were  2 in  each group. 
Thus,  low levels of anxiety and depression were reported following  completion  of the 
phase  III  exercise  programme.  Several  studies  have  shown  that  participation  in 
exercise-based  cardiac  rehabilitation  significantly  improves  anxiety  and  depression 
and  produces  low  levels  of  psychological  distress  on  programme 
184 completion 37;38;66;109;110  V  .  t" 
.  anous  ques lonnalres  were  used  to  measure  anxiety  and 
depression in these studies making it difficult to compare findings with the current trial. 
Lewin  110  found that mean  HADS scores were 4.9 for anxiety  and  3.1  for depression 
after six weeks  of home-based  cardiac  rehabilitation.  Similarly,  Hevey286  found  that 
following  completion  of  a  10-week  programme,  mean  scores  for  anxiety  and 
depression  were  4.7  and  3,  respectively.  Thus,  baseline  scores  for  anxiety  and 
depression observed in  the present study were similar to results reported  in  previous 
trials  that  used  the  HADS  scale  to  measure  anxiety  and  depression  after  cardiac 
rehabilitation. Gradual improvements in  anxiety and depression in control patients who 
received no formal rehabilitation have been demonstrated,37;59;67  which may be due to 
the natural course of recovery after a cardiac event.  Thus,  the low baseline levels  of 
anxiety and depression observed in this study may be because study participants were 
at  least  four  months  post  cardiac  event  and  had  recently  completed  a  cardiac 
rehabilitation programme. 
Results  revealed. that  anxiety  and  depression  did  not  significantly  change  from 
baseline to six and 12 months in either group. However, a slight increase in depression 
occurred in the control group compared to the experimental group from baseline to 12 
months and six to  12 months,  but this difference did  not reach  significance.  Despite 
this slight increase in  depression, scores remained  low in  the control group at follow-
up. Median scores for anxiety at 12 months follow-up were 5 in the experimental group 
and 4  in the control group.  Similarly, depression scores were 2 in  both  groups at 12 
months.  Thus,  the  results  show  that  low  levels  of  anxiety  and  depression  were 
maintained throughout the 12-month study period in  both groups. Other studies have 
shown  that  improvements  in  anxiety  and  depression  with  exercise-based  cardiac 
.  37·67·110 
rehabilitation  were  maintained  6  to  12  months  after  programme  completion.  '  , 
Lewin reported a mean score of 5 for anxiety and 3.4 for depression 12 months after 
participation in a six week home-based rehabilitation programme. 
Studies have demonstrated that the greatest psychological benefits of exercise-based 
cardiac rehabilitation occur in patients with high levels of anxiety or depression at study 
entry.108;110;112;113  Thus,  the lack of change in  anxiety and depression observed in  the 
present  study  may  be  because  median  scores  for  these  variables  were  low  at 
baseline.  Thus,  subgroup analysis was performed to determine if changes in  anxiety 
and depression  occurred  in  patients  who  had  high  baseline  levels  of psychological 
185 distress,  defined by  a HADS score of 8 or more  on  anxiety or depression subscales. 
Results  revealed  that  33%  of the  study  sample  were  psychologically  distressed  at 
baseline.  In  addition,  25%  (9/35)  of  the  control  group  and  40%  (14/35)  of  the 
experimental group had  anxiety or depression scores of 8 or more.  In  the distressed 
group,  baseline  scores  for anxiety  were  9  in  the  experimental  group  and  10  in  the 
control  group,  which  corresponded  to  mild  anxiety  according  to  the  HADS 
classification. Anxiety scores did not significantly change from  baseline to follow-up in 
either group,  suggesting that mild  levels  of anxiety persisted  in  both  groups over the 
study period.  These findings suggest that the exercise consultation had  no significant 
effect  on  anxiety  compared  to  standard  exercise  information  in  patients  who  were 
psychologically distressed at study entry.  However, the number of distressed patients 
may have been too small to detect between or within group differences in anxiety. The 
median  score for depression was  6 in  the  control  group  and  2.5  in  the  experimental 
group, which is  in the normal range.  Results show that depression did not significantly 
change  from  baseline to  six  and  12  months  in  either group.  However,  there  was  a 
slight  increase  in  depression  in  the  experimental  group  from  six  to  12  months, 
although this did not reach  significance.  Despite this  slight increase  in  depression  in 
the experimental group, depression scores remained low at six and  12 months follow-
up. 
Patients  with  a  baseline  HADS  score  less  than  8  for  anxiety  or  depression  were 
classed  as  non-psychologically  distressed.  As  expected,  median  scores  for  anxiety 
and depression at baseline were  low in  both  groups and  did  not significantly change 
from baseline to follow-up in either group. There was  a borderline significant increase 
in  depression from six to  12 months in the control group,  although depression scores 
remained  low  at  six  and  12  months  follow-up.  Thus,  low  levels  of  anxiety  and 
depression were  maintained for 12  months  in  patients who  were  not  psychologically 
distressed at study entry. 
A  randomised  controlled  trial110  evaluated  the  effect  of  a  6-week  home-based 
programme on anxiety and depression measured using the HADS scale at 6 weeks, 6 
months and  1 year.  The study found that 52% of the study group had  scores of 8 or 
more on  anxiety or depression  subscales  measured three days  post MI.  In  the  non-
distressed group,  mean anxiety and  depression scores were  low  at  baseline and  did 
not  significantly  change  at  12-months  in  the  rehabilitation  or  control  groups.  These 
186 results were similar to findings from the present study.  In the distressed group,  mean 
anxiety and depression scores significantly decreased in the rehabilitation group, with 
no change in the control group from baseline to 6 weeks,  6 months and  1 year.  These 
findings  conflict  with  the  results  of  the  present  trial,  which  reported  no  significant 
change in  anxiety  or depression  in  patients  who  were  distressed  at  baseline.  Lewin 
found that mean anxiety scores declined from  10 at baseline to six at 12 months in the 
rehabilitation  group and  remained  at  10 from  baseline to  12  months follow-up  in  the 
control group.  In the distressed group in the present study,  median scores for anxiety 
declined from  nine at baseline to  seven  at  12 months in  the  experimental group and 
increased  from  10  to  11  in  the  control  group.  Thus  similar to  the  results  by  Lewin, 
anxiety levels declined in the experimental group compared to the control group from 
baseline to 12 months, however this difference was not significant. In addition, anxiety 
decreased from the mild to normal category in the experimental group and remained in 
the  mild  category  in  the  control  group.  However,  the  small  number of patients  that 
were psychologically distressed at baseline may have prevented any between or within 
group differences from becoming significant. 
Quality of Life 
Quality  of  life  was  assessed  using  the  UK  SF-36  version  2,  which  measures  8 
dimensions of quality of life (physical functioning, social functioning, role limitations due 
to  physical problems,  role limitations due to emotional  problems,  pain,  energy/vitality, 
mental  health  and  general  health  perception.  At  baseline,  median  scores for social 
function  and  role  limitations  due  to  emotional  problems  were  100  in  both  groups, 
indicating  best  possible  health.  Scores  for  physical  function,  role  limitations  due  to 
physical  problems,  mental  health  and  pain  ranged  from  80  to  90  in  each  group.  In 
addition, median values for energy/vitality and general health perception were between 
60 to 70 in each group. These results indicate that quality of life was high at baseline in 
both  groups.  Jenkinson259  published  normative data  for a UK general  population  for 
the  questionnaire  that  was  used  in  the  present  study.  This  study  found  that  mean 
scores for four out of eight subscales ranged from  80 to 90  in the general population. 
Furthermore, values for three subscales ranged from  70  to  80,  and  the  score for the 
energy/vitality subscale was 58  in  this group.  Thus,  median scores on  several  SF-36 
subscales observed in the present study were similar to normative data for the general 
population.  Furthermore,  values  were  higher  in  the  present  study  compared  to  the 
general  population  for  social  function,  role  limitations  due  to  emotional  problems, 
187 energy/vitality and pain. 
Several  studies  have  used  the  SF-36  to  measure  quality  of  life  before  and  after 
participation  in  exercise-based  cardiac  rehabilitation. 61 ;8o;89;108;286  However,  these 
studies did  not  use version  2 of this questionnaire.  Recently,  Hevel86  found  that on 
completion of a 10 week rehabilitation programme,  median  scores ranged from  80 to 
900/0  for most SF-36 subscales except role limitations due to physical problems (45%) 
and  energy/vitality  (68%).  Thus,  comparable  quality  of  life  scores  were  reported 
between Hevey's study and the present trial, except that general health perception was 
lower and role limitations physical was  higher in the present study.  Similarly,  Morrin89 
and  Ades
80 
reported  high  quality  of life  scores  ranging  from  70  to  90%  following 
participation  in  three  months  of supervised  or home-based  cardiac  rehabilitation.  In 
addition,  Morrin
89  demonstrated that most  quality of life  scores  were  comparable for 
cardiac rehabilitation participants and normative data from the US. 
The present study found no  significant changes  in  the  eight quality of life dimensions 
from  baseline to  follow-up  in  either group.  These  results  suggest that  high  levels  of 
quality of life were maintained in both groups throughout the study period.  However, in 
the  experimental  group  there  was  a  trend  for  an  improvement  in  four  subscales 
including social function,  role  limitations due to  physical  problems,  role  limitations due 
to emotional problems and  energy/vitality,  and  a deterioration  in  pain,  although these 
changes  did  not  reach  significance.  In  the  control  group,  there  was  a trend  for  a 
decline  in  role  limitations  due  to  emotional  problems,  energy/vitality,  and  physical 
function  from  baseline  to  follow-up,  again  these  changes  were  not  significant. 
Conversely,  there was  a borderline improvement in  the  pain  subscale from  six  to  12 
months in  both  groups. Additionally,  there was  a trend  for a greater improvement in 
three dimensions in the experimental compared to the control group from  baseline to 
follow-up;  social  function,  role  limitations  due  to  emotional  problems  and 
energy/vitality. 
Several  trials  have  found  that  improvements  in  quality  of life  with  exercise-based 
cardiac  rehabilitation  are  maintained  six  to  12  months  after  programme 
completion.37;59;79  In  addition,  two  of these  studies
59
;79  found  that exercise  capacity 
and  physical  activity was  also  maintained  12  months  after programme completion. 
Whereas, Oldridge37  reported a decline in  exercise capacity at  12 months follow-up, 
188 despite  quality  of  life  scores  remaining  unchanged.  Stahle67  found  significant 
improvements  in  several  quality  of  life  dimensions  measured  using  a  disease-
specific questionnaire  after a three-month  rehabilitation  programme.  In  contrast  to 
other trials, Stahle found that some of these benefits had deteriorated at  12 months. 
In  addition,  physical  activity  levels  and  fitness  had  also  declined  from  programme 
completion  to  12  months  follow-up.  Similarly,  Stern
66  found  that  improvements  in 
several  quality of life  measures  after a three-month  rehabilitation  programme  had 
declined  at  12  months.  However,  the  improvement  in  exercise  capacity  was 
maintained at 12 months. Overall, conflicting results have been reported for changes 
in quality of life after completion of exercise-based cardiac rehabilitation.  In addition, 
the change in  quality of life did not parallel the change in fitness or physical activity 
in  many of these studies.  Similarly,  the change  in  quality of life  did  not correspond 
with the change in  exercise capacity or physical activity in  the present trial.  Newton 
reported that improvements in  psychological functioning with exercise-based cardiac 
rehabilitation  were  independent  of  changes  in  exercise  capacity.38  Thus,  it  is 
possible  that  quality  of  life  may  not  be  influenced  by  fitness  or  physical  activity, 
which  may explain the differing results found  for quality of life,  fitness  and  physical 
activity observed  in  the  present trial.  Alternatively,  a variety  of disease-specific and 
generic instruments were used to measure quality of life in the previous trials, which 
may explain the contradictory results. 
The  present  study  did  find  a  trend  for  an  improvement  in  several  quality  of  life 
dimensions in  the experimental group and  deterioration in  a few SF36  subscales  in 
the control group, although these changes did not reach significance. These lack of 
significant changes in  quality of life may be  because a generic instrument was  used 
to  measure quality of life.  This instrument may not  have been sensitive to  changes 
that  an  individual  with  CHD  experiences  as  his  or  her  condition  improves  or 
deteriorates.  However, studies have shown that disease-specific questionnaires are 
not  responsive  to  change,  whereas  the  SF-36  and  the  HADS  were  sensitive  to 
change  in  cardiac  rehabilitation  settings.
247
;249  In  addition,  many  disease-specific 
instruments  focus  on  a  specific  cardiac  condition,  thus  would  not  have  been 
appropriate  for  the  heterogeneous  population  used  in  this  study.  However,  it  is 
possible that  a disease-specific questionnaire may  have  been  more  able  to  detect 
changes in quality of life. 
189 Effect of an Exercise Consultation on Mortality and Morbidity 
Meta-analyses
31 
have  consistently found  that  exercise-based  cardiac  rehabilitation 
improves  survival  and  has  no  significant  effect  on  rates  of  non-fatal  MI,  or 
revascularisation (i.e. CABG or PTCA) compared with usual care,  although few trials 
reported  CABG  or PTCA  as  an  outcome.  In  the  present trial,  mortality was  5.7% 
(2/35)  in  the  control  group  and  0%  in  the  experimental  group  over the  12  month 
study period. The revascularisation rate (i.e.  CABG and  PTCA) was  11.4% (4/35) in 
the experimental  group and  0%  in  the control  group.  However,  the  present trial28;30 
was  not  powered  to  detect any differences  in  mortality  and  morbidity between  the 
experimental and control groups. 
Summary and Conclusions 
Participation in exercise-based cardiac rehabilitation produces many physiological and 
psychological benefits.  In  addition,  sustaining these  benefits requires  maintenance of 
physical  activity  and  other  lifestyle  changes  in  the  long-term.  However,  evidence 
suggests that improvements in  exercise capacity,  physical  activity  and  quality  of life 
are  not  maintained  following  completion  of rehabilitation  programmes.  However,  the 
research  is  limited  on  effective  interventions  to  encourage  maintenance  of  physical 
activity  in  the  long-term  during  phase  IV.  Physical  activity  counselling  and  exercise 
consultation,  based  on  theoretical  models  of  behaviour  change,  use  strategies  to 
increase and  maintain physical activity.  Research  has  shown that these  interventions 
are effective for promoting and  maintaining physical activity in the general population 
and clinical populations. 168;171;175-177;181  In  addition,  a pilot study found that the exercise 
consultation  improved  short-term  (4  weeks)  adherence  to  physical  activity  after 
completion of a phase III exercise programme.
178 
The  research  in  this  thesis  evaluated  the  effect  of  an  exercise  consultation  on 
maintenance of physical  activity  measured subjectively by  self-report and  objectively 
by accelerometry for 12 months after completion of phase III. This study demonstrated 
that exercise  consultation  was  more  effective  than  standard  exercise  information  in 
maintaining self-reported physical activity for 12 months after completion of a phase III 
exercise  programme.  However,  the  objective  measure  of  physical  activity  did  not 
support  these  findings.  This  study  found  that  the  change  in  CSA  accelerometer 
readings over the 12-month study period did  not parallel the decrease in self-reported 
physical activity observed in the control group.  Instead, the CSA accelerometer results 
190 suggested that physical activity was  maintained over the study period  in  both  groups. 
Reasons  for the  lack  of agreement  between  these  outcomes  have  been  discussed 
previously. 
This  study  also  determined  the  effect  of the  exercise  consultation  on  measures  of 
cardiorespiratory fitness.  Small significant decreases in  peak V02 from  baseline to  12 
months  were  observed  in  both  groups.  Thus,  the  exercise  consultation  was  not 
effective  in  maintaining  aerobic fitness  for  12  months  after  completion  of  phase  III. 
Reasons  for the  decline  in  peak  V02  and  the  discrepancy  between  the  results  for 
physical activity and fitness  in  the experimental group are discussed.  In  contrast,  the 
study found an improvement in the lactate threshold, which  is  an  index of submaximal 
endurance  capacity,  in  the  experimental  group compared  to  the  control  group from 
baseline to follow-up. 
The effect of this intervention on  processes of exercise behaviour change,  blood lipids 
and  psychological  function  was  also  assessed.  Results  revealed  that  the  exercise 
consultation  compared to  standard  exercise  information  had  no  significant effect on 
processes  of exercise  behaviour  change,  lipid  profile  and  psychological  function. 
However, these variables were normal at baseline, as patients had recently completed 
a phase III cardiac rehabilitation programme. 
Finally,  we expected to  find greater differences in  the study outcomes between the 
groups.  However physical activity and  other variables did  not decline  in  the  control 
group  as  much  as  was  anticipated.  It  is  possible  that  assessing  physical  activity, 
cardiorespiratory fitness and other variables at regular intervals in  experimental and 
control patients could have encouraged them to remain active over the study period. 
Without  this  level  of monitoring,  a  greater  decline  in  physical  activity  may  have 
occurred in  the control group over the study period.  In  fact,  several  patients  in  the 
control group stated that they were grateful for being invited to take part in the study 
as it "encouraged them to keep active after they finished phase III". 
Study Limitations 
The limitations of the instruments used to  measure the study outcomes have  already 
been  discussed.  The main  limitation of this  research  is  related to time  constraints  of 
doctorate  study.  The  exercise  consultation  was  evaluated  over  a  12-month  period. 
191 However,  the  effect of the  exercise  consultation  on  maintenance  of physical  activity 
and  other  outcomes  should  be  studied  over  a  longer follow-up  period.  In  addition, 
several variables were also  maintained over the  12-month study period  in  the  control 
group,  which  explains  the  lack  of  effect  of  the  exercise  consultation  on  some 
outcomes.  However,  a  more  substantial  deterioration  in  these  variables  may  have 
been observed in the control group over a longer time period. 
Seventy patients were  entered  into  the trial  and  only a small  number of participants 
dropped out over the follow-up period. The  primary aim of the study was to determine 
the  effect  of the  exercise  consultation  on  maintenance  of physical  activity.  Several 
physical  activity  counselling  trials  in  the  general  population  based  their sample  size 
calculation  on  physical  activity  measured  by  the  Stanford  Seven-Day  Reca11.171-173 
These  trials  reported  that  more  than  100  individuals  were  required  to  detect 
differences between groups.  However,  it would  not have been  possible to  recruit this 
number of patients  in  the present study.  Thus,  the  power calculation  was  based  on 
physical activity measured by accelerometry.  No  studies have evaluated the effect of 
exercise-based  cardiac  rehabilitation  on  physical  activity  measured  using 
accelerometers.  However,  a  pilot  study  compared  the  effect  of  an  exercise 
consultation with standard care on physical activity measured using accelerometry in a 
group of people with type II diabetes.
263 Thus, the difference between the experimental 
and control group for the mean change accelerometer readings was used to calculate 
the sample size. This calculation found than 50 patients in total were required to detect 
a  22%  difference  in  accelerometer  counts  between  the  experimental  and  control 
groups.  However, the  actual difference between the groups for the change  in  activity 
counts from  baseline to  12  months was  10%  (392946/4025432).  Therefore,  this  trial 
was  not  powered  to  detect small  differences  between  groups.  We  expected  to  find 
greater  differences  between  the  groups  in  physical  activity  outcomes,  however 
physical activity did not decline in the control group as  much  as was anticipated,  thus 
the trial was underpowered to detect a difference. In addition, the study did find several 
trends for differences  in  quality of life  and  processes of behaviour change favouring 
the  experimental  group.  However,  the  sample  size  may  have  been  too  small  to 
determine if these differences were  significant and  clinically  meaningful.  However,  if 
small changes in these outcomes are clinically important then future studies should be 
powered to detect these changes. 
192 The small number of women in each group means that it was not possible to compare 
maintenance of physical activity in  men  and women  after completion  of phase  III.  No 
studies have investigated maintenance of physical activity in men and women following 
cardiac  rehabilitation  to  gain  information  on  gender  differences  in  this  health 
behaviour. 
The same researcher delivered the exercise consultation and measured the outcomes 
of this study, thus the researcher was  not blinded to group allocation when conducting 
the outcome measures.  Therefore, the measurements could  have  been  influenced  in 
favour  of  the  experimental  group.  However,  standardised  procedures  for  data 
collection were followed in an  attempt to control for this limitation. For example, during 
the  exercise  tests  the  Cardiac  Clinical  Scientific  Officer,  who  was  blinded  to  group 
allocation,  was  responsible  for  encouraging  the  participants.  In  addition, 
questionnaires  measuring  psychological  function  and  the  processes  of  behaviour 
change were self-administered. Although the  researcher administered the  Seven-Day 
Physical Activity Recall,  a standardised  interview process
222  was  followed  to  limit the 
interviewer's bias. 
Implementing the Exercise Consultation 
The  results  of this  study  demonstrate  that  the  exercise  consultation  may  be  an 
effective  intervention for maintaining  physical  activity  after  completion  of phase  III 
hospital-based exercise  programmes.  Presently,  patients  completing  phase  III  can 
attend  phase  IV  maintenance  exercise  programmes  in  the  community.  However, 
these exercise  opportunities  are not  available  in  all  areas.  Furthermore,  it  is  likely 
that a minority of patients will  attend  these  phase  IV  programmes,  due  to  barriers 
associated with supervised exercise training including transportation problems,  high 
costs,  limited access,  work and  domestic conflicts.  Thus,  the  exercise consultation 
may  provide  an  alternative  to  supervised  exercise  in  phase  IV.  Furthermore,  the 
intervention could  be  used to facilitate patients' progression from  phase  III  hospital-
based  exercise  programmes  to  community-based  programmes  or  independent 
exercise.  Thus,  the  exercise  consultation  could  be  routinely  provided  to  cardiac 
patients on completion of phase III  to  encourage maintenance of physical activity in 
phase IV. 
Is  it feasible to incorporate the exercise consultation into current cardiac rehabilitation 
193 services?  Firstly,  the  consultations  are  relatively  inexpensive  in  terms  of  t'  Ime, 
resources and  personnel.  Exercise consultations last approximately 20 to  30  minutes, 
and the support phone calls are five to 10 minutes in duration. In addition, it is possible 
that  patients  could  record  their  physical  activity  habits,  and  the  pros  and  cons  for 
physical  activity  before  attending  the  intervention  to  reduce  time  during  the 
consultation.  Resources  required  to  conduct  the  exercise  consultation  include  the 
materials (e.g.  goals sheet, and guidelines for physical activity) and a quiet room.  The 
exercise consultation could  be  delivered  by  a number of professionals.  In  the  United 
Kingdom,  physiotherapists  playa central  role  in  the  exercise  component  of cardiac 
rehabilitation.  Physiotherapists  have  an  ideal  opportunity  to  deliver  the  exercise 
consultation to patients entering phase IV as they have good insight into the patient's 
progress from phases I to III  cardiac rehabilitation with regards to  physical activity and 
could incorporate the intervention into existing programmes. The approximate cost of a 
Senior 1 physiotherapist delivering a 30 minute exercise consultation is £6 to £7.17 per 
patient.  In  addition,  BACR  trained  phase  IV  exercise  staff could  use  the  exercise 
consultation to  provide support to  patients who  are  having  difficulty remaining  active. 
The approximate  cost  of a BACR trained  phase  IV instructor delivering  a 30  minute 
exercise  consultation  is  £4.40  to  £4.94  per patient.  In  order to  train  in  the  exercise 
consultation,  individuals  need to  understand the  behaviour change theories on  which 
the consultation is  based,  and the counselling skills and  strategies required to  deliver 
the intervention. This could be achieved by appropriate in-service training.  In  addition, 
individuals would need to practice the consultation process. 
Currently,  the exercise  consultation  has  been  included  in  two  courses for individuals 
involved  in  cardiac  rehabilitation  services.  The  MSc  Module  in  Rehabilitation  in 
Cardiology  at  Glasgow  Caledonian  University  is  aimed  at  specialist  nurses  and 
physiotherapists  delivering  phase  III  cardiac  rehabilitation  programmes.  Training  for 
these  individuals  involves  a  three-hour  lecture  on  theories  of  exercise  behaviour 
change, and counselling skills and strategies required to deliver the intervention. There 
is  also  a  four-hour  practical  session,  where  the  individuals  have  the  opportunity  to 
practice the exercise consultation  process.  The  exercise  consultation  has  also  been 
incorporated into  the  British Association  of Cardiac  Rehabilitation  (BACR)  Phase  IV 
Training.  This  course  trains  exercise  instructors  to  deliver  phase  IV  maintenance 
exercise programmes in the community for cardiac rehabilitation  patients.  Due to time 
constraints, this course involves a two-hour lecture on theories of behaviour change for 
194 exercise and the exercise consultation process. 
Future Research 
Reviewing  the  literature  on  exercise-based  cardiac  rehabilitation  for  this  thesis  has 
identified  several  important  areas  for  further  research.  Numerous  studies  have 
assessed  physical  activity  participation  for  up  to  11  years  after completion  of formal 
rehabilitation programmes. However, few trials have used a validated questionnaire or 
an  objective method to measure physical activity.  In  addition,  many trials reported the 
proportion  of  patients  that  "exercised  regularly",  however  the  definition  of  regular 
exercise  varied  greatly  and  was  not  based  on  current  physical  activity 
recommendations.  Only  one  study  used  the  current  physical  activity  guidelines  to 
determine  the  proportion  of  patients  who  remained  regularly  active  after  exercise 
rehabilitation.96 Thus,  more studies are required to  accurately assess  physical activity 
levels  after  completion  of  exercise  rehabilitation  and  determine  the  proportion  of 
patients that continue to meet current physical activity guidelines in phase IV. 
Cardiac  rehabilitation  guidelines
2
;5  recommend  that  all  centres  should  audit  their 
cardiac rehabilitation  programmes to  ensure  that  standards  for cardiac  rehabilitation 
set  out  by  the  Clinical  Standards  Board  for  Scotland  and  the  National  Service 
Framework for Coronary Heart Disease for England and Wales are being  met.  These 
guidelines have recommended a minimum common data set that should  be collected 
by all  centres, which could  be  accessed nationally for audit and  evaluation of cardiac 
rehabilitation.  Physical  activity  outcomes  should  be  included  in  the  data  set,  which 
could then be  used to determine the proportion of patients that meet current physical 
activity guidelines in each phase of cardiac rehabilitation. 
Many  studies  have  examined  the  factors  influencing  uptake  and  adherence  to 
supervised  cardiac  rehabilitation  exercise  programmes.  Whereas,  the  factors  that 
contribute to  maintenance of physical activity following programme completion have 
not  been  explored.  Understanding  these  factors  is  an  important  step  in  the 
development  of  interventions  to  improve  maintenance  of  physical  activity  and 
exercise.  Further research  in  this  area  is  warranted.  In  addition,  few  studies  have 
examined the effect of interventions to encourage long-term maintenance of physical 
activity following completion of phase III  cardiac rehabilitation exercise programmes. 
195 Thus,  research is  needed to test different forms  of intervention  aimed  at  improving 
long-term compliance to physical activity. 
There are numerous phase IV maintenance exercise programmes available in the UK. 
However, the efficacy of these phase IV programmes to  maintain the benefits gained 
during  phase  III  exercise training,  including  exercise capacity and  increased  physical 
activity,  has  not  been  assessed.  In  addition,  there  is  no  data  available  on  the 
proportion  of patients  who  participate  in  these  phase  IV  maintenance  programmes 
after completing phase III. 
The  modest success  of the  exercise  consultation  in  the  present  study  provides  the 
basis for further research with  this intervention.  Firstly,  can  the  exercise  consultation 
maintain physical activity for more than  12 months? Are repeat exercise consultations 
required?  Could the exercise consultation  be  delivered  successfully in  a group or by 
post,  telephone or World Wide Web? The possibility of delivering this  intervention to 
patients in  a group setting at the end  of phase III  is a good area of further study.  First 
of all,  delivering this intervention to groups of patients as  an  alternative to  one to  one 
consultations would be more feasible for cardiac rehabilitation services in terms of time 
and staff resources.  In addition, conducting an exercise consultation in a group setting 
would provide patients with the opportunity to  discuss certain  issues with  each  other, 
such as potential barriers to  maintaining activity after phase III,  problem solving these 
barriers and identifying high risk situations for relapse.  In addition, group discussion on 
exercise  opportunities  in  the  community,  such  as  phase  IV classes,  may  encourage 
patients to attend these programmes together.  In general,  patients routinely receive a 
discharge interview at  the end  of phase  III,  which  provides cardiac rehabilitation  staff 
with  an  ideal  opportunity to  review the patients'  goaJs  for remaining  active that were 
devised  during  the  group  consultations.  Physical  activity  counselling  trials  in  the 
general  population  and  other clinical  groups have  successfully delivered this  type  of 
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The exercise consultation may also be  useful at the beginning of phase  III to improve 
adherence  to  the  supervised  exercise  programme  and  encourage  patients  to 
participate  in  physical  activity  outwith  the  exercise  classes.  A  pilot  study  found  that 
web-based and  one to one exercise consultations were equally effective in increasing 
physical  activity  measured  by  the  7DPAR  in  a  group  of  patients  participating  in  a 
196 phase III  supervised exercise programme. Are there any other strategies that could be 
included in the exercise consultation to increase its efficacy? Recently, physical activity 
intervention studies and weight management programmes have found  pedometers to 
be  effective  in  promoting  physical  activity.209  Thus,  pedometers  may be  a promising 
strategy to encourage maintenance of physical  activity in  phase IV.  Results from  this 
trial showed that although physical activity was  maintained in  the experimental group, 
exercise capacity declined. Thus, should the aim of the exercise consultation in phase 
IV be maintenance of physical activity or cardiorespiratory fitness? 
197 References 
1.  US Department for Health and Human Services and Agency for Health Care 
Policy  and  Research.  Cardiac  Rehabilitation.  Clinical  Practice  Guideline 
Number 17.  1995.  Rockville,  The Agency.  AHCPR  Publication  Number 96-
0672. 
2.  Scottish Intercollegiate Guidelines Network (SIGN).  Cardiac Rehabilitation: A 
national clinical guideline. (SIGN publication no.  57). 2002. Edinburgh, SIGN. 
3.  Coats A,  McGee  H,  Stokes  H,  Thompson  D.  British  Association  of Cardiac 
Rehabilitation  (BACR):  Guidelines  for  Cardiac  Rehabilitation.  Oxford: 
Blackwell Science Ltd,  1995. 
4.  Campbell  NC,  Grimshaw  JM,  Ritchie  LD,  Rawles  JM.  Outpatient  cardiac 
rehabilitation:  are the potential benefits being  realised? Journal of the Royal 
College of  Physicians 1996;30:544-9. 
5.  Scottish Needs Assessment Programme.  Provision of Cardiac Rehabilitation 
Services  in  Scotland  - Needs  assessment  and  guidelines  for  decision-
makers.  2001. Glasgow, Public Health Institute of Scotland. 
6.  American  College  of  Sports  Medicine.  The  recommended  quality  and 
quantity  of exercise  for  developing  and  maintaining  cardiorespiratory  and 
muscular fitness in healthy adults. Med Sci Sport Exer 1990;22:265-74. 
7.  American  College  of  Sports  Medicine.  The  recommended  quantity  and 
quality  of  exercise  for  developing  and  maintaining  cardiorespiratory  and 
muscular  fitness,  and  flexibility  in  healthy  adults.  Med  Sci  Sport  Exer 
1998;30:975-91. 
8.  Pate  RR,  Pratt  M,  Blair  SN,  Haskell  WL,  Macera  CA,  Bouchard  C  et a/. 
Physical  activity snd  public health.  A recommendation  from  the  Centres for 
Disease  Control  and  Prevention  and  the  American  College  of  Sports 
Medicine. JAMA 1995;273:402-7. 
9.  Balady GJ, Ades PA, Comoss P,  Limacher M,  Pina IL, Southard D et al. Core 
components  of  cardiac  rehabilitation/secondary  prevention  programs:  A 
198 statement for healthcare professionals from the American Heart Association 
and  the  American  Association  of  Cardiovascular  and  Pulmonary 
Rehabilitation. Circulation 2000;102: 1  069-73. 
10.  Campbell NC,  Grimshaw JM,  Rawles JM,  Ritchie  LD.  Cardiac Rehabilitation 
in  Scotland:  is  current  provision  satisfactory?  Journal  of  Public  Health 
Medicine 1996;18:478-80. 
11.  NHS  Scotland.  Coronary Heart Disease/Stroke  Task Force  Report.  2001. 
Edinburgh, Scottish Executive. 
12.  Bethell,  H.  J.  N.,  Turner,  S.  C.,  Evans,  J.  A.,  and  Rose,  L.  Cardiac 
rehabilitation in the United Kingdom:  How complete is the proviSion? Journal 
of  Cardiopulmonary Rehabilitation 2001 ;21 :111-115. 
13.  Thompson  DR,  Bowman  GS,  Kitson  AL,  DeBono  DP,  Hopkins A.  Cardiac 
rehabilitation services in  England and Wales: a national survey.  International 
Journal of  Cardiology 1997;59:299-304. 
14.  Melville,  M.  R.,  Packham,  C.,  Brown,  N.,  Weston,  C.,  and  Gray,  D.  cardiac 
rehabilitation:  socially deprived patients are  less likely to attend but patients 
ineligible for thrombolysis are less likely to  be  invited.  Hearl 1999;82(3):373-
377. 
15.  Bittner,  V.,  Sanderson,  B.,  Breland,  J,  and  Green,  D.  Referral  patterns to  a 
university-based  cardaic  rehabilitation  program.  American  Journal  of 
Cardiology 1999;83(2):252-255. 
16.  Glaser,  T.  C.,  Blum,  M.,  Schmeizl,  R.,  Prigerson,  H.  G.,  Zaret,  B.,  and 
Mazure,  C.  M.  Gender  differences  in  referral  to  cardiac  rehabilitation 
programs after revascularization.  Journal of Cardiopulmonary Rehabilitation 
2001 ;21 :24-30. 
17.  Harlan WR, Sandler SA,  Lee KL,  Lam  LC,  Mark DB.  Importance of baseline 
functional  and  socioeconomic  factors  for  participation  In  cardiac 
rehabilitation. American Journal of Cardiology 1995;76:36-9. 
18.  Pell  JP,.Morrison  CE.  Factors  associated  with  low  attendance  at  cardiac 
199 rehabilitation. British Journal of  Cardiology 1998;5: 152-5. 
19.  Oldridge  NB,.Spencer J.  Exercise  habits  and  perceptions  before  and  after 
graduation or dropout from supervised cardaic exercise rehabilitation. Journal 
of  Cardiopulmonary Rehabilitation 1985;5:313-9. 
20.  Fontana AF,  Kerns  RD,  Rosenberg  RL,  Marcus  JL,  Colonese  KL.  Exercise 
training  for  cardiac  patients:  Adherence,  fitness  and  benefits.  Journal  of 
Cardiopulmonary Rehabilitation 1986;6:4-15. 
21.  McGee HM,.Horgan JH.  Cardiac rehabilitation programmes:  are women less 
likely to attend? British Medical Journal 1992;305:283-4. 
22.  Cooper A,  Lloyd  G,  Weinman  J,  Jackson  G.  Why  patients  do  not  attend 
cardiac  rehabilitation:  role  of  intentions  and  illness  beliefs.  Heart 
1999;82:234-6. 
23.  Ades  PA,  Waldmann  ML,  Polk  OM,  Coflesky  JT.  Referral  patterns  and 
exercise responses in the rehabilitation of female coronary patients aged >61 
years. American Journal of  Cardiology 1992;69:1422-5. 
24.  Pel!  JP,  Morrison  CE,  Blatchford  0,  Dargie  H.  Retrospective  study  of 
influence  of deprivation  on  uptake  of cardiac  rehabilitation.  British  Medical 
Journal 1996;313:267  -8. 
25.  Lieberman  L,  Meana  M,  Stewart  D.  Cardiac  Rehabilitation:  Gender 
differences  in  factors  influencing  participation.  Journal of Women's  Health 
1998;7:717-23. 
26.  Evenson,  K.  R.  and  Fleury,  J.  Barriers  to  outpatient  cardaic  rehabilitation 
participation  and  adherence.  Journal  of  Cardiopulmonary  Rehabilitation 
2000;20:241-246. 
27.  Blackburn,  G.  G.,  Foody,  J.  M.,  Sprecher,  D.  L.,  Park,  E.,  Hansen,  C.,  and 
Pashkow, F.  J.  Cardiac rehabilitation participation patterns in a large, tertiary 
care  centre:  Evidence  for  selection  bias.  Journal  of  Cardiopulmonary 
Rehabilitation 2000; 20: 189-195. 
200 28.  Jolliffe JA,  Rees K, Taylor RS,  Thomson D, Oldridge N, Ebrahim S.  Exercise-
based  rehabilitation  for  coronary  heart  disease  (Cochrane  Review). 
Cochrane Library 2000; 4:1-59. 
29.  Bland  M.  An  introduction  to  medical  statistics.  Oxford:  Oxford  University 
Press, 1995. 
30.  Oldridge NB,  Guyatt GH,  Fischer ME,  Rimm  AA.  Cardiac rehabilitation after 
myocardial  infarction:  Combined  experience  of  randomised  clinical  trials. 
JAMA 1988;260:945-50. 
31.  O'Conner  GT,  Buring  JE,  Yusuf  S,  Goldhaber  SZ,  Olmstead  EM, 
Paffenberger RS. An overview of randomised controlled trials of rehabilitation 
with exercise after myocardial infarction. Circulation 1989;80:234-44. 
32.  Denollet J,.Brutsaert DL.  Reducing emotional distress improves prognosis in 
coronary  heart  disease:  9-year  mortality  in  a  clinical  trial  of rehabilitation. 
Circulation 2001;104:2018-23. 
33.  NHS  Centre  for  Reviews  and  Dissemination.University  of  York.  Cardiac 
Rehabilitation. Effective Health Care 4(4).  1998. 
34.  Pollock ML,  Schmidt DH.  Heart Disease and  Rehabilitation.  Champaign,  IL: 
Human Kinetics, 1995. 
35.  DeBusk RF,  Houston N, Haskell WL, Fry M,  Parker M. Exercise training soon 
after myocardial infarction. American Journal of Cardiology 1979;44: 1226-9. 
36.  Bethell  HJN,.Mullee  MA.  A  controlled  trial  of  community  based  coronary 
rehabilitation. British Heart Journal 1990;64:370-5. 
37.  Old ridge  NB,  Guyatt G,  Jones  N,  Crowe  J,  Singer J,  Feeny  D.  Effects on 
quality  of  life  with  comprehensive  rehabilitation  after  acute  myocardial 
infarction. American Journal of  Cardiology 1991 ;67: 1  084-9. 
38.  Newton  M,  Mutrie  N,  McArthur JD.  The  effects  of  exercise  in  a  coronary 
rehabilitation programme. Scottish Medical Journal 1991 ;36:38-41. 
201 39. 
40. 
Bertie J,  King A,  Reed N,  Marshall AJ,  Ricketts C.  Benefits and weaknesses 
of  a  cardiac  rehabilitation  programme.  Journal  of the  Royal  College  of 
Physicians 1992;26:147-51. 
Haskell, W. L.,  Savin, W., Oldridge,  N.,  and  DeBusk,  R.  Factors influencing 
estimated  oxygen  uptake during  exercise testing  soom  after MI.  American 
Journal of  Cardiology 1982;50:299-304. 
41.  Miller N,  Haskell WL,  Berra  K,  DeBusk RF  . Home versus  group exercise 
training  for  increasing  functional  capacity  after  myocardial  infarction. 
Circulation 1984;70:645-9. 
42.  Lavie CJ,.Milani RV.  Effects of cardiac rehabilitation and exercise training on 
exercise capacity, coronary risk factors, behavioral characteristics and quality 
of life in women. American Journal of  Cardiology 1995;75:340-3. 
43.  Cannistra LB,  Balady GJ,  O'Malley CJ, Weiner DA,  Ryan T  J.  Comparison of 
the clinical profile and outcome of women and  men in  cardiac rehabilitation. 
American Journal of  Cardiology 1992;69: 1274-9. 
44.  O'Caliaghan  WG,  Teo  KK,  O'Riordan  J,  Webb  H,  Dolphin  T,  Horgan  J. 
Comparative  response  of  male  and  female  patients  with  coronary  artery 
disease to exercise rehabilitation. European Hearl Journal 1984;5:649-51. 
45.  Ades  PA,  Waldmann  ML,  McCann  WJ,  Weaver SO.  Predictors of cardiac 
rehabilitation  participation  in  older  coronary  patients.  Archives  of Internal 
Medicine 1992; 152: 1  033-5. 
46.  Lavie  CJ,  Milani  RV,  Littman  AB.  Benefits  of  cardiac  rehabilitation  and 
exercise training in  secondary coronary prevention in  the elderly.  Journal of 
the American College of  Cardiology 1993;22:678-83. 
47.  DeBusk RF, Miller NH, Superko R,  Dennis CA, Thomas RJ,  Henry L. A case-
management  system  for  coronary  risk  factor  modification  after  acute 
myocardial infarction. Annals of  Internal Medicine 1994;120:721-9. 
48.  Dugmore  LD,  Tipson  RJ,  Phillips  MH,  Flint  EJ,  Stentiford  NH,  Bone  MF. 
Changes in  cardiorespiratory fitness,  psychological wellbeing,  quality of life, 
202 and  vocational  status  following  a  12  month  cardiac  exercise  rehabilitation 
programme. Heart 1999; 81 :359-66. 
49.  Dressendorfer RH,  Franklin BA,  Cameron JL,  Trahan KJ,  Gordon S,  Timmis 
GC. Exercise training frequency in  early post-infarction cardiac rehabilitation: 
Influence on  aerobic conditioning.  Journal of Cardiopulmonary Rehabilitation 
1995;15:269-76. 
50.  Heldal  M,  Sire  S,  Dale  J.  Randomised  training  after myocardial  infarction: 
Short and long-term effects of exercise training after myocardial infarction in 
patients  on  beta-blocker  treatment.  A  randomised,  controlled  study. 
Scandinavian Cardiovascular Journal 2000;34:59-64. 
51.  Holmback AM,  Sawe U,  Fagher B.  Training after myocardial infarction:  Lack 
of  long-term  effects  on  physical  capacity  and  psychological  variables. 
Archives of  Physical and Medical Rehabilitation 1994;75:551-4. 
52.  Kallio  V;.Hamalainen  H.  Reduction  in  sudden  deaths  by  a  multifactorial 
intervention programme after acute myocardial infarction. Lancet 1979; 1  091-
1094. 
53.  Hamalainen H,  Luurila OJ, Kallio V,  Knuts LR, Arstila M,  Hakkila J.  Long-term 
reduction  in  sudden deaths after a multifactorial  intervention  programme in 
patients  with  myocardial  infarction:  10  year  results  of  a  controlled 
investigation. European Heart Journal 1989;10:55-62. 
54.  Roman 0, Gutierrez M,  Luksic I,  Chavez E , Camuzzi AL, Villalon E.  Cardiac 
rehabilitation  after  acute  myocardial  infarction:  9-year  controlled  follow-up 
study. Cardiology 1983;70:223-31. 
55.  Carson  P,  Phillips  R,  Lloyd  M,  Tucker H,  Neophtou  M,  Buch  NJ.  Exercise 
after myocardial infarction: a controlled trial.  Journal of the Royal College of 
PhYSicians 1982;  16: 147  -51. 
56.  Udell  E,. Fridlund  B.  Long-term  effects  of  a  comprehensive  rehabilitation 
programme after myocardial infarction. Scand J Caring Sci 1996; 1  0:67 -74. 
57.  Froelicher,  V.,  Jensen,  D.,  and Sullivan,  M.  A randomised  controlled trial  of 
203 58. 
the effects of exercise training after coronary artery bypass surgery. Archives 
of  Internal Medicine 1985;145:689-692. 
Wosornu 0, Bedford 0, Ballantyne O. A comparison of the effects of strength 
and  aerobic exercise training  on  exercise  capacity  and  lipids  after coronary 
artery bupass surgery. European Heart Journal 1996;17:854-63. 
59.  Oldenburg B,  Martin A,  Greenwood J,  Bernstein  L,  Allan  R.  A controlled trial 
of behavioral  and  educational  intervention  following  coronary  artery  bypass 
surgery. Journal of  Cardiopulmonary Rehabilitation 2001 ;15:39-46. 
60.  Willoughby, O.  S.,  Roozen,  M.,  and Barnes,  R.  Effects of aerobic exercise on 
the functional  capacity  and  cardiovascular efficiency  of elderly  post  CABG 
patients. Journal of  Aging and Physical Activity 1997;5:87-97. 
61.  Belardinelli  R,  Paolini  I,  Cianci  G,  Piva  R,  Georgiou  0, Purcaro A.  Exercise 
training  intervention  after coronary  angioplasty:  The  ETICA trial.  Journal of 
the American College of  Cardiology 2001 ;37: 1891-900. 
62.  Lisspers,  J.,  Sundin,  0.,  Hofman-Bang,  C.,  Nordlander,  R.,  Nygren,  A., 
Ryden,  L.,  and  Ohman,  A.  Behavioural  effects  of  a  comprehensive, 
multifactorial  program  for  lifestyle  change  after  percutaneous  transluminal 
coronary angioplasty: A prospective, randomized, controlled study. Journal of 
Psychosomatic Research 1999;46(2):143-154. 
63.  Hofman-Bang C,  Lisspers J,  Norlander R,  Nygren A,  Sundin  0, Ohman A. 
Two-year results of a controlled study of residential rehabilitation for patients 
treated  with  percutaneous  transluminal  coronary  angioplasty.  European 
Hearl Journal 1999;  1999:  1465-74. 
64.  Engblom  E,  Ronnemaa T,  Hamalainen  H,  Kallio V,  Vanttinen  E,  Knuts  LR. 
Coronary heart disease risk factors before and  after bypass surgery:  results 
of a  controlled  trial  on  mulitfactorial  rehabilitation.  European  Heart Journal 
1992;13:232-7. 
65.  Naughton J.  Role of physical activity as  a secondary intervention for healed 
myocardial infarction. American Journal of Cardiology 1985;55:210-60. 
204 66. 
67. 
Stern,  M.  J.,  Gorman, P. A., and Kaslow,  L.  The group counselling v exercise 
therapy  study:  A  controlled  intervention  with  subjects  following  myocardial 
infarction. Archives of  Internal Medicine 1983;143:1719-1725. 
Stahle A,  Mattsson E,  Ryden  L,  Unden AL,  Nordlander R.  Improved physical 
fitness  and  quality  of life  following  training  of elderly  patients  after  acute 
coronary events. European Heart Journal 1999;20:1475-84. 
68.  Stahle, A.,  Nordlander,  R.,  Ryden,  L.,  and Mattsson,  E.  Effects of organized 
aerobic group training in  elderly patients discharged after an  acute coronary 
syndrome:  A  randomized  controlled  study.  Scandinavian  Journal  of 
Rehabilitation Medicine 1999;31: 1  01-1 07. 
69.  Ades  PA,  Maloney  A,  Savage  P,  Carhart  RL  .  Determinants  of phYSical 
functioning in  coronary patients:  Response to  cardiac rehabilitation. Archives 
of  Internal Medicine 1999;159:2357-60. 
70.  Bethell  HJN.  Exercise  in  Rehabilitation.  British  Journal of Sports  Medicine 
1999;33:79-86. 
71.  Blumenthal  JA,  Califf  R,  Williams  S,  Hindman  M.  Continuing  medical 
education  cardiac  rehabilitation:  A  new  frontier  for  behavioral  medicine. 
Journal of  Cardiopulmonary Rehabilitation 1983;3:637-56. 
72.  Finlayson  J.  The  role  of  exercise  in  rehabilitation  after  uncomplicated 
myocardial infarction. PhYSiotherapy 1997;83 :517-24. 
73.  Ades,  P.  A.  and Coello, C.  E.  Effects of exercise and cardiac rehabilitation on 
cardiovascular outcomes.  Medical Clinics of North America 2000;84(1): 251-
265  .. 
74.  Ades,  P.  A.,  Waldmann,  M.  L.,  Meyer,  W.  L.,  Brown,  K.,  Poehlman,  E.  T., 
and  Pendlebury,  W.  W.  Skeletal  muscle and  cardiovascular adaptations  to 
exercise conditioning in older coronary patients. Circulation 1996;94:323-330. 
75.  Goodman  JM,  Pallandi  DV,  Reading  JR,  Plyley  MJ,  Liu  PP,  Kavanagh  T 
Central  and  peripheral  adaptations  after  12  weeks  of exercise  training  in 
post-coronary  artery  bypass  surgery  patients.  Journal  of Cardiopulmonary 
205 76. 
Rehabilitation 1999;  19: 144-50. 
Cottin, Y., Walker, P.,  Rouhier-Marcer, I.,  Cohen, M.,  Louis,  P.,  and Didier, J. 
P.  Relationship between increased peak oxygen uptake and modifications in 
skeletal  muscle  metabolism  following  rehabilitation  after  myocardial 
infarction. Journal of Cardiopulmonary Rehabilitation 1996;16: 169-174. 
77.  Wright OJ, Williams SG, Riley R,  Marshall P,  Tan LB.  Is early, low level, short 
term exercise cardiac rehabilitation following coronary artery bypass surgery . 
beneficial? A randomised controlled trial. Heart 2002;88:B3-4. 
78.  Horgan J,  Bethell HJN, Carson P,  Davidson C,  julian 0, Mayou RA.  Working 
party report on cardiac rehabilitation. British Heart Jouma/1992;67:412-B. 
79.  Higgins,  H.,  Hayes,  R.  L.,  and  McKenna,  K.  T.  Rehabilitation  outcomes 
following  percutaneous coronary interventions (PCI).  Patient  Education and 
Counseling 2001 :43:219-230. 
80.  Ades,  P.  A.,  Pashkow,  F.  J.,  Fletcher,  G.  F.,  Pina,  I.  L.,  Zohman,  L.,  and 
Nestor,  J.  R.  A  controlled  trial  of cardiac rehabilitation  in  the  home  setting 
using  electrocardiographic  and  voice  transtelephonic  monitoring.  American 
Heart Journal 2000;139(3):543-548. 
81.  Lavie,  C.  J.  and  Milani,  R.  V.  Effects of cardiac rehabilitation  and  exercise 
training on peak aerobic capacity and work efficiency in  obese patients with 
coronary artery disease. American Journal of Cardiology 1999;  83(  10): 1477-
1480. 
82.  Joughin  HM,  Oigenio  AG,  Daly  L,  Kgare  E.  Physiological  benefits  of  a 
prolonged moderate intensity endurance training programme in  patients with 
coronary artery disease. South African Medical Journa/1999;89:545-50. 
83.  Wasserman K,  Hansen  JE,  Sue  DY,  Whipp BJ  , Casaburi  R.  Principles  of 
exercise testing and interpretation. Williams and Wilkins, 1994. 
84.  Hambrecht R,  Niebauer J,  Marburger C,  Grunze  M,  Kalberer 8,  Hauer K. 
Various intensities of leisure-time  physical  activity  in  patients with  coronary 
artery  disease:  Effects  on  cardiorespiratory  fitness  and  progression  of 
206 coronary  atherosclerotic  lesions.  Journal  of  the  American  College  of 
Cardiology 1993;22:468-77. 
85.  Hedback  EL,  Perk  J,  Engall  J,  Areskog  N.  Cardiac  rehabilitation  after 
coronary  artery  bypass  grafting:  Effects  on  exercise  performance  and  risk 
factors. Archives of  Physical and Medical Rehabilitation 1990; 71: 1  069-73. 
86.  Schuler G,  Hambrecht  R,  Schilierf  G,  Grunze  M,  Methfessel  S,  Hauer  K. 
Myocardial perfusion and regression of coronary artery disease in patients on 
a  regimen  of intensive  physical  exercise  and  low  fat  diet.  Journal  of the 
American College of  Cardiology 1992; 19:34-42. 
87.  Kinsey MG,  Fletcher BJ,  Rice  CR,  Watson  PH,  Fletcher GF.  Coronary  risk 
factor modification followed by home-monitored exercise in  coronary bypass 
surgery  patients:  A  four  year  follow-up  study.  Journal of Cardiopulmonary 
Rehabilitation 1989;9:207-12. 
88.  Heath GW, Maloney PM,  Fure CWo  Group exercise versus home exercise in 
coronary  artery  bypass  graft  patients:  Effect  on  physical  activity  habits. 
Journal of  Cardiopulmonary Rehabilitation 1987;7: 190-5. 
89.  Morrin,  L.,  Black,  S.,  and  Reid,  R.  Impact  of  duration  in  a  cardiac 
rehabilitation program on coronary risk profile and health related quality of life 
outcomes. Journal of  Cardiopulmonary Rehabilitation 2000; 20: 115-121 . 
90.  Engblom  E,  Hietanen  EK,  Hamalainen  H,  Kallio  V,  Inberg  M,  Knuts  LR. 
Exercise  habits  and  physical  performance  during  comprehensive 
rehabilitation  after coronary artery bypass  surgery.  European Heart Journal 
1992;13: 1  053-9. 
91.  Bethell HJN, Turner SC,  Mullee MA.  Cardiac rehabilitation in the community: 
11  year follow-up after a randomized controlled trial. Heart 1999;3: 188. 
92.  Carlsson  R,  Lindberg  G,  Westin  L,  Israelsson  B.  Influence  of  coronary 
nursing management follow up  on  lifestyle after acute myocardial infarction. 
Heart 1997;77:256-9. 
93.  Haskell  WL,  Alderman  EL,  Fair  JM,  Maron  OJ,  Mackey  SF,  Superko  R. 
207 Effects of intensive multiple risk factor reduction  on  coronary  athersclerosis 
and clinical cardiac events in  men  and women with  coronary artery disease: 
The  Stanford  Coronary  Risk  Intervention  Project  (SCRIP).  Circulation 
1994;89:975-90. 
94.  Prosser G,  Carson  P,  Phillips  R.  Exercise after myocardial infarction:  Long-
term rehabilitation effects. Journal of  Psychosomatic Research 1985;29:535-
40. 
95.  Vidmar PM,.Rubinson L.  The relationship between self-efficacy and exercise 
compliance  in  a  cardiac  population.  Journal  of  Cardiopulmonary 
Rehabilitation 1994;14:246-54. 
96.  Bock,  B.  C.,  Albrecht,  A.,  Traficante,  R.  M.,  Clark,  M.  M.,  Pinto,  B.  M.,  and 
Tilkemeier,  P.  Predictors of exercise  adherence  following  participation  in  a 
cardiac  rehabilitation  program.  International Journal of Behavioral Medicine 
1997;4(1 ):60-75. 
97.  Perk J,  Hedback B,  Engvall J.  Effects of cardiac rehabilitation after coronary 
artery bypass grafting on readmissions,  return to work,  and  physical fitness. 
Scand J Soc Med 1990;18:45-51. 
98.  BenAri E,  Rothbaun DA,  Linnemeier TA,  Landin  R,  Tavel  R,  Steinmetz EF  . 
Return to work after successful coronary angioplasty: Comparison between a 
comprehensive  rehabilitation  program  and  patients  receiving  usual  care. 
Journal of  Cardiopulmonary Rehabilitation  1992;12:20-4. 
99.  Carlson  J,  Johnson  J,  Franklin  SA,  Vanderlaan  RL.  Program  participation, 
exercise  adherence,  cardiovascular  outcomes,  and  program  cost  of 
traditional  versus  modified  cardiac  rehabilitation.  American  Journal  of 
Cardiology 2000;86: 17-23. 
100.  Frasure-Smith N,  Lesperance F,  Talajic M.  Depression following  myocardial 
infarction: Impact on 6-month survival. JAMA 1993; 270: 1819-25. 
101.  Frasure-Smith  N,  Lesperance  F,  Talajic  M.  Depression  and  18-month 
prognosis after myocardial infarction.  Circulation 1995;91 :999-1 005. 
208 102. 
103. 
Mayou  RA,  Gill  D,  Thompson  DR,  Day  A,  Hicks  N,  Volmink  J.  Depression 
and  anxiety  as  predictors  of  outcome  after  myocardial  infarction. 
Psychosomatic Medicine 2000;62:212-9. 
Glazer,  K.  M.,  Emery,  C.  F.,  Frid,  D.  J.,  and  Banyasz,  R.  E.  Psychological 
predictors  of  adherence  and  outcomes  among  patients  in  cardiac 
rehabilitation. Journal of Cardiopulmonary Rehabilitation 2002;22:40-46. 
104.  Turner,  S.  C.,  Bethell,  H.  J.  N.,  Evans,  J.  A.,  Goddard,  J.  R.,  and Mullee,  M. 
A.  Patient characteristics  and  outcomes  of cardiac rehabilitation.  Journal of 
Cardiopulmonary Rehabilitation 2002;22:253-260. 
105.  Creed F.  The importance of depression following myocardial infarction. Heart 
1999;82:406-7. 
106.  Lesperance F,  Frasure-Smith N, Talajic M. Major depression before and after 
myocardial infarction: Its nature and consequences. Psychosomatic Medicine 
1996;58:'99-110. 
107.  Engblom E,  Korpilahti K,  Hamalainen H,  Ronnemaa T,  Puukka  P.  Quality of 
life  and  return  to  work 5 years  after coronary  artery  bypass  surgery:  Long-
term  results  of  cardiaac  rehabilitation.  Journal  of  Cardiopulmonary 
Rehabilitation 1997;17:29-36. 
108.  Milani  RV,  Lavie  CJ,  Cassidy  MM.  Effects  of  cardiac  rehabilitation  and 
exercise training programmes on depression in  patients after major coronary 
events. American Heart Journal 1996;132:726-32. 
109.  Sandler  DA,  Sandler  G,  Benison  D,  Wheatcroft  S,  Leakey  P,  Blair  A. 
Psychological  and  physical  benefits  of  an  exercise-based  cardiac 
rehabilitation  programme for patients  recovering  from  a first  MI.  The  British 
Journal of  Cardiology 1999;6: 102-11. 
110.  Lewin  B,  Robertson  IH,  Cay EL,  Irving  JB,  Campbell  M.  Effects of self-help 
post-myocardial-infarction rehabilitation on psychological adjustment and use 
of health services. Lancet 1992;339: 1  036-40. 
111.  Dracup  K,  Moser  D,  Marsden  C,  Taylor  SE  ,  Guzy  PM.  Effects  of  a 
209 multidimensional  cardiopulmonary  rehabilitation  program  on  psychosocial 
function. American Journal of Cardiology 1991 ;68:31-4. 
112.  Oldridge NB,  Gottlieb M,  Guyatt G,  Jones N,  Streiner D,  Feeny D.  Predictors 
of  health-related  quality  of  life  with  cardiac  rehabilitation  after  acute 
myocardial infarction. Journal of Cardiopulmonary Rehabilitation 1998;18:95-
103. 
113.  Engebretson TO,  Clark MM,  Niaura RS,  Phillips T,  Albrecht A,  Tilkemeier P. 
Quality of life  and  anxiety  in  a phase  II  cardiac rehabilitation  program.  Med 
Sci Sport Exer 1999;31 :216-23. 
114.  Scottish Intercollegiate Guidelines Network (SIGN).  Secondary prevention of 
coronary heart disease following  myocardial infarction.  SIGN  publication  no. 
41. 2000. Edinburgh, SIGN. 
115.  Wood,  D.,  Durrington,  P.,  Mcinnes,  G.,  Poulter,  N.,  Rees,  A.,  and Wray,  R. 
Joint  British  recommendations  on  prevention  of coronary  heart  disease  in 
clinical practice. Heart 1998;80(2S): 1  S-29S. 
116.  Scandinavian  Simvastatin  Survival  Study  Group.  Randomised  trial  of 
cholesterol  lowering  in  4444  patients  with  coronary  heart  disease.  Lancet 
1994;344:1383-1389. 
117.  The  Long-Term  Intervention with  Pravastatin  in  Ischaemic Disease  (LIPID). 
Prevention  of Cardiovascular events  and  death  with  pravastatin  in  patients 
with  coronary  heart disease  and  a broad  range  of initial  cholesterol  levels. 
New England Journal of  Medicine 1998;339: 1349-1357. 
118.  Sacks,  F.  M.,  Pfeffer,  M.  A.,  and  Moye,  L.  A.  The  effect of pravastatin  on 
coronary  events  after  myocardial  infarction  in  patients  with  average 
cholesterols. New England Journal of  Medicine 1996;335: 1001-1009. 
119.  Heart  Protection  Study  Collaborative  Group.  MRC/BHF  Heart  Protection 
Study of cholesterol lowering with simvastatin in 20536 high risk individuals: a 
randomised placebo-controlled trial.  Lancet 2002;360: 7-22. 
120.  Smith,  S.  C.,  Blair,  S.  N.,  Bonow,  R.  0., Brass,  L.  M.,  Cerqueira,  M.  D.,  and 
210 Dracup,  K.  AHA/ACC  guidelines  for  preventing  heart  attack  and  death  in 
patients with atherosclerotic cardiovascular disease:  2001  update.  Journal of 
the American College of  Cardiology 2001 ;38:1581-1583. 
121.  Brochu,  M.,  Poehlman,  E.  T.,  Savage,  P.,  Munn,  K.  F.,  Ross,  S.,  and Ades, 
P.  A.  Modest effects of exercise training  alone  on  coronary risk factors  and 
body  composition  in  coronary  patients.  Journal  of  Cardiopulmonary 
Rehabilitation 2000;20: 180-188. 
122.  Warner,  J.  G.,  Brubaker,  P.  H.,  Zhu,  Y.,  Morgan,  T.  M.,  Ribisl,  P.  M.,  and 
Miller,  H.  S.  Long-term  (5-year)  changes  in  HDL  cholesterol  in  cardiac 
rehabilitation  patients:  Do  sex  differences  exist?  Circulation  1995;92:773-
777. 
123.  Fox,  K.  F.,  Nuttall,  M.,  Wood,  D. A.,  Wright, M., Arora,  B.,  and Dawson,  E.  A 
cardiac  prevention  and  rehabilitation  programme  for  all  patients  at  first 
presentation with coronary heart disease.  Heart 2001 ;85:533-538. 
124.  Johnston M,  Foulkes J,  Johnston 0, Pollard B,  Gudmundsdottir H.  Impact on 
patients  and  partners  of  inpatient  and  extended  cardiac  counseling  and 
rehabilitation: A controlled trial. Psychosomatic Medicine 1999;61 :225-33. 
125.  Oldridge NB,  Wicks JR,  Hanley C,  Sutton JR,  Jones NL.  Non-compliance in 
an  exercise rehabilitation  program  for men  who  have  suffered a myocardial 
infarction. CMA Journal 1978;118:361-4. 
126.  Carmody  TP,  Senner  JW,  Malinow  MR,  Matarazzo  JD.  Physical  exercise 
rehabilitation:  Long-term  dropout  rate  in  cardiac  patients.  Journal  of 
Behavioral Medicine 1980;3: 163-8. 
127.  Darn,  J.,  Naughton,  J,  Imamura,  0,  and  Trevisan,  M.  Correlates  of 
compliance  in  a randomised  exercise trial  in  myocardial  infarction  patients. 
Medicine and Science in Sport and Exercise 2001 ;33(7): 1  081-1 089. 
128.  Marcus  B,  Dubbert  P,  Forsyth  LH,  McKenzie  TL,  Stone  EJ,  Dunn  AL. 
Physical  activity  behavior  change:  issues  in  adoption  and  maintenance. 
Health Psychology 2000;19:32-41. 
211 129.  Oldridge  NB, .Streiner  DL.  The  Health  Belief  Model:  predicting  compliance 
and dropout in cardiac rehabilitation.  Med Sci Sport Exer 1990;22:678-83. 
130.  Oldridge  NB,  Jones  N,  Buck  CW,  Jones  NL  ,  Andrew  GM,  Parker  JO. 
Predictors  of dropout from  cardiac exercise  rehabilitation:  Ontario Exercise-
Heart Collaborative Study. American Journal of  Cardiology 1983;51 :70-4. 
131.  Blumenthal  JA,  Williams  S,  Wallace  AG,  Williams  RB,  Needles  TL. 
Physiological  and  psychological  variables  predict  compliance  to  prescribed 
exercise  therapy  in  patients  recovering  from  myocardial  infarction. 
Psychosomatic Medicine 1982;44:519-27. 
132.  Old ridge NB,  Ragowski B,  Gottlieb M.  Use of outpatient cardiac rehabilitation 
services:  Factors  associated  with  attendance.  Journal of Cardiopulmonary 
Rehabilitation 1992;12:25-31. 
133.  Halm  M,  Penque  S,  Doll  N,  Beahrs  M.  Women  and  cardiac  rehabilitation: 
referral  .  and  compliance  patterns.  Journal  of  Cardiovascular  Nursing 
1999; 13: 145-55. 
134.  Biddle SJH,.Nigg CR.  Theories of exercise behavior.  International Journal of 
Sports Psychology 2000;31 :290-304. 
135.  Becker MH,.Maiman  LA.  Sociobehavioural  determinants of compliance with 
health  care  and  medical care  recommendations.  Medical Care  1975;13:10-
24. 
136.  Biddle SJH,  Mutrie N.  The psychology of physical activity for health.  London: 
Routledge, 2001. 
137.  Fishbein  M,  Ajzen  I.  Belief,  Attitude,  intention  and  behavior.  New  York: 
Addison-Wesley, 1975. 
138.  Ajzen I,  Fishbein M.  Understanding attitudes and predicting social behaviour. 
NJ:  Prentice Hall, 1980. 
139.  Hausenblas  HA,  Carron  AV,  Mack  DE.  Application  of  the  theories  of 
reasoned  action  and  planned  behaviour  to  exercise  behaviour:  A  meta-
212 analysis. Journal of  Sport and Exercise Psychology 1997;19:36-51. 
140.  Blanchard CM,  Courneya KS,  Rodgers WM,  Fraser SN,  Murray TC,  Daub B. 
Is  the  theory  of planned  behaviour  a  useful  framework  for  understanding 
exercise  adherence  during  phase  II  cardiac  rehabilitation.  Journal  of 
Cardiopulmonary Rehabilitation 2003; 23:29-39. 
141.  Andrew GM,.Oldridge  NB.  Reasons  for dropout from  exercise  programs  in 
post-coronary patients. Med Sci Sport Exer 1981 ;  13: 164-8. 
142.  Robertson D,.Kelier C.  Relationships among health beliefs,  self-efficacy, and 
exercise adherence in patients with coronary artery disease. Heart and Lung 
1992;21 :56-63. 
143.  Tirrell  BE,.Hart  LK.  The  relationship  of  health  beliefs  and  knowledge  to 
exercise compliance in patients after coronary artery bypass.  Heart and Lung 
1980;9:487  -93. 
144.  Hellman  EA.  use  of the  stages  of  change  in  exercise  adherence  model 
among  older  adults  with  a  cardiac  diagnosis.  Journal of Cardiopulmonary 
Rehabilitation 1997;17:145-55. 
145.  Bandura  A.  Towards  a unifying  theory  of  behaviour  change.  Psychol Rev 
1977;84: 191-215. 
146.  Wankel  LM.  Decision  making  and  social  support  strategies  for  increasing 
exercise involvement. Journal of Cardiopulmonary Rehabilitation 1984;4: 124-
35. 
147.  King  AC,.Fredrickson  OS.  Low-cost  strategies  for  increasing  exercise 
behavior. Behavior Modification 1984;8:3-21. 
148.  Martin JE,  Dubbert P,  Katell AP.  Behavioural control of exercise in sedentary 
adults. Journal of  Consulting and Clinical Psych~/ogy  1984;52:795-811. 
149.  Nigg CR,  Courneya KS,  Estabrooks PA.  Maintaining attendance at a fitness 
center: An  application of the decisional balance sheet.  Behavioral Meidicine 
213 1997;23: 130-7. 
150.  Belisle M,  Roskies E,  Levesqie JM.  Improving adherence to physical activity. 
Health Psychology 1987; 52: 159-72. 
151.  Oldridge  NB,.Jones  NL.  Improving  patient  compliance  in  cardiac  exercise 
rehabilitation:  Effects  of written  agreement  and  self monitoring.  Journal of 
Cardiopulmonary Rehabilitation 1984;4:257-62. 
152.  Daltroy  LH.  Improving  cardiac  patient  adherence  to  exercise  regimens:  A 
clinical  trial  of health  education.  Journal of Cardiopulmonary Rehabilitation 
1985;5:40-9. 
153.  Marlatt GA,  Gordon  JR.  Relapse  prevention:  maintenance strategies  in  the 
treatment of addictive behaviours. New York: Guilford Press,  1985. 
154.  Simkin  LR,.Gross  AM.  Assessment  of  coping  with  high-risk  situations  for 
exercise relapse among healthy women. Health Psychology 1994;13:274-7. 
155.  King AC, Taylor CB,  Haskell WL,  DeBusk RF.  Strategies for increasing early 
adherence to and long-term maintenance of home-based exercise training in 
healthy  middle-aged  men  and  women.  American  Journal  of Cardiology 
1988;61 :628-32. 
156.  Marcus BH,.Simkin LR.  The transtheoretical model:  applications to  exercise 
behaviour. Med Sci Sport Exer 1994;26:1400-4. 
157.  Marcus BH,.Simkin LR.  The stages of exercise behaviour. Journal of Sports 
Medicine and Physical Fitness 1993;33:83-8. 
158.  Cardinal BJ.  The stages of exercise scale and  stages of exercise behaviour 
in  female  adults.  Journal  of  Sports  Medicine  and  Physical  Fitness 
1995;35:87-92. 
159.  Marshall,  S.  J.  and  Biddle,  S.  J.  H.  The transtheoretical model  of behaviour 
change:  A  meta-analysis  of applications  to  physical  activity  and  exercise. 
Annals of  Behavioral Medicine 2001 ;23(4): 229-246. 
214 160. 
161. 
Marcus  BH,  Rossi  JS,  Selby VC,  Niaura  RS,  Abrams  DB.  The  stages  and 
processes  of  exercise  adoption  and  maintenance  in  a  worksite  sample. 
Health Psychology 1992; 11 :  386-95. 
Jue NH,.Cunningham SL.  Stages of exercise behaviour change at two time 
periods  following  coronary  artery  bypass  graft  surgery.  Progress  in 
Cardiovascular Nursing 1998; 13:23-33. 
162.  Marcus BH,  Simkin LR,  Rossi JS,  Pinto BM.  Longitudinal shifts in employees 
stages  and  processes  of exercise  behaviour  change.  American Journal of 
Health Promotion 1996;10:195-200. 
163.  Marcus  BH,  Rakowski  W,  Rossi  JS.  Assessing  motivational  readiness  and 
decision making for exercise. Health Psychology 1992; 11: 257  -61. 
164.  Marcus  BH,.Owen  N.  Motivational  readiness,  self-efficacy  and  decision-
making for exercise. Journal of  Applied Social Psychology 1992;22:3-16. 
165.  Marcus  BH,  Banspach  SW,  Lefebvre  RC,  Rossi  JS,  Carleton  RA,  Abrams 
DB.  Using the stages of change  model to  increase the adoption of physical 
activity  among  community  participants.  American  Journal  of  Health 
Promotion 1992;6:424-9. 
166.  Marcus BH,  Emmons KM,  Simkin-Silverman LR,  Linnan LA, Taylor ER,  Bock 
BC  et al.  Evaluation of motivationally tailored vs  standard  self-help physical 
activity interventions at the workplace. American Journal of  Health Promotion 
1998;12:246-53. 
167.  Marcus  BH,  Bock BC,  Pinto  BM,  Forsyth  LH,  Roberts  MB,  Traficante  RM  . 
Efficacy  of  an  individualized,  motivationally-tailored  physical  activity 
intervention. Annals of  Behavioral Medicine 1998;20: 174-80. 
168.  Bock BC,  Marcus BH,  Pinto BM,  Forsyth LH.  Maintenance of physical activity 
following  an  individualized  motivationally  tailored  intervention.  Annals  of 
Behavioral Medicine 2001 ;23:79-87. 
169.  Goldstein  MG,  Pinto  BM,  Marcus  B.  Physician-based  physical  activity 
counseling  for middle-aged  and  older adults:  A randomised  controlled  trial. 
215 Annals of  Behavioral Medicine  1999;21:40-7. 
170.  Steptoe  A,  Doherty  S,  Rink  E,  Kerry  S,  Kendrick  T,  Hilton  S.  Behavioural 
counselling in general practice for the promotion of healthy behaviour among 
adults at increased  risk  of coronary  heart disease:  a randomised  controlled 
trial. British Medical Journal 1999;319:943-8. 
171.  Dunn AL, Marcus B,  Kampert J, Garcia ME , Kohl HW,  Blair SN. Comparison 
of  lifestyle  and  structured  interventions  to  increase  physical  activity  and 
cardiorespiratory fitness. JAMA 1999;281 :327-34. 
172.  Calfas  KJ,  Long  BJ,  Sallis JF,  Wooten WJ,  Pratt M,  Patrick  K.  A controlled 
trial  of physician  counseling  to  promote  the  adoption  of  physical  activity. 
Preventive Medicine 1996;25:225-33. 
173.  The Writing Group for the Activity Counseling Trial research group. Effects of 
physical  activity counseling  in  primary care.The Activity Counseling  Trial:  A 
randomized controlled trial. JAMA 2001 ;286:687. 
174.  Loughlan  C,.Mutrie  N.  Conducting  an  exercise  consultation:  Guidelines  for 
health professionals. Journal Institute of  Health Education 1995;33:78-82. 
175.  Loughlan  C,.Mutrie  N.  An  evaluation  of  the  effectiveness  of  three 
interventions in  promoting  physical activity in  a sedentary population.  Health 
Education Journal 1997;56:154-65. 
176.  Lowther  M,.Mutrie  N.  The  long-term  effect  of  two  physical  activity 
interventions on the physical activity levels of members of the general public 
who are not regularly active. Journal of  Sports Science 2000;18:17-8. 
177.  Kirk, A.  F.  Promoting and  maintaining physical activity in  people with Type 2 
diabetes. Thesis 2003.  University of Glasgow. 
178.  Hughes,  A.  R.,  Kirk,  A.  F.,  Mutrie,  N.,  and  Macintyre,  P.  D.  Exercise 
consultation improves exercise adherence in phase IV cardiac Rehabilitation. 
Journal of  Cardiopulmonary Rehabilitation 2003;22(6):421-425. 
179.  DeBusk RF,  Haskell WL, Miller N,  Berra K,  Taylor CB,  Berger WE.  Medically 
216 directed  at-home  rehabilitation  soon  after  clinically  uncomplicated  acute 
myocardial  infarction:  A  new  model  for  patient  care.  American  Joumal of 
Cardiology 1985;55:251-7. 
180.  Thompson  DR.  Cardiac  Rehabilitation:  How  can  it  improved?  Journal  of 
Psychosomatic Research 1995;39:519-23. 
181.  Brubaker PH,  Rejeski WJ, Smith MJ,  Sevensky KH,  Lamb KA,  Sotile WM. A 
home-based  maintenance  exercise  program  after  center-based  cardiac 
rehabilitation:  effects  on  blood  lipids,  body  composition  and  functional 
capacity. Journal of Cardiopulmonary Rehabilitation 2000;20:50-6. 
182.  Caspersen  C,  Powell  KE,  Christenson  GM.  Physical  activity,  exercise,  and 
physical  fitness:  Definitions  and  distinctions  for  health  related  research. 
Public Health Reports 1985;100:126-31. 
183.  Montoye HJ,  Kemper HCG, Saris WHM, Washburn RA.  Basic Principles and 
Laboratory Methods.  Measuring physical activity and energy expenditure, pp 
6-10. Human Kinetics,  1996. 
184.  Bland,  J.  M.  and Altman,  D.  G.  Statistical methods for assessing agreement 
between two methods of clinical measurement. Lancet 1986:1 :307-310. 
185.  Patterson,  P.  Reliability,  validity,  and  methodological  response  to  the 
assessment  of  physical  activity  via  self-report.  Research  Quarterly  for 
Exercise and Sport 2000;71(2):15-20. 
186.  Gretebeck,  R.  J. and  Montoye,  H.  J.  Variability of some objective measures 
of physical  activity.  Medicine  & Science  in  Sports  & Exercise  1992;24(10): 
1167-1172. 
187.  Chen,  K.  Y.  and Sun,  M.  Improving energy expenditure estimation by using a 
triaxial accelerometer. Journal of Applied Physiology 1997;83(6): 2112-2122. 
188.  Montoye  HJ,  Kemper  HCG,  Saris  WHM,  Washburn  RA.  Doubly  labeled 
water.  Measuirng physical activity and energy expenditure, pp 17-21. Human 
217 Kinetics, 1996. 
189.  Montoye  HJ,  Kemper  HCG,  Saris  WHM,  Wash  bum  RA.  Movement 
assessment devices. Measuring physical activity and energy expenditure, pp 
72-9. Human Kinetics, 1996. 
190.  Computer  Science  and  Applications  Inc.  Activity  monitor  operator's 
manual:ModeI7164.  2002. 
191.  Hendelman, D.,  Miller,  K.,  Baggett, C.,  Debold,  E.,  and  Freedson,  P.  Validity 
of accelerometry for the assessment of moderate intensity physical activity in 
the field. Medicine & Science in Sports &  Exercise 2000;32(9):S442-S449. 
192.  Fairweather, S.,  Reilly,  J.  J.,  Grant, S., Whittaker, A.,  and Paton, J.  Y.  Using 
the Computer Science and Applications  (CSA) activity monitor in  preschool 
children. Pediatric Exercise Science 1999;11 :413-420. 
193.  Melanson,  E.  and  Freedson,  P.  Validity  of  the  Computer  Science  and 
Applications,  Inc.  (CSA)  activity  monitor.  Medicine  & Science  in  Sports  & 
Exercise 1995;27(6):934-940. 
194.  Trost,  S.  G., Ward, D.  S.,  Moorehead, S.  M.,  Watson,  P.  D.,  Riner, W., and 
Burke, J.  R.  Validity of the computer science and  applications (CSA) activity 
monitor in children. Medicine & Science in Sports & Exercise 1998;30(4):629-
633. 
195.  Freedson,  P.,  Melanson,  E.,  and  Sirard,  J.  Calibration  of  the  Computer 
Science and Applications, Inc.  accelerometer.  Medicine & Science in  Sports 
& Exercise 1998;30(5):777-781. 
196.  Bassett, D.  R.,  Ainsworth, B.  E., Swartz, A.  M.,  Strath, S.  J., O'Brien, W. L., 
and  King,  G.  A.  Validity  of four  motion  sensors  in  measuring  moderate 
intensity  physical  activity.  Medicine  &  Science  in  Sports  &  Exercise 
2000;32(9):S471-S480. 
197.  Strath,  S.  J.,  Bassett,  D.  R.,  Swartz,  A.  M.,  and  Thompson,  D.  L. 
Simultaneous  heart  rate-motion  sensor  technique  to  estimate  energy 
expenditure.  Medicine  &  Science  in  sports  & Exercise  2001 ;33(12):2118-
218 2123. 
198.  Leenders,  N.  Y.  J.  M,  Sherman,  W.  M,  Nagaraja,  H.  N.,  and  Kien,  C.  L. 
Evaluation  of methods  to  assess  physical  activity  in  free-living  conditions. 
Medicine & Science in Sports &  Exercise 2001 ;  33(7): 1233-1240. 
199.  Ekelund,  U.  and  Sjostrom,  M.  Physical  activity assessed  by  activity  monitor 
and  doubly  labeled  water  in  children.  Medicine  &  Science  in  Sports  & 
Exercise 1999;31 (1 ):171-175. 
200.  Kochersberger,  G.,  McConnell,  E.,  Kuchibhatla,  M.  N.,  and  Pieper,  C.  The 
reliability, validity,  and stability of a measure of physical activity in the elderly. 
Arch Phys Med Rehabil1996;77:793-795. 
201.  Nichols,  J.  F.,  Morgan,  C.  G.,  Sarkin,  J.  A.,  Sallis,  J.  F.,  and  Calfas,  K.  J. 
Validity,  reliability,  and calibration of the Tritrac accelerometer as  a measure 
of physical activity. Medicine & Science in Sports & Exercise 1999;31 (6):908-
912. 
202.  Jakicic, J.  M., Winters, C.,  Lagally,  K.,  Ho,  J., Robertson,  R.  J.,  and Wing, R. 
R.  The  accuracy  of  the  Tritrac-R30  accelerometer  to  estimate  energy 
expenditure. Medicine & Science in Sports & Exercise 1999;31(5):747-754. 
203.  Welk,  G.  J.,  Blair,  S.  N.,  Wood,  K.,  Jones,  S.,  and  Thompson,  R.  A 
comparative  evaluation  of  three  accelerometry  based  physical  activity 
monitors. Medicine & Science in Sports &  Exercise 2000;32(9):S489-S497. 
204.  Meijer,  G.  A.,  Westerterp,  K.  R.,  Koper,  H.,  and  Hoor,  F.  T.  Assessment of 
energy expenditure by recording  heart rate and  body acceleration.  Medicine 
& Science in Sports & Exercise 1989;21(3):343-347. 
205.  Sherman, W.  M,  Morris,  D.  M.,  Kirby,  T.  E.,  Petosa,  R.  A.,  Smith,  B. A.,  Frid, 
D.  J.,  and  Leenders,  N.  Evaluation  of a commercial  accelerometer (Tritrac-
R3  D)  to  measure  energy  expenditure  during  ambulation.  International 
Journal of  Sports Medicine 1998;19:43-47. 
206.  Fehling  PC,  Smith  DL,  Warner  SE,  Oalsky  GP.  Comparison  of 
accelerometers  with  oxygen  consumption  in  older  adults  during  exercise. 
219 Medicine & Science in Sports & Exercise 1999;31(1):171-175. 
207.  Johnson  NA,.Helier RF.  Prediction  of patient  non-adherence to  with  home-
based exercise for cardiac rehabilitation:  The  role  of perceived  barriers and 
perceived benefits. Preventive Medicine 1998; 27: 56-64. 
208.  Eston,  R.  G.,  Rowlands,  A.  V.,  and  Ingledew,  D.  K.  Validity  of heart  rate, 
pedometry,  and  accelerometry  for  predicting  the  energy  cost  of  children's 
activities. Journal of  Applied Physiology 1998;84(1 ):362-371. 
209.  Bassett,  D.  R.,  Ainsworth,  B.  E.,  Leggett,  S.  R.,  Mathien,  C.  A.,  Main,  J.  A., 
Hunter,  D.  C.,  and  Duncan,  G.  E.  Accuracy of five electronic pedometers for 
measuring  distance  walked.  Medicine  &  Science  in  Sports  &  Exercise 
1996;28(8):1071-1077. 
210.  Montoye  HJ,  Kemper HCG,  Saris  WHM,  Washburn  RA.  Estimating  energy 
expenditure from physiologic response to activity.  Measuring physical activity 
and energy expenditure, pp 97-109. Human Kinetics,  1996. 
211.  Freedson,  P.  S.  and  Miller,  K.  Objective monitoring of physical activity using 
motion  sensors  and  heart  rate.  Research  Quarterly for Exercise  and Sport 
2000;71 (2):21-29. 
212.  Racette, S.  B., Schoeller,  D. A.,  and Kushner,  R.  F.  Comparison of heart rate 
and  physical  activity  recall  with  doubly  labeled  water  in  obese  women. 
Medicine & Science in Sports &  Exercise 1995;27(1):126-133. 
213.  Luke, A.,  Maki,  K.  C.,  Barkey,  N.,  Cooper,  R.,  and  McGee,  D.  Simultaneous 
monitoring of heart rate and motion to  assess energy expenditure.  Medicine 
& Science in Sports & Exercise 1997;29(1):144-148. 
214.  Spurr,  G.  B.,  Prentice, A.  M.,  Murgatroyd,  P.  R.,  Goldberg,  G.  R.,  Reina,  J. 
C.,  and  Christman,  N.  T.  Energy  expenditure from  minute-by  minute  heart 
rate  recording:  comparison  with  indirect  calorimetry.  American  Journal  of 
Clinical Nutrition 1988;48:552-559. 
215.  Livingstone,  M.  B.  E.,  Coward,  W.  A.,  Prentice,  A.  M.,  Davies,  P.  S.  W., 
St  'n  J  J  a  d  McKenna  P.  G.  Daily  energy  expenditure  in  free-living  ral,  .  .,  n  , 
220 children:  comparison  of heart rate  monitoring with  the doubly labeled water 
method. Am J Clin Nutr 1992;56:343-352. 
216.  Rennie,  K.  L.,  Hennings, S.  J.,  Mitchell,  J.,  and Wareham,  N.  J.  Estimating 
enrgy  expenditure  by  heart-rate  monitoring  without  individual  calibration. 
Medicine & Science in Sports & Exercise 2001 ;33(6):939-945. 
217.  Schutz  Y,  Weinsier  RL,  Hunter  GR.  Assessment  of  free  living  physical 
activity  in  humans:  An  overview  of currently  available  and  proposed  new 
measures. Obesity Research 2001 ;9:368-79. 
218.  Montoye HJ,  Kemper HCG, Saris WHM, Washburn RA.  Questionnaires and 
interviews.  Measuring Physical Activity and Energy Expenditure,  pp 42-56. 
Human Kinetics, 1996. 
219.  Sallis, J.  F.  and Saelens, B.  E.  Assessment of physical activity by self-report: 
Status, limitations and future directions. Research Quarterly for Exercise and 
Sport 2000; 71 (2): 1-14. 
220.  Blair, S.  N.,  Haskell, W. L.,  Ho,  P.,  Paffenbarger, R.  S., Vranizan, K.  M., and 
Farquhar,  J.  W.  Assessment of habitual  physical  activity  by  a  seven  day 
recall  in  a community survey and  controlled experiments.  American Journal 
of  Epidemiology 1985;122:794-804. 
221.  Riki,  R.  E.  Reliability, validity and methodological issues in assessing physical 
activity  in  older  adults.  Research  Quarterly  for  Exercise  and  Sport 
2000;71 (2):89-96. 
222.  Pereira,  M.  A.,  Fitzgerald,  S.  J.,  Gregg,  E.  W.,  Joswiak,  M.  L.,  Ryan,  W.  J., 
and Suminski,  R.  R.  Seven-Day physical activity recall.  Medicine & Science 
in Sports & Exercise 1997;29(6):S89-S103. 
223.  Duncan, G.  E.,  Sydeman, S.  J.,  Perri, M.  G., Limacher, M.  C.,  and Martin, A. 
D.  Can  sedentary  adults  accurately  recall  the  intensity  of  their  physical 
activity. Preventive Medicine 2001 ;33: 18-26. 
224.  Williams, E.,  Kleges, R,  Hanson, C.  L.,  and Eck,  L.  H. A prospective study of 
the reliability and convergent validity of three physical activity measures in  a 
221 225. 
field research trial. Journal of Clinical Epidemiology 1989;42(12):1161-1170. 
Gross,  L.  D.,  Sallis,  J.  F.,  Buono,  M.  J.,  and  Roby,  J.  J.  Reliability  of 
interviewers using the seven-day phYSical  activity recall.  Research Quarterly 
for Exercise and Sport 1990;61 (4):321-325. 
226.  Sallis,  J.  F.,  Haskell, W. L.,  Wood,  P.  D.,  Fortmann,  S.  P.,  Rogers,  T.,  and 
Blair,  S.  N.  PhYSical  activity assessment methodology in  the five-city project. 
American Journal of Epidemiology 1985;121(1):91-106. 
227.  Jacobs,  D.  R.,  Ainsworth,  B.  E.,  Hartman,  T.  J.,  and  Leon,  A.  S.  A 
simultaneous  evaluation  of  10  commonly  used  physical  activity 
questionnaires. Medicine & Science in Sports &  Exercise 1993;25(1):81-91. 
228.  Richardson  MT,  Ainsworth  BE,  Jacobs  DR,  Leon  AS.  Validation  of  the 
Stanford  7  -Day  Recall  to  assess  habitual  physical  activity.  Ann  Epidemiol 
2001 ;11 :145-53. 
229.  Baranowski  T.  Validity  and  reliability  of  self-report  measures  of  physical 
activity:  An  information-processing  perspective.  Research  Quarterly  for 
Exercise and Sport 1988;59:314-27. 
230.  Bonnefoy  M,  Normand  S,  Pachiaudi  C,  Lacour  JR,  Laville  M,  Kostka  T. 
Simultaneous validation of ten physical activity questionnaires in  older men: 
A doubly labeled water study. JAm Geriatr Soc 2001 ;49:28-35. 
231.  Conway, J.  M.,  Seale, J.  L.,  Jacobs,  D.  R.,  Irwin,  M.  L.,  and Ainsworth,  B.  E. 
Comparison of energy expenditure estimates from  doubly  labeled water,  a 
physical activity questionnaire and physical activity records. American Journal 
of Clinical Nutrition 2002;75(3):519-525. 
232.  Irwin,  M.  L.,  Ainsworth,  B.  E.,  and  Conway,  J.  M.  Estimation  of  energy 
expenditure  from  physical  activity  measures:  Determinants  of  accuracy. 
Obesity Research 2001 ;9(9):517-525. 
233.  Leenders,  N.  Y.  J.  M,  Sherman, W. M,  and Nagaraja, H.  N.  Comparisons of 
four  methods  of estimating  physical  activity  in  adult  women.  Medicine  & 
222 234. 
Science in Sports & Exercise 2000;32(7):1320-1326. 
Taylor,  C.  B,  Coffey, T.,  Berra,  K.,  laffaldano,  R.,  Casey,  K.,  and Haskell, W. 
L.  Seven-day  activity  and  self-report  compared  to  a  direct  measure  of 
physical activity. American Journal of  Epidemiology 1984;120:818-824. 
235.  Fletcher GJ,  Balady GJ,  Froelicher V,  Hartley  LH,  Haskell WL,  Pollock ML. 
Exercise  Standards:  A  statement  for  healthcare  professionals  from  the 
American Heart Association. Circulation 1995;91 :580-615. 
236.  American College of Sports Medicine. ACSM's guidelines for exercise testing 
and prescription. Williams and Wilkins, 1995. 
237.  ESC  Working  Group  on  Exercise  Physiology  PaE.  Guidelines  for  cardiac 
exercise testing. European Heart Journal 1993;14:969-88. 
238.  Beaver WL, Wasserman K,  Whipp BJ. A new method for detecting anaerobic 
threshold by gas exchange. J Appl Physio/1986;60:2020-7. 
239.  Zigmond  AS,.Snaith  RP.  The  hospital  anxiety  and  depression  scale.  Acta 
Psychiatr Scand 1983;67:361-70. 
240.  Snaith  RP,  Zigmond  AS.  The  hospital  anxiety  and  depression  scale. 
Berkshire: NFER-NELSON, 1994. 
241.  Herrmann  C.  International  experiences  with  the  hospital  anxiety  and 
depression scale:  a review of validation  data  and  clinical  results.  Journal of 
Psychosomatic Research 1997;42: 17-41. 
242.  Visser MC,  Koudstaal PJ,  Erdman  RAM,  Deckers JW,  Passchier J,  Gijn JV. 
Measuring  quality  of life  in  patients  with  myocardial  infarction  or  stroke:  a 
feasibility  study  of  four  questionnaires  in  The  Netherlands.  Journal  of 
Epidemiology and Community Health 1995;49:513-7. 
243.  Johnston  M,  Pollard  B,  Hennessey  P.  Construct  validation  of the  hospital 
anxiety  and  depression  scale  with  clinical  populations.  Journal  of 
Psychosomatic Research 2000;48:579-84. 
223 244.  Bjelland  I,  Dahl  AA,  Haug  TI, Neckelmann  D.  The  validity  of the  Hospital 
Anxiety and Depression Scale: An updated review. Journal of  Psychosomatic 
Research 2002;52:69-77. 
245.  Crawford JR, Henry JD,  Crombie C, Taylor EP.  Normative data for the HADS 
from  a  large  non-clinical  sample.  British  Journal  of Clinical  Psychology 
2001 ;40:429-34. 
246.  McGhee HM,  Hevey D,  Horgan JH.  Psychosocial outcome assessments for 
use in  cardiac rehabilitation service evaluation:  a 10-year systematic review. 
Social Science and Medicine 1999;48: 1373-93. 
247.  Hevey,  D.  and  McGhee,  H.  M.  Responsiveness of psychosocial instruments 
to  multifactorial  cardiac  rehabilitation.  Hughes,  A.  R.  Personal 
Communication 20-6-2000. 
248.  AACVPR  outcome  committee.  Outcome  measurement  in  cardiac  and 
pulmona-ry  rehabilitation.  Journal  of  Cardiopulmonary  Rehabilitation 
1995;15:394-405. 
249.  Smith  HJ,  Taylor  R,  Mitchell  A.  A  comparison  of  four  quality  of  life 
instruments  in  cardiac  patients:  SF-36,  QU,  QLMI,  and  SEIQoL.  Heart 
2000;84:390-4. 
250.  Spertus  J,  Winder JA,  Dewhurst  T,  Deyo  RA,  Prodzinski  J,  McDonell  M. 
Development  and  evaluation  of the  Seattle  Angina  Questionnaire:  A  new 
functional  status  measure  for  coronary  artery  disease.  Journal  of  the 
American College of  Cardiology 1995;25:333-41. 
251.  Dempster  M,.Donnelly  M.  Measuring  the  health  related  quality  of  life  of 
people with ischaemic heart disease. Heart 2000;83:641-4. 
252.  Evidence  regarding  the  validity,  reliability,  and  responsiveness  of  health 
related  quality  of  life  instruments  among  people  with  ischaemic  heart 
disease. Heart 2002. 
253.  Brown N,  Melville M, Gray D,  Young T,  Skene AM,  Hampton JR. Comparison 
of the SF-36 health survey questionnaire with the Nottingham Health Profile 
224 in  long-term  survivors  of a  myocardial  infarction.  Journal of Public  Health 
Medicine 2000;22:167-75. 
254.  Jette  DU,.Downing  J.  Health  status  of  individuals  entering  a  cardiac 
rehabilitation program as  measured by the medical outcomes study 36-item 
short-form survey (SF-36). Physical Therapy 1994;74:521-7. 
255.  Marquis  P,  Fayol  C,  Joire  JE.  Clinical  validation  of  a  quality  of  life 
questionnaire  in  angina  pectoris  patients.  European  Heart  Journal 
1995;16: 1554-60. 
256.  Wolinsky  FD,  Wyrwich  KW,  Nienaber  NA,  Tierney  WM.  Generic  versus 
disease-specific health status measures: An  example using  coronary artery 
disease  and  congestive  heart  failure  patients.  Evaluation  and  the  Health 
Professionals 1998;21 :216-43. 
257.  Dougherty  CM,  Dewhurst  T,  Nichol  WP,  Spertus  J.  Comparison  of three 
quality  of  life  instruments  in  stable  angina  pectoris:  Seattle  Angina 
Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-
Cardiac Version"  I.  Journal of  Clinical Epidemiology 1998;51 :569-75. 
258.  Brown N,  Melville M,  Gray D,  Young  T,  Munro J,  Skene AM.  Quality of life 
four years after acute myocardial infarction: short form 36 scores compared 
with a normal population. Heart 1999;81 :352-8. 
259.  Jenkinson C,  Stewart-Brown S,  Petersen S,  Paice C. Assessment of the SF-
36 version 2 in the United Kingdom. Journal of  Epidemiology and Community 
Health 1999;53:46-50. 
260.  Loughlan,  C.  and  Mutrie,  N.  Recruitment  of  sedentary  NHS  staff  for  a 
workplace exercise programme using an  adapted stages of change exercise 
questionnaire. Journal of  Sports Science 1995; 13:63-64. 
261.  Jenkinson,  C.,  Layte,  R.,  Wright,  L.,  and  Coulter,  A.  The  UK  SF-36:  An 
analysis and interpretation manual.  1996. Oxford, Health Services Research 
Unit. 
262.  Florey, C.  Sample size for beginners. British Medical Journal 1993;306:1181-
225 1184. 
263.  Kirk  AF,  Higgins  LA,  Hughes  AR,  Fisher  BM,  Mutrie  N,  Hillis  S  et  a/.  A 
randomized, controlled trial to study the effect of exercise consultation on the 
promotion of physical  activity in  people with  Type 2 diabetes:  a pilot study. 
Diabetic Medicine 2001 ;18:877-82. 
264.  Rose,  D.  and  O'Reilly,  K.  The  ESRC  Review  of  Government  Social 
Classification.  1998. Essex,  Office for National Statistics and  Economic and 
Social Research Council. 
265.  Mutrie,  N.  Exercise  Consultation.  1999.  University  of  Glasgow,  Media 
Services. Video Recording 
266.  British Heart Foundation. Physical activity and your heart. 1999 
267.  Marcus,  B.  H.,  Selby, V.  C.,  Niaura, R.  S.,  and Rossi,  J.  S.  Self-efficacy and 
the  stages of exercise  behaviour change.  Research  Quarterly for Exercise 
and Sport 1992;63:60-66. 
268.  Lowther, M. The effects of a fitness assessment and exercise consultation on 
physical  activity  intention  and  behaviour  in  a  socially  and  economically 
deprived  community:  an  application  of  the  transtheoretical  model  of 
behaviour change.  2000.  University of Glasgow. Thesis 
269.  Kirk,  A.  F.,  Hughes,  A.  R.,  Tait,  A.,  Thomson,  T.,  and  Macintyre,  P.  D. 
Physical  assessment  in  clinical  populations  in  Scotland.  Medicine  and 
Science in Sport and Exercise 2001 ;33(5):S56. 
270.  McLaughlin, J.  E.,  King, G. A., Howley, E.  T.,  Bassett, D.  R.,  and Ainsworth, 
B.  E.  Validation of the Cosmed K4b
2 portable metabolic system. International 
Journal of  Sports Medicine 2001 ;22:280-284. 
271.  Parr,  B.  B.,  Strath, S.  J.,  Bassett,  D.  R.,  and Howley,  E.  T.  Validation of the 
Cosmed K4b2  portable metabolic measurement system. Medicine & Science 
in Sports & Exercise 2002;S300. 
272.  Crowe,  A.  Validation  of the  Cosmed  K4b
2  for  measuring  gas  exchange  in 
226 cardiac rehabilitation participants. 2002 University of Glasgow. Thesis 
273.  MacFarlane,  D.  J.  Automated  metabolic  gas  analysis  systems:  A  review. 
Sports Medicine 2001 ;31(12):841-861. 
274.  Cosmed. Cosmed K4b
2 user manual. Third Edition.  1998. Italy. 
275.  Neder,  A.  Exercise  testing  protocol  for  cardiac  rehabilitation  patients. 
Personal Communication 1999. 
276.  Ward,  S.  and  Neder,  A.  Procedures  for  determining  the  lactate  threshold 
using  the  V-slope  and  ventilatory  equivalent  methods.  Personal 
Communication 1999. 
277.  Rodgers  WM,  Courneya  KS,  Sayduza  AL.  Examination  of  the 
transtheoretical  model  in  exercise  in  3  populations.  American  Journal  of 
Health Behaviour 2001 ;25:33-41. 
278.  Friedewald,  W.  T.,  Levy,  R.  I.,  and  Fredrickson,  D.  S.  Estimation  of the 
concentration of lOW-density lipoprotein cholesterol  in  plasma,  without use of 
the preparation ultracentrifuge. Clinical Chemistry 1972; 18:499-502. 
279.  Lowther M,  Mutrie N,  Loughlan  C,  McFarlane C.  Development of a Scottish 
physical activity questionnaire: A tool for use in physical activity interventions. 
British Journal of  Sports Medicine 1999;33:244-9. 
280.  Milani  RV,.Lavie CJ.  The effects of body  composition  changes to  observed 
improvements  in  cardiopulmonary  parameters  after  exercise  training  with 
cardiac rehabilitation. Chest 1998;113:599-601. 
281.  Brubaker PH,  Warner JG,  Rejeski  WJ,  Edwards  DG,  Matrazzo  SA,  Ribisl 
PM.  Comparison  of standard  and  extended  length  participation  in  cardiac 
rehabilitation  on  body  composition,  functional  capacity,  and  blood  lipids. 
American Journal of  Cardiology 1996;78:769-73. 
282.  Vanhees  L,  Fagard  R,  Lutgarde  T,  Amery  A.  Prognostic  value  of training-
induced  change  in  peak  exercise  capacity  in  patients  with  myocardial 
infarcts and  patients with  coronary artery bypass surgery.  American Joumal 
227 of  Cardiology 1995;76:1014-9. 
283.  Kavanagh  T,  Mertens  OJ,  Hamm  L,  Beyene  J,  Kennedy  J,  Corey  P. 
Prediction  of  long-term  prognosis  in  12169  men  referred  for  cardiac 
rehabilitation. Circulation 2002;106:666-71. 
284.  Dorn  J,  Naughton  J,  Imamura  0,  Trevisan  M.  Results  of  a  multicenter 
randomised  clinical  trial  of exercise  and  long-term  survival  in  myocardial 
infarction  patients:  The  National  Exercise  and  Heart  Disease  Project. 
Circulation 1999;100: 1764-9. 
285.  Cheuk-Man Y,  Chu-Pak L,  Cheung B,  Vee-Man F,  Ho Y,  Kam-Bik L.  Clinical 
predictors of morbidity and mortality in  patients with myocardial infarction or 
revascularisation  who  underwent  cardiac  rehabilitation,  and  importance  of 
diabetes  mellitus  and  exercise  capacity.  American  Journal  of Cardiology 
2000;85:344-9. 
286.  Hevey  0,  Brown  A,  Cahill  A,  Newton  H,  Kierns  M,  Horgan  J.  Four-week 
multidisciplinary  cardiac  rehabilitation  produces  similar  improvements  in 
exercise  capacity  and  quality  of life  to  a  10-week programme.  Journal  of 
Cardiopulmonary Rehabilitation 2003;23:17-21. 
287.  Underwood,  S.  J.,  Barlow,  C.  E.,  Chandler,  J.  L.,  Kampert,  J.,  Dunn,  A.  L., 
and Blair, S.  N.  Project Prime: 6 month changes in physical activity. Medicine 
and Science in Sport and Exercise 2000;32;97. 
228 APPENDIX A 
0141  842 7266 
Elizabeth I-Iutchenson 
0141  8427308 
Dr Paul MacIntyre 
Consultant Physician and Cardiologist 
Argyll and Clyde Acute Hospitals NHS Trust 
Royal Alexandra Hospital 
Corsebar Road 
PAISLEY 
PA29PN 
Dear Dr MacIntyre 
LREC 5/99 
--1-th July 2000 
THE  EFFECT  OF  AN  EXERCISE  CONSULTATION  ON  EXERCISE 
ADHERENCE IN PHASE IV CARDIAC REHABILITATION 
Many thanks for submitting an amendment to the above protocol. The committee reviwed 
this on the 5th July, 2000 and are happy to grant approval. 
A list of Conunittee members present at meeting held on 19th January 2000 is appended. 
Yours sincerely 
J.J. Morrice F.R.C.S. 
Chairman 
LOCAL RESEARCH ETHICS COMMITTEE 
c: \:-\DIU&'lNE\  11,esis \_\ppendices  \P1II()\ ()2.  \[2J.doc 
229 APPENDIX 8 
CARDIAC REHABILITATION RESEARCH 
FORM OF INFORMATION AND CONSENT 
Title of  Research 
Physical activity levels in a group of  cardiac rehabilitation patients 
Summary 
We  i~:ite. you  t? take  part  in  a  study  looking  at  physical  activity  in  a  group  of cardiac 
reh.a~lhtatlOn ~atlents.  This study will allow you to learn more about the benefits of physical 
activIty and wIll provide regular medical check-ups over one year as part of  your rehabilitation. 
If  you agree to take part, you will be asked to visit the Royal Alexandra Hospital between 6 and 
8 times over the course of 1 year.  These visits will  last 30 to  60 minutes: the details of each 
visit are described in more detail below. 
Visit 1: Total duration Ihour. 
During visit one you will be asked to complete a personal health questionnaire and your weight 
and height will be measured.  You will also be asked to perform an exercise test, which will last 
approximately 10 minutes.  We will assess your exercise performance by asking you to exercise 
on a treadmiII and measuring the amount of oxygen you use.  During the test, we will monitor 
your heart rate using an ECG and measure your blood pressure by an  inflation cuff.  We  will 
measure your breathing during the exercise test by asking you to breathe through a mouthpiece. 
You will be asked to keep exercising until you can no longer continue.  The test will be stopped 
if you develop chest pain or if there are changes on the ECG. You wi II  also be given a small 
monitor about the size of  a 50p piece, which you will be asked to wear on your ankle. This will 
record the amount of physical activity you do. The researcher will show you how to attach the 
monitor and instruct you to wear it  during all waking hours (except during bathing or other 
water activities) for 7 days immediately after the first visit. 
You will be asked to return for visit 2 one week after your first visit. 
Visit 2: Total duration 30 minutes. 
During this visit, a  blood sample will be taken from your arm.  A fasting blood sample is 
required, therefore you will be asked to refrain from eating for  12  hours before your visit. 
Breakfast will be provided after you have given the sample. During this visit you will return 
the activity monitor and the researcher will ask you about your physical activity during the 
previous 7 monitored days. You will also be asked to complete a questionnaire about your 
present exercise habits. 
You may be asked to return for a third visit within 7 days after visit 2. 
Visit 3: Total duration 30 minutes. 
This visit involves a discussion with the research assistant on exercise. You will also receive a 
telephone call phone call 3 months after this visit. 
Six and  12  months after visit 3, you will be asked to return to the Royal Alexandra Hospital 
where the procedures carried out during visits 1,  2 and 3 will be repeated. Visit 3 will not be 
230 repeated at 1 year. 
Final Points to Note 
If  you do not wish to participate, it will not affect your current or future medical treatment in 
anyway.  You  are  free  to  withdraw  from  the  study  at  any  point  without  providing  any 
explanation and with no obligation. Should you decide to take part your GP will be informed. 
The only people who will have access to your results with be  those involved  in  the testing 
and analysis of the data.  It is  possible that the results of this study will  be  published  in  a 
medical journal. Although your own results will be part of any publication your identity will 
not be disclosed at any point. If you are,  or are likely to become pregnant, you should not 
participate in this study.  If  you are harmed by taking part in this research, there is no special 
compensation arrangements. If you are harmed due to  someone' s negligence, then you may 
have grounds for legal action but you may have to pay for it.  Regardless of this, if you wish 
to complain about any aspect of the way you have  been  approached or treated during the 
course of  this study, the normal National Health complaints mechanism is available to you. 
If  you have any questions about the study or need to contact us for any reason, please use any of 
the following means: 
Adrienne Hughes, Research assistant, L5  North, RAH,  Paisley.  0141  580  4628 or 0141  330 
2830 
Dr Paul MacIntyre, Consultant Cardiologist: L5 North, RAH, Paisley. 0141  5804628 
Consent: 
I, .....................................................................................................  . 
give my consent to the research procedures  de~cribed above, the nature, purpose and 
possible consequences of  which have been descnbed. 
SIgned·  ........ .  =_ ..  ' .........................................  . 
Date: .........................................  . 
WItness .................... ····························  ... . 
~=~ 
Date: .........................................  . 
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EXERCISE CONSULTATION 
•  Current  physical  activity  status  (summarise  from  7  -day  recall  and  Stage  of 
Change) 
Decisional Balance Table 
Benefits/Pros  Barriers/Cons 
•  Problem solving barriers/cons of physical activity 
•  Review current physical activity guidelines 
•  Past physical activity Status 
•  Possible activities 
•  High risk situations for lapse/relapse 
•  Plan to to cope with these situations . 
•  Sources of support for physical activity. 
Goals 
One Month  Three Month  Six Month 
232 APPENDIX D 
ACTIVITY MONITOR INFORMATION 
•  THE ACTIVITY MONITOR IS  NOT WATERPROOF,  HOWEVER, SMALL 
WATER SPLASHES WILL NOT CAUSE ANY  DAMAGE. YOU  WILL  HAVE 
TO TAKE THE MONITOR OFF  TO  BATHE,  SWIM  OR  SHOWER.  PLEASE 
RECORD THE TIME YOUR REMOVE AND  RE-ATTACH THE  MONITOR ON 
THE BACK OF THIS SHEET. 
•  THE  ACTIVITY  MONITOR  SHOULD  BE  WORN  ON  YOUR  ANKLE 
ABOVE YOUR ANKLE  BONE.  USE  THE  STRAP  PROVIDED,  AND  MAKE 
SURE THE ARROW IS POINTING UPWARD. 
•  WEAR THE MONITOR DURING ALL WAKING HOURS,  EXCEPT WHEN 
BATHING.  LEAVE  THE  MONITOR  IN  PLACE  UNTIL  YOU  GO  TO  BED. 
WHEN YOU TAKE THE MONITOR OFF RECORD THE TIME ON THE BACK 
OF  THIS  SHEET.  ON  WAKING  IN  THE  MORNING,  REATTACH  THE 
MONITOR  TO  YOUR  ANKLE  IMMEDIATELY.  RECORD  THE  TIME  OF 
REATTACHMENT ON  THE BACK OF  THIS  SHEET.  CONTINUE WEARING 
THE MONITOR IN THIS MANNER EVERY DAY UNTIL YOUR NEXT VISIT. 
•  AS  THESE  TOP-OF-THE-RANGE  MONITORS  ARE  EXPENSIVE, YOU 
ARE ASKED TO TAKE VERY GOOD CARE OF THEM. 
•  PLEASE  RECORD  ANY  DAY  AND  TIME  THE  ACTIVITY  MONITOR  IS 
NOT WORN ON THE BACK OF THIS SHEET. 
2.33 RECORD FOR ACTIVITY MONITOR 
Please be as accurate as possible with this record 
SLEEPING 
DAY  MONITOR ATTACHED  MONITOR REMOVED 
Example 
Tuesday  9.05am  10.16pm 
BATHING OR SWIMMING 
DAY  MONITOR ATTACHED  MONITOR REMOVED 
I 
ANY PROBLEMS WITH ACTIVITY MONITOR 
DAY  REASON  MONITOR  MONITOR 
ATTACHED  REMOVED 
I 
I 
~ 
, 
! 
-------~ . 
_ ..  .  -
---- - ----APPENDIX E 
PHYSICAL  ACTIVITY  RECORDING SHEET 
Please keep a record of any activities you do over the following week. 
However, only record activities that are of a MODERATE INTENSITY 
OR  ABOVE. Moderate intensity activities require about the same effort 
as a brisk walk. 
DAY 
e.g. Monday 
TYPE  OF  ACTIVITY  & DURATION 
Attended an exercise class lasting 30 minutes. 
---- -~~---
GU,SGOVV 
UNIVERSITY 
BRARY 
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